Symbol	Test	Control
p_10006_1	"large airways, smoker, lung; tissue"	"large airways, non-smoker, lung"
p_10006_2	"small airways, chronic obstructive pulmonary disease (COPD), lung; tissue"	"small airways, non-smoker, lung"
p_10006_3	"small airways, smoker, lung; tissue"	"small airways, non-smoker, lung"
p_10006_4	"small airways, early-chronic obstructive pulmonary disease (COPD), lung; tissue"	"small airways, non-smoker, lung"
p_10041_1	"Healthy subject, 8 weeks of relaxation response practice"	"healthy subject, No relaxation response practice"
p_10041_2	Long-term practitioner of daily relaxation response practice	"healthy subject, No relaxation response practice"
p_10046_2	"MCF10A cell, co-cultured with breast cancer tissue"	"MCF10A cell, control"
p_10046_3	"MCF10A, with breast cancer fibroblast treated"	"MCF10A, with normal breast fibroblast"
p_10063_1	"MSK-Leuk1 cells, Tobacco Smoke treated, 0.5h"	"MSK-Leuk1 cells, control, 0.5h"
p_10063_2	"MSK-Leuk1 cells, Tabacco Smoke treated, 3h"	"MSK-Leuk1 cells, control, 3h"
p_10063_3	"MSK-Leuk1 cells, Tabacco Smoke treated, 6h"	"MSK-Leuk1 cells, control, 6h"
p_10063_4	"MSK-Leuk1 cells, Tabacco Smoke treated, 12h"	"MSK-Leuk1 cells, control, 12h"
p_10063_5	"MSK-Leuk1 cells, Tabacco Smoke treated, 24h"	"MSK-Leuk1 cells, control, 24h"
p_10070_1	"MCF10A cell, Transwell treated, 1d"	"MCF10A cell, control"
p_10070_2	"MCF10A cell, Transwell treated, 2d"	"MCF10A cell, control"
p_10070_3	"MCF10A cell, Transwell treated, 3d"	"MCF10A cell, control"
p_10138_1	"CLL lymphocytes, Chronic lymphocytic leukemia, progressive disease"	"CLL lymphocytes, Chronic lymphocytic leukemia, stable disease"
p_10147_1	"pDC, IL-3 + p17 treated"	"pDC, IL-3 treated"
p_10147_2	"pDC, IL-3 + CpG treated"	"pDC, IL-3 treated"
p_10178_1	CD8+ CCR7- NKp80+ T cells	CD8+ CCR7- NKp80- T cells
p_10196_1	"MCF10A, YAP-overexpressing cells"	"MCF10A, control"
p_10232_1	"Jurkat cell line, cyclin T1 knockdown, PMA treated"	"Jurkat cell line, control shRNA-transduced, PMA treated"
p_10234_1	"MM6 cell line, cyclin T1 knockdown, LPS treated"	"Jurkat cell line, control shRNA-transduced, Mock treated"
p_10245_1	"NSCLC, adenocarcinoma"	"NSCLC, squamous cell carcinoma"
p_10270_1	"Breast epithelial cells treated with 17-beta estradiol (E2), progesterone (PG)"	"Breast epithelial cells, 17-beta estradiol (E2)"
p_10270_2	"Breast epithelial cells treated with 17-beta estradiol (E2), progesterone (PG), bisphenol A"	"Breast epithelial cells, 17-beta estradiol (E2)"
p_10281_1	"breast tumor, Letrozole treated, 2.5mg/day,oral, 3 months"	"breast tumor, pre-treatement"
p_10282_1	Braf mutant melanoma; skin cancer	Braf wild-type melanoma; skin cancer
p_10282_2	Nras mutant mleanoma; skin cancer	Nras wild-type mleanoma; skin cancer
p_10289_1	"Hep3B cells, transfected with plasmid siSDHB (SDHB siRNA containing vector)"	"Hep3B cells, transfected with plasmid pU6"
p_10299_1	"SQ20B cells, Go6976 treated, 12h"	"SQ20B cells, control"
p_10299_2	"SQ20B cells, Go6976 treated, 24h"	"SQ20B cells, control"
p_10309_1	"CL1-5 cell, CLDN1 overexpressed"	"CL1-5 cell, control"
p_10311_1	"Primary human osteoblast like cells (HOb), BMP2 induced, 2h"	"Primary human osteoblast like cells (HOb), untreated, 2h"
p_10311_2	"Primary human osteoblast like cells (HOb), BMP2 induced, 24h"	"Primary human osteoblast like cells (HOb), untreated, 24h"
p_10311_3	"Primary human osteoblast like cells (HOb), dexamethasone induced, 2h"	"Primary human osteoblast like cells (HOb), untreated, 2h"
p_10311_4	"Primary human osteoblast like cells (HOb), dexamethasone induced, 24h"	"Primary human osteoblast like cells (HOb), untreated, 24h"
p_10311_5	osteoblast HOb514 untreated 24h; time course	HOb506_untreated_24h
p_10313_1	"Lymphoblastoid cell line, MNNG treated"	"Lymphoblastoid cell line, control"
p_10315_1	"BM-MSC, BMP2-stimulated, day1"	"BM-MSC, unstimulated, control"
p_10315_2	"BM-MSC, BMP2-stimulated, day3"	"BM-MSC, unstimulated, control"
p_10315_3	"BM-MSC, BMP2-stimulated, day7"	"BM-MSC, unstimulated, control"
p_10315_4	"BM-MSC, BMP2-stimulated, day21"	"BM-MSC, unstimulated, control"
p_10315_5	"BM-MSC, TGFb3 -stimulated, day1"	"BM-MSC, unstimulated, control"
p_10315_6	"BM-MSC, TGFb3 -stimulated, day3"	"BM-MSC, unstimulated, control"
p_10315_7	"BM-MSC, TGFb3 -stimulated, day7"	"BM-MSC, unstimulated, control"
p_10315_8	"BM-MSC, TGFb3 -stimulated, day21"	"BM-MSC, unstimulated, control"
p_10316_11	"Dendritic cells, Schuler treated, 8h"	"Immature dendritic cells, unstimulated"
p_10316_2	"Dendritic cells , LPS treated, 8h"	"Immature dendritic cells, unstimulated"
p_10316_5	"Dendritic cells, CD40L treated, 8h"	"Immature dendritic cells, unstimulated"
p_10316_8	"Dendritic cells, Poly(I:C) treated, 8h"	"Immature dendritic cells, unstimulated"
p_10317_1	Parathyroid Tumour	Normal Parathyroid Tissue
p_10327_1	desmoplastic medulloblastoma; brain cancer	classic medulloblastoma
p_10334_1	"Gingival tissue, Affected site"	"Gingival tissue, Unaffected site"
p_10406_1	Sinus mucosa tissue from cystic fibrosis-patient with chronic rhinosinusitis	Normal sinus mucosa tissue
p_10406_2	Sinus mucosa tissue from the cystic fibrosis patient	Normal sinus mucosa tissue
p_10406_3	Sinus mucosa tissue from patient with chronic rhinosinusitis	Normal sinus mucosa tissue
p_10410_2	"hepatocyte, Myclobutanil, 30uM"	"hepatocyte, DMSO 0.001, control"
p_10410_5	"hepatocyte, Propiconazole, 30uM"	"hepatocyte, PB 1000uM, positive control"
p_10410_8	"hepatocyte, Triadimefon, 30uM"	"hepatocyte, Rifampicin 30uM, positive control"
p_10437_1	"CD4+ Tcell, activated"	"CD4+ Tcell, resting"
p_10444_1	"dental pulp cells, passage 10"	"dental pulp cells, passage 4"
p_10463_1	"hMoDC, VAF347 stimulated, 8h"	"hMoDC, control, 8h"
p_10479_1	"HUVEC, bg-CAT treated"	"HUVEC, control"
p_10508_1	"Tesi cells, tetracycline treated"	"Tesi cells, control"
p_10520_1	"U937 cells, expressing AML1/ETO"	"U937 cells, empty vector"
p_10524_1	Testicular DLBCL	Central nervous system DLBCL
p_10524_2	Nodal DLBCL	Central nervous system DLBCL
p_10524_3	Nodal DLBCL	Testicular DLBCL
p_10575_1	Chondrogenic progenitor cells from Osteoarthritis; tissue	Healthy chondrocytes
p_10580_1	"U2OS cells, HA-tagged PRDM5 expression (doxycycline induced), 8h"	"U2OS cells, empty vector, doxycycline induced, 8h"
p_10580_2	"U2OS cells, HA-tagged PRDM5 expression (doxycycline induced), 24h"	"U2OS cells, empty vector, doxycycline induced, 24h"
p_10580_3	"U2OS cells, HA-tagged PRDM5 expression (doxycycline induced), 48h"	"U2OS cells, empty vector, doxycycline induced, 48h"
p_10585_1	"M12 cell, UV treated"	"M12 cell, control"
p_10586_1	Recent-onset T1D; Treg cells; blood tissue	Healthy control
p_10591_1	"HepG2 cells, Tmprss6 transfection"	"HepG2 cells, empty vector"
p_10591_2	"HepG2 cells, Mutant Tmprss6 transfection"	"HepG2 cells, empty vector"
p_10592_2	"HBE cell, PBS treated, 24h"	"HBE cell, control"
p_10592_4	"HBE cell, SMM treated, 24h"	"HBE cell, control"
p_10592_6	"HBE cell, AZIT treated, 24h"	"HBE cell, control"
p_10592_9	"HBE cell, AZIT treated, 72h, SMM treated, 24h"	"HBE cell, control"
p_10595_1	"HS5 cell, MO co-cultured"	"HS5 cell, control"
p_10595_2	"HS27a cell, MO co-cultured"	"HS27a cell, control"
p_10609_4	"T-acute lymphoblastic leukemia, HOX11L2; blood cancer"	"T-acute lymphoblastic leukemia, TAL1"
p_10609_5	"T-acute lymphoblastic leukemia, Unknown; blood cancer"	"T-acute lymphoblastic leukemia, TAL1"
p_10616_1	"colon, only crohn's disease; tissue"	"colon, healthy control"
p_10616_2	"colon, ileo-colonic crohn's disease; tissue"	"colon, healthy control"
p_10616_3	"colon, ulcerative colitis; tissue"	"colon, healthy control"
p_10650_2	"HCT116 cell, PCLKC expressed"	"HCT116 cell, control"
p_10683_1	Vervet Limbus	Vervet Cornea
p_10683_2	Vervet Limbus	Vervet Conjunctiva
p_10685_1	"Human skeletal muscle biopsy, IL-6 infusion, 3h"	"Human skeletal muscle biopsy, IL-6 infusion, 0h"
p_10685_2	"Human skeletal muscle biopsy, IL-6 infusion, 6h"	"Human skeletal muscle biopsy, IL-6 infusion, 0h"
p_10696_1	"A431 cells, Gefitinib-resistant"	"A431 cells, wild type"
p_10714_1	"human colonic biopsy sample, Hyperplastic polyp"	"human colonic biopsy sample, normal control"
p_10714_2	"human colonic biopsy sample, CRC-B"	"human colonic biopsy sample, normal control"
p_10714_3	"human colonic biopsy sample, CRC-CD"	"human colonic biopsy sample, normal control"
p_10714_4	"human colonic biopsy sample, Crohn Disease"	"human colonic biopsy sample, normal control"
p_10714_5	"human colonic biopsy sample, Adenoma with low-grade dysplasia"	"human colonic biopsy sample, normal control"
p_10714_6	"human colonic biopsy sample, Ulcerative Colitis"	"human colonic biopsy sample, normal control"
p_10714_7	colonic biopsy-UC (ulcerative colitis); tissue	colonic biopsy-normal
p_10715_1	"PBMC, CRC patient stage duke A,B"	"PBMC, control"
p_10715_2	"PBMC, CRC patient stage duke C,D"	"PBMC, control"
p_10718_1	"NHBE cells, smoke exposed, 1h"	"NHBE cells, mock exposed, 1h"
p_10718_2	"NHBE cells, smoke exposed, 2h"	"NHBE cells, mock exposed, 2h"
p_10718_3	"NHBE cells, smoke exposed, 4h"	"NHBE cells, mock exposed, 4h"
p_10718_4	"NHBE cells, smoke exposed, 24h"	"NHBE cells, mock exposed, 24h"
p_10737_1	"Jurkat cell line, cyclin T1 knockdown"	"Jurkat cell line, control shRNA-transduced"
p_10746_1	"Mucositis, pre-chemotherapy treated"	"Mucositis, healthy control"
p_10746_2	"Mucositis, post-chemotherapy treated"	"Mucositis, healthy control"
p_10767_1	"EBV-immortalized B-cells, BMPR2 mutation carrier, with clinical PAH (pulmonary arterial hypertension)"	"EBV-immortalized B-cells, BMPR2 mutation carrier, with no clinical disease"
p_10780_1	Invasive ductal carcinoma (IDC)	"Unremarkable breast ducts, Normal"
p_10791_1	"sigmoid colon biopsy, ulcerative colitis (UC)"	"sigmoid colon biopsy, healthy control"
p_10792_1	C-acute lymphoblastic leukemia (ALL) with t(12;21); leukemia; blood cancer	C-ALL-preB without t(9;22)
p_10792_2	C-acute lymphoblastic leukemia (ALL)-preB with t(9;22); leukemia; blood cancer	C-ALL-preB without t(9;22)
p_10792_3	C-acute lymphoblastic leukemia (ALL)-preB without t(9;22) and TEL deleted; leukemia; blood cancer	C-ALL-preB without t(9;22)
p_10792_4	prepreB-C-acute lymphoblastic leukemia (ALL) with MLL; leukemia; blood cancer	C-ALL-preB without t(9;22)
p_10799_1	"Human pulmonary adenocarcinoma, bone marrow negative"	"female pulmonary adenocarcinoma, normal tissue"
p_10799_2	"Human pulmonary adenocarcinoma, bone marrow positive"	"female pulmonary adenocarcinoma, normal tissue"
p_10809_1	"CA1 HESC, SOX7 over-expression"	"CA1 HESC, parental control"
p_10809_2	"CA2 HESC, SOX17 over-expression"	"CA2 HESC, parental control"
p_10810_1	breast cancer	"breast, control"
p_10810_2	"breast cancer, ki-67 > 25"	"breast cancer, ki-67 < 25"
p_10810_3	"breast cancer, estrogen receptor (+)"	"breast cancer, estrogen receptor (-)"
p_10820_1	"acute lymphoblastic leukemia (ALL), Poor prognosis; cancer"	"acute lymphoblastic leukemia (ALL), Favorable prognosis"
p_10821_1	"GC B cells, LMP1-transfected"	"GC B cells, pSC5-transfected, control"
p_10831_1	"HRS cell, L1236 HL Cell line"	GC B cell
p_10831_2	"HRS cell, KMH2 HL Cell line"	GC B cell
p_10831_3	"HRS cell, L428 HL Cell line"	GC B cell
p_10831_4	"HRS cell, L591 HL Cell line"	GC B cell
p_10832_1	"PC3 cell, sphere type"	"PC3 cell, monolayer type"
p_10832_2	"DU145 cell, sphere type"	"DU145 cell, monolayer type"
p_10846_1	"lymphoma, Rituximab-CHOP treated"	"lymphoma, CHOP"
p_10847_1	"NCI-H522 cells, BRG1 expression, treated with TGFbeta, 2h."	"NCI-H522 cells, BRG1 expression, untreated"
p_10847_2	"NCI-H522 cells, TGFbRII expression, treated with TGFbeta, 2h."	"NCI-H522 cells, TGFbRII expression, untreated"
p_10847_3	"NCI-H522 cells, TGFbRII + BRG1 expression, TGFbeta treated, 2h"	"NCI-H522 cells, TGFbRII + BRG1 expression, untreated"
p_10856_1	"MDM cells, DcR3 treated, 2 days"	"MDM cells, hIgG1 treated, 2 days, control"
p_10879_1	"MCF-7:5C cells, Estrogen-deprived"	"MCF-7 cells, wild type"
p_10879_2	"MCF-7:2A cells, Estrogen-deprived"	"MCF-7 cells, wild type"
p_10880_1	"MRC cell, IFN gamma treated"	MRC cell
p_10880_2	"MRC cell, IFN gamma treated"	PGF cell
p_10896_1	"differentiated U937 cells, 1uM curcumin treated, 4h"	"differentiated U937 cells, untreated, 4h"
p_10896_2	"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 4h"	"differentiated U937 cells, ROS exposed, 4h"
p_10896_3	"differentiated U937 cells, 1uM curcumin treated, 18h"	"differentiated U937 cells, untreated, 18h"
p_10896_4	"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 18h"	"differentiated U937 cells, ROS exposed, 18h"
p_10916_1	"melanoma, melphalan & temozolomide treated"	"melanoma, ,melphalan"
p_10916_2	Braf mutant melanoma; skin cancer	Braf WT melanoma
p_10916_3	Nras mutant mleanoma; skin cancer	Nras WT mleanoma
p_10927_1	adrenocortical Adenoma; cancer	"adrenal Cortex, normal"
p_10927_2	adrenocortical Carcinoma; cancer	"adrenal Cortex, normal"
p_10943_1	"ascitic fluid, ovarian cancer, IFN-alpha treated non-side population"	"ascitic fluid, ovarian cancer, untreated non-side population"
p_10946_1	cumulus_PCOS_Obese; tissue	cumulus_PCOS_Lean
p_10946_2	cumulus_nonPCOS_Obese; tissue	cumulus_nonPCOS_Lean
p_10946_3	cumulus_PCOS_Obese; tissue	cumulus_nonPCOS_Obese
p_10946_4	cumulus_PCOS_Lean; tissue	cumulus_nonPCOS_Lean
p_10960_1	"HeLa cells, s/as"	"HeLa cells, s/as mock"
p_10960_2	"HeLa cells, meT-s/as"	"HeLa cells, s/as mock"
p_10960_3	"HeLa cells, s/meT-as"	"HeLa cells, s/as mock"
p_10960_4	"HeLa cells, meT-a/meT-as"	"HeLa cells, s/as mock"
p_10960_5	"HeLa cells, PIK3CB-6340"	"HeLa cells, PIK3CB-6340 mock"
p_10961_1	Synchronous liver metastasis colorectal cancer	Metachronous liver metastasis from colorectal cancer
p_10971_1	high grade serous carcinoma; ovary cancer	non-malignant FTEn
p_10971_2	non-malignant FTEb; ovary cancer	non-malignant FTEn
p_10979_1	"FL cell, 0.05uM BPDE treated, control, 1h"	"FL cell, DMSO treated, control, 1h"
p_10979_2	"FL cell, 0.05uM BPDE treated, control, 10h"	"FL cell, DMSO treated, control, 10h"
p_10979_3	"FL cell, 0.05uM BPDE treated, control, 22h"	"FL cell, DMSO treated, control, 22h"
p_11001_1	ER+ breast cancer	ER- breast cancer
p_11001_2	PR+ breast cancer	PR- breast cancer
p_11001_3	HER2+ breast cancer	HER2- breast cancer
p_11001_4	Node+ breast cancer	Node- breast cancer
p_11024_1	"kidney, clear cell; cancer"	"kidney, normal"
p_11024_2	"kidney, chromophobe; cancer"	"kidney, normal"
p_11024_3	"kidney, papillary type1; cancer"	"kidney, normal"
p_11024_4	"kidney, papillary type2; cancer"	"kidney, normal"
p_11024_5	"kidney, oncocytoma; cancer"	"kidney, normal"
p_11024_6	"kidney, wilms tumor; cancer"	"kidney, normal"
p_11045_1	liver	kidney
p_11057_1	Central memory cell	"PMBC, control"
p_11057_2	Effector memory cell	"PMBC, control"
p_11057_3	Naive cell	"PMBC, control"
p_11083_1	"Neutrophil, JIA patient"	"Neutrophil, healthy"
p_11083_2	"Neutrophil, JDM patient"	"Neutrophil, healthy"
p_11083_3	"PBMC, JIA patient"	"PBMC, healthy"
p_11083_4	"PBMC, JDM patient"	"PBMC, healthy"
p_11092_1	"CD34- cells, stimulated by G-CSF"	"CD34+ cells, stimulated by G-CSF"
p_11100_1	"Human GBM cell, tumor, post vaccination"	"Human GBM cell, normal, post vaccination"
p_11100_2	"Human GBM cell, tumor, pre vaccination"	"Human GBM cell, normal, pre vaccination"
p_11118_1	"Jurkat Cell, mitogen stimulated , 0.5h"	"Jurkat Cell, control"
p_11118_2	"Jurkat Cell, mitogen stimulated , 1h"	"Jurkat Cell, control"
p_11135_1	MILE training; blood cancer	proficiency
p_11142_1	"T cell line, 10 nM nicotine, 1h"	"T cell line, control"
p_11142_2	"T cell line, 10 uM nicotine, 1h"	"T cell line, control"
p_11142_3	"T cell line, 1 mM nicotine, 1h"	"T cell line, control"
p_11151_1	conventional renal cell cancer	adult normal kidney
p_11151_2	papillary renal cell cancer	adult normal kidney
p_11151_3	renal oncocytoma	adult normal kidney
p_11151_4	rhabdoid tumor of kidney	adult normal kidney
p_11151_5	WIlms' tumor	adult normal kidney
p_11151_6	collecting duct carcinoma	adult normal kidney
p_11151_7	clear cell sarcoma of the kidney	adult normal kidney
p_11185_3	"293-tet-On, NOR1 with doxycycline treated"	"293-tet-On, NOR1 without doxycycline"
p_11190_1	"blood cells, after interferon treatment"	"blood cells, before interferon treatment"
p_11190_2	"blood cells, rapid-responder (RR) group, Post-interferon treatment"	"blood cells, rapid-responder (RR) group, Pre-interferon treatment"
p_11190_3	"blood cells, non-rapid-responder (RR) group, Post-interferon treatment"	"blood cells, non-rapid-responder (RR) group, Pre-interferon treatment"
p_11196_3	"non-contractile polyribosomal RNA, IPF treated"	"non-contractile polyribosomal RNA, control"
p_11196_4	"non-contractile total RNA, IPF treated"	"non-contractile total RNA, control"
p_11199_1	"Macrophage, LTB stimulated"	"Macrophage, control"
p_11199_2	"Macrophage, PTB stimulated"	"Macrophage, control"
p_11199_3	"Macrophage, TBM stimulated"	"Macrophage, control"
p_11208_1	"peripheral ganglion, nicotine, 1hr"	"peripheral ganglion, control, 1hr"
p_11208_2	"peripheral ganglion, nicotine, 24hr"	"peripheral ganglion, control, 24hr"
p_11227_1	"Whole blood, after NHD (Nocturnal home hemodialysis) treatment"	"Whole blood, before NHD treatment"
p_11238_23	"HeLa Cell Line, unknown: VVdelE3L, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_24	"HeLa Cell Line, unknown: VVE3Ldel83N, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_25	"HeLa Cell Line, unknown: VVE3Ldel26C, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_26	"HeLa Cell Line, unknown: VVE3Ldel7C, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_27	"HeLa Cell Line, unknown: VVE3L Y48A, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_28	"HeLa Cell Line, unknown: VVE3L Y48F, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_29	"HeLa Cell Line, unknown: VV-ATV, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_30	"HeLa Cell Line, unknown: VV-ADAR/E3L, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_31	"HeLa Cell Line, unknown: VVdel37N, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11238_32	"HeLa Cell Line, unknown: VVdelK3L, 9 HPI"	"HeLa cell line, mock infected, 9HPI"
p_11279_1	"SW480 cells, ezrin RNAi"	"SW480 cells, luciferase RNAi, control"
p_11281_1	"PBMC, SEI treated, 100pg/ml"	"PBMC, untreated, control"
p_11281_2	"PBMC, SEB treated, 100pg/ml"	"PBMC, untreated, control"
p_11285_1	"U251 cells, Enzastaurin treated, 4h"	"U251 cells, DMSO, 4h"
p_11285_2	"U251 cells, Enzastaurin treated, 10h"	"U251 cells, DMSO, 10h"
p_11285_3	"U251 cells, Enzastaurin treated, 18h"	"U251 cells, DMSO, 18h"
p_11292_1	"Human T cell, GARP overexpressed, 0m"	"Human T cell, GPF expressed, 0m"
p_11292_2	"Human T cell, GARP overexpressed, 100m"	"Human T cell, GPF expressed, 100m"
p_11292_3	"Human T cell, GARP overexpressed, 360m"	"Human T cell, GPF expressed, 360m"
p_11309_1	"monocyte-differenciated dendritic cells, candida-,patient"	"monocyte-differenciated dendritic cells, candida-,control"
p_11309_2	"monocyte-differenciated dendritic cells, candida+,patient"	"monocyte-differenciated dendritic cells, candida+,control"
p_11324_1	"MCF-7 cells, estrogen treated, 3h"	"MCF-7 cells, estrogen treated, 0h"
p_11324_2	"MCF-7 cells, estrogen treated, 6h"	"MCF-7 cells, estrogen treated, 0h"
p_11324_3	"MCF-7 cells, estrogen treated, 12h"	"MCF-7 cells, estrogen treated, 0h"
p_11327_1	"dendritic cell, LPS+IFNg treated, 6h"	"dendritic cells, unstimulated control, 6h"
p_11327_2	"dendritic cell, LPS+IFNg treated, 12h"	"dendritic cells, unstimulated control, 12h"
p_11327_3	"dendritic cell, LPS+IFNg treated, 24h"	"dendritic cells, unstimulated control, 24h"
p_11327_4	"dendritic cell, LPS+IFNg treated, 48h"	"dendritic cells, unstimulated control, 48h"
p_11330_1	"MCF-7 cell, SOX2 expressed"	"MCF-7 cell, control"
p_11336_1	"CCRF-CEM-C7H2 cell line, treated with dexamethansone (a GC), 100nM, 6h"	"CCRF-CEM-C7H2 cell line, treated with EtOH, 6h, control"
p_11336_2	"CCRF-CEM-C7H2 cell line, treated with dexamethansone (a GC), 100nM, 24h"	"CCRF-CEM-C7H2 cell line, treated with EtOH, 24h, control"
p_11345_1	"T84 cell, IL17 stimulated"	"T84 cell, control"
p_11345_2	"T84 cell, IL22 stimulated"	"T84 cell, control"
p_11348_1	"Nasal epithelium, rhinovirus, infection 8hr, treatment; time course"	"rhinovirus, preinfection"
p_11348_2	"Nasal epithelium, rhinovirus, infection 2day, treatment; time course"	"rhinovirus, preinfection"
p_11350_1	"hGS cells from testis, cultivated with KO Medium+GDNF treated"	"H1 cells from testis, cultivated in ES Medium+FGF2"
p_11350_2	"haGSC cells from testis, cultivated with KO Medium+GDNF treated"	"H1 cells from testis, cultivated in ES Medium+FGF2"
p_11352_1	"MCF7 cells, E2 treated, 12h"	"MCF7 cells, untreated, 12h"
p_11352_2	"MCF7 cells, E2 treated, 24h"	"MCF7 cells, untreated, 24h"
p_11352_3	"MCF7 cells, E2 treated, 48h"	"MCF7 cells, untreated, 48h"
p_11367_1	"VSMCs, IL-17 treated"	"VSMCs, untreated, control"
p_11373_1	"PSF8 cells ,Fascin-knockdown"	"PSC cells, vector control"
p_11375_1	Inpatient rehabilitation facility; blood leukocytes from trauma patients; tissue	control
p_11375_2	Skilled nursing facility; blood leukocytes from trauma patients; tissue	control
p_11375_3	Home with services; blood leukocytes from trauma patients; tissue	control
p_11375_4	Home; blood leukocytes from trauma patients; tissue	control
p_11375_5	Another acute care facility; blood leukocytes from trauma patients; tissue	control
p_11375_6	Death; blood leukocytes from trauma patients; tissue	control
p_11407_1	"MDA-MB-231 cell, C1OH-Ac3ManNAc"	"MDA-MB-231 cell, EtOH , control"
p_11407_2	"MDA-MB-231 cell, C1OH-But3GalNAc"	"MDA-MB-231 cell, EtOH , control"
p_11407_3	"MDA-MB-231 cell, C1OH-But3GlcNAc"	"MDA-MB-231 cell, EtOH , control"
p_11407_4	"MDA-MB-231 cell, C1OH-But3ManlNAc"	"MDA-MB-231 cell, EtOH , control"
p_11407_5	"MDA-MB-231 cell, C6OH-But3ManlNAc"	"MDA-MB-231 cell, EtOH , control"
p_11407_6	"MDA-MB-231 cell, AC4ManNLev"	"MDA-MB-231 cell, EtOH , control"
p_11418_1	"NHDF, passage 13, adult donor"	"NHDF, passage 4, adult donor"
p_11418_2	"NHDF, passage 6, neonatal donor"	"NHDF, passage 4, adult donor"
p_11428_1	"LNCaP cells, siRNA targeting Androgen Receptor"	"LNCaP cells, siRNA control"
p_11428_2	"abl cells, siRNA targeting Androgen Receptor"	"abl cells, siRNA control"
p_11428_3	"abl cells, DHT treated, 4h"	"abl cells, ethanol treated"
p_11428_4	"abl cells, DHT treated, 16h"	"abl cells, ethanol treated"
p_11430_1	"whole blood, monocyte"	"whole blood, macrophage"
p_11440_1	"HT29 cell, resistant to methotrxate"	"HT29 cell, sensitive to methotrxate"
p_11450_1	oocyte	HEPG2
p_11450_2	oocyte	MCF7
p_1145_1	idiopathic cardiomyopathy; heart tissue	normal
p_1145_2	familial cardiomyopathy; heart tissue	normal
p_1145_3	hypertrophic cardiomyopathy; heart tissue	normal
p_1145_4	post-partum cardiomyopathy; heart tissue	normal
p_1145_5	ischemic cardiomyopathy; heart tissue	normal
p_1145_6	viral cardiomyopathy; heart tissue	normal
p_11462_1	"MM6 cell, control, PMA treated"	"MM6 cell, control, Mock treated"
p_11462_10	MM6 cyclin T1 shRNA PMA treated	MM6 control shRNA PMA treated
p_11462_11	MM6 control shRNA LPS treated	MM6 control shRNA Mock treated
p_11462_12	MM6 cyclin T1 shRNA LPS treated	MM6 control shRNA LPS treated
p_11462_13	MM6 cyclin T1 shRNA LPS treated	MM6 cyclin T1 shRNA Mock treated
p_11462_2	"MM6 cell, control, LPS treated"	"MM6 cell, control, Mock treated"
p_11462_3	"MM6 cell, Cyclin T1 knockdown, PMA treated"	"MM6 cell, Cyclin T1 knockdown, Mock treated"
p_11462_4	"MM6 cell, Cyclin T1 knockdown, LPS treated"	"MM6 cell, Cyclin T1 knockdown, Mock treated"
p_11462_5	"MM6 cell, Control knockdown, PMA treated"	"MM6 cell, Control knockdown, Mock treated"
p_11462_6	"MM6 cell, Control knockdown, LPS treated"	"MM6 cell, Control knockdown, Mock treated"
p_11462_7	"Jurkat cell, control knockdown, PMA treated"	"Jurkat cell, control knockdown, Mock treated"
p_11462_8	"Jurkat cell, cyclin T1 knockdown, PMA treated"	"Jurkat cell, cyclin T1 knockdown, Mock treated"
p_11462_9	MM6 cyclin T1 shRNA PMA treated	MM6 cyclin T1 shRNA Mock treated
p_11499_1	"peripheral blood, Ulcerative colitis"	"peripheral blood, Crohn's disease"
p_11504_1	"Human composite bone marrow, 3 months"	"Human composite bone marrow, 2 month"
p_11504_10	"Human composite bone marrow, 74 months"	"Human composite bone marrow, 2 month"
p_11504_20	"Human composite bone marrow, 313 months"	"Human composite bone marrow, 2 month"
p_11504_5	"Human composite bone marrow, 32 months"	"Human composite bone marrow, 2 month"
p_11506_1	"MCF-7 cells, E2 treated, 3h"	"MCF-7 cells, vehicle treated, 3h"
p_11506_2	"MCF-7 cells, E2 treated, 6h"	"MCF-7 cells, vehicle treated, 3h"
p_11524_1	"platele, sickle cell patients"	"platelet, control"
p_11550_1	"Hs 294T cell line, 0.01% DMSO treated, 6h"	"Hs 294T cell line, untreated"
p_11550_2	"Hs 294T cell line, 100nM elesclomol treated ,6h"	"Hs 294T cell line, untreated"
p_11550_3	"Hs 294T cell line, 250nM paclitaxel treated, 6h"	"Hs 294T cell line, untreated"
p_11550_4	"Hs 294T cell line, 100nM elesclomol + 250nM paclitaxel treated, 6h"	"Hs 294T cell line, untreated"
p_11551_1	"Hs 294T cell line, 100nM elesclomol treated at 6h"	"Hs 294T cell line, 0.01% DMSO treated at 6h"
p_11551_2	"Hs 294T cell line, 5mM NAC treated at 6h"	"Hs 294T cell line, 0.01% DMSO treated at 6h"
p_11551_3	"Hs 294T cell line, 100nM elesclomol + 5mM NAC treated at 6h"	"Hs 294T cell line, 0.01% DMSO treated at 6h"
p_11581_1	"MCF-7 cells, siRNA targeting FAK"	"MCF-7 cells, siRNA control"
p_11618_1	"HCT116, luciferase late passage; treated"	"HCT116, luciferase early passage"
p_11618_2	"HCT116, XIAP late passage; treated"	"HCT116, XIAP early passage"
p_11622_1	"Vaginal tissue, E2 treated"	"Vaginal tissue, control"
p_11626_1	"H1299 cells, transduced with TAp73beta expressing adenovirus"	"H1299 cells, transduced with GFP expressing adenovirus"
p_11670_1	"K562 cell, ICL670 10uM treated"	"K562 cell, untreated"
p_11670_2	"K562 cell, ICL670 50uM treated"	"K562 cell, untreated"
p_11673_1	"H1299 cells, transduced with TAp73beta expressing adenovirus, 5h"	"H1299 cells, transduced with GFP expressing adenovirus, 5 h, control"
p_11683_1	MDA-MB-468GFP-LN	MDA-MB-468GFP
p_11710_12	"HaCaT cells, siRNA targeting Smad2, TGF-beta stimulation, 24"	"HaCaT cells, TGF-beta3 stimulation, control siRNA, 24h"
p_11710_15	"HaCaT cells, siRNA targeting Smad3,TGF-beta stimulation, 24"	"HaCaT cells, TGF-beta3 stimulation, control siRNA, 24h"
p_11710_6	"HaCaT cells, siRNA targeting ETS1, TGF-beta3 stimulation, 24h"	"HaCaT cells, TGF-beta3 stimulation, control siRNA, 24h"
p_11710_9	"HaCaT cells, siRNA targeting TFAP2A, TGF-beta3 stimulation, 24"	"HaCaT cells, TGF-beta3 stimulation, control siRNA, 24h"
p_11729_12	"H1299 cell, EGFR-wt, EGF, Iressa treated, 10h"	"H1299 cell, EGFR-wt, control"
p_11729_18	"H1299 cell, EGFR-wt, Iressa treated, 10h"	"H1299 cell, EGFR-wt, control"
p_11729_24	"H1299_L858R cell, EGF treated, 10h"	"H1299_L858R cell, control"
p_11729_30	"H1299_L858R cell, EGF, Iressa treated, 10h"	"H1299_L858R cell, control"
p_11729_36	"H1299_L858R cell, Iressa treated, 10h"	"H1299_L858R cell, control"
p_11729_42	"H1299 cell, EGF treated, 10h"	"H1299 cell, control"
p_11729_48	"H1299 cell, EGF, Iressa treated, 10h"	"H1299 cell, control"
p_11729_54	"H1299 cell, Iressa treated, 10h"	"H1299 cell, control"
p_11729_6	"H1299 cell, EGFR-wt, EGF treated, 10h"	"H1299 cell, EGFR-wt, control"
p_11755_10	Blood_T72; meningococcal sepsis; infection; time course	Control_Blood
p_11755_2	Lymphocyte_T8; meningococcal sepsis; infection; time course	Control_Lymphocyte
p_11755_4	Lymphocyte_T72; meningococcal sepsis; infection; time course	Control_Lymphocyte
p_11755_6	Monocyte_T8; meningococcal sepsis; infection; time course	Control_Monocyte
p_11761_1	"PBMCs, after exercisep treatment"	"PBMCs, before exercise"
p_11783_1	"Bladder tissue, IC, non-ulcer tissue"	"Bladder tissue, healthy"
p_11783_2	"Bladder tissue, IC, ulcer tissue"	"Bladder tissue, healthy"
p_11791_1	"MCF-7 cells, ICI 182780 pretreatment, then treated with E2"	"MCF-7 cells, ICI 182780 pretreatment, then treated with ethanol vehicle"
p_11791_2	"MCF-7 cells, Myc-containing vector, ICI 182780 pretreatment, then treated with Zn"	"MCF-7 cells, empty vector, ICI 182780 pretreatment, then treated with Zn"
p_11791_3	"MCF-7 cells, Zip-containing vector, ICI 182780 pretreatment, then treated with Zn"	"MCF-7 cells, empty vector, ICI 182780 pretreatment, then treated with Zn"
p_11791_4	"MCF7, Zip_Zn; treated"	"MCF7, EtOH"
p_11839_1	"Interstial cystitis, differentiated; tissue"	"Control, differentiated"
p_11839_2	"Interstial cystitis, differentiated; tissue"	"Interstial cystitis, non-differentiated"
p_11839_3	"Control, differentiated; tissue"	"Control, non-differentiated"
p_11839_4	"Interstial cystitis, non-differentiated; tissue"	"Control, non-differentiated"
p_11854_1	"fibroblast, hCycle11, 1hr"	"fibroblast, hCycle11, 0hr"
p_11854_12	"fibroblast, hCycle11, 12hr"	"fibroblast, hCycle11, 0hr"
p_11854_6	"fibroblast, hCycle11, 6hr"	"fibroblast, hCycle11, 0hr"
p_11864_1	"M-CSF, IFN-gamma"	"M-CSF, control"
p_11864_2	"M-CSF, Pam3Cys"	"M-CSF, control"
p_11864_3	"M-CSF, Pam3Cys + IFN-gamma"	"M-CSF, control"
p_11864_4	"monocyte, M-CSF & IFN-gamma & Pam3Cys treated"	"monocyte, control"
p_11869_1	"Ishikawa cell, 17alpha-ethynyl estradiol 8 h very low dose treated; time course"	"Ishikawa cell, control 8 h"
p_11869_10	"Ishikawa cell, 17alpha-ethynyl estradiol 48 h low dose treated; time course"	"Ishikawa cell, control 48 h"
p_11869_11	"Ishikawa cell, 17alpha-ethynyl estradiol 48 h high dose treated; time course"	"Ishikawa cell, control 48 h"
p_11869_12	"Ishikawa cell, 17alpha-ethynyl estradiol 48 h very high dose treated; time course"	"Ishikawa cell, control 48 h"
p_11869_2	"Ishikawa cell, 17alpha-ethynyl estradiol 8 h low dose treated; time course"	"Ishikawa cell, control 8 h"
p_11869_3	"Ishikawa cell, 17alpha-ethynyl estradiol 8 h high dose treated; time course"	"Ishikawa cell, control 8 h"
p_11869_4	"Ishikawa cell, 17alpha-ethynyl estradiol 8 h very high dose treated; time course"	"Ishikawa cell, control 8 h"
p_11869_5	"Ishikawa cell, 17alpha-ethynyl estradiol 24 h very low dose treated; time course"	"Ishikawa cell, control 24 h"
p_11869_6	"Ishikawa cell, 17alpha-ethynyl estradiol 24 h low dose treated; time course"	"Ishikawa cell, control 24 h"
p_11869_7	"Ishikawa cell, 17alpha-ethynyl estradiol 24 h high dose treated; time course"	"Ishikawa cell, control 24 h"
p_11869_8	"Ishikawa cell, 17alpha-ethynyl estradiol 24 h very high dose treated; time course"	"Ishikawa cell, control 24 h"
p_11869_9	"Ishikawa cell, 17alpha-ethynyl estradiol 48 h very low dose treated; time course"	"Ishikawa cell, control 48 h"
p_11877_1	"Acute lymphoblastic leukemia (ALL), congenital abnormality: Downs; cancer tissue"	"Acute lymphoblastic leukemia (ALL), congenital abnormality: None"
p_11877_2	"Acute lymphoblastic leukemia (ALL), MLL(+), cancer tissue"	"Acute lymphoblastic leukemia (ALL), MLL(-)"
p_11877_3	"Acute lymphoblastic leukemia (ALL), TEL-AML, t(12:21)(+); cancer tissue"	"Acute lymphoblastic leukemia (ALL), TEL-AML, t(12:21)(-)"
p_11877_4	"Acute lymphoblastic leukemia (ALL), Trisomy 4 & 10 (+); cancer tissue"	"Acute lymphoblastic leukemia (ALL), Trisomy 4 & 10 (-)"
p_11877_5	"Acute lymphoblastic leukemia (ALL), E2A-PBX, t(1,19) (+); cancer tissue"	"Acute lymphoblastic leukemia (ALL), E2A-PBX, t(1,19) (-)"
p_11881_1	Tolerant PBMC; tissue	Non-tolerant PBMC
p_11882_1	"brain HC, age_60-99; tissue"	"brain HC, age_20-59"
p_11882_2	"brain EC, age_60-99; tissue"	"brain EC, age_20-59"
p_11882_3	"brain SG, age_60-99; tissue"	"brain SG, age_20-59"
p_11882_4	"brain PCG, age_60-99; tissue"	"brain PCG, age_20-59"
p_11882_5	"brain HC, female; tissue"	"brain HC, male"
p_11882_6	"brain EC, female; tissue"	"brain EC, male"
p_11882_7	"brain SG, female; tissue"	"brain SG, male"
p_11882_8	"brain PCG, female; tissue"	"brain PCG, male"
p_11883_1	"Mz-ChA-1 cells, IL-6 over-expression"	Mz-ChA-1 cells
p_11886_1	"Patient Macrophages, IFN treated"	"Patient Macrophages, None"
p_11886_2	"Control Macrophages, IFN treated"	"Control Macrophages, None"
p_11886_3	"Patient Macrophages, IFN treated"	"Control Macrophages, IFN treated"
p_11886_4	"Patient Macrophages, None; tissue"	"Control Macrophages, None"
p_11916_1	"Huh7 cells, stably expressing S33Y beta-catenin"	"Huh7 Cells, control"
p_11919_1	"GM5659 cell, AA treated"	"GM5659 cell, control"
p_11919_2	"GM5659 cell, AA2P treated"	"GM5659 cell, control"
p_11940_1	"Primary human hepatocytes, Doxorubicin treated"	"Primary human hepatocytes, control"
p_11941_1	"Hepatocyte , Trovafloxacin treated"	"Hepatocyte , control"
p_11942_1	"Human Hepatocytes, Doxorubicin treated"	"Human hepatocytes, control"
p_11942_2	"Human Hepatocytes, Trovofloxacin treated"	"Human hepatocytes, control"
p_11951_1	"MDA-MB-231, transfected with a vector containing a shRNAs against CD146"	"MDA-MB-231, transfected with the original vector plasmid"
p_11951_2	"MDA-MB-231, transfected with a vector containing a shRNAs against CD146"	"MDA-MB-231, transfected with a vector containing a non-effective shRNA cassette against GFP"
p_11951_3	"MDA-MB-231, transfected with a vector containing a shRNAs against CD146"	"MDA-MB-231, native cell"
p_11952_1	"small airways, smoker; lung tissue"	"small airways, non-smoker"
p_11954_1	"hepatic stellate cells, Senescent"	"hepatic stellate cells, Growing"
p_11956_1	High TCF activity Huh7 treated	Control Huh7
p_11959_1	"human SK-N-AS neuroblastoma xenografts, 10H5 treated, 24 hr"	"human SK-N-AS neuroblastoma xenografts, vehicle"
p_11981_1	"pancreatic tumor xenograft, HhAntag treated"	"pancreatic tumor xenograft, vehicle"
p_12034_1	human oocyte (Pool of 10 human oocytes)	human reference (Pool of ten normal human tissues for reference)
p_12056_1	"K562 cell, CREB knock-out"	"K562 cell, control"
p_12079_1	"CD3-CD4+ T cell, hypereosinophilic syndrome, 0y"	"CD3-CD4+ T cell, control"
p_12079_2	"CD3-CD4+ T cell, hypereosinophilic syndrome, 4y"	"CD3-CD4+ T cell, control"
p_12079_3	"CD3-CD4+ T cell, hypereosinophilic syndrome, 6y"	"CD3-CD4+ T cell, control"
p_12079_4	"CD3-CD4+ T cell, hypereosinophilic syndrome, 0y, rhIL2 stimulated"	"CD3-CD4+ T cell, hypereosinophilic syndrome, 0y"
p_12086_1	"Lymphoblast cell line, Recessive retinitis pigmentosa"	"Lymphoblast cell line,control"
p_12086_2	Lymphoblast of Retinitis Pigmentosa Unrelated Patients; tissue	Control Lymphoblast
p_12090_1	Chromophobe renal cell carcinoma (RCC)	Benign Oncocytoma
p_12102_1	"EWD cell, relapse"	"EWD cell, control"
p_12102_2	"EWD cell, metastasis"	"EWD cell, control"
p_12108_1	"human monocyte, F.novicida infected"	"human monocyte, uninfected"
p_12108_2	"human monocyte, Schu S4 infected"	"human monocyte, uninfected"
p_12113_1	"Pancreatic Cancer cell, IPI-504"	"Pancreatic Cancer cell, control"
p_12121_1	"HIGK cell, Streptococcous gordonii"	"HIGK cell, Sham infected, control"
p_12121_2	"HIGK cell, Streptococcous gingivalis"	"HIGK cell, Sham infected, control"
p_12121_3	"HIGK cell, Streptococcous gordonii + gingivalis"	"HIGK cell, Sham infected, control"
p_12131_1	"HUVEC cell, intoxicated, 4h"	"HUVEC cell, non intoxicated"
p_12131_2	"HUVEC cell, intoxicated, 8h"	"HUVEC cell, non intoxicated"
p_12141_1	"Brain tumor, metastastic"	"Brain tumor, ependymoma, non-metastatic"
p_12155_1	"Endothelial Progenitor Cells , after 3 months of exercise"	"Endothelial Progenitor Cells , baseline"
p_12161_1	"HepG2 cells, TNF alpha treated"	"HepG2 cells, control"
p_12172_1	"ovarian carcinoma, serous; ovary cancer"	"ovarian tumor, serous LMP (low malignant potential) tumor"
p_12187_1	mild or moderate Chronic Allograft Nephropathy; kidney tissue	severe Chronic Allograft Nephropathy
p_12195_1	DLBCL; blood cancer	"CD10(+), CD77(-) B cells"
p_12195_2	DLBCL; blood cancer	CD77(+) B cells
p_12198_1	NKAES-derived NK cell	Primary human NK cell
p_12198_2	NKAES-derived NK cell	"NK cell, stimulated by low dose IL2"
p_12198_3	NKAES-derived NK cell	"NK cell, stimulated by high dose IL2"
p_12199_1	MDA-MB-231	"MCF-7, control"
p_12205_1	"HLF cell, 1um Cr(VI) treated"	"HLF cell, control"
p_12205_2	"HLF cell, 10um SOV+ 1um Cr(VI) treated"	"HLF cell, control"
p_12251_1	"colonic biopsy, week 8 Response to infliximab: Yes"	"colonic biopsy, week 8 Response to infliximab: No"
p_12253_1	"airway epithelial cells, Ethanol treated, 50mM"	"airway epithelial cells, untreated"
p_12253_2	"airway epithelial cells, Ethanol treated, 100mM"	"airway epithelial cells, untreated"
p_12254_10	"liver tissue, LCMV-ARM infected but not diseased, day 5"	"liver tissue, uninfected"
p_12254_5	"liver tissue, LCMV-WE infected, day 6"	"liver tissue, uninfected"
p_12254_8	"liver tissue, LCMV-WE infected, day 12"	"liver tissue, uninfected"
p_12261_1	"HASMC cell, ME treated, 4h"	"HASMC cell, control, 4h"
p_12261_2	"HASMC cell, ME treated, 30h"	"HASMC cell, control, 30h"
p_12267_1	"hOB, mineralization, 24h"	hOB confluence
p_12267_10	"hMSC, mineralization, 10-14 days"	"hMSC, confluence"
p_12267_3	"hOB, mineralization, 10-14 days"	hOB confluence
p_12267_8	"hMSC, mineralization, 24h"	"hMSC, confluence"
p_12276_1	breast tumor metastasized to brain; cancer	local breast tumor
p_12276_2	breast tumor metastasized to other regions; cancer	local breast tumor
p_12278_1	"Burkitt lymphoma cell line, miR26a transfection"	"Burkitt lymphoma cell line, empty vector"
p_12287_1	"ATL cell line E10, 17AAG treated, 100nM"	"ATL cell line E10, mock treated"
p_12287_2	"ATL cell line E10, 17AAG treated, 300nM"	"ATL cell line E10, mock treated"
p_12287_3	"ATL cell line E10, 17DMAG treated, 150nM"	"ATL cell line E10, mock treated"
p_12287_4	"ATL cell line MT-2, 17AAG treated, 700nM"	"ATL cell line MT-2, mock treated"
p_12287_5	"ATL cell line MT-2, 17DMAG treated, 150nM"	"ATL cell line MT-2, mock treated"
p_12287_6	"ATL cell line MT-4, 17AAG treated, 500nM"	"ATL cell line MT-4, mock treated"
p_12287_7	"ATL cell line MT-4, 17DMAG treated, 150nM"	"ATL cell line MT-4, mock treated"
p_12305_1	"U251 cells, glioblastoma"	Normal Human Astrocytes from Lonza
p_12320_1	"GBS6 cell, POU5F1 siRNA transfected"	"GBS6 cell, negative control siRNA"
p_12326_1	"CD34+ cells, Peripheral blood"	"CD34+ cells, Bone marrow"
p_12336_1	Xenografted 2MLN-dnTbRII tumors	Xenografted 2MLN-GFP tumors
p_12355_10	"Human B cell, EBNA2, 24h"	"Human B cell, CAT, control, 24h"
p_12355_3	"Human B cell, N1, 24h"	"Human B cell, CAT, control, 24h"
p_12355_7	"Human B cell, N2, 24h"	"Human B cell, CAT, control, 24h"
p_12366_3	Memory B cells; tissue	Germinal Center B cells
p_12368_1	"Adrenal cortex, Adrenocortical adenoma"	"Adrenal cortex, normal"
p_12368_2	"Adrenal cortex, Adrenocortical carcinoma"	"Adrenal cortex, normal"
p_12390_2	"BJ HiPS, 6p9"	"HUES8 (human ESC line), 8p30, control"
p_12390_6	"BJ HiPS, 6p9"	human BJ (Donor line)
p_12400_1	"Burkitt lymphoma cell line, Namalwa, miR26a, siRNA treatment"	"Burkitt lymphoma cell line, Namalwa, empty"
p_12400_2	"Raji_miR26a, siRNA treatment"	Raji_empty
p_12400_3	"Ramos_ miR26a, siRNA treatment"	Ramos_empty
p_12408_1	Cornelia de Lange Syndrome (CdLS) patient; lymphoblastoid cell lines; tissue	healthy control
p_12408_2	Alagille syndrome patient; tissue; lymphoblastoid cell lines	healthy control
p_12408_3	RBS patient; tissue; lymphoblastoid cell lines	healthy control
p_12427_1	"KM-H2 cell, EBER overexpressed"	"KM-H2 cell, control"
p_12427_2	"L428 cell, EBER overexpressed"	"L428 cell, control"
p_12444_1	"Human primary prostate stromal cells, siRNA targeting FOXF2"	"Human primary prostate stromal cells, control siRNA"
p_12446_1	"Endometrium, postmenopausal, estradiol; treated"	"Endometrium, postmenopausal, control"
p_12446_2	"Endometrium, postmenopausal, estradiol + MPA; treated"	"Endometrium, postmenopausal, control"
p_12446_3	"Endometrium, postmenopausal, tibolone; treated"	"Endometrium, postmenopausal, control"
p_12452_1	Nasopharyngeal carcinoma; cancer	Normal nasopharyngeal tissue
p_12453_1	classical Hodgkin lymphoma; blood cancer	Nomral plasma
p_12453_10	centroblasts; tissue	Nomral plasma
p_12453_2	nodular lymphocte-predominant Hodgkin lymphoma; blood cancer	Nomral plasma
p_12453_3	T-cell rich B-cell lymphoma; blood cancer	Nomral plasma
p_12453_4	follicular lymphoma; blood cancer	Nomral plasma
p_12453_5	Burkitt lymphoma; blood cancer	Nomral plasma
p_12453_6	diffuse large B-cell lymphoma; blood cancer	Nomral plasma
p_12453_7	naive B-cells; tissue	Nomral plasma
p_12453_8	memory B cells; tissue	Nomral plasma
p_12453_9	centrocytes; tissue	Nomral plasma
p_12460_1	"neuroblastoma, MYCN amplified; brain cancer"	"neuroblastoma, MYCN non-amplified"
p_12474_1	"Skeletal muscle cell, after heating"	"Skeletal muscle cell, before heating"
p_12504_1	"left ventricle biopsy, Post operation off-pump cardiac surgery"	"left ventricle biopsy, pre-operation off-pump cardiac surgery"
p_12504_2	"left ventricle biopsy, Post operation on-pump cardiac surgery"	"left ventricle biopsy, pre-operation on-pump cardiac surgery"
p_12510_1	"Human Umbilical Cord lining Epithelial cells, GFP integrated using Phage Integrase"	"Human Umbilical Cord lining Epithelial cells, control"
p_12524_1	"293 cell, OE/ZL3 treated"	"293 cell, Control"
p_12548_1	"ARPE-19 cells, TGF and TNF-treated, 1h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12548_2	"ARPE-19 cells, TGF and TNF-treated, 6h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12548_3	"ARPE-19 cells, TGF and TNF-treated, 16h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12548_4	"ARPE-19 cells, TGF and TNF-treated, 24h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12548_5	"ARPE-19 cells, TGF and TNF-treated, 42h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12548_6	"ARPE-19 cells, TGF and TNF-treated, 60h"	"ARPE-19 cells, TGF and TNF-treated, 0h"
p_12583_1	"KiPSC, obtained from reprogramming human keratinocyte, 3 factors (Oct4+Sox2+Klf4) treated"	human embryonic stem cell line
p_12583_2	"KiPSC, obtained from reprogramming human keratinocyte, 4 factors (Oct4+Sox2+Klf4+cMyc) treated"	human embryonic stem cell line
p_12583_3	"KiPSC, obtained from reprogramming human keratinocyte, 3 factors (Oct4+Sox2+Klf4) treated"	Human foreskin fibroblast
p_12583_4	"KiPSC, obtained from reprogramming human keratinocyte, 4 factors (Oct4+Sox2+Klf4+cMyc) treated"	Human foreskin fibroblast
p_12583_5	"KiPSC, obtained from reprogramming human keratinocyte, 3 factors (Oct4+Sox2+Klf4) treated"	Human foreskin keratinocyte
p_12583_6	"KiPSC, obtained from reprogramming human keratinocyte, 4 factors (Oct4+Sox2+Klf4+cMyc) treated"	Human foreskin keratinocyte
p_12606_1	"Kidney cell, RCC, normal"	"Kidney cell, normal"
p_12606_2	"Kidney cell, RCC, tumor"	"Kidney cell, normal"
p_12606_3	"Kidney cell, RCC, metastatic"	"Kidney cell, normal"
p_12621_1	"retina, macula; tissue"	"retina, nasal"
p_12621_2	"retina, macula; tissue"	"retina, surround"
p_12631_1	"human conjunctivae (HuCNJE), non-side population"	"human conjunctivae (HuCNJE), side population"
p_12644_1	"aortic valve, calcified; tissue"	"aortic valve, normal"
p_12650_1	"MCF-7 cells, 10ug/ml alpha-amanitin"	MCF-7 cells
p_12662_1	M0 acute myeloid leukemia (AML); blood cancer	CD34+ cells
p_12662_10	M3 acute myeloid leukemia (AML); blood cancer	CD34+ cells
p_12662_11	M3 acute myeloid leukemia (AML); blood cancer	PMNs
p_12662_12	M3 acute myeloid leukemia (AML); blood cancer	Promyelocytes
p_12662_13	M4 acute myeloid leukemia (AML); blood cancer	CD34+ cells
p_12662_14	M4 acute myeloid leukemia (AML); blood cancer	PMNs
p_12662_15	M4 acute myeloid leukemia (AML); blood cancer	Promyelocytes
p_12662_16	FLT3 D835 mutation acute myeloid leukemia (AML); blood cancer	FLT3 D835 normal acute myeloid leukemia (AML)
p_12662_17	FLT3 ITD + acute myeloid leukemia (AML); blood cancer	FLT3 ITD - acute myeloid leukemia (AML)
p_12662_18	NPM1 ins + acute myeloid leukemia (AML); blood cancer	NPM1 ins - acute myeloid leukemia (AML)
p_12662_19	"PR-9 cells, zinc-induced 2 hrs; treat; time course"	"PR-9 cells, resting (no Zinc induction)"
p_12662_2	M0 acute myeloid leukemia (AML); blood cancer	PMNs
p_12662_20	"PR-9 cells, zinc-induced 4 hrs; treat; time course"	"PR-9 cells, resting (no Zinc induction)"
p_12662_21	"PR-9 cells, zinc-induced 8 hrs; treat; time course"	"PR-9 cells, resting (no Zinc induction)"
p_12662_22	"PR-9 cells, zinc-induced 16 hrs; treat; time course"	"PR-9 cells, resting (no Zinc induction)"
p_12662_23	"PR-9 cells, zinc-induced 24 hrs; treat; time course"	"PR-9 cells, resting (no Zinc induction)"
p_12662_3	M0 acute myeloid leukemia (AML); blood cancer	Promyelocytes
p_12662_4	M1 acute myeloid leukemia (AML); blood cancer	CD34+ cells
p_12662_5	M1 acute myeloid leukemia (AML); blood cancer	PMNs
p_12662_6	M1 acute myeloid leukemia (AML); blood cancer	Promyelocytes
p_12662_7	M2 acute myeloid leukemia (AML); blood cancer	CD34+ cells
p_12662_8	M2 acute myeloid leukemia (AML); blood cancer	PMNs
p_12662_9	M2 acute myeloid leukemia (AML); blood cancer	Promyelocytes
p_12679_1	"dorsolateral prefrontal cortex, endothelial; tissue"	"dorsolateral prefrontal cortex, neuron"
p_12710_1	"direct draw, tempus tube; tissue"	"heparin, tempus tube"
p_12710_2	"direct draw, PAXgene tube; tissue"	"heparin, PAXgene tube"
p_12720_1	"Liver biopsy, No manipulation, Deseased donor"	"Liver biopsy, No manipulation, Living donor"
p_12720_2	"Liver biopsy, Post Reperfusion, Deseased donor"	"Liver biopsy, Post Reperfusion, Living donor"
p_12720_3	"Liver biopsy, Cold Preservation, Deseased donor"	"Liver biopsy, Cold Preservation, Living donor"
p_12734_1	chronic lymphocytic leukemia (CLL) patient ZAP70 low; blood cancer	"chronic lymphocytic leukemia (CLL) patient, ZAP70 high"
p_12734_2	"chronic lymphocytic leukemia (CLL), ZAP70 mutated; blood cancer"	"chronic lymphocytic leukemia (CLL), ZAP70 wild type"
p_12734_3	"chronic lymphocytic leukemia (CLL), LPL+; blood cancer"	"chronic lymphocytic leukemia (CLL), LPL-"
p_12734_4	"chronic lymphocytic leukemia (CLL), CD38+; blood cancer"	"chronic lymphocytic leukemia (CLL), CD38-"
p_12763_1	Her2 type breast cancer	luminal type breast cancer
p_12763_2	basal-like breast cancer	luminal type breast cancer
p_12764_1	"MCF10A cell, HRas vector treated"	"MCF10A cell, null vector"
p_12764_2	"MCF10A cell, MEK1 vector treated"	"MCF10A cell, null vector"
p_12767_1	"chorionic villus sampling, preeclamsia"	"chorionic villus sampling, control"
p_12773_1	"monocyte-derive dendritic cells, differentiated without AEC"	"monocyte-derive dendritic cells, control"
p_12777_1	Basal type breast cancer cell line	Luminal type breast cancer cell line
p_12777_2	HER2 amplified breast cancer cell line	HER2 non-amplified breast cancer cell line
p_12806_1	"Dendritic cells,  Chlamydia pneumoniae infected"	"Dendritic cells, non infected MOCK control"
p_12814_1	female non-del(7q) fibroid; uterus cancer	female myometrium
p_12814_2	female with del(7q) fibroid; uterus cancer	female myometrium
p_12843_1	LM6 cell	AM3 cell
p_12846_1	"LEC, Prox1 silenced"	"LEC, control"
p_12846_2	"LEC, NR2F2 silenced"	"LEC, control"
p_12846_3	"LEC, NR2F2,Prox1 silenced"	"LEC, control"
p_12854_1	"OVCAR8, RIA transfectant"	"OVCAR8, control"
p_12854_2	"OVCAR8, RIIB transfectant"	"OVCAR8, control"
p_12875_1	"CD4+ T-cell, novel ICOS patient"	"CD4+ T-cell, normal"
p_12875_2	"CD4+ T-cell, novel ICOS patient, aCD28+aCD3 treated"	"CD4+ T-cell, normal, aCD28+aCD3 treated"
p_12886_1	"PLC/PRF/5 cells, WT1 specific siRNA duplexes transfected"	"PLC/PRF/5 cells, control siRNA duplexes transfected"
p_12891_1	"Outgrowth endothelial cell, differentiated from human umbilical cord blood derived-endothelial progenitor"	"endothelial progenitor cell, human umbilical cord blood derived, control"
p_12917_1	"human mammary epithelial cell, RhoA G14V"	"human mammary epithelial cell, control"
p_12917_2	"human mammary epithelial cell, RhoA T37A"	"human mammary epithelial cell, control"
p_12917_3	"human mammary epithelial cell, RhoA wild type"	"human mammary epithelial cell, control"
p_12949_1	Glioblastma Multiforme exposed to cilengitide for 8 hrs; treated	Glioblastma Multiforme with no exposure to cilengtide
p_12949_2	Glioblastma Multiforme exposed to cilengitide for 4 hrs; treated	Glioblastma Multiforme with no exposure to cilengtide
p_12963_1	"Human CD4+ T-lymphocyte, HIV Vpr- infected"	"Human CD4+ T-lymphocyte, GFP treated"
p_12963_2	"Human CD4+ T-lymphocyte, HIV Vpr+ infected"	"Human CD4+ T-lymphocyte, GFP treated"
p_12992_1	CTNNB1 mutant pediatric medulloblastoma; brain cancer	CTNNB1 WT pediatric medulloblastoma
p_12992_2	large cell/anaplastic pediatric medulloblastoma; brain cancer	classic pediatric medulloblastoma
p_12992_3	medullomyoblastoma; brain cancer	classic pediatric medulloblastoma
p_12992_4	nodular demoplastic pediatric medulloblastoma; brain cancer	classic pediatric medulloblastoma
p_13002_1	"multi oitent stromal cells, outside of colony"	"multi oitent stromal cells, inside of colony"
p_13027_1	"Endometrium, on day of oocyte retrieval, dated as d4 of the luteal phase by Noyes' criteria, not pregnant"	"Endometrium, on day of oocyte retrieval, dated as d2 or d3 of the luteal phase by Noyes' criteria, not pregnant"
p_13054_1	"HUVEC cell, empty adenovirus treated"	"HUVEC cell, control"
p_13054_2	"HUVEC cell, HLX expressing adenovirus treated"	"HUVEC cell, control"
p_13059_1	primary cells at 0h; tissue; time course	tissue at reference
p_13059_2	primary cells at 24h; tissue; time course	tissue at reference
p_13059_3	primary cells at 72h; tissue; time course	tissue at reference
p_13067_1	"primary colorectal adenocarcinoma, Microsatellite Instable"	"primary colorectal adenocarcinoma, Microsatellite Stable"
p_13073_1	"MSCs, Exposed to Keratinocyte Condition Medium, 30 days"	"MSCs, Exposed to Keratinocyte Growth Medium, 30 days"
p_13122_1	Lcl-balanced	Lcl-control
p_13122_2	Lcl-unbalanced	Lcl-control
p_13124_1	"MCF-7 cells, NSC76022 (thaspine) treated"	MCF-7 cells. DMSO control
p_13136_1	"MYC amplification, glioma; brain cancer"	No MYC amplified glioma
p_13136_2	1p del glioma; brain cancer	No 1p del glioma
p_13136_3	11q del glioma; brain cancer	No 11q del glioma
p_13136_4	17q gain glioma; brain cancer	No 17q gain glioma
p_13139_11	aortic endothelial cells treated with LOX1 oxLDL 24hr; time course	LOX1 Untreated 24hr
p_13139_12	aortic endothelial cells treated with LOX1 oxLDL 2hr; time course	LOX1 Untreated 2hr
p_13139_15	aortic endothelial cells LOX1 Untreated 24hr; time course	GFP Untreated 24hr
p_13139_16	aortic endothelial cells LOX1 Untreated 2hr; time course	GFP Untreated 2hr
p_13139_3	aortic endothelial cells treated with LOX1 oxLDL 24hr; time course	GFP oxLDL 24hr
p_13139_4	aortic endothelial cells treated with LOX1 oxLDL 2hr; time course	GFP oxLDL 2hr
p_13139_7	aortic endothelial cells treated with GFP oxLDL 24hr; time course	GFP Untreated 24hr
p_13139_8	aortic endothelial cells treated with GFP oxLDL 2hr; time course	GFP Untreated 2hr
p_13142_1	"HepG2/C3A cells, cultured in leucine-devoid DMEM (-LEU), 42h"	"HepG2/C3A cells, cultured in complete DMEM (+LEU), 42h"
p_13205_1	"muscle, septic; tissue"	"muscle, control"
p_13210_1	"Raji cell, CD9 transfected"	"Raji cell, control"
p_13218_1	"MCF10A cell, YAP wt infected"	"MCF10A cell, vector infected"
p_13218_2	"MCF10A cell, YAP-S94A infected"	"MCF10A cell, vector infected"
p_13218_3	"MCF10A cell, YAP-W1W2 infected"	"MCF10A cell, vector infected"
p_13218_4	MCF10A human mammary epithelial cell line with pQCXIH-YAP-S94A	MCF10A human mammary epithelial cell line with pQCXIH-YAP-WT
p_13218_5	MCF10A human mammary epithelial cell line with pQCXIH-YAP-W1W2	MCF10A human mammary epithelial cell line with pQCXIH-YAP-WT
p_13234_1	"Treg cell, THU"	"Treg cell, GFP , control"
p_13234_2	"Treg cell, FoxP3"	"Treg cell, GFP , control"
p_13234_3	"Treg cell, Garp"	"Treg cell, GFP , control"
p_13273_1	"SY5Y cell, control siLSD1 treated"	"SY5Y cell, control siRNA treated"
p_13274_1	Quiescent Ad-HER2-ki infected HMECs	Quiescent AD-GFP infected HMECs
p_13274_2	Quiescent Ad-HER2-ki infected HMECs	Quiescent Ad-HER2wt infected HMECs
p_13284_1	"CD34-derived erythroid progenitors, BCL11A-targeting siRNA"	"CD34-derived erythroid progenitors, non-targeting siRNA, control"
p_13294_1	"primary colorectal adenocarcinoma, Microsatellite Instable"	"primary colorectal adenocarcinoma, Microsatellite Stable"
p_13296_1	"DC cell, Anti-miR-155"	"DC cell, scramble LNA, control"
p_13296_2	"DC cell, Anti-miR-155, LPS treated"	"DC cell, scramble LNA, control, LPS treated"
p_13300_1	"new emigrant B cells, non stimulated"	"mature naive B cells, non stimulated"
p_13307_1	"hNPC cell, derived from VM"	"hNPC cell, derived from CTX"
p_13309_1	"A549 cells, treated with Tobacco smoking condensate, 0.0005puffs/ml"	"A549 cells, control"
p_13309_2	"A549 cells, treated with Tobacco smoking condensate, 0.001puffs/ml"	"A549 cells, control"
p_13309_3	"A549 cells, treated with Tobacco smoking condensate, 0.003puffs/ml"	"A549 cells, control"
p_13309_4	"Calu-6 cells, treated with Tobacco smoking condensate, 0.0005puffs/ml"	"Calu-6 cells, control"
p_13309_5	"Calu-6 cells, treated with Tobacco smoking condensate, 0.001puffs/ml"	"Calu-6 cells, control"
p_13309_6	"Calu-6 cells, treated with Tobacco smoking condensate, 0.003puffs/ml"	"Calu-6 cells, control"
p_13314_1	"Pulmonary mucosa-associated lymphoid tissue (MALT), MALT lymphoma"	"Pulmonary mucosa-associated lymphoid tissue (MALT), normal"
p_13314_2	IgH-MALT1 lymphoma; cancer	None pulmonary lymphoma
p_13315_1	"721 lymphoblastoid cells, DomNeg1-encoding retroviral vector, EBNA1 inhibition"	"721 lymphoblastoid cells, empty retroviral vector"
p_13319_1	Leiomyoma; uterus cancer	Myometrium
p_13330_1	"Human Foreskin BJ fibroblasts, late passage"	"Human Foreskin BJ fibroblasts, young passage"
p_13330_2	"Human Foreskin BJ fibroblasts, bleomycin treated"	"Human Foreskin BJ fibroblasts, young passage"
p_13351_1	"precursor-B acute lymphoblastic leukemia (ALL), subtype: TEL-AML1; blood cancer"	T-acute lymphoblastic leukemia (ALL)
p_13351_2	"precursor-B  acute lymphoblastic leukemia (ALL), subtype: Hyperdiploid; blood cancer"	T-acute lymphoblastic leukemia (ALL)
p_13351_3	"precursor-B acute lymphoblastic leukemia (ALL), subtype: E2A-rearranged; blood cancer"	T-acute lymphoblastic leukemia (ALL)
p_13351_4	"precursor-B acute lymphoblastic leukemia (ALL), subtype: MLL; blood cancer"	T-acute lymphoblastic leukemia (ALL)
p_13351_5	"precursor-B acute lymphoblastic leukemia (ALL), subtype: other; blood cancer"	T-acute lymphoblastic leukemia (ALL)
p_13353_1	"aneurysm, ruptured aneurysm"	"aneurysm, unruptured aneurysm"
p_13355_1	"non-lesional skin, psoriatic patient"	Normal skin
p_13355_2	"lesional skin, psoriatic patient"	Normal skin
p_13367_1	"Human colonic mucosa biopsy, UC inflamed"	"Human colonic mucosa biopsy, control"
p_13367_2	"Human colonic mucosa biopsy, UC non-inflamed"	"Human colonic mucosa biopsy, control"
p_13367_3	UC inflamed colonocyte	normal colonocytes
p_13367_4	UC non-inflamed colonocyte	normal colonocytes
p_13367_5	Collagen colitis colon tissue	normal colon
p_13367_6	Collagen colitis colonocyte	normal colonocytes
p_13378_1	"HET-1A cell, exposed to DCA, 4h"	"HET-1A cell, control, 4h"
p_13378_2	"HET-1A cell, exposed to DCA, 8h"	"HET-1A cell, control, 8h"
p_13378_3	"HET-1A cell, exposed to DCA, 12h"	"HET-1A cell, control, 12h"
p_13378_4	"HET-1A cell, exposed to DCA, 24h"	"HET-1A cell, control, 24h"
p_13396_1	"PBE cell, mock infected, asthmatic patient"	"PBE cell, mock infected, normal"
p_13396_2	"PBE cell, HRV infected, asthmatic patient"	"PBE cell, HRV infected, normal"
p_13396_3	"mock-infected PBE cells, asthmatic; treat"	"mock-infected PBE cells, normal"
p_13396_4	"HRV-infected PBE cells, asthmatic; treat"	"HRV-infected PBE cells, normal"
p_13401_1	"DLBCL cell, PU-H71 exposed , 6h"	"DLBCL cell, control"
p_13401_2	"DLBCL cell, PU-H71 exposed , 12h"	"DLBCL cell, control"
p_13434_1	"Hela cell, aiRNA treated"	"Hela cell, mock treated"
p_13434_2	"Hela cell, siRNA treated"	"Hela cell, mock treated"
p_13458_1	"MCF-7 cell, luciferase ko, Estradiol treated"	"MCF-7 cell, luciferase ko, control"
p_13458_2	"MCF-7 cell, NMNAT1 ko, Estradiol treated"	"MCF-7 cell, NMNAT1 ko, control"
p_13458_3	MCF-7 cells_NMNAT1 knockdown_E2; treated	MCF-7 cells_luciferase knockdown_E2
p_13458_4	MCF-7 cells_NMNAT1 knockdown_control; treated	MCF-7 cells_luciferase knockdown_control
p_13471_1	Colon tumor	Normal colon
p_13475_1	"choriocarcinoma cells, STOX1 overexpression"	"choriocarcinoma cells, control"
p_13477_1	"MCF7 cells, ARC treated, 2uM, 24h"	"MCF7 cells, control"
p_13477_2	"MCF7 cells, Sangivamycin treated, 2uM, 24h"	"MCF7 cells, control"
p_13477_3	"MCF7 cells,  Doxorubicin treated, 2uM, 24h"	"MCF7 cells, control"
p_13487_1	RAF inhibitor-1 treatment of A375 parental cells	DMSO treatment of A375 parental cells
p_13487_10	No treatment of A375 shBRAF-2 cells	No treatment of A375 shGFP cells
p_13487_11	No treatment of A375 shBRAF-1 cells	No treatment of A375 shGFP cells
p_13487_2	BAY-43-9006 treatment of A375 parental cells	DMSO treatment of A375 parental cells
p_13487_3	RAF inhibitor-1 treatment of A375 shBRAF-2 cells	No treatment of A375 shBRAF-2 cells
p_13487_4	BAY-43-9006 treatment of A375 shBRAF-2 cells	No treatment of A375 shBRAF-2 cells
p_13487_5	Doxycycline treatment of A375 shBRAF-2 cells	No treatment of A375 shBRAF-2 cells
p_13487_6	RAF inhibitor-1 treatment of A375 shBRAF-1 cells	No treatment of A375 shBRAF-1 cells
p_13487_7	Doxycycline treatment of A375 shBRAF-1 cells	No treatment of A375 shBRAF-1 cells
p_13487_8	RAF inhibitor #2 treatment of A375 shGFP cells	No treatment of A375 shGFP cells
p_13487_9	Doxycycline treatment of A375 shGFP cells	No treatment of A375 shGFP cells
p_13488_1	"peripheral blood leukocyte, late respiratory recovery"	"peripheral blood leukocyte, early respiratory recovery"
p_13491_1	"Umbrilical cord blood derived MSC, differentiated state"	"Umbrilical cord blood derived MSC, native state"
p_13501_1	"PBMC, enthesitis-related arthritis; tissue"	"PBMC, control"
p_13501_2	"PBMC, persistent oligoarthritis; tissue"	"PBMC, control"
p_13501_3	"PBMC, RF- polyarthritis; tissue"	"PBMC, control"
p_13501_4	"PBMC, systemic; tissue"	"PBMC, control"
p_13503_1	"U937 cells, hyperthermia treated, 0h"	"U937 cells, control"
p_13503_2	"U937 cells, hyperthermia treated, 1h"	"U937 cells, control"
p_13503_3	"U937 cells, hyperthermia treated, 3h"	"U937 cells, control"
p_13503_4	"U937 cells, hyperthermia treated, 6h"	"U937 cells, control"
p_13504_1	"Saos2 cell, p53 treated"	"Saos2 cell, GFP treated"
p_13504_2	"Saos2 cell, TAp73beta treated"	"Saos2 cell, GFP treated"
p_13525_1	"epithelial ovarian cancer, carboplatin 24hr; treat; time course"	"epithelial ovarian cancer, control 24hr"
p_13525_2	"epithelial ovarian cancer, carboplatin 30hr; treat; time course"	"epithelial ovarian cancer, control 30hr"
p_13525_3	"epithelial ovarian cancer, carboplatin 36hr; treat; time course"	"epithelial ovarian cancer, control 36hr"
p_13548_1	"HeLa, glucose-free 15hr; treated; time course"	"HeLa, normal growth 15hr"
p_13548_10	"HT29, glucose-free 18hr; treated; time course"	"HT29, normal growth 18hr"
p_13548_11	"HT29, glucose-free & VST 18hr; treated; time course"	"HT29, normal growth & VST 18hr"
p_13548_12	"HT1080, glucose-free 18hr; treated; time course"	"HT1080, normal growth 18hr"
p_13548_13	"HT1080, glucose-free &VST 18hr; treated; time course"	"HT1080, normal growth & VST 18hr"
p_13548_14	"HT1080, 2-deoxyglucose & buformin18hr; treated; time course"	"HT1080, normal growth & buformin 18hr"
p_13548_15	"HT1080, 2-deoxyglucose & metformin 18hr; treated; time course"	"HT1080, normal growth & metformin 18hr"
p_13548_16	"HT1080, 2-deoxyglucose & phenformin 18hr; treated; time course"	"HT1080, normal growth & phenformin 18hr"
p_13548_17	"HT1080, 2-deoxyglucose & pyrvinium pamoate 18hr; treated; time course"	"HT1080, normal growth & pyrvinium pamoate 18hr"
p_13548_18	"HT1080, 2-deoxyglucose & VST 18hr; treated; time course"	"HT1080, 2-deoxyglucose 18hr"
p_13548_19	"HT1080, 2-deoxyglucose & buformin18hr; treated; time course"	"HT1080, 2-deoxyglucose 18hr"
p_13548_2	"HeLa, glucose-free & buformin15hr; treated; time course"	"HeLa, normal growth 15hr"
p_13548_20	"HT1080, 2-deoxyglucose & metformin 18hr; treated; time course"	"HT1080, 2-deoxyglucose 18hr"
p_13548_21	"HT1080, 2-deoxyglucose & phenformin 18hr; treated; time course"	"HT1080, 2-deoxyglucose 18hr"
p_13548_22	"HT1080, 2-deoxyglucose & pyrvinium pamoate 18hr; treated; time course"	"HT1080, 2-deoxyglucose 18hr"
p_13548_23	"HT1080, tunicamycin & VST 18hr; treated; time course"	"HT1080,  tunicamycin 18hr"
p_13548_24	"MKN74, glucose-free"	"MKN74, normal growth 18hr"
p_13548_25	"MKN74, glucose-free & VST 18hr; treated; time course"	"MKN74, normal growth & VST 18hr"
p_13548_3	"HeLa, glucose-free & metformin15hr; treated; time course"	"HeLa, normal growth 15hr"
p_13548_4	"HeLa, glucose-free & phenformin_15h; treated; time course"	"HeLa, normal growth 15hr"
p_13548_5	"HeLa, glucose-free 18hr; treated; time course"	"HeLa, normal growth 18hr"
p_13548_6	"HeLa, glucose-free & VST 18hr; treated; time course"	"HeLa, normal growth & VST 18hr"
p_13548_7	"HeLa, 2-deoxyglucose 18h; treated; time course"	"HeLa, normal growth 18hr"
p_13548_8	"HeLa, 2-deoxyglucose & VST 18h; treated; time course"	"HeLa, 2-deoxyglucose 18h"
p_13548_9	"HeLa, tunicamycin_18h; treated; time course"	"HeLa, normal growth 18hr"
p_13568_1	"M5 cells, enhanced metastatic abilities to liver"	"SW480 cells, relatively low metastatic abilities to liver"
p_13576_1	"white blood cell, pediatric acute leukemia, early relapse"	"white blood cell, pediatric acute leukemia, no relapse"
p_13576_2	"white blood cell, pediatric acute leukemia, late relapse"	"white blood cell, pediatric acute leukemia, no relapse"
p_13576_3	"white blood cell, pediatric acute leukemia, late relapse"	"white blood cell, pediatric acute leukemia, early relapse"
p_13604_1	"hMSC, BMP6 treated, 8h"	"hMSC, control"
p_13606_1	"human dermal skin fibroblasts, treatead with PAPC, 100ug/ml, 4h"	"human dermal skin fibroblasts, control"
p_13606_2	"human dermal skin fibroblasts, treatead with OXPAPC, 100ug/ml, 4h"	"human dermal skin fibroblasts, control"
p_13606_3	"human dermal skin fibroblasts, treatead with UV-PAPC"	"human dermal skin fibroblasts, control"
p_13606_4	"human dermal skin fibroblasts, treatead with UVA-1, 4h"	"human dermal skin fibroblasts, control"
p_13606_5	"human dermal skin fibroblasts, treatead with RB-PAPC"	"human dermal skin fibroblasts, control"
p_13637_1	"HUVEC, FPV-infected"	"HUVEC, untreated control"
p_13637_10	FPV-infected IKK2kd-transfected HUVEC	FPV-infected HUVEC
p_13637_11	FPV-infected pEGZ-transfected HUVEC	FPV-infected HUVEC
p_13637_12	H5N1-infected IKK2kd-transfected HUVEC	H5N1-infected HUVEC
p_13637_13	H5N1-infected pEGZ-transfected HUVEC	H5N1-infected HUVEC
p_13637_14	PR8-infected IKK2kd-transfected HUVEC	PR8-infected HUVEC
p_13637_15	PR8-infected pEGZ-transfected HUVEC	PR8-infected HUVEC
p_13637_2	"HUVEC, PR8-infected"	"HUVEC, untreated control"
p_13637_3	"HUVEC, H5N1-infected"	"HUVEC, untreated control"
p_13637_4	"IKK2kd-transfected HUVEC, H5N1-infected,"	"pEGZ-transfected HUVEC,H5N1-infected, control"
p_13637_5	"IKK2kd-transfected HUVEC, FPV-infected,"	"pEGZ-transfected HUVEC, FPV-infected, control"
p_13637_6	"IKK2kd-transfected HUVEC, PR8-infected,"	"pEGZ-transfected HUVEC, PR8-infected, control"
p_13637_7	PR8-infected HUVEC	HUVEC control
p_13637_8	PR8-infected IKK2kd-transfected HUVEC	HUVEC control
p_13637_9	PR8-infected pEGZ-transfected HUVEC	HUVEC control
p_13639_1	"HeLa, siDrosha 24hr; siRNA treated; time course"	"HeLa, siGFP 24hr"
p_13639_2	"HeLa, siCGCR8 24hr; siRNA treated; time course"	"HeLa, siGFP 24hr"
p_13639_3	"HeLa, siDrosha 48hr; siRNA treated; time course"	"HeLa, siGFP 48hr"
p_13639_4	"HeLa, siCGCR8 48hr; siRNA treated; time course"	"HeLa, siGFP 48hr"
p_13662_1	"MM1S, Zalypsis; treated"	"MM1S, control"
p_13662_2	"OPM1, Zalypsis; treated"	"OPM1, control"
p_13670_1	"human monocyte-derived macrophages, S. aureus-treated, 8h"	"human monocyte-derived macrophages, control, 8h"
p_13670_2	"human monocyte-derived macrophages, S. aureus-treated, 24h"	"human monocyte-derived macrophages, control, 24h"
p_13670_3	"human monocyte-derived macrophages, S. aureus-treated, 48h"	"human monocyte-derived macrophages, control, 48h"
p_13671_1	"Breast epithelial cell, BRCA1 carrier"	"Breast epithelial cell, control"
p_13712_1	"HUVEC, old, static"	"HUVEC, young, static"
p_13712_2	"HUVEC, old, shear"	"HUVEC, young, shear"
p_13712_3	"HUVECs, young & shear; tissue"	"HUVECs, young & static"
p_13712_4	"HUVECs, old & shear; tissue"	"HUVECs, old & static"
p_13715_1	"NP cell, 2d before differentiation"	"NP cell, neural sphere"
p_13715_2	"NP cell, 3d before differentiation"	"NP cell, neural sphere"
p_13715_3	"NP cell, 2d after differentiation"	"NP cell, neural sphere"
p_13715_4	"NP cell, 3d after differentiation"	"NP cell, neural sphere"
p_13732_1	"CD4+ Tcells, Clinically Isolated Syndrome (CIS)"	"CD4+ Tcells, healthy control"
p_13732_2	"CD4+ Tcells, Clinically Isolated Syndrome (CIS), resampled after 1 year"	"CD4+ Tcells, healthy control, resampled after 1 year"
p_13736_1	"HUVEC, S. aureus infected, septic patient"	"HUVEC, positive control"
p_13736_2	"HUVEC, S. aureus infected, septic patient"	"HUVEC, negative control"
p_13736_3	"HUVEC, S. aureus infected, septic patient"	"HUVEC, S. aureus infected, normal people"
p_13738_1	"T cell, directly activated"	"T cell, control"
p_13738_2	"T cell, bystander activated"	"T cell, control"
p_13762_1	"5d immature dendritic cell,  treated with 1,25-vitD,  10 nM, 5 days"	"5d immature dendritic cell, treated with vehicle, 5 days"
p_13762_2	"26h differentiating human dendritic cell, treated with 1,25-vitD for 12h, 10 nM 1,25-vitD added 14h after separation"	"26h differentiating human dendritic cell, vehicle treated, 12h, vehicle added 14h after separation"
p_13763_1	"IGROV cell, CXCR4 silenced"	"IGROV cell, control"
p_13763_2	"IGROV-1, shCXCR4-2; shRNA treated"	"IGROV-1, control"
p_13763_3	"IGROV-1, shCXCR4-1; shRNA treated"	"IGROV-1, mock"
p_13763_4	"IGROV-1, shCXCR4-2; shRNA treated"	"IGROV-1, mock"
p_13787_1	"Breast cancer sample, basal-like"	"Breast cancer sample, her2+"
p_13791_1	Fibroblasts infected with T. cruzi	Fibroblasts uninfected control
p_13791_2	Fibroblasts on infected transwell top	Fibroblasts on control transwell top
p_13791_3	Endothelial cells infected with T. cruzil	Endothelial cells uninfected control
p_13791_4	Endothelial cells on infected transwell top	Endothelial cells on control transwell top
p_13791_5	Smooth muscle cells infected with T. cruzi for 24 h	"Smooth muscle cells uninfected control, 24 h"
p_13791_6	Smooth muscle cells infected with T. cruzi for 48 h	"Smooth muscle cells uninfected control, 48 h"
p_13806_1	"MDA-MB-231 cell, sFRP1 treated, in vitro"	"MDA-MB-231 cell, control, in vitro"
p_13806_2	"MDA-MB-231 cell, sFRP1 treated, in vivo"	"MDA-MB-231 cell, control, in vivo"
p_13811_1	"chronic lymphocytic leukemia (CLL), NLC 14days; treated"	"chronic lymphocytic leukemia (CLL), control"
p_13816_1	"PBMC, from SJS patients"	"blister cells, from SJS patients"
p_13818_1	786-O cells treated with compound 40	786-O cells treated with DMSO
p_13818_2	786-O cells treated with compound 41	786-O cells treated with DMSO
p_13818_3	786-O cells treated with compound 76	786-O cells treated with DMSO
p_13818_4	786-O cells treated with compound 77	786-O cells treated with DMSO
p_13818_5	HIF-2a shRNAi in 786-O cells; treated	shRNA vector only control 786-O cells (pTV)
p_13818_6	VHL reconstituted 786-O cells (WT8); treated	Vector only 786-O cells (PRC3)
p_13827_1	"Melanocyte, BRAF treated"	"Melanocyte, control"
p_13828_1	iPSC derived from SMA (Spinal muscular atrophy)	human embryonic stem cell line
p_13828_2	iPSC derived from SMA (Spinal muscular atrophy)	"Human Fibroblast cells, SMA patients"
p_13837_1	"rheumatoid arthritis (RA) patient, TGF stimulated 1hr; treated; time course"	"RA patient, TGF stimulated 0hr"
p_13837_10	"osteoarthritis (OA) patient, TNF  stimulated 1hr; treated; time course"	"OA patient, TNF  stimulated 0hr"
p_13837_11	"osteoarthritis (OA) patient, TGF stimulated 2hr; treated; time course"	"OA patient, TGF stimulated 0hr"
p_13837_12	"osteoarthritis (OA) patient, TNF  stimulated 2hr; treated; time course"	"OA patient, TNF  stimulated 0hr"
p_13837_13	"osteoarthritis (OA) patient, TGF stimulated 4hr; treated; time course"	"OA patient, TGF stimulated 0hr"
p_13837_14	"osteoarthritis (OA) patient, TNF  stimulated 4hr; treated; time course"	"OA patient, TNF  stimulated 0hr"
p_13837_15	"osteoarthritis (OA) patient, TGF stimulated 12hr; treated; time course"	"OA patient, TGF stimulated 0hr"
p_13837_16	"osteoarthritis (OA) patient, TNF  stimulated 12hr; treated; time course"	"OA patient, TNF  stimulated 0hr"
p_13837_2	"rheumatoid arthritis (RA) patient, TNF  stimulated 1hr; treated; time course"	"RA patient, TNF  stimulated 0hr"
p_13837_3	"rheumatoid arthritis (RA) patient, TGF stimulated 2hr; treated; time course"	"RA patient, TGF stimulated 0hr"
p_13837_4	"rheumatoid arthritis (RA) patient, TNF  stimulated 2hr; treated; time course"	"RA patient, TNF  stimulated 0hr"
p_13837_5	"rheumatoid arthritis (RA) patient, TGF stimulated 4hr; treated; time course"	"RA patient, TGF stimulated 0hr"
p_13837_6	"rheumatoid arthritis (RA) patient, TNF  stimulated 4hr; treated; time course"	"RA patient, TNF  stimulated 0hr"
p_13837_7	"rheumatoid arthritis (RA) patient, TGF stimulated 12hr; treated; time course"	"RA patient, TGF stimulated 0hr"
p_13837_8	"rheumatoid arthritis (RA) patient, TNF  stimulated 12hr; treated; time course"	"RA patient, TNF  stimulated 0hr"
p_13837_9	"osteoarthritis (OA) patient, TGF stimulated 1hr treated; time course"	"OA patient, TGF stimulated 0hr"
p_13849_1	"PBMC, RF- polyarthritis; blood tissue"	"PBMC, control"
p_13849_2	"PBMC, RF+ polyarthritis; blood tissue"	"PBMC, control"
p_13887_1	"T cells, stimulated through CD3/CD28, 24h"	"T cells, unstimulated"
p_13887_2	"T cells, stimulated through Nitric Oxide (NOC-18), 600uM, 24h"	"T cells, unstimulated"
p_13887_3	"T cells, unstimulated, SLE (Lupus) patients"	"T cells, unstimulated"
p_13896_1	"alveolar macrophages, chronic obstructive pulmonary disease (COPD); tissue"	"alveolar macrophages, non-smoker"
p_13896_2	"alveolar macrophages, smoker; tissue"	"alveolar macrophages, non-smoker"
p_13899_1	"CD14+ monocytes, daily supplimentation of quercetin, 150mg per day, 2 weeks"	"CD14+ monocytes, untreated"
p_13904_1	"White blood cell, SIRS"	"White blood cell, normal"
p_13904_2	"White blood cell, sepsis"	"White blood cell, normal"
p_13904_3	"White blood cell, septic shock"	"White blood cell, normal"
p_13904_4	children sepsis day3; treated	"children, control"
p_13904_5	children septic shock day1; treated	"children, control"
p_13904_6	children septic shock day3; treated	"children, control"
p_13904_7	children SIRS resolved day3; treated	"children, control"
p_13906_1	"Gamma delta T cell, nasal T cell lymphoma"	"Gamma delta T cell, normal"
p_13906_2	"Gamma delta T cell, chronic active EBV infection"	"Gamma delta T cell, normal"
p_13906_3	Gamma-delta T cell line derived from patient with nasal T cell lymphoma; treat	Normal lymphocyte
p_13906_4	Gamma-delta T cell line derived from patient with chronic active EBV infection	Normal lymphocyte
p_13909_1	IL-2 dependent normal PB T lymphocytes after IL-2 withdrawal treated	IL-2 dependent normal peripheral blood T lymphocytes from IL-2-containing cultures
p_13909_2	spontaneously immortalised T lymphocytes after IL-2 withdrawal treated	spontaneously immortalised normal spleen-derived T lymphocytes from IL-2-containing cultures
p_13909_3	"spontaneously immortalised T lymphocytes of NBS patient, after IL-2 withdrawal treated"	"spontaneously immortalised PBMC-derived T lymphocytes of NBS patient, from IL-2-containing cultures"
p_13911_1	Gastric tumor tissue	Adjacent normal tissue
p_13911_2	MSI gastric tumor; stomach cancer	MSS gastric tumor
p_13917_1	"anergic naive B cells, Rheumatoid Arthritis patients, unstimulated"	"mature naive B cells, Rheumatoid Arthritis patients, unstimulated"
p_13917_2	"anergic naive B cells, Common Variable Immunodeficiency Disease patients, unstimulated"	"mature naive B cells, Common Variable Immunodeficiency Disease patients, unstimulated"
p_13931_1	"small airway epithelial cells, normal smokers"	"small airway epithelial cells, healthy non-smokers"
p_13931_2	"alveolar macrophages, normal smoker"	"alveolar macrophages, healthy non-smoker"
p_13933_1	"small airways, smoker; lung tissue"	"small airways, non-smoker"
p_13933_2	"trachea, smoker; lung tissue"	"trachea, non-smoker"
p_13975_1	MGIO labelled fMSC	"fMSC, control"
p_13975_2	Ferucarbutran labelled fMSC	"fMSC, control"
p_13985_1	"white blood cells, Familial hypercholesterolemia"	"white blood cells, control"
p_13987_1	"chronic lymphocytic leukemia (CLL) donor, rolipram treated"	"chronic lymphocytic leukemia (CLL) donor, control"
p_13987_2	"B cell donor, rolipram treated"	"B cell donor, control"
p_13987_3	"T cell donor, rolipram treated"	"T cell donor, control"
p_14000_1	"monocyte-derived dendritic cells, total RNA, 0h"	"monocyte-derived dendritic cells, polysomal RNA, 0h"
p_14000_2	"monocyte-derived dendritic cells, total RNA, 4h"	"monocyte-derived dendritic cells, polysomal RNA, 4h"
p_14000_3	"monocyte-derived dendritic cells, total RNA, 16h"	"monocyte-derived dendritic cells, polysomal RNA, 16h"
p_14000_4	LPS stimulated monocyte-derived dendritic cells; 16h total RNA	0h_TotRNA
p_14001_1	"Ovarian serous carcinoma, low-grade"	"human ovarian epithelial cells (HOSE), normal control"
p_14001_2	"Ovarian serous carcinoma, high-grade"	"human ovarian epithelial cells (HOSE), normal control"
p_14011_1	"H929 cells, pristimerin treated, 500nM, 4h"	"H929 cells, DMSO treated, 4h, control"
p_14017_1	"breast cancer, bone metastasis"	"breast cancer, lung metastasis"
p_14017_2	"breast cancer, brain metastasis"	"breast cancer, lung metastasis"
p_14017_3	"breast cancer, brain metastasis"	"breast cancer, bone metastasis"
p_14054_1	"HeLa cell, Imp8siRNA, total RNA"	"HeLa cell, control, total RNA"
p_14054_2	"HeLa cell, TNRC6Bsi, total RNA"	"HeLa cell, control, total RNA"
p_14054_3	"HeLa cell, Imp8siRNA, Iped RNA"	"HeLa cell, control, Iped RNA"
p_14062_1	"White blood cell, ALL with MLL"	"White blood cell, ALL without MLL"
p_14062_2	"White blood cell, AML with MLL"	"White blood cell, AML without MLL"
p_14103_1	"HCT116, Nocodazole 7hr; cell line treatment; time course"	"HCT116, control 7hr"
p_14103_2	"HCT116, Nocodazole 8hr; cell line treatment; time course"	"HCT116, control 8hr"
p_14103_3	"HCT116, Nocodazole 9hr; cell line treatment; time course"	"HCT116, control 9hr"
p_14103_4	"HCT116, Nocodazole 10hr; cell line treatment; time course"	"HCT116, control 10hr"
p_14231_1	"833K cell, cisplatin resistant"	"833K cell, control"
p_14231_2	"GCT27 cell, cisplatin resistant"	"GCT27 cell, control"
p_14231_3	"Susa cell, cisplatin resistant"	"Susa cell, control"
p_14245_1	"saliva, early pancreatic cancer"	"saliva, healthy control"
p_14257_1	"HT29 cells, HERV-HX knock-down"	"HT29 cells, control"
p_14278_1	"CD4+ T cells, HIV resistant"	"CD4+ T cells, HIV high-risk negative"
p_14302_1	"P493-6 cell, Lin28B vector, Tet- , Myc+"	"P493-6 cell, empty vector, Tet- , Myc+"
p_14302_2	"P493-6 cell, Lin28B vector, Tet+ , Myc-"	"P493-6 cell, empty vector, Tet+ , Myc-"
p_14302_3	P493-6 MSCV-Lin28B +tet (low Myc) treated	"P493-6 MSCV-empty, low Myc"
p_14302_4	P493-6 MSCV-Lin28B -tet (high Myc) treated	"P493-6 MSCV-empty, high Myc"
p_14315_1	"A549 cell line, aza treatment"	"A549 cell line, untreated"
p_14315_10	"SW2 Cell line, aza treatment"	"SW2 Cell line, untreated"
p_14315_2	"H460 Cell line, aza treatment"	"H460 Cell line, untreated"
p_14315_3	"H125 Cell line, aza treatment"	"H125 Cell line, untreated"
p_14315_4	"ZL25 Cell line, aza treatment"	"ZL25 Cell line, untreated"
p_14315_5	"Calu3 Cell line, aza treatment"	"Calu3 Cell line, untreated"
p_14315_6	"Hotz Cell line, aza treatment"	"Hotz Cell line, untreated"
p_14315_7	"U1752 Cell line, aza treatment"	"U1752 Cell line, untreated"
p_14315_8	"Calu1 Cell line, aza treatment"	"Calu1 Cell line, untreated"
p_14315_9	"Calu6 Cell line, aza treatment"	"Calu6 Cell line, untreated"
p_14328_1	"Kidney allograft biopsy, stable"	"Kidney allograft biopsy, acute rejection"
p_14346_1	"Peripheral blood, kidney transplant recipients, AR(presence of acute rejection)"	"Peripheral blood, kidney transplant recipients, STA(absence of acute rejection)"
p_14378_1	"pulmonary metastases, late; kidney cancer"	"pulmonary metastases, early"
p_14378_2	"pulmonary metastases, multiple; kidney cancer"	"pulmonary metastases, only few"
p_14380_1	"LS174T cell, CDX1 silenced"	"LS174T cell, control"
p_14380_2	"HCT116 cell, CDX1 silenced"	"HCT116 cell, control"
p_14386_1	"PBMC, CIS patients, Interferon beta-1a-induced"	"PBMC, CIS patients, control"
p_14390_1	"Human alveolar macrophage, control"	"Human alveolar macrophage, control"
p_14405_1	TEM4-18 cells; cell line	PC3 cells
p_14405_2	TEM205 cells; cell line	PC3 cells
p_14407_1	ovarian cancer epithelial cells	"Ovarian Surface Epithelium, Normal"
p_14429_1	"HEK293 cell, Epoxomicin treatec, 1h"	"HEK293 cell, control"
p_14429_2	"HEK293 cell, Epoxomicin treatec, 6h"	"HEK293 cell, control"
p_14434_1	"HeLa cell,anti-PCSK9 silenced"	"HeLa cell, control"
p_14434_2	"HeLa cell,anti-PCSK9 Adaptor treated"	"HeLa cell, control"
p_14461_1	"normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment, 1 month"	"BEAS-2B; DMSO treatment, 1 month"
p_14461_2	"normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment, 2 months"	"BEAS-2B; DMSO treatment, 2 months"
p_14461_3	"normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment, 3 months"	"BEAS-2B; DMSO treatment, 3 months"
p_14461_4	"normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment, 4 months"	"BEAS-2B; DMSO treatment, 4 months"
p_14461_5	"normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment, 5-aza"	normal human bronchial epithelial cells (BEAS-2B); cigarette smoking condensate treatment
p_14461_6	normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: aza	normal human bronchial epithelial cells (BEAS-2B); Treatment: dmso; Demethylation: none
p_14461_7	normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: aza	normal human bronchial epithelial cells (BEAS-2B); Treatment: untreated; Demethylation: none
p_14464_1	"PC3 cell, PUR alpha treated"	"PC3 cell, mock treated"
p_14464_2	"LNCaP cell, PUR alpha treated"	"LNCaP cell, vector treated"
p_14465_1	"PMN cell, inflammation"	"PMN cell, control"
p_14465_2	"PMN cell, inflammation, CGS treated"	"PMN cell, inflammation"
p_14465_3	"PMN cell, inflammation, PGE2 treated"	"PMN cell, inflammation"
p_14465_4	"PMN cell, inflammation, RO, F_ treated"	"PMN cell, inflammation"
p_14468_1	acute myeloid leukemia (AML) 11q23; blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_10	acute myeloid leukemia (AML) t(6;9); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_11	acute myeloid leukemia (AML) t(8;21); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_12	acute myeloid leukemia (AML) t(9;22); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_3	acute myeloid leukemia (AML) -9q; blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_4	acute myeloid leukemia (AML) abn(3q); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_5	acute myeloid leukemia (AML) Complex karyotype; blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_6	acute myeloid leukemia (AML) idt(16); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_7	acute myeloid leukemia (AML) MDS -7(q); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_8	acute myeloid leukemia (AML) MDS complex; blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14468_9	acute myeloid leukemia (AML) t(15;17); blood cancer	acute myeloid leukemia (AML) NN karyotype
p_14474_1	"Human embryonic cell, magnetic field, 1d"	"Human embryonic cell, control"
p_14474_2	"Human embryonic cell, magnetic field, continuous day"	"Human embryonic cell, control"
p_14474_3	"Human embryonic cell, magnetic field, continuous day, recover 1d"	"Human embryonic cell, control"
p_14479_1	"acute myeloid leukemia (AML), CEBPA mutant; blood cancer"	"acute myeloid leukemia (AML), CEBPA silenced"
p_14479_2	acute myeloid leukemia (AML) blasts; blood cancer	T-acute lymphoblastic leukemia (ALL) blasts
p_14491_1	"MDA-MB-231 cell, shGFP, TGF beta treated"	"MDA-MB-231 cell, shGFP, untreated"
p_14491_2	"MDA-MB-231 cell, shp53, untreated"	"MDA-MB-231 cell, shGFP, untreated"
p_14491_3	"MDA-MB-231 cell, shp53, TGF beta treated"	"MDA-MB-231 cell, shGFP, untreated"
p_14491_4	"MDA shp53, TGFbeta treated; siRNA treatment"	"MDA shGFP, TGFbeta treated"
p_14507_1	"A549 cell, miR-7 treated"	"A549 cell, control"
p_14509_1	"Human pancreatic adenocarcinoma cells (BxPC3), on the chick-chorio-allantoic membrane, day6"	"Human pancreatic adenocarcinoma cells (BxPC3), on the chick-chorio-allantoic membrane, day1"
p_14519_12	"KMS11 cell, DAR treated, 24h"	KMS11 cell
p_14519_14	"KMS11 cell, ATO treated, 24h"	KMS11 cell
p_14519_17	"8226/S cell, DAR treated, 24h"	8226/S cell
p_14519_19	"8226/S cell, ATO treated, 24h"	8226/S cell
p_14519_2	"U266 cell, DAR treated, 24h"	"U266 cell, control"
p_14519_4	"U266 cell, ATO treated, 24h"	"U266 cell, control"
p_14519_7	"MM.1s cell, DAR treated, 24h"	MM.1s cell
p_14519_9	"MM.1s cell, ATO treated, 24h"	MM.1s cell
p_14526_1	"SW480 cell, aza 0, tsa 0 treated"	"HCT116 cell, aza 0, tsa 0 treated"
p_14526_2	"SW480 cell, aza 3, tsa 0 treated"	"HCT116 cell, aza 3, tsa 0 treated"
p_14526_3	"SW480 cell, aza 3, tsa 300 treated"	"HCT116 cell, aza 3, tsa 300 treated"
p_14526_4	SW480_aza3_tsa300; treat	SW480_aza0_tsa0
p_14526_5	Fetal colon	Adult normal colon
p_14537_1	"HEK293 cells, MOCK, AGO2-IP RNA; treated"	"HEK293 cells, MOCK, control"
p_14537_2	"HEK293 cells, miR-7 AGO2-IP RNA; siRNA treated"	"HEK293 cells, miR-7, control"
p_14537_3	"HEK293 cells, miR-124, AGO2-IP RNA; siRNA treated"	"HEK293 cells, miR-124, control"
p_14537_4	"HEK293 cells, miR-7 transfected; siRNA treated"	"HEK293 cells, MOCK transfected"
p_14537_5	"HEK293 cells, miR-124 transfected; siRNA treated"	"HEK293 cells, MOCK transfected"
p_14538_1	"Caco2 cell, 5-ASA treated"	"Caco2 cell, control"
p_14580_1	"Colon cell, UC disease, infliximab response"	"Colon cell, control"
p_14580_2	"Colon cell, UC disease, infliximab non-response"	"Colon cell, control"
p_14596_1	"Primary T cells, 1-day activated T cells"	"Primary T cell, Quiescent"
p_14596_2	"Primary T cells, 2-day activated (stimulated) T cells"	"Primary T cell, Quiescent"
p_14615_1	"Primary T-acute lymphoblastic leukemia (ALL), no response (induction failture); blood cancer"	"primary T-acute lymphoblastic leukemia (ALL), complete continuous remission"
p_14615_2	"Primary T-acute lymphoblastic leukemia (ALL), failure (relapse); blood cancer"	"primary T-acute lymphoblastic leukemia (ALL), complete continuous remission"
p_14642_1	"PBMC, after exercise, early girls; treated"	"PBMC, before exercise, early girls"
p_14642_2	"PBMC, after exercise, late girls; treated"	"PBMC, before exercise, late girls"
p_14671_1	"CD34+ cells, CML patients, responder"	"CD34+ cells, CML patients, non-responder"
p_14680_1	"OPM2 cell, lentiviral CS1 shRNA transfected"	"OPM2 cell, control vector"
p_14680_2	"U266 cell, CS1 expression vector transfected"	"U266 cell, control vector"
p_14701_1	"PaTu8988t, adenovirus sensitive pancreatic cancer cell line"	"PaTu8988s, adenovirus insensitive pancreatic cancer cell line"
p_14711_1	"induced pluripotent stem cells , virus-carrying"	fibroblasts
p_14711_2	"induced pluripotent stem cells , factor-free"	fibroblasts
p_14711_3	"induced pluripotent stem cells , virus-carrying"	Embryonic Stem Cells
p_14711_4	"induced pluripotent stem cells , factor-free"	Embryonic Stem Cells
p_14746_1	"Hut 78 cells, suppression of AHI-1 expression"	"Hut 78 cells, control vector"
p_14746_2	"hut78, AHI-1 clone; treated"	"hut78, control"
p_14762_1	clear cell renal cell carcinoma; kidney cancer	"Kidney, normal"
p_14773_1	"HT29 cell, 1st sphere type"	"HT29 cell, parental , control"
p_14773_2	"SW480, snail overexpressed"	"SW480, vector"
p_14801_1	"HUVEC, non-sense siRNA"	"HUVEC, control"
p_14801_2	"HUVEC, ERG siRNA"	"HUVEC, control"
p_14807_1	"HEK293 cell, ALXR treated"	"HEK293 cell, control"
p_14807_2	"HEK293 cell, AC226 treated"	"HEK293 cell, control"
p_14807_3	"HEK293 cell, Annexin1 treated"	"HEK293 cell, control"
p_14825_1	"RD cells, MyoD~E heterodimers expression"	"RD cells, control vector"
p_14834_1	B-acute lymphoblastic leukemia (ALL)_BCR/ABL; blood cancer	B-acute lymphoblastic leukemia (ALL)_No molecular abnormalities
p_14834_2	B-acute lymphoblastic leukemia (ALL)_E2A/PBX1; blood cancer	B-acute lymphoblastic leukemia (ALL)_No molecular abnormalities
p_14834_3	B-acute lymphoblastic leukemia (ALL)_MLL/AF4; blood cancer	B-acute lymphoblastic leukemia (ALL)_No molecular abnormalities
p_14841_1	"Jejunal biopsy, baseline, diarrhea-IBS"	"Jejunal biopsy, healthy"
p_14842_1	"Jejunal biopsy, diarrhea-IBS, baseline"	"Jejunal biopsy, diarrhea-IBS, control"
p_14842_2	"Jejunal biopsy, diarrhea-IBS, oral cromoglycate treatment"	"Jejunal biopsy, diarrhea-IBS, control"
p_14844_1	"whole blood, at 2.p.m., after 10 months"	"whole blood, at 2.p.m., day one"
p_14844_2	"whole blood, at 10.a.m., after 10 months"	"whole blood, at 10.a.m., day one"
p_14844_3	"10 am, 10 months; blood tissue"	"10am, day one"
p_14844_4	"2pm, 10 months; tissue"	"2pm, day one"
p_14858_1	"Bone marrow or peripheral blood cell, JMML, AML-like signature"	"Bone marrow or peripheral blood cell, JMML, non-AML-like signature"
p_14879_1	ALK- ALCL; blood cancer	tcr-cHL
p_14879_2	ALK+ ALCL; blood cancer	tcr-cHL
p_14879_3	cALCL; blood cancer	CD8R_T cells
p_14880_1	MYCN amplified neuroblastoma; brain cancer	MYCN non-amplified neuroblastoma
p_14883_1	"BEAS-2B cells, SOX2 over-expression"	"BEAS-2B cells, control"
p_14886_1	"HTETOP cell, doxycycline"	"HTETOP cell, control"
p_14886_2	"HTETOP cell, dexrazoxane"	"HTETOP cell, control"
p_14897_1	"WAO9 human ESC, undifferentiated"	human foreskin fibroblasts
p_14897_2	"WAO9 human ESC, differentiated, day 20"	human foreskin fibroblasts
p_14897_3	"ATCC CRL2097(iPSC derived from human foreskin fibroblasts), differentiated, day 20"	human foreskin fibroblasts
p_14897_4	"ATCC CRL2097(iPSC derived from human foreskin fibroblasts), undifferentiated"	human foreskin fibroblasts
p_14905_1	Uninvolved skin	Normal skin
p_14905_2	Lesion skin	Normal skin
p_14924_2	"CD8 T cell, acute myeloid leukemia (AML); blood cancer"	"CD8 T cell, healthy"
p_14924_3	"CD4 T cell, acute myeloid leukemia (AML) intermediate prognosis; blood cancer"	"CD4 T cell, acute myeloid leukemia (AML) favorable prognosis"
p_14924_4	"CD8 T cell, acute myeloid leukemia (AML) intermediate prognosis; blood cancer"	"CD8 T cell, acute myeloid leukemia (AML) favorable prognosis"
p_14951_1	tissue: donor liver	tissue: normal liver
p_14951_2	"tissue: transplanted liver, 2 hours after reperfusion"	tissue: normal liver
p_14964_1	"HeLa cell, shYY1 expressed"	"HeLa cell, control vector"
p_14964_2	"HeLa cell, shYY2 expressed"	"HeLa cell, control vector"
p_14964_3	"HeLa cell, shYY1+shYY2 expressed"	"HeLa cell, control vector"
p_14970_1	"Myocardial cell, cyanotic Tetralogy of Fallot"	"Myocardial cell, acyanotic Tetralogy of Fallot"
p_14973_1	chronic lymphocytic leukemia (CLL) with 1mM VPA; cancer drug treatment	chronic lymphocytic leukemia (CLL) without VPA
p_14975_1	"Left atrial myocardium cell, Atrial Fibirillation patient"	"Left atrial myocardium cell, control"
p_14986_1	Fulvestrant treated MCF-7	vehicle treated MCF-7
p_14987_1	"MCF10A cell, ERBB2 overexpressed"	"MCF10A cell, control"
p_14987_2	"MCF10A cell, EGF overexpressed"	"MCF10A cell, control"
p_14987_3	LNCaP DHT stimulation	LNCaP
p_14988_1	"LNCap cell, DHT stimulated"	"LNCap cell, control"
p_15013_1	MLL partial tandem duplication	MLL translocation
p_15061_1	"Bone marrow cell, MDS patient"	"Bone marrow cell, normal"
p_15061_2	"Bone marrow cell, AML patient"	"Bone marrow cell, normal"
p_15061_3	MDS; blood cancer	None of the targets
p_15065_1	"MCF-10A cell, C/EBPbeta-2 overexpressed"	"MCF-10A cell, control"
p_15083_1	"Synovial fluid mononuclear cells, Extended oligoarticular JIA"	"Synovial fluid mononuclear cells, Persistent oligoarticular JIA"
p_15090_1	"Muscle biopsies, FSHD patients; tissue"	"Muscle biopsies, normal control"
p_15090_2	"Muscle biopsies, asymptomatic carriers; tissue"	"Muscle biopsies, normal control"
p_15091_1	"PC3 cell, AR_ETOH treated"	"PC3 cell, control"
p_15091_2	"PC3 cell, AR_1nM androgen treated"	"PC3 cell, control"
p_15091_3	"PC3 cell, AR_10nM androgen treated"	"PC3 cell, control"
p_15098_1	Nasopharyngeal carcinoma cell line (CNE1)	"immortalized nasopharyngeal epithelial cell line (NP69), control"
p_15098_2	Nasopharyngeal carcinoma cell line (CNE2)	"immortalized nasopharyngeal epithelial cell line (NP69), control"
p_15098_3	Nasopharyngeal carcinoma cell line (HONE1)	"immortalized nasopharyngeal epithelial cell line (NP69), control"
p_15132_1	"Caco-2 cell, ribo deficient, 24h"	"Caco-2 cell, control, 24h"
p_15132_2	"Caco-2 cell, ribo deficient, 48h"	"Caco-2 cell, control, 48h"
p_15132_3	"Caco-2 cell, ribo deficient, 72h"	"Caco-2 cell, control, 72h"
p_15148_1	iPS cells from episomal vectors	human embryonic stem cell lines
p_15148_2	Embryonic Stem Cells	Foreskin Cells Parental
p_15148_3	iPS cells from episomal vectors	Foreskin Cells Parental
p_15151_1	"NOMO-1 cells, shRNA targeting STK33"	"NOMO-1 cells, control"
p_15151_2	"SKM cells, shRNA targeting STK33"	"SKM cells, control"
p_15162_1	"HepG2 cell, quercetin treated, 2h"	"HepG2 cell, control 2h"
p_15162_2	"HepG2 cell, quercetin treated, 4h"	"HepG2 cell, control 4h"
p_15162_3	"HepG2 cell, quercetin treated, 12h"	"HepG2 cell, control 12h"
p_15162_4	"HepG2 cell, quercetin treated, 24h"	"HepG2 cell, control 24h"
p_15175_1	iPS cells from episomal vectors	human embryonic stem cell lines
p_15175_2	iPS cells from episomal vectors	"Foreskin Cells, Parental Foreskin"
p_15176_1	iPS cells from episomal vectors	human embryonic stem cell lines
p_15176_2	iPS cells from episomal vectors	"Foreskin Cells, Parental Foreskin"
p_15192_1	CD44-/CD24+ cells	CD44+/CD24- cells
p_15205_1	"ARPE-19 cell, TGF treated, 6h"	"ARPE-19 cell, TNF treated, 6h"
p_15205_2	"ARPE-19 cell, TGF treated, 42h"	"ARPE-19 cell, TNF treated, 42h"
p_15209_3	foetal cortex derived NS cell; brain tissue	Non-malignant human cortex
p_15214_1	mutant MSCs from root	"WT MSCs from root, control"
p_15220_1	Cancer testis cell	Normal testis cell
p_15237_1	"Eol1 cells, cultured in presence of Glivec"	"Eol1 cells, cultured in absence of Glivec"
p_15258_1	whole blood from rheumatoid arthritis patient; medium response; tissue	whole blood from rheumatoid arthritis patient; no response
p_15258_2	whole blood from rheumatoid arthritis patient; response; tissue	whole blood from rheumatoid arthritis patient; no response
p_15271_1	"centrocyte, tonsil"	"centroblast, tonsil"
p_15322_1	"CCD-18Co fibroblasts, pre-digested orange extractrixh in flavanones, 24h"	"CCD-18Co fibroblasts, control mixture, 24h"
p_15323_1	"Rhabdomyosarcoma cell, EV71 infected, 4h"	"Rhabdomyosarcoma cell, uninfected"
p_15323_2	"Rhabdomyosarcoma cell, EV71 infected, 8h"	"Rhabdomyosarcoma cell, uninfected"
p_15367_1	"Saos-2-null cell, Prima treated, 6h"	"Saos-2-null cell, control"
p_15367_2	"Saos-2-null cell, Prima treated, 12h"	"Saos-2-null cell, control"
p_15368_1	"Saos-2-His273 cell, Prima treated, 6h"	"Saos-2-His273 cell, control"
p_15368_2	"Saos-2-His273 cell, Prima treated, 12h"	"Saos-2-His273 cell, control"
p_15372_1	"Round5 A2780 cells, cisplatin-resistant"	"Parental A2780 cells, cisplatin-sensitive"
p_15385_1	"T84 cell, miR-210, miR-338-3p, miR-33a,miR-451 treated, 5d"	"T84 cell, negative control"
p_15385_2	"T84 cell, miR-338-3p, miR-451 treated, 5d"	"T84 cell, negative control"
p_15389_1	"PMBC cell, IC90 treated, 2h"	"PMBC cell, vehicle treated, 2h"
p_15389_2	"PMBC cell, IC90 treated, 24h"	"PMBC cell, vehicle treated, 24h"
p_15389_3	"PMBC cell, 3*IC90 treated, 2h"	"PMBC cell, vehicle treated, 2h"
p_15389_4	"PMBC cell, 3*IC90 treated, 24h"	"PMBC cell, vehicle treated, 24h"
p_15392_1	"DU145 cell, IC50 treated, 2h"	"DU145 cell, DMSO treated, 2h"
p_15392_3	"DU145 cell, IC50 treated, 24h"	"DU145 cell, DMSO treated, 24h"
p_15392_4	"DU145 cell, IC90 treated, 2h"	"DU145 cell, DMSO treated, 2h"
p_15392_6	"DU145 cell, IC90 treated, 24h"	"DU145 cell, DMSO treated, 24h"
p_15392_7	"DU145 cell, 3*IC90 treated, 2h"	"DU145 cell, DMSO treated, 2h"
p_15392_9	"DU145 cell, 3*IC90 treated, 24h"	"DU145 cell, DMSO treated, 24h"
p_15395_1	"HCT116 cell, IC50 treated, 1h"	"HCT116 cell, DMSO treated, 1h"
p_15395_10	"HCT116 cell, IC90 treated, 24h"	"HCT116 cell, DMSO treated, 24h"
p_15395_11	"HCT116 cell, 3*IC90 treated, 1h"	"HCT116 cell, DMSO treated, 1h"
p_15395_15	"HCT116 cell, 3*IC90 treated, 24h"	"HCT116 cell, DMSO treated, 24h"
p_15395_5	"HCT116 cell, IC50 treated, 24h"	"HCT116 cell, DMSO treated, 24h"
p_15395_6	"HCT116 cell, IC90 treated, 1h"	"HCT116 cell, DMSO treated, 1h"
p_15396_1	"PBMCs, IC90 2hr treatment; time course"	"PBMCs, control 2hr"
p_15396_10	"DU145 cell line, IC90 24hr treatment; time course"	"DU145, control 24hr"
p_15396_11	"DU145 cell line, 3xIC90 2hr treatment; time course"	"DU145, control 2hr"
p_15396_12	"DU145 cell line, 3xIC90 6hr treatment; time course"	"DU145, control 6hr"
p_15396_13	"DU145 cell line, 3xIC90 24hr treatment; time course"	"DU145, control 24hr"
p_15396_14	"HCT116 cell line, IC50 1hr treatment; time course"	"HCT116, control 1hr"
p_15396_15	"HCT116 cell line, IC50 2hr treatment; time course"	"HCT116, control 2hr"
p_15396_16	"HCT116 cell line, IC50 4hr treatment; time course"	"HCT116, control 4hr"
p_15396_17	"HCT116 cell line, IC50 6hr treatment; time course"	"HCT116, control 6hr"
p_15396_18	"HCT116 cell line, IC50 24hr treatment; time course"	"HCT116, control 24hr"
p_15396_19	"HCT116 cell line, IC90 1hr treatment; time course"	"HCT116, control 1hr"
p_15396_2	"PBMCs, IC90 24hr treatment; time course"	"PBMCs, control 24hr"
p_15396_20	"HCT116 cell line, IC90 2hr treatment; time course"	"HCT116, control 2hr"
p_15396_21	"HCT116 cell line, IC90 4hr treatment; time course"	"HCT116, control 4hr"
p_15396_22	"HCT116 cell line, IC90 6hr treatment; time course"	"HCT116, control 6hr"
p_15396_23	"HCT116 cell line, IC90 24hr treatment; time course"	"HCT116, control 24hr"
p_15396_24	"HCT116 cell line, 3xIC90 1hr treatment; time course"	"HCT116, control 1hr"
p_15396_25	"HCT116 cell line, 3xIC90 2hr treatment; time course"	"HCT116, control 2hr"
p_15396_26	"HCT116 cell line, 3xIC90 4hr treatment; time course"	"HCT116, control 4hr"
p_15396_27	"HCT116 cell line, 3xIC90 6hr treatment; time course"	"HCT116, control 6hr"
p_15396_28	"HCT116 cell line, 3xIC90 24hr treatment; time course"	"HCT116, control 24hr"
p_15396_3	"PBMCs, 3xIC90 2hr treatment; time course"	"PBMCs, control 2hr"
p_15396_4	"PBMCs, 3xIC90 24hr treatment; time course"	"PBMCs, control 24hr"
p_15396_5	"DU145 cell line, IC50 2hr treatment; time course"	"DU145, control 2hr"
p_15396_6	"DU145 cell line, IC50 6hr treatment; time course"	"DU145, control 6hr"
p_15396_7	"DU145 cell line, IC50 24hr treatment; time course"	"DU145, control 24hr"
p_15396_8	"DU145 cell line, IC90 2hr treatment; time course"	"DU145, control 2hr"
p_15396_9	"DU145 cell line, IC90 6hr treatment; time course"	"DU145, control 6hr"
p_15400_1	D551 cell	SDEC cell from hESC
p_15400_2	WI38 cell	SDEC cell from hESC
p_15434_1	NPM1+ acute myeloid leukemia (AML); cancer	NPM1- acute myeloid leukemia (AML)
p_15434_2	FLT3-ITD positive acute myeloid leukemia (AML); cancer	FLT3-ITD negative acute myeloid leukemia (AML); cancer
p_15434_3	CEBPA+ acute myeloid leukemia (AML); cancer	CEBPA- acute myeloid leukemia (AML); cancer
p_15464_1	"HUVEC, VEGF induced, 30m"	"HUVEC, uninduced"
p_15464_2	"HUVEC, VEGF induced, 60m"	"HUVEC, uninduced"
p_15464_3	"HUVEC, VEGF induced, 150m"	"HUVEC, uninduced"
p_15471_1	"pancreatic cancer patients, pancreas; cancer"	"pancreatic cancer patients., normal"
p_15477_1	ementine treated cell lines treated	control treated cell lines
p_15481_1	"MCF-7 cells, AP-2 gamma targetting siRNA 1"	"MCF-7 cells, non-silencing control siRNA"
p_15481_2	"MCF-7 cells, AP-2 gamma targetting siRNA 2"	"MCF-7 cells, non-silencing control siRNA"
p_15481_3	"MCF-7 cells, AP-2 gamma targetting siRNA 3"	"MCF-7 cells, non-silencing control siRNA"
p_15481_4	"MCF-7 cells, AP-2 gamma targetting siRNA 1"	"MCF-7 cells, Transfection reagent only"
p_15481_5	"MCF-7 cells, AP-2 gamma targetting siRNA 2"	"MCF-7 cells, Transfection reagent only"
p_15481_6	"MCF-7 cells, AP-2 gamma targetting siRNA 3"	"MCF-7 cells, Transfection reagent only"
p_15490_1	"CD19 selected B cell, rituximab treated"	"CD19 selected B cell, control"
p_15490_2	"CD19 selected B cell, fludarabine, cyclophosphamide treated"	"CD19 selected B cell, control"
p_15490_3	"CD19 selected B cell, rituximab, fludarabine, cyclophosphamide treated"	"CD19 selected B cell, control"
p_15495_1	"HCAE cell, S.agalactiae stimulated"	"HCAE cell, control"
p_15499_1	"HUVEC, HDAC5 silenced, 24h"	"HUVEC, control, 24h"
p_15520_1	"HG23 cells, Norwalk virus replicon-harboring cells"	naive Huh-7 cells
p_15543_1	expanded islet cells	fresh pancreatic islets
p_15543_2	re-differentiated cells	fresh pancreatic islets
p_15553_1	"hESC, cultured in SB, cinhibit TGF-b"	"hESC, cultured in EB, control"
p_15575_1	"HEK293 cells, in high glucose, 450mg/dl, 7 days"	"HEK293 cells, in low glucose, 100mg/dl, 7 days"
p_15578_1	High risk ovarian epithelium	Normal ovarian surface epithelium
p_15578_2	Epithelial ovarian cancer	High risk ovarian epithelium
p_15583_1	"Neuroblastoma cell line, hypoxic treatment"	"Neuroblastoma cell, normoxic"
p_15602_1	"RA Synovial biopsy, post-adalimumab therapy, Poor response"	"RA Synovial biopsy, post-adalimumab therapy, moderate response"
p_15602_2	"RA Synovial biopsy, post-adalimumab therapy, Good response"	"RA Synovial biopsy, post-adalimumab therapy, moderate response"
p_15605_1	primary melanoma	normal skin
p_15615_1	"Fibroblast-like Synovial cell, RA patient, TNF alpha"	"Fibroblast-like Synovial cell, RA patient, control"
p_15615_2	"Fibroblast-like Synovial cell, RA patient, IL1 beta"	"Fibroblast-like Synovial cell, RA patient, control"
p_15636_1	"Caco-2 cell line, cocultured with L. acidophilus NCFM, 8 h"	"Caco-2 cell line, medium-only control, 8 h"
p_15636_2	"Caco-2 cell line, cocultured with B. lactis 420, 8 h"	"Caco-2 cell line, medium-only control, 8 h"
p_15636_3	"Caco-2 cell line, cocultured with L. salivarius Ls-33, 8 h"	"Caco-2 cell line, medium-only control, 8 h"
p_15636_4	"Caco-2 cell line, treated with L. acidophilus NCFM cell-free supernatant, 24 h"	"Caco-2 cell line, medium-only control, 24 h"
p_15636_5	"Caco-2 cell line, treated with B. lactis 420 cell-free supernatant, 24 h"	"Caco-2 cell line, medium-only control, 24 h"
p_15636_6	"Caco-2 cell line, treated with L. salivarius Ls-33 cell-free supernatant, 24 h"	"Caco-2 cell line, medium-only control, 24 h"
p_15636_7	"Caco-2 cell line, treated with E. coli O157:H7 cell-free supernatant, 24 h"	"Caco-2 cell line, medium-only control, 24 h"
p_15645_1	"PBMC cell, JIA, active symptom"	"PBMC cell, JIA, control"
p_15645_2	"PBMC cell, JIA, CR symptom"	"PBMC cell, JIA, control"
p_15645_3	"PBMC cell, JIA, CRM symptom"	"PBMC cell, JIA, control"
p_15658_1	"Saos-2 osteosarcoma, p53-His273, untreated"	"Saos-2 osteosarcoma, p53-null, untreated"
p_15658_2	"Saos-2 osteosarcoma, p53-His273, 6 hours treatment"	"Saos-2 osteosarcoma, p53-null, 6 hours treatment"
p_15658_3	"Saos-2 osteosarcoma, p53-His273, 12 hours treatment"	"Saos-2 osteosarcoma, p53-null, 12 hours treatment"
p_15659_1	"CD4+ Tregs,  Activated CD45RA- FoxP3high CD4+ Tregs treated"	"CD4+ Tregs, Resting CD45RA+ FoxP3low"
p_15735_1	CD4-HDACi-2h; HDAC inhibitor treatment	CD4-HDACi-0h
p_15735_2	CD4-HDACi-12h; HDAC inhibitor treatment	CD4-HDACi-0h
p_15743_1	"Human NK cell, MHH1 treated, low, 6h"	"Human NK cell, control"
p_15743_2	"Human NK cell, MHH1 treated, medium, 6h"	"Human NK cell, control"
p_15743_3	"Human NK cell, MHH1 treated, high, 6h"	"Human NK cell, control"
p_15749_1	"MCF-7 cells, transfected with miR-9"	"MCF-7 cells, control"
p_15773_1	"subcutaneous adipose, insulin resistant patients"	"subcutaneous adipose, insulin sensitive patients"
p_15773_2	"omental adipose tissue, insulin resistant patients"	"omental adipose tissue, insulin sensitive patients"
p_15792_1	"LNCaP cells, siRNA targeting PCARNEQ"	"LNCaP cells, control siRNA"
p_15799_1	"HT29 cells, NS398 treated"	"HT29 cells, control"
p_15811_1	"CD34+ cord blood cells, expressing BCR/FGFR1"	"CD34+ cord blood cells, expressing the empty MIG control vector, control"
p_15811_2	"CD34+ cord blood cells, expressing BCR/ABL1"	"CD34+ cord blood cells, expressing the empty MIG control vector, control"
p_15811_3	"CD34+ cord blood cells, expressing ZMYM2/FGFR1"	"CD34+ cord blood cells, expressing the empty MIG control vector, control"
p_15893_1	"MDA-MB-231 cell, express CXCR4"	"MDA-MB-231 cell, not express CXCR4"
p_15893_2	"MDA-MB-231 cell, express CXCR4, SDF-1 alpha treated"	"MDA-MB-231 cell, not express CXCR4"
p_15903_1	"NPC cell, 6-10B type"	"NPC cell, 5-8F type"
p_15913_1	"chronic lymphocytic leukemia (CLL) patient, thalidomide treated; cancer treatment"	"chronic lymphocytic leukemia (CLL) patient, untreated"
p_15913_2	"chronic lymphocytic leukemia (CLL), deletion 17p13; cancer"	"chronic lymphocytic leukemia (CLL), No deletion 17p13; cancer"
p_15913_3	"chronic lymphocytic leukemia (CLL), deletion 11q22-q23; cancer"	"chronic lymphocytic leukemia (CLL), No deletion 11q22-q23; cancer"
p_15918_1	"H295R cell, angiotensin II treated, 100nM"	"H295R cell, control"
p_15918_2	"H295R cell, test compound CP-529414 treated, 100nM"	"H295R cell, control"
p_15935_1	"Huh7 cell line, 5uM NIM811 12hr treatment; time course"	"Huh7, control 12hr"
p_15935_10	"clone A cell line, 5uM CsA 12hr treatment; time course"	"clone A, control 12hr"
p_15935_11	"clone A cell line, 5uM NIM811 24hr treatment; time course"	"clone A, control 24hr"
p_15935_12	"clone A cell line, 1uM CsA 24hr treatment; time course"	"clone A, control 24hr"
p_15935_13	"clone A cell line, 5uM CsA 24hr treatment; time course"	"clone A, control 24hr"
p_15935_14	"clone A cell line, 1uM NIM811 48hr treatment; time course"	"clone A, control 48hr"
p_15935_15	"clone A cell line, 5uM NIM811 48hr treatment; time course"	"clone A, control 48hr"
p_15935_16	"clone A cell line, 5uM CsA 48hr treatment; time course"	"clone A, control 48hr"
p_15935_2	"Huh7 cell line, 5uM CsA 12hr treatment; time course"	"Huh7, control 12hr"
p_15935_3	"Huh7 cell line, 5uM NIM811 24hr treatment; time course"	"Huh7, control 24hr"
p_15935_4	"Huh7 cell line, 5uM CsA 24hr treatment; time course"	"Huh7, control 24hr"
p_15935_5	"Huh7 cell line, 1uM NIM811 48hr treatment; time course"	"Huh7, control 48hr"
p_15935_6	"Huh7 cell line, 5uM NIM811 48hr treatment; time course"	"Huh7, control 48hr"
p_15935_7	"Huh7 cell line, 1uM CsA 48hr treatment; time course"	"Huh7, control 48hr"
p_15935_8	"Huh7 cell line, 5uM CsA 48hr treatment; time course"	"Huh7, control 48hr"
p_15935_9	"clone A cell line, 5uM NIM811 12hr treatment; time course"	"clone A, control 12hr"
p_15947_1	"RWPE1 cells, 100 nM of 1,25(OH)2D treated , 6h"	"RWPE1 cells, EtOH treated, 6h"
p_15947_2	"RWPE1 cells, 100 nM of 1,25(OH)2D treated , 24h"	"RWPE1 cells, EtOH treated, 24h"
p_15947_3	"RWPE1 cells, 100 nM of 1,25(OH)2D treated , 48h"	"RWPE1 cells, EtOH treated, 48h"
p_15949_1	"MDM cell, hypoxia"	"MDM cell, normoxia"
p_15960_1	"Colonic epithelial cell, adenoma"	"Colonic epithelial cell, normal"
p_15960_2	"Colonic epithelial cell, colorectal cancer"	"Colonic epithelial cell, normal"
p_15969_1	mixture of cultured adult human MSCs and NOD/scid mouse lung	"lung tissue, NOD/scid mouse lung"
p_15969_2	"NOD/scid mouse lung, 10 h after IV infusion of hMSCs"	"lung tissue, NOD/scid mouse lung"
p_16015_1	"Bone marrow cell, AML patient, NPM1 mutant"	"Bone marrow cell, AML patient, NPM1 wt"
p_16015_2	"acute myeloid leukemia (AML), 3-positive(mutated); cancer"	"acute myeloid leukemia (AML), 1-negative(wild)"
p_16020_1	autosomal dominant monocytopenia; polymorphonuclear leukocytes; cancer; Rneasy	polymorphonuclear leukocytes; control
p_16020_2	autosomal dominant monocytopenia; polymorphonuclear leukocytes; cancer; STAT60	polymorphonuclear leukocytes; control
p_16028_1	"Venous blood, female 1day; tissue"	"Venous blood, male 1day"
p_16028_2	"Venous blood, female 14day; tissue"	"Venous blood, male 14day"
p_16028_3	"Venous blood, female 28day; tissue"	"Venous blood, male 28day"
p_16028_4	"Venous blood, female 90day; tissue"	"Venous blood, male 90day"
p_16028_5	"Venous blood, female 180day; tissue"	"Venous blood, male 180day"
p_16032_1	"PBMC, Acute stage"	"PBMC, convalescent stage"
p_16051_1	"HUVEC, transduced with MSCVneo expressing 4-OHT-inducible K13-ERTAM"	"HUVEC, MSCVneo vector, control"
p_16051_2	"HUVEC_K13_ER_4OHT, treatment"	HUVEC_K13_ER_UT
p_16051_3	HUVEC_K13_ER_UT treated	HUVEC_Vector_UT
p_16051_4	"HUVEC_K13_ER_4OHT, treatment"	HUVEC_Vector_4OHT treated
p_16054_1	"HEK293 cell, Delta Exon 4 mutant"	"HEK293 cell, control"
p_16054_2	"HEK293 cell, L188Q mutant"	"HEK293 cell, control"
p_16059_1	"PBLs, pair_CFS; chronic fatigue syndrome; blood tissue"	"PBLs, pair_unaffected"
p_16059_2	"PBLs, pair_ICF; idiopathic fatigue syndrome; blood tissue"	"PBLs, pair_unaffected"
p_16066_1	"Caco2 cells, resistant to methotrexate"	"Caco2 cells, sensitive to methotrexate"
p_16070_1	"MCF7 cells, resistant to methotrexate"	"MCF7 cells, sensitive to methotrexate"
p_16080_1	"MDA-MB-468 cells, resistant to methotrexate"	"MDA-MB-468 cells, sensitive to methotrexate"
p_16082_1	"MIA PaCa2 cells, resistant to methotrexate"	"MIA PaCa2 cells, sensitive to methotrexate"
p_16085_1	"K562 cells, resistant to methotrexate"	"K562 cells, sensitive to methotrexate"
p_16089_1	"Saos-2 cells, resistant to methotrexate"	"Saos-2 cells, sensitive to methotrexate"
p_16093_1	H9 Human Embryonic Stem Cell	Human newborn fibroblast
p_16093_2	"Human iPSC, Direct Delivery of Reprogramming Proteins"	Human newborn fibroblast
p_16093_3	"Human iPSC, retroviral transfection of Reprogramming genes"	Human newborn fibroblast
p_16093_4	"iPS cell, retroviral transfection of reprogramming genes"	"H9, embryonic stem cell"
p_16097_1	"HEK293 cell, BAHD1 silenced"	"HEK293 cell, control"
p_16098_1	"PBM cell, p30 treated, total RNA"	"PBM cell, control, total RNA"
p_16098_2	"PBM cell, p30 treated, Cytoplasmic RNA"	"PBM cell, control, Cytoplasmic RNA"
p_16118_1	"U937 cell, Sonazoid treated"	"U937 cell, control"
p_16118_2	"U937 cell, Ultrasound treated"	"U937 cell, control"
p_16118_3	"U937 cell, Sonazoid, Ultrasound treated"	"U937 cell, control"
p_16119_1	"Microglia, derived from glioblastoma"	Glioblastoma
p_16130_1	CD4 T cell	"DN T cell, control"
p_16130_2	CD8 T cell	"DN T cell, control"
p_16134_1	"gingival tissue, periodontitis-affected site"	"gingival tissue, unaffected site"
p_16149_1	"Buccal mucosa cells, smoker"	"Buccal mucosa cells, non-smoker"
p_16155_1	"Ependymona cell, recurrent"	"Ependymona cell , non-recurrent"
p_16161_1	atopic dermatitis (AD) skin; tissue	normal skin
p_16176_1	"amniotic fluid, down syndrome female; tissue"	"amniotic fluid, euploid female"
p_16176_2	"amniotic fluid, down syndrome male; tissue"	"amniotic fluid, euploid male"
p_16179_1	"BT474 cell, Lap treated"	"BT474 cell, DMSO treated"
p_16179_2	"BT474-J4 cell, GSK089 treated"	"BT474-J4 cell, DMSO treated"
p_16179_3	"BT474-J4 cell, Lap treated"	"BT474-J4 cell, DMSO treated"
p_16179_4	"BT474-J4 cell, Lap, GSK089 treated"	"BT474-J4 cell, DMSO treated"
p_16191_1	"Cryptorchidism, unilateral"	"Cryptorchidism, control"
p_16191_2	"Cryptorchidism, bilateral"	"Cryptorchidism, control"
p_16193_1	"THP-1 cell, CO treated"	"THP-1 cell, control"
p_16193_2	"THP-1 cell, LPS treated"	"THP-1 cell, control"
p_16193_3	"THP-1 cell, CO, LPS treated"	"THP-1 cell, control"
p_16194_1	H441 snail overexpressed	"H441 cell, control"
p_16194_2	H292 snail overexpressed	"H292 cell, control"
p_16194_3	H1437 snail overexpressed	"H1437 cell, control"
p_16214_1	"PBMC, IFN beta treated"	"PBMC, control"
p_16214_2	"PBMC, GA treated"	"PBMC, control"
p_16219_1	"HuT-102 cells, shRNA targeting TAK1"	"HuT-102 cells, vector control"
p_16226_3	"siLincIRX5, siRNA treatment"	"Non-targetting siRNA Control, foot fibroblast"
p_16226_4	"siLincMTX2, siRNA treatment"	"Non-targetting siRNA Control, foot fibroblast"
p_16226_5	"siLincSTXBP5, siRNA treatment"	"Non-targetting siRNA Control, foot fibroblast"
p_16226_6	"siLincTNS1, siRNA treatment"	"Non-targetting siRNA Control, lung fibroblast"
p_16226_7	"siLincZFP161, siRNA treatment"	"Non-targetting siRNA Control, lung fibroblast"
p_16226_8	"siTUG1, siRNA treatment, lung"	"Non-targetting siRNA Control, lung fibroblast"
p_16226_9	"siTUG1, siRNA treatment, foot"	"Non-targetting siRNA Control, foot fibroblast"
p_16236_1	"Lesional myeloid cells, from MDS (Myelodysplastic Syndromes) patients"	"Normal lymphoid cells, from MDS (Myelodysplastic Syndromes) patients"
p_16236_2	"Lesional blastic cells, from MDS (Myelodysplastic Syndromes) patients"	"Normal lymphoid cells, from MDS (Myelodysplastic Syndromes) patients"
p_16236_3	"Lesional erythroid cells, from MDS (Myelodysplastic Syndromes) patients"	"Normal lymphoid cells, from MDS (Myelodysplastic Syndromes) patients"
p_16236_4	"Normal lymphoid cells, from MDS (Myelodysplastic Syndromes) patients"	"normal lymophoid cells, of normal person"
p_16237_1	"primary neuroblastoma, MYCN amplified; brain cancer"	"primary neuroblastoma, MYCN single copy"
p_16237_2	"primary neuroblastoma, alive"	"primary neuroblastoma, died of disease"
p_16238_1	"HTB-58 cell, AntiEvil1 silenced"	"HTB-58 cell, control"
p_16238_2	"TF-1 cell, AntiEvil1 silenced"	"TF-1 cell, control"
p_16249_1	"NZM15 cells, media only, siRNA targeting MITF, 30h"	"NZM15 cells, media only, 30h, control"
p_16354_1	"LEC cell, KSHV treated , 72h"	"LEC cell, control"
p_16354_2	"BEC cell, KSHV treated , 72h"	"BEC cell, control"
p_16355_1	"lymphatic endothelial cells, KSHV microRNA cluster"	"lymphatic endothelial cells, pSIN-MCS (empty vector)"
p_16356_1	"lymphatic endothelial cells, MAF-siRNA"	"lymphatic endothelial cells, non-targeted-siRNA"
p_16357_1	"lymphatic endothelial cell, KSHV-infected, 72h"	"lymphatic endothelial cell, uninfected control"
p_16357_2	"blood vessel endothelial cell, KSHV-infected, 72h"	"blood vessel endothelial cell, uninfected control"
p_16357_3	"lymphatic endothelial cells, KSHV microRNA cluster"	"lymphatic endothelial cells, empty vector"
p_16357_4	"lymphatic endothelial cells, MAF siRNA"	"lymphatic endothelial cells, control siRNA"
p_16363_1	"HIV-1 infection, asymptomatic stages; blood tissue"	"HIV-1 infection, uninfected"
p_16363_2	"HIV-1 infection, acute stages; blood tissue"	"HIV-1 infection, uninfected"
p_16363_3	"HIV-1 infection, AIDS; blood tissue"	"HIV-1 infection, uninfected"
p_16386_1	"CD14 macrophage, IL-4, Rosiglitazone treated"	"CD14 macrophage, IL-4 treated"
p_16387_13	"macrophages,treated with IL-4 and Rosiglitazone, 24h"	"macrophages, treated with Rosiglitazone, 24h"
p_16387_14	"macrophages,treated with IFNg+TNF and Rosiglitazone, 24h"	"macrophages, treated with Rosiglitazone, 24h"
p_16387_5	"macrophages, treated with IL-4 and vehicle, 24h"	"macrophages, treated with vehicle, 24h"
p_16387_6	"macrophages, treated with IFNg+TNF and vehicle, 24h"	"macrophages, treated with vehicle, 24h"
p_16391_1	"breast cancer, postmenopausal"	"breast cancer, premenopausal"
p_16391_2	"breast cancer, ER, PGR (+)"	"breast cancer, ER, PGR (-)"
p_16391_3	"breast cancer, adj neoadj chemotherapy received"	adj neoadj chemotherapy not received
p_16391_4	"breast cancer, node (+)"	"breast cancer, node (-)"
p_16391_5	"breast cancer, HER2 (+)"	"breast cancer, HER2 (-)"
p_16416_1	"Human foreskin fibroblast cell, medium as parasite conditioned"	"Human foreskin fibroblast cell, medium as control"
p_16416_2	"Human foreskin fibroblast cell, treated TGF, medium as parasite conditioned"	"Human foreskin fibroblast cell, treated TGF"
p_16447_1	"skin fibroblast, cerebral palsy"	"skin fibroblast, control"
p_16450_1	"BE(2)-C cell line, immature, IFN treated, 6h"	"BE(2)-C cell line, immature, untreatead control"
p_16450_2	"BE(2)-C cell line, immature, IFN treated, 12h"	"BE(2)-C cell line, immature, untreatead control"
p_16450_3	"BE(2)-C cell line, mature, IFN treated, 6h"	"BE(2)-C cell line, mature, untreatead control"
p_16450_4	"BE(2)-C cell line, mature, IFN treated, 12h"	"BE(2)-C cell line, mature, untreatead control"
p_16451_1	"BE-C cell, immature, WEEV infected"	"BE-C cell, immature, unstimulated"
p_16451_2	"BE-C cell, mature, WEEV infected"	"BE-C cell, mature, unstimulated"
p_16452_1	"BE(2)-C, immature IFN 6hr treatment"	"BE(2)-C, immature unstimulated"
p_16452_2	"BE(2)-C, immature IFN 12hr treatment"	"BE(2)-C, immature unstimulated"
p_16452_3	"BE(2)-C, mature IFN 6hr treatment"	"BE(2)-C, mature unstulated"
p_16452_4	"BE(2)-C, mature IFN 12hr treatment"	"BE(2)-C, mature unstulated"
p_16452_5	"BE(2)-C, immature WEEV infection 6hr treatment"	"BE(2)-C, immature unstimulated"
p_16452_6	"BE(2)-C, mature WEEV infection 6hr treatment"	"BE(2)-C, mature unstulated"
p_16455_1	iMCL (indolent mantle cell lymphoma)	cMCL (conventional mantle cell lymphoma)
p_16455_2	iMCL (indolent mantle cell lymphoma)	HCL (Hairy Cell Leukemia)
p_16455_3	MCL (mantle cell lymphoma)	SMLZ (Splenic Marginal Zone Lymphoma)
p_16455_4	MCL (mantle cell lymphoma)	CLL (Chronic Lymphocytic Leukemia)
p_16455_5	MCL (mantle cell lymphoma)	LF (follicular lymphoma)
p_16464_1	"Chondrocytes, OA patient, monolayer type"	"Chondrocytes, normal, monolayer type"
p_16464_2	"Chondrocytes, OA patient, 3D-culture type"	"Chondrocytes, normal, 3D-culture type"
p_16515_1	"pancreatic, tumor; pancreas cancer"	"pancreatic, normal"
p_16524_1	"skin fibroblasts, Setleis Syndrome, Homozygous for the Q119X mutation in the TWIST2 gene"	"skin fibroblasts, normal, Wild type for TWIST2"
p_16538_1	"Lung cell, Pulmonary sarcoidosis patient"	"Lung cell, control"
p_16547_1	"LEC cell, pSin co-culture, DLL4 overexpressed"	"LEC cell, pSin co-culture, control"
p_16547_2	"LEC cell, pSin co-culture, JAG1 overexpressed"	"LEC cell, pSin co-culture, control"
p_16584_1	"meningioma tumor, grade 2"	"meningioma tumor, grade 1"
p_16584_2	"meningioma tumor, grade 3"	"meningioma tumor, grade 1"
p_16589_1	"Lin+ UCB cells, freshly isolated"	"Lin- UCB cells, freshly isolated"
p_16589_2	"Lin+ UCB cells, cultured 4 days"	"Lin- UCB cells, cultured 4 days"
p_16589_3	"Lin+ UCB cells, cultured 8 days, S/E at day 4"	"Lin- UCB cells, cultured 8 days, S/E at day4"
p_16589_4	"Lin+ UCB cells, cultured 8 days, NS/NE at day4"	"Lin- UCB cells, cultured 8 days, NS/NE at day 4"
p_16589_5	"Lin+ UCB cells, cultured 12 days"	"Lin- UCB cells, cultured 12 days"
p_16615_1	CLA 1 adipocyte c9t11 treated	CLA 1 adipocyte control
p_16615_2	CLA 1 adipocyte mixture treated	CLA 1 adipocyte control
p_16615_3	CLA 1 adipocyte t10c12 treated	CLA 1 adipocyte control
p_16625_1	"CD34+ cells, AML-TLD patients,5-azacytidine+entinostat treated, day 15"	"CD34+ cells, AML-TLD patients, untreated, day 0"
p_16625_2	"CMMoL, 5-azacytidine & entinostat 15day treated; blood cancer"	"CMMoL, 5-azacytidine & entinostat 0day"
p_16625_3	"MDS, 5-azacytidine & entinostat 15day treated; blood cancer"	"MDS, 5-azacytidine & entinostat 0day"
p_16650_1	"BEAS2b cell, Stretch"	"BEAS2b cell, control"
p_16650_2	"BEAS2b cell, LPS"	"BEAS2b cell, control"
p_16650_3	"BEAS2b cell, TNF-alpha"	"BEAS2b cell, control"
p_16650_4	"BEAS2b cell, Stretch + LPS"	"BEAS2b cell, control"
p_16650_5	"BEAS2b cell, Stretch + TNF-alpha"	"BEAS2b cell, control"
p_16659_1	"DU145N cell, HGF treated, 2h"	"DU145N cell, control, 2h"
p_16659_2	"DU145N cell, HGF treated, 8h"	"DU145N cell, control, 8h"
p_16659_3	"DU145N cell, HGF treated, 24h"	"DU145N cell, control, 24h"
p_16674_1	"K562 cell, miR-34a treated, 24h"	"K562 cell, control, 24h"
p_16677_1	Down Syndrome AMKL (acute megakaryoblastic leukemia or FAB M7 leukemia)	Non-Down Syndrome AMKL (acute megakaryoblastic leukemia or FAB M7 leukemia)
p_16683_1	"HUVEC, estradiol treated, 1nM, 24h"	"HUVEC, EtOH treated, control"
p_16694_1	CBiPS 2F (iPS from Cord Blood cells reprogrammed with Oct4 and Sox2)	sorted Cord Blood cells (CD133+)
p_16694_2	"CBiPS 4F (iPS from Cord Blood cells reprogrammed with Oct4, Sox2, Klf4 and C-Myc)"	sorted Cord Blood cells (CD133+)
p_16694_4	"CBiPS 4F 1 (iPS from Cord Blood cells reprogrammed with Oct4, Sox2, Klf4 and C-Myc - Sample"	sorted Cord Blood cells CD133+
p_16728_1	"peripheral blood, RNAprep: PAXgene Globin reduced, sickle-cell disease"	"peripheral blood, RNAprep: PAXgene Globin reduced, Control"
p_16728_2	"peripheral blood, RNAprep: PAXgene, sickle-cell patients"	"peripheral blood, RNAprep: PAXgene, Control"
p_16728_3	"peripheral blood, RNAprep: PBMC, sickle-cell patients"	"peripheral blood, RNAprep: PBMC, Control"
p_16745_1	"CD34+ cell, MN1 transduced"	"CD34+ cell, control"
p_16748_1	"Human chondrosarcoma cell, ET-743 treated"	"Human chondrosarcoma cell, control"
p_16748_2	"Human chondrosarcoma cell, PM00104 treated"	"Human chondrosarcoma cell, control"
p_16755_1	"primary macrophages, IFNa-treated"	"primary macrophages, control"
p_16759_1	"Parietal lobe, Alzheimer's disease"	"Parietal lobe, Control"
p_16797_1	"whold blood, IVIG-responsive, post"	"whold blood, IVIG-responsive, pre"
p_16797_2	"whold blood, single-IVIG treatment, post"	"whold blood, single-IVIG treatment, pre"
p_16797_3	"whold blood, IVIG-plus-IVMP combined therapy, post"	"whold blood, IVIG-plus-IVMP combined therapy, pre"
p_16798_1	"U937 myelomonocytic cell line, PIR knock-down"	"U937 myelomonocytic cell line, control"
p_16836_1	"Peripheral blood monocytes, CD16+"	"Peripheral blood monocytes, CD16-"
p_16837_1	"Polymorphonuclear leukocytes, S.aureus-exposed, incubated at 37C, 1h"	"Polymorphonuclear leukocytes, healthy donor"
p_16837_2	"Polymorphonuclear leukocytes, S.aureus-exposed, incubated at 37C, 2h"	"Polymorphonuclear leukocytes, healthy donor"
p_16837_3	"Polymorphonuclear leukocytes, S.aureus-exposed, incubated at 37C, 3h"	"Polymorphonuclear leukocytes, healthy donor"
p_16837_4	"Polymorphonuclear leukocytes, S.aureus-exposed, incubated at 37C, 6h"	"Polymorphonuclear leukocytes, healthy donor"
p_16844_1	"Skin lesion cell, LL"	"Skin lesion cell, ENL"
p_16856_1	"LNCaP cells, caffeine treated, 10mM"	"LNCaP cells, untreated, control"
p_16856_2	"LNCaP cells, treated with both caffeine and actinomycin D after treatment with caffeine"	"LNCaP cells, untreated, control"
p_16856_3	"LNCaP cells, treated with actinomycin D alone after treatment with caffeine"	"LNCaP cells, untreated, control"
p_16856_4	"22Rv1 cells, caffeine treated, 10mM"	"22Rv1 cells, untreated, control"
p_16856_5	"22Rv1 cells, treated with both caffeine and actinomycin D after treatment with caffeine"	"22Rv1 cells, untreated, control"
p_16856_6	"22Rv1 cells, treated with actinomycin D alone after treatment with caffeine"	"22Rv1 cells, untreated, control"
p_16870_7	"HeLa cell, BafA treated, 24h"	"HeLa cell, control , 24h"
p_16870_8	"HeLa cell, DFO treated 24h"	"HeLa cell, control , 24h"
p_16870_9	"HeLa cell, low LDL 24h"	"HeLa cell, control , 24h"
p_16879_1	UC colon; tissue	Normal colon
p_16879_2	CD colon; tissue	Normal colon
p_16879_3	CD Ileum; tissue	Normal Ileum Mucosa
p_16879_4	Infliximab responsive UC colon; tissue	Infliximab non-responsive UC colon
p_16879_5	Infliximab responsive CD colon; tissue	Infliximab non- responsive CD colon
p_16879_6	Infliximab responsive CD ileum; tissue	Infliximab non-responsive CD ileum
p_16906_1	"Endometrial stromal cell, Jag1 retrovirus infected"	"Endometrial stromal cell, control"
p_16910_1	"hES-T3, grown on MEF feeder"	grown on feeder-free Matrigel in MEF-conditioned medium
p_16910_2	hES-T3 grown in hES medium (containing 4 ng/ml bFGF) supplemented with 5 ng/ml activin A	grown on feeder-free Matrigel in MEF-conditioned medium
p_16924_1	"AGS cells, GFP and MIST1 transfected"	"AGS cells, GFP and empty vector-transfected"
p_16924_2	"HGC-27 cells, GFP and MIST1 transfected"	"HGC-27 cells, GFP and empty vector-transfected"
p_16924_3	HGC+MIST1; transfection treated	HGC-27 parental
p_16924_4	HGC+MIST1; transfection treated	HGC+GFP control
p_16934_1	"SW480 cell, High SCP51"	"SW480 cell, EGFP"
p_16934_2	"SW480 cell, Low SCP58"	"SW480 cell, EGFP"
p_16962_1	"Umbilical vein cell, miR-210 overexpressed"	"Umbilical vein cell, control"
p_16962_2	"Umbilical vein cell, miR-210 downmodulated"	"Umbilical vein cell, control"
p_16969_1	"Brain cell, tuberous sclerosis complex disease, cortical tuber"	"Brain cell, control"
p_17007_1	"Kit225 cell, control ,NC1153 treated"	"Kit225 cell, control , DMSO"
p_17009_1	"Human MM cell, Onconase treated"	"Human MM cell, control"
p_17014_1	"Dermal cell isolate from 4 neonatal foreskin, HD-1dim"	"Dermal cell isolate from 4 neonatal foreskin, HD-1bri"
p_17032_1	skin fibroblasts; tissue	lung fibroblasts
p_17044_1	"LNCaP cell, Androgen treated"	"LNCaP cell, control"
p_17054_1	Human acute myeloid leukemia stem cells	Normal human bone marrow hematopoietic stem cells
p_17090_1	Adipose stem cells expanded in allogeneic human serum	Adipose stem cells expanded in fetal bovine serum
p_17119_1	"HMVEC, PNF1-treated, 1h"	"HMVEC, control, 1h"
p_17119_2	"HMVEC, PNF1-treated, 2h"	"HMVEC, control, 2h"
p_17119_3	"HMVEC, PNF1-treated, 4h"	"HMVEC, control, 4h"
p_17119_4	"HMVEC, PNF1-treated, 8h"	"HMVEC, control, 8h"
p_17119_5	"HMVEC, PNF1-treated, 16h"	"HMVEC, control, 16h"
p_17119_6	"HMVEC, PNF1-treated, 24h"	"HMVEC, control, 24h"
p_17119_7	"HMVEC, PNF1-treated, 48h"	"HMVEC, control, 48h"
p_17129_1	"BL Ramos cell line, transfected with pRTS-CA-IKK2"	"BL Ramos cell line, transfected with pRTS-GFP (control)"
p_17183_1	liver biopsy after interferon treatment	liver biopsy before treatment
p_17183_2	hepatocytes after interferon treatment	hepatocytes before treatment
p_17183_3	lymphocytes after interferon treatment	lymphocytes before treatment
p_17187_1	"gastric cancer, node stage: positive"	"gastric cancer, node stage: negative"
p_17254_1	"primary hepatocyte, Wy14643 treated, 6 hr; time course"	"primary hepatocyte, DMSO, 6 hr"
p_17254_2	"primary hepatocyte, Wy14643 treated, 24 hr; time course"	"primary hepatocyte, DMSO, 24 hr"
p_17269_1	"Naive B cell, CVID patient"	"Naive B cell, healthy"
p_17269_2	"CD21 low B cell, CVID patient"	"Naive B cell, healthy"
p_17300_1	"HEK293T cell, USF1 overexpressed"	"HEK293T cell, control"
p_17307_1	"A549 cell, dexamethasone, 6h"	"A549 cell, control"
p_17307_2	"A549 cell, mifepriston + dexamethasone, 48h"	"A549 cell, control"
p_17307_3	"A549 cell, match polyamide + dexamethasone, 48h"	"A549 cell, control"
p_17307_4	"A549 cell, mismatch polyamide + dexamethasone, 48h"	"A549 cell, control"
p_17347_1	"A459 cells, 3D culture"	"A459 cells, 2D culture"
p_17347_2	"UT-15 cells, 3D culture"	"UT-15 cells, 2D culture"
p_17351_1	esophageal squamous cell carcinoma (ESCC)	"esophagus tissue, normal"
p_17353_1	"EPC2-hTERT cell, Hypoxia"	"EPC2-hTERT cell, Normoxia, control"
p_17368_4	"Postnatal epiphyseal cartilage, passage 4"	"Postnatal epiphyseal cartilage, primary"
p_17368_8	"Postnatal epiphyseal cartilage, passage 8"	"Postnatal epiphyseal cartilage, primary"
p_17375_1	"colon cancer stem cells (CSC), high Wnt"	"colon cancer stem cells (CSC), low Wnt"
p_17375_2	C200 Colon CSC culture high Wnt; overexpression	C200 Colon CSC culture low Wnt
p_17385_1	"Multiple myeloma line (MM1.S), beta-catenin knockdown"	"Multiple myeloma line (MM1.S), control"
p_17386_1	"CD133-HCC cell, miR-130b treated"	"CD133-HCC cell, control"
p_17400_1	"Bronchial epithelial cell line (2B4), SARS-CoV-infected, 12h"	"Bronchial epithelial cell line (2B4), mock-infected, 12h"
p_17400_2	"Bronchial epithelial cell line (2B4), DOHV-infected, 12h"	"Bronchial epithelial cell line (2B4), mock-infected, 12h"
p_17400_3	"Bronchial epithelial cell line (2B4), SARS-CoV-infected, 24h"	"Bronchial epithelial cell line (2B4), mock-infected, 24h"
p_17400_4	"Bronchial epithelial cell line (2B4), DOHV-infected, 24h"	"Bronchial epithelial cell line (2B4), mock-infected, 24h"
p_17400_5	"Bronchial epithelial cell line (2B4), SARS-CoV-infected, 48h"	"Bronchial epithelial cell line (2B4), mock-infected, 48h"
p_17400_6	"Bronchial epithelial cell line (2B4), DOHV-infected, 48h"	"Bronchial epithelial cell line (2B4), mock-infected, 48h"
p_17407_1	"MM.1S cell, cultured with pDCs"	"MM.1S cell, cultured alone, control"
p_17440_1	"Brain, frontal cortex, HIV patients, Major depressive disorder (MDD)"	"Brain, frontal cortex, HIV patients, no MDD"
p_17466_1	"iPrEC cell, Empty vector"	"iPrEC cell, control"
p_17466_2	"iPrEC cell, USP2A mutant"	"iPrEC cell, control"
p_17476_1	"Heart, E161K mutant"	"Heart, ISC Control"
p_17480_1	"CD34+ mononuclear cells, fenretinide treated, 4uM, 48h"	"CD34+ mononuclear cells, untreated"
p_17482_1	"DU145 cells, Stat3 down-regulated"	"DU145 cells, control"
p_17482_2	"DU145 cells, Stat5a/b down-regulated"	"DU145 cells, control"
p_17482_3	"CWR22Rv1 cells, Stat3 down-regulated"	"CWR22Rv1 cells, control"
p_17482_4	"CWR22Rv1 cells, Stat5a/b down-regulated"	"CWR22Rv1 cells, control"
p_17483_1	"DU145 cell, Stat5a/b silenced"	"DU145 cell, control"
p_17508_1	"MCF-7 cells, miR-22 duplex transfection, 24h"	"MCF-7 cells, negative control RNA duplex transfection, 24h"
p_17539_1	"cultured skin substitute, in vitro, 3 days of culture"	normal human skin
p_17539_3	"cultured skin substitute, in vitro, 14 days of culture"	normal human skin
p_17539_4	"cultured skin substitute, in vivo, 3 days of culture"	normal human skin
p_17539_9	"cultured skin substitute, in vivo, 56 days of culture"	normal human skin
p_17540_1	"MCF7 cell, CEACAM1-4S treated"	"MCF7 cell, control"
p_17543_1	"vascular smooth muscle cells, siRNA targeting FoxM1, 48h"	"vascular smooth muscle cells, control siRNA"
p_17549_1	"CD14 cell, CHM patient"	"CD14 cell, control"
p_17549_2	"Primary Fibroblast cell, CHM patient"	"Primary Fibroblast cell, control"
p_17551_1	"WM-266 cells, Pirin knockdown"	"WM-266 cells, transfected with control siRNA"
p_17551_2	"WM-266 cells, Pirin knockdown"	"WM-266 cells, transfection without adding oligonucleotide"
p_17612_1	Brain BA10 post-mortem schizophrenic; tissue	Brain BA10 post-mortem control
p_17624_11	Ishikawa_VeryLowDose_BPA_24h treated; time course	Ishikawa_Control_24h
p_17624_2	Ishikawa_HighDose_BPA_24h treated; time course	Ishikawa_Control_24h
p_17624_5	Ishikawa_LowDose_BPA_24h treated; time course	Ishikawa_Control_24h
p_17624_8	Ishikawa_VeryHighDose_BPA_24h treated; time course	Ishikawa_Control_24h
p_17625_1	"Caco-2 cell, co-cultured THP-1 cell, 1h"	"Caco-2 cell, control"
p_17625_2	"Caco-2, coculture_3h"	"Caco-2, coculture_0h"
p_17625_3	"Caco-2, coculture_6h"	"Caco-2, coculture_0h"
p_17625_4	"Caco-2, coculture_24h"	"Caco-2, coculture_0h"
p_17625_5	"Caco-2, coculture_48h"	"Caco-2, coculture_0h"
p_17636_1	"MDA-MB-436 cells, NF1-C2 over-expression"	"MDA-MB-436 cells, wildtype"
p_17639_1	"Reticulocytes, umbilical cord blood"	"Reticulocytes, adult periperal blood"
p_17700_1	"breast cancer sample, lab: Jules Bordet Institute"	"breast cancer sample, lab: MD Anderson Cancer Center"
p_17708_4	"A549 cell line, TGFB1 treated, 4h"	"A549 cell line, untreated"
p_17708_7	"A549 cell line, TGFB1 treated, 24h"	"A549 cell line, untreated"
p_17714_1	neuroblastoma cell line under hypoxic conditions	neuroblastoma cell line under normoxic conditions
p_17718_1	"StED cell, HTLV-1 positive"	Postmitotic CD4 T cell
p_17718_2	"MT-2 cell, HTLV-1 positive"	Postmitotic CD4 T cell
p_17743_1	"gastrointestinal stromal tumor, KIT mutation detected"	"gastrointestinal stromal tumor, wild type, control"
p_17743_2	"gastrointestinal stromal tumor, PDGFRA mutation detected"	"gastrointestinal stromal tumor, wild type, control"
p_17763_1	"Lesion patent macrophage cell, BT lesion"	"Lesion patent macrophage cell, LL lesion"
p_17763_2	"Lesion patent macrophage cell, RR lesion"	"Lesion patent macrophage cell, LL lesion"
p_17768_1	"HCC38 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_2	"HCC1008 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_3	"HCC1143 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_4	"HCC1395 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_5	"HCC1599 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_6	"HCC1937 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_7	"HCC2218 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_8	"BT474 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17768_9	"MCF7 cells, breast cancer cell line"	"MCF10A cells, non-breast cancer cell line"
p_17777_1	"HMVEC, VEGF treated"	"HMVEC, control"
p_17777_2	"HMVEC, VEGF, 8CPT treated"	"HMVEC, control"
p_17777_3	"HMVEC, VEGF, ET treated"	"HMVEC, control"
p_17785_1	"MCF10A cell, PI3K mutate, DMSO treated"	"MCF10A cell, WT, DMSO treated"
p_17785_2	"MCF10A cell, PI3K mutate, GDC0941 treated"	"MCF10A cell, WT, GDC0941 treated"
p_17827_1	"IMR32, inducible MEIS1-shRNA, doxycycline induction, 24h"	"IMR32, inducible MEIS1-shRNA, 0h"
p_17827_2	"IMR32, inducible MEIS1-shRNA, doxycycline induction, 48h"	"IMR32, inducible MEIS1-shRNA, 0h"
p_17827_3	"IMR32, inducible MEIS1-shRNA, doxycycline induction, 96h"	"IMR32, inducible MEIS1-shRNA, 0h"
p_17827_4	"IMR32, inducible MEIS1-shRNA, doxycycline induction, 192h"	"IMR32, inducible MEIS1-shRNA, 0h"
p_17832_1	"MCF-7 cell, Desferrioxamine treated"	"MCF-7 cell, control"
p_17832_2	"MCF-7 cell, 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone treated"	"MCF-7 cell, control"
p_17861_1	"Acute rejection biopsy grade Ib, IIA from human transplanted kidney"	Biopsy from non-rejecting human transplanted kidney
p_17889_1	"MCF7-I6, highly invasive cells"	"MCF7-I0, weakly invasive cells"
p_17906_1	prostate cancer	normal prostate
p_17906_2	bladder cancer	normal bladder tissues
p_17907_1	breast cancer	normal breast
p_17907_10	IGF1R IHC+ breast cancer	IGF1R IHC- breast cancer
p_17907_11	EGFR IHC+ breast cancer	EGFR IHC- breast cancer
p_17907_12	TOP2A IHC+ breast cancer	TOP2A IHC- breast cancer
p_17907_13	FOXA1  IHC+ breast cancer	FOXA1  IHC- breast cancer
p_17907_2	ERBB2 type breast cancer	normal type breast cancer
p_17907_3	luminalA type breast cancer	normal type breast cancer
p_17907_4	Basal type breast cancer	normal type breast cancer
p_17907_5	ERBB2 IHC+ breast cancer	ERBB2 IHC- breast cancer
p_17907_6	ER IHC+ breast cancer	ER IHC- breast cancer
p_17907_7	PR IHC+ breast cancer	PR IHC- breast cancer
p_17907_8	P53 IHC+ breast cancer	P53 IHC- breast cancer
p_17907_9	Ki67 IHC+ breast cancer	Ki67 IHC- breast cancer
p_17913_1	"Buccal mucosa cell, Smoker"	"Buccal mucosa cell, Non-smoker"
p_17920_1	chronic Hodgkin lymphoma; early relapse	chronic Hodgkin lymphoma; refractory
p_17920_2	chronic Hodgkin lymphoma; late relapse	chronic Hodgkin lymphoma; refractory
p_17938_1	"T cell, cocultured RPE"	RPE cell
p_17938_2	"T cell, cocultured RPE, AMD disease"	"RPE cell, AMD disease"
p_17938_3	"T cell, cocultured RPE, AMD disease"	"T cell, AMD disease"
p_17938_4	AMD: RPE only	t-cell co-culture: RPE only
p_17938_5	AMD: RPE co-Tcells	t-cell co-culture: RPE co-Tcells
p_17939_1	"HUVEC cell, MEK5 activated"	"HUVEC cell, control"
p_17951_1	prostate cancer	normal prostate
p_17987_1	"MIA.PACA2 cell, masitinib treated"	"MIA.PACA2 cell, control"
p_17987_2	"MIA.PACA2 cell, gemcitabine treated"	"MIA.PACA2 cell, control"
p_17987_3	"MIA.PACA2 cell, masitinib,gemcitabine treated"	"MIA.PACA2 cell, control"
p_18000_1	"Panc1 cell, syk-silenced"	"Panc1 cell, control"
p_18015_1	"CD133/2+ cells, primary glioblastoma"	"CD133/2- cells, primary glioblastoma"
p_18043_1	BM-mesenchymal stem cells (MSC) culture osteogenic induction for 1 day treated	BM-mesenchymal stem cells (MSC) culture
p_18043_2	BM-mesenchymal stem cells (MSC) culture osteogenic induction for 3 days treated	BM-mesenchymal stem cells (MSC) culture
p_18043_3	BM-mesenchymal stem cells (MSC) culture osteogenic induction for 7 days treated	BM-mesenchymal stem cells (MSC) culture
p_18047_1	H929 transfected with IKKB treated	H929 control
p_18047_2	H929 transfected with NIK treated	H929 control
p_18047_3	SACHI transfected with IKKB treated	SACHI control
p_18047_4	SACHI transfected with IKKB treated	SACHI control
p_18070_1	cell line derived from a xenograft of the MCF10ATk.cl2(MII) cells in nude mice that progressed to carcinoma (MIIIpB)	MCF10A H-Ras transformed cell line (MIIpB)
p_18070_2	"MCF10CA1h (MIII), overexpressing the inhibitory Smad8"	cell line derived from a xenograft of the MCF10ATk.cl2(MII) cells in nude mice that progressed to carcinoma (MIIIpB)
p_18105_1	"colorectal tissue, cancer"	"colorectal tissue, adjacent normal"
p_18105_2	colorectal cancer	normal
p_18113_1	"HMVEC cell, co-cultured with LS180 cell"	"HMVEC cell, quiescent"
p_18113_2	"HMVEC cell, co-cultured with HT-29 cell"	"HMVEC cell, quiescent"
p_18113_3	"HMVEC cell, co-cultured with Blood component"	"HMVEC cell, quiescent"
p_18113_4	"HMVEC cell, co-cultured with Blood component + LS180 cell"	"HMVEC cell, quiescent"
p_18113_5	"HMVEC cell, co-cultured with Blood component + HT-29 cell"	"HMVEC cell, quiescent"
p_18123_1	"peripheral blood, Autism Spectrum Disorder"	"peripheral blood, control"
p_18140_1	"Endometrium, on day of oocyte retrieval, pregnant"	"Endometrium, on day of oocyte retrieval, not pregnant"
p_18146_1	"T47D cells, testosterone tested"	"T47D cells, untreated"
p_18146_2	"T47D cells, testosterone-BSA treated"	"T47D cells, untreated"
p_18146_3	"MDA-MB-231 cells, testosterone tested"	"MDA-MB-231 cells, untreated"
p_18146_4	"MDA-MB-231 cells, testosterone-BSA treated"	"MDA-MB-231 cells, untreated"
p_18147_1	fully reprogrammed iPS cell line	Human embryonic stem cells
p_18147_2	partial iPS cell line	Human embryonic stem cells
p_18147_3	fully reprogrammed iPS cell line	Human foreskin fibroblast (HFF1)
p_18150_1	"Gliospheres, DZNep treated"	"Gliospheres, control"
p_18180_1	Human gut mesentery derived MCiPS	Human gut mesentery derived MSC
p_18180_2	hESC	Human gut mesentery derived MSC
p_18182_1	"A549 cell, NME2 silenced"	"A549 cell, control"
p_18195_1	"Hec50co cell, avastin dosed"	"Hec50co cell, undosed control"
p_18198_1	"KOPT-K1 cells, treated with SAHM1"	"KOPT-K1 cells, treated with DMSO"
p_18198_2	"HPB-ALL cells, treated with SAHM1"	"HPB-ALL cells, treated with DMSO"
p_18226_1	iPS	fibroblast
p_18235_1	"Airway epithelial cell, tobacco type 1"	"Airway epithelial cell, control"
p_18235_10	"Airway epithelial cell, tobacco type 10"	"Airway epithelial cell, control"
p_18235_2	"Airway epithelial cell, tobacco type 2"	"Airway epithelial cell, control"
p_18235_3	"Airway epithelial cell, tobacco type 3"	"Airway epithelial cell, control"
p_18235_4	"Airway epithelial cell, tobacco type 4"	"Airway epithelial cell, control"
p_18235_5	"Airway epithelial cell, tobacco type 5"	"Airway epithelial cell, control"
p_18235_6	"Airway epithelial cell, tobacco type 6"	"Airway epithelial cell, control"
p_18235_7	"Airway epithelial cell, tobacco type 7"	"Airway epithelial cell, control"
p_18235_8	"Airway epithelial cell, tobacco type 8"	"Airway epithelial cell, control"
p_18235_9	"Airway epithelial cell, tobacco type 9"	"Airway epithelial cell, control"
p_18239_1	"T-ALL cells, JAK1 mutation"	"T-ALL cells, wild type JAK1"
p_18269_1	Undifferentiated elongate HepaRG; treat	Differentiated well-confluent HepaRG
p_18269_2	HepG2; treat	Differentiated well-confluent HepaRG
p_18269_3	Primary hepatocyte; treat	Differentiated well-confluent HepaRG
p_18269_4	Liver; treat	Differentiated well-confluent HepaRG
p_18271_1	ganglioneuromas	ganglioneuroblastomas
p_18277_1	MIAPaCa2 cells expressing alpha2 and maintained on collagenI	MIAPaCa2 cells  maintained under drug selection
p_18277_2	MIAPaCa2 cells expressing alpha2 and maintained in standard culture	MIAPaCa2 cells  maintained under drug selection
p_18277_3	MIAPaCa2 cells expressing alpha9alpha2 chimera and maintained on tenascin FNIII	MIAPaCa2 cells  maintained under drug selection
p_18277_4	MIAPaCa2 cells expressing alpha2 cytoplasmic deletion and maintained on collagenI	MIAPaCa2 cells  maintained under drug selection
p_18309_1	"PBMC, from Alzheimer's disease patient"	"PBMC, from normal elder individuals"
p_18309_2	"PBMC, from mild cognitive impairment patients"	"PBMC, from normal elder individuals"
p_18313_1	"CD57 positive T cell, paraproteinemia patients"	"CD57 negative T cell, paraproteinemia patients"
p_18323_1	PBMC; Protected from malaria vaccine trial treated	PBMC; NonProtected
p_18323_2	PBMC; Delay from malaria vaccine trial treated	PBMC; NonProtected
p_18331_1	"Breast cancer cell, no-sensitive to Valproic acid"	"Breast cancer cell, sensitive to Valproic acid"
p_18331_2	"Breast cancer cell, resistant to Valproic acid"	"Breast cancer cell, sensitive to Valproic acid"
p_18349_1	"Fetal cortex, XY_trisomy 7"	"Fetal cortex, XY_diploid"
p_18370_1	NTci	PTci
p_18370_2	MT1	PTci
p_18370_3	MT1	NTci
p_18373_1	"HUVEC, MAGP2 treated"	"HUVEC, control"
p_18373_2	"OVCA429 cell, MAGP2 treated"	"OVCA429 cell, control"
p_18391_1	"Adipose-derived stromal/stem cells (ASC), adipogenic induced"	"Adipose-derived stromal/stem cells (ASC), control"
p_18454_1	"Normal human bronchial epithelian cell, 5-aza treated"	"Normal human bronchial epithelian cell, control"
p_18454_2	"Normal human small airway epithelian cell, 5-aza treated"	"Normal human small airway epithelian cell, control"
p_18462_1	primary colorectal carcinoma	normal colon
p_18462_2	liver metastasis	normal liver
p_18476_1	"U937T cells, PLZF-RAR induction, 48h"	"U937T cells, no induction of PLZF-RAR, control"
p_18486_1	"A2780 cell, CDk-125 treated"	"A2780 cell, untreated"
p_18486_2	"A2780 cell, CDk-509 treated"	"A2780 cell, untreated"
p_18494_1	HepG2 hypoxia (0.5%O2) treatment 4h; time course	HepG2 normoxia
p_18494_3	HepG2 hypoxia (0.5%O2) treatment 12h; time course	HepG2 normoxia
p_18494_4	U87 hypoxia (0.5%O2) treatment 4h; time course	U87 normoxia
p_18494_6	U87 hypoxia (0.5%O2) treatment 12h; time course	U87 normoxia
p_18494_7	MB231 hypoxia (0.5%O2) treatment 4h; time course	MB231 normoxia
p_18494_9	MB231 hypoxia (0.5%O2) treatment 12h; time course	MB231 normoxia
p_18497_1	Pre-B-ALL	Common ALL
p_18497_2	T-ALL	Common ALL
p_18498_1	"A2780 cells, CDK-887 treated"	"A2780 cells, untreated"
p_18501_1	"MCF-7 cells, CDK-125 treated"	"MCF-7 cells, untreated"
p_18504_1	"A2780 cells, Flavopiridol treated"	"A2780 cells, untreated"
p_18521_1	HUVEC+MAGP2 treatment	HUVEC control
p_18521_2	OVCA429+MAGP2 treatment	OVCA429 control
p_18521_3	Ovarian Tumor; ovary cancer	normal ovary
p_18557_1	"Endometrium, on the day of oocyte retrieval, hCG treated"	"Endometrium, on the day of oocyte retrieval, rFSH treated"
p_18560_1	"Ls174T cell, pTER-B-catenin, dox treated"	"Ls174T cell, pTER-B-catenin, control"
p_18560_2	"Ls174T cell, L8 treated dox treated"	"Ls174T cell, L8 treated control"
p_18565_1	CD16+ monocytes	CD16- monocytes
p_18571_1	"MDA-MB-468 cell line, Rapa-treated, 24 h"	"MDA-MB-468 cell line, DMSO-treated, 24 h"
p_18571_2	"breast tumor xenograft, Rapamycin treated, 1 day"	"breast tumor xenograft, DMSO-treated, 1 day"
p_18571_3	"breast tumor xenograft, Rapamycin treated, 22 day"	"breast tumor xenograft, DMSO-treated, 22 day"
p_18590_1	"primary human keratinocytes, differentiated with addition of Ca2+ (1.2mM), 3 days"	"primary human keratinocytes, undifferentiated"
p_18590_2	"primary human keratinocytes, DNMT1 knock down"	"primary human keratinocytes, undifferentiated"
p_18590_3	primary keratinocytes; DNMT1 knockdown	primary keratinocytes; differentiated
p_18608_1	"CD133 cell, coronary artery disease (CAD) patient, before exercise"	"CD133 cell, healthy"
p_18608_2	"CD133 cell, coronary artery disease (CAD) patient, after exercise 3month"	"CD133 cell, healthy"
p_18608_3	"CD133 cell, coronary artery disease (CAD) patient, after exercise 3month"	"CD133 cell, coronary artery disease (CAD) patient, before exercise"
p_18618_1	hiPSC footprint-free clone1	Neural progenitor cells
p_18618_2	hiPSC footprint-free clone2	Neural progenitor cells
p_18618_3	HUES6 ES; Human Embryonic Stem Cells	Neural progenitor cells
p_18618_4	Cythera ES; Human Embryonic Stem Cells	Neural progenitor cells
p_18625_1	"DLD-1 cells, transfected with miR-145"	"DLD-1 cells, mock transfected"
p_18632_1	"HEK293E cell, TDP-43 knockdown"	"HEK293E cell, control"
p_18640_1	"CD34 cell, HPIP-wt"	"CD34 cell, control"
p_18640_2	"CD34 cell, NRPID mutant"	"CD34 cell, control"
p_18679_1	Human embryonic stem cells	Human erythroblast
p_18680_1	"Ovarian cancer cell, low CXCR4"	"Ovarian cancer cell, high CXCR4"
p_18681_1	ascites cell sample from non-responsive patient to infliximab; ovary cancer; treat	ascites cell sample from responsive patient to infliximab
p_18728_1	breast cancer; responder	breast cancer; non-responder
p_18728_2	"breast cancer, ER+"	"breast cancer, ER-"
p_18728_3	"breast cancer, PR+"	"breast cancer, PR-"
p_18728_4	"breast cancer, HER2+"	"breast cancer, HER2-"
p_18736_1	"Lymph node, mantle cell lymphoma patient"	"Lymph node, follicular lymphoma patient"
p_18739_1	"HEK293 cells, in vivo cell expansion (NOD.Scid mice), 3 weeks"	"HEK293 cells, cultivated in DMEM"
p_18773_1	"CAL-51 cell, side population"	"CAL-51 cell, non-side population"
p_18781_1	Blood - Axial Spondyloarthropathy; tissue	Blood - Control
p_18781_2	Blood - Sarcoidosis; tissue	Blood - Control
p_18791_10	"Dendritic cells infected with Newcastle disease virus (NDV), 18 hr"	"Dendritic cells infected with allantoic fluid (AF), 18 hr"
p_18809_1	"Placenta, Preterm spontaneous delivery"	"Placenta, Term spontaneous delivery"
p_18810_1	"neutrophils, exposed to E.coli strain MG1655, 60 min"	"Neutrophile, mock treated, 60 min"
p_18810_2	"neutrophils, exposed to E.coli strain UTI89, 60 min"	"Neutrophile, mock treated, 60 min"
p_18811_1	"retinal pigment epithelium (RPE), adult"	"retinal pigment epithelium (RPE), fetal"
p_18826_1	"UMCL01-101 cell, cultured in RWV Bioreactor (3D assembly)"	"UMCL01-101 cell, grown in suspension culture"
p_18842_1	"lung, tumor"	"lung, control"
p_18850_1	"Placenta cell, Cesarean delivery"	"Placenta cell, Labour spontaneous delivery"
p_18864_1	breast cancer p53 mutated	breast cancer WT
p_18864_2	breast cancer ER+	breast cancer ER-
p_18864_3	breast cancer PR+	breast cancer PR-
p_18864_4	breast cancer HER2+	breast cancer HER2-
p_18864_5	breast cancer BRCA mutated	breast cancer BRCA WT
p_18866_1	"CLL-I83E95 cells, miR-15a/16-1 expression"	"CLL-I83E95 cells, empty vector"
p_18892_1	"U87MG glial cell, AEBP silenced with siRNA"	"U87MG glial cell, scrambled siRNA"
p_18897_1	DietSensitive _1 day; blood	DietResistant _1 day
p_18897_2	DietSensitive _3 weeks; blood	DietResistant _3 weeks
p_18897_3	DietSensitive _6 weeks; blood	DietResistant _6 weeks
p_18897_4	DietSensitive _1 day; blood	Lean_1 day
p_18897_6	Human XYY triploid; tissue	Human male diploid
p_18901_1	GBS6 cells transfected with POU5F1 siRNA-1 treated	GBS6 cells transfected with negative control siRNA 2nd
p_18901_2	GBS6 cells transfected with POU5F1 siRNA-2 treated	GBS6 cells transfected with negative control siRNA 2nd
p_18903_1	MCF-7 cell	MCF-7-14 cell
p_18903_2	MDA-MB-231 cell	MCF-7-14 cell
p_18906_1	"CD36+EPC cell, B19V NS1 treated, 12h"	"CD36+EPC cell, control, 12h"
p_18906_2	"CD36+EPC cell, B19V NS1 treated, 24h"	"CD36+EPC cell, control, 24h"
p_18906_3	"CD36+EPC cell, B19V NS1 treated, 48h"	"CD36+EPC cell, control, 48h"
p_18912_1	MCF-7R4 cells	MCF-7 cells
p_18913_1	"HUVEC, VEGF treated, siRNA targeting Egr-3, 0h"	"HUVEC, VEGF treated, 0h"
p_18913_2	"HUVEC, VEGF treated, siRNA targeting Egr-3, 1h"	"HUVEC, VEGF treated, 1h"
p_18913_3	"HUVEC, VEGF treated, siRNA targeting Egr-3, 4h"	"HUVEC, VEGF treated, 4h"
p_18913_4	"HUVEC, Egr-3 siRNA #2, VEGF 0h treatment; time course"	"control, VEGF 0h"
p_18913_5	"HUVEC, Egr-3 siRNA #2, VEGF 1h treatment; time course"	"control, VEGF 1h"
p_18913_6	"HUVEC, Egr-3 siRNA #2, VEGF 4h treatment; time course"	"control, VEGF 4h"
p_18914_1	"Somatic cell, GDNF-TSC"	"Spermatogonia cell, GDNF-SSC"
p_18931_1	"Mammary epithelial cells, FACS sorted, PKH-Positive"	"Mammary epithelial cells, FACS sorted, PKH-Negative"
p_18946_1	"DG75, miR-K10 treated"	"DG75, miR-GFP treated"
p_18946_2	"DG75, miR-K12 treated"	"DG75, miR-GFP treated"
p_18946_3	"EA.hy296 cell, miR-K10 treated"	"EA.hy296 cell, miR-GFP treated"
p_18946_4	"EA.hy296 cell, miR-K12 treated"	"EA.hy296 cell, miR-GFP treated"
p_18947_1	"Sosp-9607 cells, high metastatic potential"	"Sosp-9607cells, low metastatic potential"
p_18947_2	"Saos-2 cells, high metastatic potential"	"Saos-2 cells, low metastatic potential"
p_18959_1	"RA-specified astrocyte, 210d"	"Neuroepithelial cell, 17d"
p_18959_2	"FGF8-specified astrocyte, 210d"	"Neuroepithelial cell, 17d"
p_18959_3	Day-180 FGF8-specified astrocytes	Day-17 neuroepithelial cells
p_18969_1	obstructed fetal kidney	normal fetal kidney
p_18973_1	"HepG2 cell, HNF4a,g knockdown"	"HepG2 cell, control"
p_18995_1	"Lung cell, Donation after cardiac death (DCD) patient, post-transplant"	"Lung cell, Donation after cardian death (DCD) patient, pre-transplant"
p_18995_2	"Lung cell, Donation after brain death (DBD) patient, post-transplant"	"Lung cell, Donation after brain death (DBD) patient, pre-transplant"
p_18997_1	"testicular biopsy,spermatogenic stage - score 3"	"testicular biopsy,spermatogenic stage - score 2"
p_19018_1	"Imr 90 cell, old, 3% oxygen"	"Imr 90 cell, young, 3% oxygen"
p_19018_2	"Imr 90 cell, senescent, 20% oxygen"	"Imr 90 cell, young, 20% oxygen"
p_19060_1	"meniscal tissue, osteoarthritis"	"meniscal tissue, normal"
p_19069_01	Adult T-cell leukemia/lymphoma	Activated CD4+ T-cell
p_19069_02	Anapalstic Large cell lymphoma ALK-	Activated CD4+ T-cell
p_19069_03	Anapalstic Large cell lymphoma ALK+	Activated CD4+ T-cell
p_19069_04	Angioimmunoblastic T-cell lymphoma	Activated CD4+ T-cell
p_19069_05	"Peripheral T-Cell lymphoma, unspecified"	Activated CD4+ T-cell
p_19069_06	Resting CD4+ T-cells	Activated CD4+ T-cell
p_19069_07	"T-cell acute lymphoblastic leukemia, JURKAT"	Activated CD4+ T-cell
p_19069_08	"T-cell acute lymphoblastic leukemia, MOLT3"	Activated CD4+ T-cell
p_19069_09	"T-cell acute lymphoblastic leukemia, PEER"	Activated CD4+ T-cell
p_19069_10	"T-cell line, Sezary syndrome"	Activated CD4+ T-cell
p_19069_11	T-cell prolymphocytic leukemia	Activated CD4+ T-cell
p_19098_1	"HUVEC cell, unspread, VEGF"	"HUVEC cell, unspread, no VEGF"
p_19098_2	"HUVEC cell, spread, VEGF"	"HUVEC cell, spread, no VEGF"
p_19123_1	"MCF7 cells, media with 25mM lactic acid, 1h"	"MCF7 cells, control media, 1h"
p_19123_2	"MCF7 cells, media with 25mM lactic acid, 4h"	"MCF7 cells, control media, 4h"
p_19123_3	"MCF7 cells, media with 25mM lactic acid, 12h"	"MCF7 cells, control media, 12h"
p_19123_4	"MCF7 cells, media with 25mM lactic acid, 24h"	"MCF7 cells, control media, 24h"
p_19123_5	"MCF7 cell, lactic acidosis"	"MCF7 cells, control"
p_19123_6	"MCF7 cell, glucose deprivation"	"MCF7 cells, control"
p_19123_7	"MCF7 cell, hypoxia"	"MCF7 cells, control"
p_19128_1	"PBMC, Astragalus treated, 18h"	"PBMC, untreated, 18h"
p_19128_2	"PBMC, Astragalus treated, 18h"	"PBMC, EtOH treated, 18h"
p_19128_3	"PBMC, Sambucus treated, 18h"	"PBMC, EtOH treated, 18h"
p_19128_4	"PBMC, Urtica treated, 18h"	"PBMC, EtOH treated, 18h"
p_19128_5	"PBMC, Sambucus treated, 18h"	"PBMC, untreated, 18h"
p_19128_6	"PBMC, Urtica treated, 18h"	"PBMC, untreated, 18h"
p_19197_1	"SK-N-MC cells,hypoxia, grown as spheroid"	"SK-N-MC cells, normoxia, grown as spheroid"
p_19197_2	"TC-252 cells, hypoxia, grown as spheroid"	"TC-252 cells, normoxia, grown as spheroid"
p_19201_1	"NB4 cells, ATRA treated, 4h"	"NB4 cells, untreatead"
p_19201_2	"NB4 cells, ATRA treated, 12h"	"NB4 cells, untreatead"
p_19201_3	"NB4 cells, ATRA treated, 24h"	"NB4 cells, untreatead"
p_19201_4	"NB4 cells, ATRA treated, 48h"	"NB4 cells, untreatead"
p_19201_5	"NB4 cells, ATRA treated, 72h"	"NB4 cells, untreatead"
p_19240_1	"Endothelial cell, IL-1 beta treated, 4h"	"Endothelial cell, control"
p_19240_2	"Endothelial cell, IL-1 beta treated, 8h"	"Endothelial cell, control"
p_19240_3	"Endothelial cell, IL-1 beta treated, 16h"	"Endothelial cell, control"
p_19246_1	"B cell lymphoma, activated, fresh/frozen"	"B cell lymphoma, unclassified, fresh/frozen"
p_19246_2	"B cell lymphoma, greminal center, fresh/frozen"	"B cell lymphoma, unclassified, fresh/frozen"
p_19246_3	"B cell lymphoma, activated, formalin fixed paraffin embedded"	"B cell lymphoma, unclassified, formalin fixed paraffin embedded"
p_19246_4	"B cell lymphoma, greminal center, formalin fixed paraffin embedded"	"B cell lymphoma, unclassified, formalin fixed paraffin embedded"
p_19314_1	"peripheral blood mononuclear cells, Sarcoidosis"	"peripheral blood mononuclear cells, healthy control"
p_19314_2	"peripheral blood mononuclear cells, hypersensitivity pneumonitis"	"peripheral blood mononuclear cells, healthy control"
p_19315_1	"THP-1 cell, LPS treated"	"THP-1 cell, control"
p_19315_2	"THP-1 cell, ST treated"	"THP-1 cell, control"
p_19332_1	"motor neuron, CHMP2B mutant individual"	"motor neuron, Neurologically normal control"
p_19339_1	"leukocyte, myocardial infarction"	"leukocyte, normal"
p_19345_1	"Neural progenitor cell, HCMV infected, 4h"	"Neural progenitor cell, control"
p_19345_2	"Neural progenitor cell, HCMV infected, 12h"	"Neural progenitor cell, control"
p_19345_3	"Neural progenitor cell, HCMV infected, 24h"	"Neural progenitor cell, control"
p_19352_1	ovary cancer	Ovarian surface epithelium cells
p_19383_1	"Breast cell, BRCA1 mutant"	"Breast cell, wild type"
p_19383_2	"Breast cell, BRCA2 mutant"	"Breast cell, wild type"
p_19383_3	"Ovary cell, BRCA1 mutant"	"Ovary cell, wild type"
p_19383_4	"Ovary cell, BRCA2 mutant"	"Ovary cell, wild type"
p_19393_1	"Primary subcutaneous preadipocyte cell, exposed to glucocorticoid"	"Primary subcutaneous preadipocyte cell, control"
p_19406_1	"FADU cell, expressed dODD"	"FADU cell, expressed control"
p_19406_2	"FADU cell, expressed Twist1"	"FADU cell, expressed control"
p_19406_3	"FADU cell, expressed Bmi1"	"FADU cell, expressed control"
p_19445_1	"LNCaP cells, DHT treated"	"LNCaP cells, serum starved, control"
p_19445_2	"LNCaP cells, DHT + Etoposide treated"	"LNCaP cells, serum starved, control"
p_19445_3	"LNCaP cells, DHT + Merbarone treated"	"LNCaP cells, serum starved, control"
p_19445_4	"LNCaP cells, control shRNA, DHT treated"	"LNCaP cells, control shRNA"
p_19445_5	"LNCaP cells, shRNA targeting TOPO2B"	"LNCaP cells, control shRNA"
p_19445_6	"LNCaP cells, shRNA targeting TOPO2B, DHT treated"	"LNCaP cells, control shRNA"
p_19495_1	"Hepatocellular caicinoma cells, HisOH treated"	"Hepatocellular carcinoma cells, control"
p_19510_1	"WI-38 cell, 0.1uM BPDE"	"WI-38 cell, DMSO control"
p_19510_2	"WI-38 cell, 0.5uM BPDE"	"WI-38 cell, DMSO control"
p_19510_3	"WI-38 cell, 1uM BPDE"	"WI-38 cell, DMSO control"
p_19533_1	"Diaphargm muscle, after surgery"	"Diaphargm muscle, before surgery"
p_19592_1	"H460 cell, DUSP1/MKP1 stimulated"	"H460 cell, control"
p_19615_1	Recurrent breast cancer	non-recurrent breast cancer
p_19615_2	ER+ breast cancer	ER- breast cancer
p_19615_3	PR+ breast cancer	PR- breast cancer
p_19615_4	HER2+ breast cancer	HER2- breast cancer
p_19615_5	Node + breast cancer	Node - breast cancer
p_19615_6	Ductal breast cancer	lobular breast cancer
p_19625_1	"THP1 cell, LPS treated"	"THP1 cell, control"
p_19625_2	"THP1 cell, LPS treated, Q10 treated"	"THP1 cell, control"
p_19627_1	"THP1 cell, LPS treated"	"THP1 cell, control"
p_19627_2	"THP1 cell, LPS treated, Q10H2 treated"	"THP1 cell, control"
p_19638_1	"MCF cells, 17AAG treated"	"MCF cells, untreated"
p_19638_2	"MCF cells, AUY922 treated"	"MCF cells, untreated"
p_19638_3	"MCF cells, CDK-887 treated"	"MCF cells, untreated"
p_19638_4	"MCF cells, doxorubicin treated"	"MCF cells, untreated"
p_19638_5	"MCF cells, E973 treated"	"MCF cells, untreated"
p_19638_6	"MCF cells, SN38 treated"	"MCF cells, untreated"
p_19639_1	"MCF7 cell, Long-term estrogen-deprived"	"MCF7 cell, control"
p_19639_2	"ZR75-1 cell, Long-term estrogen-deprived"	"ZR75-1 cell, control"
p_19639_3	"MDA-361 cell, Long-term estrogen-deprived"	"MDA-361 cell, control"
p_19639_4	"HCC-1428 cell, Long-term estrogen-deprived"	"HCC-1428 cell, control"
p_19643_1	"MSC cell, PGC-1 alpha infected"	"MSC cell, Ad-GFP infected"
p_19650_1	Intraductal papillary-mucinous adenoma cell	Normal main pancreatic duct cell
p_19650_2	Intraductal papillary-mucinous carcinoma cell	Normal main pancreatic duct cell
p_19650_3	Intraductal papillary-mucinous tumor	Normal main pancreatic duct cell
p_19670_1	"SKBR3 cells, siRNA targeting p53"	"SKBR3 cells, siRNA targeting LacZ, control"
p_19670_10	"SKBR3 cells knocked down for mutp53 expression, treated with vitamin D3 for50h; time course"	SKBR3 control treated with vitamin D3 for 50h
p_19670_2	"SKBR3 cells, siRNA targeting p53., vitamin D3 treated, 8h"	"SKBR3 cells, siRNA targeting LacZ, vitamin D3 treated, 8h, control"
p_19670_3	"SKBR3 cells, siRNA targeting p53, vitamin D3 treated, 20h"	"SKBR3 cells, siRNA targeting LacZ, vitamin D3 treated, 20h, control"
p_19670_4	"SKBR3 cells, siRNA targeting p53, vitamin D3 treated, 50h"	"SKBR3 cells, siRNA targeting LacZ, vitamin D3 treated, 50h, control"
p_19670_5	"SKBR3 cells knocked down for mutp53 expression, treated with vitamin D3 for 20h; time course"	SKBR3 cells knocked down for mutp53 expression
p_19670_6	"SKBR3 cells knocked down for mutp53 expression, treated with vitamin D3 for50h; time course"	SKBR3 cells knocked down for mutp53 expression
p_19670_7	SKBR3 cells knocked down for mutp53 expression; treat; time course	SKBR3 control cells
p_19670_8	"SKBR3 cells knocked down for mutp53 expression, treated with vitamin D3 for 8h; time course"	SKBR3 control treated with vitamin D3 for 8h
p_19670_9	"SKBR3 cells knocked down for mutp53 expression, treated with vitamin D3 for 20h; time course"	SKBR3 control treated with vitamin D3 for 20h
p_19672_1	"CCSM cell, MaxiK silenced"	"CCSM cell, control"
p_19678_1	"U87TR-Da cells, DACH1-induced, DMEMF (serum-containing)"	"U87TR-Da cells, DACH1-silenced, DMEMF (serum-containing)"
p_19678_2	"U87TR-Da cells, DACH1-induced, NBE (serum-free)"	"U87TR-Da cells, DACH1-silenced, NBE (serum-free)"
p_19680_1	"M07 cell line, anti-miR-125b treated"	"M07 cell line, non-silencing control"
p_19680_2	"CMK cell line, anti-miR-125b treated"	"CMK cell line, non-silencing control"
p_19680_3	"M07 cell line, anti-miR-125b; siRNA treat"	"M07 cell line, non-silencing control"
p_19681_1	"Leukemic blast cell, ML, Down syndrome patient"	"Leukemic blast cell, AML patient"
p_19681_2	"Leukemic blast cell, Down syndrome, transient leukemia"	"Leukemic blast cell, AML patient"
p_19686_1	"Hs683 cell, shQk-2 infected"	"Hs683 cell, shGFP infected"
p_19686_2	"Hs683 cell, shQk-5 infected"	"Hs683 cell, shGFP infected"
p_19688_1	"Hs683 cell , QK-knockdown, miR-20a treated"	"Hs683 cell , QK-knockdown, control"
p_19690_1	"U87 cell , QK-knockdown, miR-20a treated"	"U87 cell , QK-knockdown, control"
p_19693_1	Hs683 cells infected with shQk-2; treat	Hs683 cells infected with shGFP as control
p_19693_2	Hs683 cells infected with shQk-5; treat	Hs683 cells infected with shGFP as control
p_19693_3	QK-knockdown Hs683 cells transduced with and miR-20a; siRNA treat	QK-knockdown Hs683 cells transduced with a scrambled non-targeting microRNA (miR-NT)
p_19693_4	QK-knockdown U87 transduced with miR-20a; siRNA treat	QK-knockdown U87 transduced with a scrambled non-targeting microRNA (miR-NT)
p_19697_1	HER2+ breast cancer	HER2- breast cancer
p_19697_2	Node + breast cancer	Node - breast cancer
p_19697_3	Recurrent breast cancer	non-recurrent breast cancer
p_19703_1	"P493-6 B cell, Low Myc"	"P493-6 B cell, No Myc"
p_19703_2	"P493-6 B cell, High Myc"	"P493-6 B cell, No Myc"
p_19713_1	"PCSC-1 cell, sphere type"	"PCSC-1 cell, parental"
p_19713_2	"PCSC-2 cell, sphere type"	"PCSC-2 cell, parental"
p_19713_3	"PCSC-3 cell, sphere type"	"PCSC-3 cell, parental"
p_19728_1	Apilocytic astrocytoma	pooled normal brain tissue
p_19728_2	diffusely infiltrating astrocytic gliomas	pooled normal brain tissue
p_19728_3	anaplastic astrocytomas	pooled normal brain tissue
p_19728_4	Glioblastoma multiforme (GBM) glioblastomas	pooled normal brain tissue
p_19735_1	hESC Ebs differentiated for 14 days in pro-angiogenic cytokines	Human Umbilical Vein ECs cultured in serum free conditions for 48 hours
p_19735_2	purified hESC-derived ECs isolated at day 14 of differentiation in the presence of TGFbeta inhibition	Human Umbilical Vein ECs cultured in serum free conditions for 48 hours
p_19735_3	purified hESC-derived ECs isolated at day 14 of differentiation and cultured for an additional 10 days in the presence of TGFbeta inhibition	Human Umbilical Vein ECs cultured in serum free conditions for 48 hours
p_19735_4	Human Umbilical Vein Smooth Muscle Cells cultured in serum free conditions for 48 hours	Human Umbilical Vein ECs cultured in serum free conditions for 48 hours
p_19735_5	isolated and Human Cord Blood CD34+ Cells	Human Umbilical Vein ECs cultured in serum free conditions for 48 hours
p_19737_1	"MDA-MB-231 cell, miR-145 overexpress"	"MDA-MB-231 cell, control"
p_19777_1	"Fulvestrant-resistant breast cancer cell, si221 treated"	"Fulvestrant-resistant breast cancer cell, control"
p_19777_2	"Fulvestrant-resistant breast cancer cell, si222 treated"	"Fulvestrant-resistant breast cancer cell, control"
p_19797_1	"HeLa cell, chicken HSF1"	"HeLa cell, wt HSF1"
p_19797_2	"HeLa cell, mutated human HSF1"	"HeLa cell, wt HSF1"
p_19804_1	lung cancer	normal lung tissue
p_19810_1	"HTR-8 cell, P.gingivalis infected"	"HTR-8 cell, control"
p_19816_1	"HUVEC cell, IL1-beta treated"	"HUVEC cell, control"
p_19816_2	"HUVEC cell, Actinomycin D treated"	"HUVEC cell, control"
p_19816_3	"HUVEC cell, Actinomycin D +IL1-beta treated"	"HUVEC cell, control"
p_19816_4	"HUVEC cell, with Hank's buffered salt + vWF"	"HUVEC cell, with Hank's buffered salt"
p_19826_1	"Gastric cell, cancer, stage 2"	"Gastric adjacent tissue, non cancer"
p_19862_1	"colorectal cancer tissue, bevacizumab_non-responder"	"colorectal cancer tissue, bevacizumab_responder"
p_19864_01	shRB  (Growing)	MLP (Growing)
p_19864_02	shp107 (Growing)	MLP (Growing)
p_19864_03	shp130  (Growing)	MLP (Growing)
p_19864_04	shRB  (0.1% FBS)	MLP (0.1% FBS)
p_19864_05	shp107  (0.1% FBS)	MLP (0.1% FBS)
p_19864_06	shp130  (0.1% FBS)	MLP (0.1% FBS)
p_19864_07	shRB (Confluent)	MLP (Confluent)
p_19864_08	shp107 (Confluent)	MLP (Confluent)
p_19864_09	shp130 (Confluent)	MLP (Confluent)
p_19864_1	"IMR 90 cell, MLP treated, 0.1% FBS"	"IMR 90 cell, MLP treated, growing"
p_19864_10	"IMR 90 cell, shRB treated, senescent"	"IMR 90 cell, shRB treated, growing"
p_19864_11	"IMR 90 cell, shp107 silenced, senescent"	"IMR 90 cell, shp107 silenced, growing"
p_19864_12	"IMR 90 cell, shp130 silenced, senescent"	"IMR 90 cell, shp130 silenced, growing"
p_19864_2	"IMR 90 cell, shRB treated, 0.1% FBS"	"IMR 90 cell, shRB treated, growing"
p_19864_3	"IMR 90 cell, shp107 silenced, 0.1% FBS"	"IMR 90 cell, shp107 silenced, growing"
p_19864_4	"IMR 90 cell, shp130 silenced, 0.1% FBS"	"IMR 90 cell, shp130 silenced, growing"
p_19864_5	"IMR 90 cell, MLP treated, confluent"	"IMR 90 cell, MLP treated, growing"
p_19864_6	"IMR 90 cell, shRB treated, confluent"	"IMR 90 cell, shRB treated, growing"
p_19864_7	"IMR 90 cell, shp107 silenced, confluent"	"IMR 90 cell, shp107 silenced, growing"
p_19864_8	"IMR 90 cell, shp130 silenced, confluent"	"IMR 90 cell, shp130 silenced, growing"
p_19864_9	"IMR 90 cell, MLP treated, senescent"	"IMR 90 cell, MLP treated, growing"
p_19882_1	PTL ECs	Reactive lymph node-derived ECs
p_19882_2	DLBCL ECs	Reactive lymph node-derived ECs
p_19899_1	"IMR90 cells, growing, shRNA targeting RB"	"IMR90 cells, growing, vector control"
p_19899_10	"IMR90 cells, ras-induced senescence, shRNA targeting RB"	"IMR90 cells, ras-induced senescence, vector control"
p_19899_11	"IMR90 cells, ras-induced senescence, shRNA targeting p107"	"IMR90 cells, ras-induced senescence, vector control"
p_19899_12	"IMR90 cells, ras-induced senescence, shRNA targeting p130"	"IMR90 cells, ras-induced senescence, vector control"
p_19899_2	"IMR90 cells, growing, shRNA targeting p107"	"IMR90 cells, growing, vector control"
p_19899_3	"IMR90 cells, growing, shRNA targeting p130"	"IMR90 cells, growing, vector control"
p_19899_4	"IMR90 cells, low serum quiescence (0.1% FBS), shRNA targeting RB"	"IMR90 cells, low serum quiescence (0.1% FBS), vector control"
p_19899_5	"IMR90 cells, low serum quiescence (0.1% FBS), shRNA targeting p107"	"IMR90 cells, low serum quiescence (0.1% FBS), vector control"
p_19899_6	"IMR90 cells, low serum quiescence (0.1% FBS), shRNA targeting p130"	"IMR90 cells, low serum quiescence (0.1% FBS), vector control"
p_19899_7	"IMR90 cells, confluent quiescence, shRNA targeting RB"	"IMR90 cells, confluent quiescence, vector control"
p_19899_8	"IMR90 cells, confluent quiescence, shRNA targeting p107"	"IMR90 cells, confluent quiescence, vector control"
p_19899_9	"IMR90 cells, confluent quiescence, shRNA targeting p130"	"IMR90 cells, confluent quiescence, vector control"
p_19902_1	"T3 cell, MEF controled medium"	"T3 cell, MEF medium"
p_19902_2	"T3 cell, HDF controled medium"	"T3 cell, HDF medium"
p_19959_1	"Endometrium, on day of oocyte retrieval, hCG: 1-1.5 ng/ml"	"Endometrium, on day of oocyte retrieval, hCG <=0.9ng/ml"
p_19959_2	"Endometrium, on day of oocyte retrieval, hCG > 1.5ng/ml"	"Endometrium, on day of oocyte retrieval, hCG <=0.9ng/ml"
p_19963_1	"hyperplastic polyp, familial, proximal"	"normal colonic mucosa cell, familial, proximal"
p_19963_2	"hyperplastic polyp, sporadic, proximal"	"normal colonic mucosa cell, familial, proximal"
p_19963_3	"hyperplastic polyp, sporadic, distal"	"normal colonic mucosa cell, familial, distal"
p_19963_4	"hyperplastic polyp, familial, distal"	"normal colonic mucosa cell, familial, distal"
p_19982_1	Renal oncocytoma	Chromophobe renal cell carcinoma
p_20033_1	"iPSC, derived from hASC, using minicircle reprogramming vector"	hESC
p_20033_2	"iPSC, derived from hASC, using lentiviral reprogramming vector"	hESC
p_20033_3	"iPSC, from episomal vectors"	hESC
p_20033_4	"iPSC, from episomal vectors"	"Foreskin Cells, Parental"
p_20033_5	"iPSC, derived from hASC, using minicircle reprogramming vector"	"adipose stem cells, parental"
p_20033_6	"iPSC, derived from hASC, using lentiviral reprogramming vector"	"adipose stem cells, parental"
p_20036_1	antler mesemchyme	antler velvet
p_20036_2	antler pedicle skin	antler velvet
p_20036_3	antler frontal skin	antler velvet
p_20037_1	"HeLa cell, Cdr2 siRNA"	"HeLa cell, control siRNA"
p_20058_1	"AGS cell, non-side population"	"AGS cell, unsorted"
p_20058_2	"AGS cell, side population"	"AGS cell, unsorted"
p_20070_1	"Seg-1 cells, siRNA targeting FGF-AS"	"Seg-1 cells, negative control"
p_20081_1	"HeLa cell, SRA siRNA"	"HeLa cell, control siRNA"
p_20081_2	"MCF-7 cell, SRA siRNA"	"MCF-7 cell, control siRNA"
p_20081_3	"MCF-7 cell, E2 10nM treated, SRA siRNA"	"MCF-7 cell, E2 10nM treated, control siRNA"
p_20081_4	MCF-7_minus E2_SRA siRNA	MCF-7_minus E2_NT siRNA
p_20081_5	MCF-7_10 nM E2 (6h)_SRA siRNA	MCF-7_10 nM E2 (6h)_NT siRNA
p_20086_1	"Fibroblast, breast carcinoma"	"Fibroblast, adjacent normal breast tissue"
p_20089_1	"U87 cell, cell body fraction"	"U87 cell, pseudopodial fraction"
p_20089_2	"U251 cell, cell body fraction"	"U251 cell, pseudopodial fraction"
p_20089_3	"HT1080 cell, cell body fraction"	"HT1080 cell, pseudopodial fraction"
p_20089_4	"DU145 cell, cell body fraction"	"DU145 cell, pseudopodial fraction"
p_20089_5	"MDA231 cell, cell body fraction"	"MDA231 cell, pseudopodial fraction"
p_20089_6	"MDA435 cell, cell body fraction"	"MDA435 cell, pseudopodial fraction"
p_20114_1	"blood cell, vehicle treated, DHA treated"	"blood cell, vehicle treated, control"
p_20114_2	"blood cell, LPS treated, DHA treated"	"blood cell, LPS treated, control"
p_20115_1	"Reh cell, IKK treated"	"Reh cell, mock treated"
p_20115_2	"Reh cell, shCBFA2T3 treated"	"Reh cell, mock treated"
p_20115_3	"Reh cell, shCBFA2T3, IKK treated"	"Reh cell, mock treated"
p_20125_1	"Wharton's jelly stem cell line, passage 3"	"D551 cells, fetal fibroblast cell line"
p_20125_2	"Wharton's jelly stem cell line, passage 4"	"D551 cells, fetal fibroblast cell line"
p_20125_3	"Wharton's jelly stem cell line, passage 5"	"D551 cells, fetal fibroblast cell line"
p_20125_4	"Wharton's jelly stem cell line, passage 8"	"D551 cells, fetal fibroblast cell line"
p_20125_5	"Wharton's jelly stem cell line, passage 20"	"D551 cells, fetal fibroblast cell line"
p_20141_1	"Substantia Nigra pars compacta, Parkinson's disease"	"Substantia Nigra pars compacta, control"
p_20146_1	"Gpi cell, Parkinson disease"	"Gpi cell, Control"
p_20153_1	Parkinson's disease; B lymphocytes	control; B lymphocytes
p_20193_1	"HEK293 cell, hMOF overexpressed"	"HEK293 cell, control"
p_20193_2	"HEK293 cell, hMOF knock down"	"HEK293 cell, control"
p_20196_1	"Synovial sarcoma tumor tissue, higtological subtype: PDSS"	"Synovial sarcoma (SS) tumor tissue, higtological subtype: Monophasic SS"
p_20196_2	"Synovial sarcoma tumor tissue, higtological subtype: PDSS"	"Synovial sarcoma tumor tissue (SS), higtological subtype: Biphasic SS"
p_20211_1	"CLL cells, LMP-420 treated"	"CLL cell, control"
p_20238_1	"hepatocellular carcinoma, vascular invasion: YES"	"hepatocellular carcinoma, vascular invasion: NO"
p_20266_1	"Saliva, Breast cancer patients"	"Saliva, healthy control"
p_20272_1	"SKOV-3 cells, IL-6 treated"	"SKOV-3 cells, control"
p_20272_2	"SKOV-3 cells, IL-6+CNTO328 treated"	"SKOV-3 cells, control"
p_20272_3	"Caov-3 cells, IL-6 treated"	"Caov-3 cells, control"
p_20272_4	"Caov-3 cells, IL-6+CNTO328 treated"	"Caov-3 cells, control"
p_20285_1	"MCF-10A cell, full-length Notch 1"	"MCF-10A cell, control"
p_20285_2	"MCF-10A cell, Notch1, L1601P+del P"	"MCF-10A cell, control"
p_20285_3	"MCF-10A cell, NICD induced"	"MCF-10A cell, control"
p_20297_1	"HaCat cell, TNF + IFNg"	"HaCat cell, control"
p_20297_2	"HaCat cell, TNF + IFNg + terbutaline"	"HaCat cell, control"
p_20297_3	"HaCat cell, TNF + IFNg + GW9508"	"HaCat cell, control"
p_20300_1	"whole blood, acute rejection pediatric kidney transplant patients"	"whole blood, stable pediatric kidney transplant patients"
p_20318_1	"CL1-0 cells, YWHAZ overexpressed"	"CL1-0 cells, mock control"
p_20357_1	"RM82 cell, sh280 treated"	"RM82 cell, control"
p_20357_2	"RM82 cell, sh2495 treated"	"RM82 cell, control"
p_20357_3	"TC32 cell, sh280 treated"	"TC32 cell, control"
p_20357_4	"TC32 cell, sh2495 treated"	"TC32 cell, control"
p_20357_5	"STAET10 cell, sh280 treated"	"STAET10 cell, control"
p_20357_6	"STAET10 cell, sh2495 treated"	"STAET10 cell, control"
p_20361_1	"MCF7 cell, day 3"	"MCF7 cell, day 0"
p_20361_2	"MCF7 cell, day 15"	"MCF7 cell, day 0"
p_20361_3	"MCF7 cell, day 30"	"MCF7 cell, day 0"
p_20361_4	"MCF7 cell, day 90"	"MCF7 cell, day 0"
p_20361_5	"MCF7 cell, day 120"	"MCF7 cell, day 0"
p_20361_6	"MCF7 cell, day 150"	"MCF7 cell, day 0"
p_20361_7	"MCF7 cell, day 180"	"MCF7 cell, day 0"
p_20368_1	"RM82 cell line, pLKO.1-280-shRNA"	"RM82 cell line, non-targeting shRNA, control"
p_20368_2	"RM82 cell line, pLKO.1-2495-shRNA"	"RM82 cell line, non-targeting shRNA, control"
p_20368_3	"TC32 cell line, pLKO.1-280-shRNA"	"TC32 cell line, non-targeting shRNA, control"
p_20368_4	"TC32 cell line, pLKO.1-2495-shRNA"	"TC32 cell line, non-targeting shRNA, control"
p_20368_5	"STAET10 cell line, pLKO.1-280-shRNA"	"STAET10 cell line, non-targeting shRNA, control"
p_20368_6	"STAET10 cell line, pLKO.1-2495-shRNA"	"STAET10 cell line, non-targeting shRNA, control"
p_20433_1	"LNCaP cells, siRNA targeting EZH2, 60h"	"LNCaP cells, control siRNA, 60h"
p_20433_2	"LNCaP cells, siRNA targeting EZH2 + RNAi resistant EZH2 plasmid, 60h"	"LNCaP cells, control siRNA, 60h"
p_20433_3	"LNCaP cells, siRNA targeting EZH2 + RNAi resistant T350A mutated EZH2 plasmid, 60h"	"LNCaP cells, control siRNA, 60h"
p_20433_4	"LNCaP cells, TSA treated, 5uM, 24h"	"LNCaP cells, DMSO treated, 24h"
p_20433_5	"LNCaP cells, Roscovitine treated, 10uM, 24h"	"LNCaP cells, DMSO treated, 24h"
p_20436_1	"tarsal conjunctive, trachoma"	"tarsal conjunctive, normal control"
p_20484_1	"primary human monocyte-derived macrophages, differentiation factor: CXCL4"	"primary human monocyte-derived macrophages, differentiation factor: MCSF"
p_20499_1	Endometrial NK cell	Decidual NK cell
p_20505_1	"CD34+ cells; S1 stimulation, 48 h"	CD34+ cells; 0 hr
p_20505_2	"CD34+ cells; S2 stimulation, 48 h"	CD34+ cells; 0 hr
p_20505_3	"CD34+ cells; S1 stimulation, 72 h"	CD34+ cells; 0 hr
p_20505_4	"CD34+ cells; S2 stimulation, 72 h"	CD34+ cells; 0 hr
p_20505_5	"CD34+ cells; S1 stimulation, 96 h"	CD34+ cells; 0 hr
p_20505_6	"CD34+ cells; S2 stimulation, 96 h"	CD34+ cells; 0 hr
p_20508_1	"THP-1 cell, SS2 infected"	"THP-1 cell, control"
p_20538_1	"skin fibroblast, cultured with T3, 0nM, patients"	"skin fibroblast, cultured with T3, 0nM, normal"
p_20538_2	"skin fibroblast, cultured with T3, 1nM, patients"	"skin fibroblast, cultured with T3, 1nM, normal"
p_20538_3	"skin fibroblast, cultured with T3, 10nM, patients"	"skin fibroblast, cultured with T3, 10nM, normal"
p_20540_1	"MM1S cell, co-cultured BMSCs"	"MM1S cell, mono-cultured"
p_20540_2	"MM1R cell, co-cultured BMSCs"	"MM1R cell, mono-cultured"
p_20540_3	"INA-6 cell, co-cultured BMSCs"	"INA-6 cell, mono-cultured"
p_20543_1	"LNCaP prostate cells, miR-616 stably overexpressed"	"LNCaP prostate cells, empty lentivirus vector"
p_20559_1	Liposarcoma; dedifferentiated	Liposarcoma; well-differentiated
p_20559_2	Liposarcoma; myxoid	Liposarcoma; well-differentiated
p_20559_3	Liposarcoma; myxoid round cell	Liposarcoma; well-differentiated
p_20559_4	Liposarcoma; pleomorphic	Liposarcoma; well-differentiated
p_20559_5	Liposarcoma; well-differentiated spindle cell	Liposarcoma; well-differentiated
p_20569_1	"C33-A cell, CA 9 overexpressed"	"C33-A cell, control"
p_20578_1	Lung tumor	Adjacent normal tissue
p_20585_1	Lung cancer	Adjacent normal
p_20615_1	"HEK293T cell, transfected"	"HEK293T cell, control"
p_20615_2	"HEK293T cell, untransfected"	"HEK293T cell, control"
p_20641_1	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 2h"	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 0h"
p_20641_2	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 4h"	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 0h"
p_20641_3	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 6h"	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 0h"
p_20641_4	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 8h"	"primary fibroblasts, serum starved 48h + restimulated with 10% serum, 0h"
p_20666_1	"DLBCL cell, trichostatin A treated"	"DLBCL cell, control"
p_20667_1	"T-ALL1 cell line, IKK Nemo binding domain (NBD) inhibitory peptide treated, 100mM, 16h"	"T-ALL1 cell line, control peptide treated"
p_20667_2	"CEM cell line, IKK Nemo binding domain (NBD) inhibitory peptide treated, 100mM, 16h"	"CEM cell line, control peptide treated"
p_20667_3	"KOPT-K cell line, IKK Nemo binding domain (NBD) inhibitory peptide treated, 100mM, 16h"	"KOPT-K cell line, control peptide treated"
p_20667_4	"DND41 cell line, IKK Nemo binding domain (NBD) inhibitory peptide treated, 100mM, 16h"	"DND41 cell line, control peptide treated"
p_20667_5	"HPB-ALL cell line, IKK Nemo binding domain (NBD) inhibitory peptide treated, 100mM, 16h"	"HPB-ALL cell line, control peptide treated"
p_20677_2	"PBMCs, AuNP EGFP oligonucleotide complex treated, 48h"	"PBMCs, control"
p_20677_4	"PBMCs, infected with HIV"	"PBMCs, treated with Oligofectamine without oligonucleotide"
p_20677_6	"293T cells, treated with AuNP EGFP oligonucleotide complex, 24 hours"	"293T cells, control"
p_20689_1	"SW620 cell, SOX2 knockdown"	"SW620 cell, control"
p_20697_1	"hASC cell, without FGF"	"hASC cell, control"
p_20711_1	breast tumor	normal breast tissue
p_20719_1	"T47D breast cancer cell, GDC-0941 treated, 1mM, 6h"	"T47D breast cancer cell, control"
p_20736_1	"GBM cell, Differentitation, 4d"	"GBM cell, control, 4d"
p_20745_1	"HUVEC, Pre-17 transfected, 24h"	"HUVEC, control pre-miR transfected, 24h"
p_20752_3	"hASC pre-adipocyte, day 1"	"hASC pre-adipocyte, day -2, no FGF"
p_20752_8	"hASC pre-adipocyte, day 9"	"hASC pre-adipocyte, day -2, no FGF"
p_20847_1	lrpprc expression vs. control: 20%	lrpprc expression vs. control: 100%
p_20847_2	lrpprc expression vs. control: 33%	lrpprc expression vs. control: 100%
p_20847_3	lrpprc expression vs. control: 58%	lrpprc expression vs. control: 100%
p_20847_4	lrpprc expression vs. control: 69%	lrpprc expression vs. control: 100%
p_20847_5	lrpprc expression vs. control: 81%	lrpprc expression vs. control: 100%
p_20847_6	lrpprc expression vs. control: 9%	lrpprc expression vs. control: 100%
p_20854_1	"Ishikawa Hcells, undosed, 12 hr"	"Hec50co cells, undosed, 12 hr"
p_20854_2	"Ishikawa Hcells, dosed with egf, 12 hr"	"Hec50co cells, dosed with egf, 12 hr"
p_20854_3	"Ishikawa Hcells, dosed with iressa, 12 hr"	"Hec50co cells, dosed with iressa, 12 hr"
p_20854_4	"Ishikawa Hcells, undosed, 24 hr"	"Hec50co cells, undosed, 24 hr"
p_20854_5	"Ishikawa Hcells, dosed with egf, 24 hr"	"Hec50co cells, dosed with egf, 24 hr"
p_20854_6	"Ishikawa Hcells, dosed with iressa, 24 hr"	"Hec50co cells, dosed with iressa, 24 hr"
p_20854_7	"Ishikawa H cells, dosed with iressa, harvested at 12 hr"	"Ishikawa H cells, undosed, harvested at 24 hr"
p_20854_8	"Ishikawa H cells, dosed with iressa, harvested at 24 hr"	"Ishikawa H cells, undosed, harvested at 24 hr"
p_20891_1	"CORD BLOOD CD34+ CELLS, SDF-1 treated, 100ng/mL, 4h"	"CORD BLOOD CD34+ CELLS, control"
p_20910_1	Down syndrome (DS) ALL cases	non-Down syndrome (NDS) ALL cases
p_20915_1	"HBL2 cell, Borezomib-induced resistant"	"HBL2 cell, parental"
p_20915_2	"JEKO cell, Borezomib-induced resistant"	"JEKO cell, parental"
p_20916_1	"mucosa, colon tumor tissue, malignincy: adenoma"	"mucosa, colon tumor tissue, malignincy: normal colon"
p_20916_2	"mucosa, colon tumor tissue, malignincy: carcinoma"	"mucosa, colon tumor tissue, malignincy: normal colon"
p_20916_3	"mucosa, colon tumor tissue, malignincy: carcinoma"	"mucosa, colon tumor tissue, malignincy: adenoma"
p_20923_1	"HT-29 cells, siRNA targeting IFITM1"	"HT-29 cells, siRNA targeting luciferase"
p_20928_1	"K562 cells, calactin treated, 0.15mM, 12h"	"K562 cells, untreated, 12h"
p_20948_1	"Huh7 cell, JFH-1 infected, 6h"	"Huh7 cell, control, 6h"
p_20948_2	"Huh7 cell, JFH-1 infected, 12h"	"Huh7 cell, control, 12h"
p_20948_3	"Huh7 cell, JFH-1 infected, 18h"	"Huh7 cell, control, 18h"
p_20948_4	"Huh7 cell, JFH-1 infected, 24h"	"Huh7 cell, control, 24h"
p_20948_5	"Huh7 cell, JFH-1 infected, 48h"	"Huh7 cell, control, 48h"
p_20950_1	"subcutaneous adipose tissue, insulin resistant"	"subcutaneous adipose tissue, insulin sensitive"
p_20950_2	"omental adipose tissue, insulin resistant"	"omental adipose tissue, insulin sensitive"
p_21029_1	"CLL cells, bone marrow-derived"	"CLL cells, peripheral blood-derived"
p_21029_2	"CLL cells, lymph node-derived"	"CLL cells, peripheral blood-derived"
p_21039_1	"PBMC, 2hr processing delay"	"PBMC, 0hr processing delay (immediate)"
p_21039_2	"PBMC, 4hr processing delay"	"PBMC, 0hr processing delay (immediate)"
p_21066_1	"MCF 10A cell, radiation treated"	"MCF 10A cell, control"
p_21066_2	"MCF 10A cell, smoke treated"	"MCF 10A cell, control"
p_21066_3	"MCF 10A cell, smoke, radiation treated"	"MCF 10A cell, control"
p_21094_1	"Bone marrow tissue, ALL, Down syndrome"	"Bone marrow tissue, ALL, Non-Down syndrome"
p_21105_1	"DLD-1 cells, p53 expression"	"DLD-1 cells, control"
p_21132_1	"Jurkat T FF3 cell, miR146a overexpressed"	"Jurkat T FF3 cell, control"
p_21132_2	"Jurkat T FF3 cell, miR146a knock down"	"Jurkat T FF3 cell, control"
p_21138_1	"BA46 cell, Haloperidol, Chlorpromazine, Clozapine treated"	"BA46 cell, control"
p_21164_1	"Quadriceps muscle, arthroplasty treatment, 0h"	"Quadriceps muscle, control, 0h"
p_21164_2	"Quadriceps muscle, arthroplasty treatment, 1h"	"Quadriceps muscle, control, 1h"
p_21216_1	"DMS79, siRNA targeting ASCL1, 72h"	"DMS79 cells, control"
p_21225_1	"endometrium, on the day of oocyte retrieval, pregnant"	"endometrium, on the day of oocyte retrieval, not pregnant"
p_2125_1	"Human alveolar macrophage, smoker, koth"	"Human alveolar macrophage, nonsmoker, koth"
p_2125_2	"Human alveolar macrophage, smoker, woodruff"	"Human alveolar macrophage, nonsmoker, woodruff"
p_2125_3	"Human alveolar macrophage, asthmatic, woodruff"	"Human alveolar macrophage, nonsmoker, woodruff"
p_21261_1	"mononuclear cells, AML-NOS plus AML-MLD-sole"	"mononuclear cells, AML with MDS-related changes (AML-MRC)"
p_21306_1	"HT1080 cell, RECK overexpressed"	"HT1080 cell, control"
p_21306_2	"HT1080 cell, RECK,4NQ overexpressed"	"HT1080 cell, control"
p_21327_1	"Podocytes, GH treated, 2m"	"Podocytes, control"
p_21327_2	"Podocytes, GH treated, 5m"	"Podocytes, control"
p_21327_3	"Podocytes, GH treated, 15m"	"Podocytes, control"
p_21327_4	"Podocytes, GH treated, 30m"	"Podocytes, control"
p_21369_1	"Lung tissue, interstitial lung disease"	"Lung tissue, control"
p_21422_1	Ductal carcinoma in situ	"healthy breast cell, control"
p_21422_2	Invasive ductal carcinomas cell	"healthy breast cell, control"
p_21483_1	"SCC1 cells, Cetuximab-resistant"	"SCC1 cells, cetuximab-sensitive"
p_21496_1	"Muscle cell, Unroading, 48h"	"Muscle cell, Unroading, 0h"
p_21496_2	"Muscle cell, Reroading, 24h"	"Muscle cell, Unroading, 0h"
p_21497_1	"vastus laterlais muscle, spinal cord injury (SCI), 5 days after SCI"	"vastus laterlais muscle, spinal cord injury (SCI), 2 days after SCI"
p_21514_1	"astrocyte, RISC-IP miRNA"	"astrocyte, global miRNA"
p_21514_2	"astrocytoma, RISC-IP miRNA"	"astrocytoma, global miRNA"
p_21547_1	"microvascular endothelial cells, DSG2 silenced, healthy subject"	"microvascular endothelial cells, healthy control"
p_21550_1	"U937 transfected with GFP-PRWT, 6h"	"U937 transfected with control GFP, 6h"
p_21550_2	"U937 transfected with GFP-PR2VR, 6h"	"U937 transfected with control GFP, 6h"
p_21550_3	"U937 transfected with GFP-PRWT, 9h"	"U937 transfected with control GFP, 9h"
p_21550_4	"U937 transfected with GFP-PR2VR, 9h"	"U937 transfected with control GFP, 9h"
p_21567_1	CD200 + CD49 cell	CD49 cell
p_21569_1	CD200-CD49+ keratinocytes	CD200+CD49+ hair follicle keratinocytes
p_21570_1	"U87MG cell, non-invasive"	"U87MG cell, Parental"
p_21570_2	"U87MG cell, invasive"	"U87MG cell, Parental"
p_21574_1	"HEK 293 cells, QKI siRNA"	"HEK 293 cells, mock-transfected"
p_21575_1	"HEK 293 cells, IGF2BP siRNA"	"HEK 293 cells, mock-transfected"
p_21577_1	"HEK 293 cells, top 25 miRNAs are inhibited"	"HEK 293 cells, mock-transfected"
p_21578_1	"HEK 293 cells, expressing FLAG/HA-tagged QKI, siRNA (targeting QKI) set A transfected"	"HEK 293 cells, expressing FLAG/HA-tagged QKI, mock-transfected,"
p_21578_2	"HEK 293 cells, expressing FLAG/HA-tagged QKI, siRNA (targeting QKI) set B transfected"	"HEK 293 cells, expressing FLAG/HA-tagged QKI, mock-transfected,"
p_21578_3	"HEK 293 cells expressing FLAG/HA-tagged IGF2BP1, siRNA (targeting IGF2BP1, IGF2BP2, IGF2BP3) -transfected"	"HEK 293 cells expressing FLAG/HA-tagged IGF2BP1, mock-transfected,"
p_21578_4	"HEK 293 cells, top 25 miRNAs inhibited, siRNA-transfected"	"HEK 293 cells, mock-transfected"
p_21668_1	"hESC H9, Mesodermal progenitor population"	"hESC H9, Undifferentiated embryonic stem cells"
p_21723_1	"endothelial cells, condition B"	"endothelial cells, condition A"
p_21760_1	"HeLa cell, IFN-gamma treated, 2h"	"HeLa cell, control"
p_21760_2	"HeLa cell, IFN-gamma treated, 4h"	"HeLa cell, control"
p_21760_3	"HeLa cell, IFN-gamma treated, 6h"	"HeLa cell, control"
p_21774_1	CD3- CD56dim CD62L+	CD3- CD56bright CD62L+
p_21774_2	CD3- CD56dim CD62L-	CD3- CD56bright CD62L+
p_21826_1	"peripheral blood, Infected colitis"	"peripheral blood, Diverticulitis"
p_21832_1	"MDA-MB-231 cell, trasfected with Qmimic"	"MDA-MB-231 cell, trasfected with Allstar"
p_21832_2	"MDA-MB-231 cell, trasfected with Dmimic"	"MDA-MB-231 cell, trasfected with Allstar"
p_21858_1	"parieto-temporal cortex, right side, 19 gestational weeks"	"parieto-temporal cortex, right side, 17 gestational weeks"
p_21858_2	"parieto-temporal cortex, left side, 19 gestational weeks"	"parieto-temporal cortex, left side, 17 gestational weeks"
p_21858_3	"prefrontal/orbito-frontal cortex, right side, 19 gestational weeks"	"prefrontal/orbito-frontal cortex, right side, 17 gestational weeks"
p_21858_4	"prefrontal/orbito-frontal cortex, left side, 19 gestational weeks"	"prefrontal/orbito-frontal cortex, left side, 17 gestational weeks"
p_21901_1	"HEK 293 cell, miR-212 overexpressed"	"HEK 293 cell, control"
p_21930_1	"Caco-2 cell, control, 4h"	"Caco-2 cell, control, 0h"
p_21942_1	"peripheral blood mononuclear cells, disease state: multiple sclerosis)"	"peripheral blood mononuclear cells, healthy donors)"
p_21979_1	"Daoy medulloblastoma cell, Thapsigargin treated, 3h"	"Daoy medulloblastoma cell, control"
p_21979_2	"Daoy medulloblastoma cell, Thapsigargin treated, 8h"	"Daoy medulloblastoma cell, control"
p_21989_1	"HUVEC at 40 min., exposed to insulin"	"HUVEC at 40 min., control"
p_21989_2	"HUVEC at 100 min., exposed to insulin"	"HUVEC at 100 min., control"
p_21989_3	"HUVEC at 200 min., exposed to insulin"	"HUVEC at 200 min., control"
p_21989_4	"HUVEC at 340 min., exposed to insulin"	"HUVEC at 340 min., control"
p_21989_5	"HUVEC at 440 min., exposed to insulin"	"HUVEC at 440 min., control"
p_22002_1	"HeLa cell, miR-155 transfected"	"HeLa cell, mock-transfected"
p_22002_2	"HeLa cell, miR-1 transfected"	"HeLa cell, mock-transfected"
p_22025_1	"CD4+ T cells, Cord blood, progesterone + IL-2 treated"	"CD4+ T cells, Cord blood, control"
p_22025_2	"CD4+ T cells, Cord blood, TGFb1 + IL-2 treated"	"CD4+ T cells, Cord blood, control"
p_22025_3	"CD4+ T cells, Cord blood, progesterone + TGFb1 + IL-2 treated"	"CD4+ T cells, Cord blood, control"
p_22025_4	"CD4+ T cells, Peripheral blood, progesterone + IL-2 treated"	"CD4+ T cells, Peripheral blood, control"
p_22025_5	"CD4+ T cells, Peripheral blood, TGFb1 + IL-2 treated"	"CD4+ T cells, Peripheral blood, control"
p_22025_6	"CD4+ T cells, Peripheral blood, progesterone + TGFb1 + IL-2 treated"	"CD4+ T cells, Peripheral blood, control"
p_22036_1	"HuT-102 cell, IRF4 siRNA"	"HuT-102 cell, Luciferase siRNA"
p_22038_1	"GRANTA cells, AZA treated"	"GRANTA cells, mock treated"
p_22038_10	"HBL2 cells, AZA+TSA treated"	"HBL2 cells, mock treated"
p_22038_11	"Z138 cells, AZA treated"	"Z138 cells, mock treated"
p_22038_12	"Z138 cells, AZA+TSA treated"	"Z138 cells, mock treated"
p_22038_13	"MAVER cells, AZA treated"	"MAVER cells, mock treated"
p_22038_14	"MAVER cells, AZA+TSA treated"	"MAVER cells, mock treated"
p_22038_2	"GRANTA cells, AZA+TSA treated"	"GRANTA cells, mock treated"
p_22038_3	"NCEB cells, AZA treated"	"NCEB cells, mock treated"
p_22038_4	"NCEB cells, AZA+TSA treated"	"NCEB cells, mock treated"
p_22038_5	"UPN1 cells, AZA treated"	"UPN1 cells, mock treated"
p_22038_6	"UPN1 cells, AZA+TSA treated"	"UPN1 cells, mock treated"
p_22038_7	"JEKO cells, AZA treated"	"JEKO cells, mock treated"
p_22038_8	"JEKO cells, AZA+TSA treated"	"JEKO cells, mock treated"
p_22038_9	"HBL2 cells, AZA treated"	"HBL2 cells, mock treated"
p_22045_1	"nTreg cells, unstimulated"	"naive CD4 cells, unstimulated"
p_22061_1	"HCT116 cell, FK228 treated"	"HCT116 cell, control"
p_22061_2	"HCT116 cell, SAHA treated"	"HCT116 cell, control"
p_22061_3	"HCT116 cell, Largazole treated"	"HCT116 cell, control"
p_22106_1	"H4 cell, Hyrdocortisone treated, 12h"	"H4 cell, control"
p_22106_2	"H4 cell, Hyrdocortisone treated, 1d"	"H4 cell, control"
p_22106_3	"H4 cell, Hyrdocortisone treated, 2d"	"H4 cell, control"
p_22106_4	"H4 cell, Hyrdocortisone treated, 5d"	"H4 cell, control"
p_22109_1	"Human erythroid progenitor cells (HEPs), Hereditary Persistence of Fetal Hemoglobin (HPFH)"	"Human erythroid progenitor cells (HEPs), wild type"
p_22132_1	"platelets, systemic lupus erythematosus (SLE) patients"	"platelets, Normal"
p_22138_1	"Uveal Melanoma (eye), metastasis: YES"	"Uveal Melanoma (eye), metastasis: NO"
p_22139_1	"DAOY cell, Empty vector infected"	"DAOY cell, wt"
p_22139_2	"DAOY cell, siRNA scrambled"	"DAOY cell, wt"
p_22139_3	"DAOY cell, siRNA cMYC treated"	"DAOY cell, wt"
p_22152_1	"C7H2 cell, GC resistant, GC treated, 6h"	"C7H2 cell, GC resistant, EtOH treated, 6h"
p_22152_2	"C7H2 cell, GC sensitive, TC treated, 6h"	"C7H2 cell, GC sensitive, EtOH treated, 6h"
p_22217_1	"Human Osteoblasts, titanium grit-blasted, 24h"	"Human Osteoblasts, titanium polished, 24h"
p_22217_2	"Human Osteoblasts, titanium grit-blasted, HF treated 24h"	"Human Osteoblasts, titanium polished, 24h"
p_22229_1	"B cell, Tolerant"	"B cell, Healthy control"
p_22229_2	"B cell, Standard Immunotherapy"	"B cell, Healthy control"
p_22242_1	Colorectal adenoma biopsy specimens	Normal colorectal mucosa
p_22242_2	Colorectal carcinoma biopsy specimens_stage of Duke's A	Normal colorectal mucosa
p_22242_3	Colorectal carcinoma biopsy specimens_stage of Duke's B	Normal colorectal mucosa
p_22242_4	Colorectal carcinoma biopsy specimens_stage of Duke's C/D	Normal colorectal mucosa
p_22246_1	"hiPSC line, long term passage"	Fibroblast cell line
p_22250_1	"MCF-7 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"MCF-7 cell line, wild type"
p_22250_2	"T47D cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"T47D cell lne, wild type"
p_22250_3	"SKBR3 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"SKBR3 cell lne, wild type"
p_22250_4	"BT20 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"BT20 cell lne, wild type"
p_22250_5	"MDA-MB-231 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"MDA-MB-231 cell lne, wild type"
p_22250_6	"MDA-MB 361 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"MDA-MB-361 cell lne, wild type"
p_22250_7	"ZR-75-1 cell line, 5-aza-2-deoxycytidine treated, 1M, 4 days"	"ZR-75-1 cell lne, wild type"
p_22256_1	"786-VHL cells, contains functional allele of VHL"	"Renal cell carcinoma cell line (786-0), mutated allele of VHL"
p_22282_1	"Mature dendritic cells (mDC), hypoxia"	"Mature denritic cells (mDC), normoxia"
p_22331_1	"Spermatozoa cell, asthenozoospermic men"	"Spermatozoa cell, normozoospermic men"
p_22336_1	"Capan-I cells, siGNE-transfected"	"Capan-1 cells, allStar-transfected"
p_22342_1	CD11cLO cells	CD11cHI cells
p_22356_1	"PMBC, Idiopathic pulmonary arterial hypertension"	"PMBC, control"
p_22356_2	"PMBC, Scleroderma with pulmonary hypertension"	"PMBC, Scleroderma without pulmonary hypertension"
p_22373_1	"Macrophage, Flagellin stimulated"	"Macrophage, unstimulated"
p_22373_2	"Monocyte, Flagellin stimulated"	"Monocyte, unstimulated"
p_22377_1	"Gastric adenocarcinoma tissue, intestinal type"	"Gastric adenocarcinoma tissue, diffuse type"
p_22392_1	"hiPSC line 3975 (p6), newly generated"	"hiPSC line IMR90, already established"
p_22392_2	"hiPSC line 3975 (p9), newly generated"	"hiPSC line IMR90, already established"
p_22467_1	"SK-N-AS cells, RE-EX1 expression construct, 24h"	"SK-N-AS cells, RE-EX1 expression construct, 0h"
p_22467_2	"SK-N-AS cells, RE-EX1 expression construct, 48h"	"SK-N-AS cells, RE-EX1 expression construct, 0h"
p_22467_3	"SK-N-AS cells, HZ4 expression construct, 24h"	"SK-N-AS cells, HZ4 expression construct, 0h"
p_22467_4	"SK-N-AS cells, HZ4 expression construct, 48h"	"SK-N-AS cells, HZ4 expression construct, 0h"
p_22483_1	"LNCaP cell, R1881 treated"	"LNCaP cell, control"
p_22483_2	"LNCaP cell, AR knockdown"	"LNCaP cell, control"
p_22490_1	"Placenta cell, recurrent miscarriage"	"Placenta cell, elective termination"
p_22501_1	"Regulatory T Cell (T-reg), cord blood"	"Regulatory T Cell (T-reg), peripheral blood"
p_22513_1	"breast needle biopsy, pretreatment, pathological complete response"	"breast needle biopsy, pretreatment, No pathological complete response"
p_22522_1	"lymphatic endothelial cells (LEC) shperoid, KSHV infected (K-LEC)"	"lymphatic endothelial cells (LEC) shperoid, control"
p_22533_1	"MCF-7/LTED cell, fulv treated"	"MCF-7/LTED cell, Etoh treated"
p_22533_2	"HCC-1428/LTED cell, fulv treated"	"HCC-1428/LTED cell, Etoh treated"
p_22544_1	"Breast cancer, infiltrating ductal carcinoma (IDC)"	"Breast tissue, normal"
p_22552_1	"PBMC-derived erythroblasts, colony-forming unit-erythroid (CFU-E)"	"PBMC-derived erythroblasts, late (Late-E) erythroblasts"
p_22552_2	"PBMC-derived erythroblasts, intermediate (Int-E)"	"PBMC-derived erythroblasts, late (Late-E) erythroblasts"
p_22552_3	"PBMC-derived erythroblasts, late (Late-E) erythroblasts"	"PBMC-derived erythroblasts, late (Late-E) erythroblasts"
p_22560_1	"HuCCT-1 cells, SPRR2a expression"	"HuCCT-1 cells, vehicle"
p_22560_2	"SG231 cells, SPRR2a expression"	"SG231 cells, vehicle"
p_22572_1	"Caco-2 cell, shCDX2-2 treated"	"Caco-2 cell, shGFP treated"
p_22580_1	"hMECs, type 1 hTERT-immotalized"	hMECs
p_22580_2	"hMECs, type 2 hTERT-immotalized"	hMECs
p_22589_1	"Monocyte-derived dendritic cell, HIVGFP infected"	"Monocyte-derived dendritic cell, control"
p_22589_2	"Monocyte-derived dendritic cell, SIVVLP infected"	"Monocyte-derived dendritic cell, control"
p_22589_3	"Monocyte-derived dendritic cell, HIVGFP,SIVVLP infected"	"Monocyte-derived dendritic cell, control"
p_22598_1	"colorectal tissue, cancerous cell"	"colorectal tissue, non-cancerous cell"
p_22598_2	"HT29 cell line, 5aza treated"	"HT29 cell line, control"
p_22598_3	"HCT15 cell line, 5aza treated"	"HCT15 cell line, control"
p_22600_1	"2008 cell, Estrogen treated"	"2008 cell, placebo control"
p_22600_2	"PEO4 cell, Estrogen treated"	"PEO4 cell, placebo control"
p_22611_1	"HEK293 cells, NOD2 expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 0h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 0h"
p_22611_2	"HEK293 cells, NOD2L1007fsinsC expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 0h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 0h"
p_22611_3	"HEK293 cells, NOD2 expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 2h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 2h"
p_22611_4	"HEK293 cells, NOD2L1007fsinsC expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 2h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 2h"
p_22611_5	"HEK293 cells, NOD2 expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 6h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 6h"
p_22611_6	"HEK293 cells, NOD2L1007fsinsC expression. Muramyl-dipeptide (MDP) treated, 10 g/ml, 6h"	"HEK293 cells, mock-transfectant. Muramyl-dipeptide (MDP) treated, 10 g/ml, 6h"
p_22619_1	"primary mucosal tissue, colon, diseased (ulcerative colitis)"	"primary mucosal tissue, colon, healthy control"
p_22632_1	"PBMC cells, PCB138 treated"	"PBMC cells, control"
p_22667_1	"PBMC cells, PCB153 treated, 48h"	"PBMC cells, control"
p_22707_1	"PBMC, Kidney recipient, under immunosuppression, stable graft"	"PBMC, Kidney recipient, under immunosuppression, deteriorating"
p_22707_2	"PBMC, Kidney recipient, not immunosuppression, stable graft"	"PBMC, Kidney recipient, under immunosuppression, deteriorating"
p_22707_3	"PBMC, liver recipient, not immunosuppression, stable graft"	"PBMC, liver recipient, under immunosuppression, acute reject"
p_22771_1	"neuroblastoma cell line, mutated ALK"	"neuroblastoma cell line, wild type ALK"
p_22779_1	"Mononuclear cells, epilepsy patient, before administration of GC"	"Mononuclear cells, healthy donor, before administration of GC"
p_22779_2	"Mononuclear cells, epilepsy patient, 2 hours after GC administration"	"Mononuclear cells, healthy donor, 2 hours after GC administration"
p_22779_3	"Mononuclear cells, epilepsy patient, 6 hours after GC administration"	"Mononuclear cells, healthy donor, 6 hours after GC administration"
p_22779_4	"Mononuclear cells, epilepsy patient, 24 hours after GC administration"	"Mononuclear cells, healthy donor, 24 hours after GC administration"
p_22779_5	"Mononuclear cells, epilepsy patient, 24 hours after GC administration"	"Mononuclear cells, epilepsy patient, before administration of GC"
p_22781_1	Renal Cell Carcinoma Cell line (SN19(3i)YY)	Renal Cell Carcinoma Cell line (SN12C19)
p_22783_1	"MCF7 cell, p53 silenced"	"MCF7 cell, control"
p_22810_1	"CL1-0 cell, HA-G9a expressed"	"CL1-0 cell, control"
p_22810_2	"CL1-5 cell, G9a shRNA expressed"	"CL1-5 cell, control"
p_22842_1	"SAOS cell, RB transfected"	"SAOS cell, control"
p_22842_2	"SAOS cell, SMYD2 transfected"	"SAOS cell, control"
p_22842_3	"SAOS cell, RB, SMYD2 transfected"	"SAOS cell, control"
p_22845_1	"mononuclear cell, CEBPA single mutant"	"mononuclear cell, wt"
p_22845_2	"mononuclear cell, CEBPA double mutant"	"mononuclear cell, wt"
p_22853_1	"Ea.hy926 cell, TCF11 treated , DMSO"	"Ea.hy926 cell, control , DMSO"
p_22853_2	"Ea.hy926 cell, TCF11 treated , epoxomicin"	"Ea.hy926 cell, control , epoxomicin"
p_22859_1	"HeLa cell, LSD2 knockdown"	"HeLa cell, control"
p_22865_1	"Hs578T cells, treated with oligonucleotide (unmethylated CDH13 sequence (CDH13 U))"	"Hs578T cells, treated with oligonucleotide (methylated CDH13 sequence (CDH13 M))"
p_22865_2	"BT-20 cells, treated with oligonucleotide (unmethylated CDH13 sequence (CDH13 U))"	"BT-20 cells, treated with oligonucleotide (methylated CDH13 sequence (CDH13 M))"
p_22868_1	"Blood cell, High PCB exposure"	"Blood cell, control"
p_22872_1	"HeLa cells, LSD2 knockdown"	"HeLa cells, scrambled control knockdown"
p_22919_1	"NK cell, IL-2, IL-12, IL-18 stimulated, 24h"	"NK cell, unstimulated, 24h"
p_22927_1	"brainstem, low-grade glioma"	"brainstem, normal"
p_22973_1	"AsPC-1 cell, PMA treated"	"AsPC-1 cell, control"
p_22973_2	"BxPC-3 cell, PMA treated"	"BxPC-3 cell, control"
p_22998_1	"skin, seborrheic keratosis"	"skin, control"
p_23025_1	"peripheral blood stem cell, Therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML)"	"peripheral blood stem cell (CD34+ cells), control"
p_23025_2	"Bone marrow (CD34+ cells), Therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML)"	"Bone marrow (CD34+ cells), control"
p_23031_1	"Huh7.5.1 cell line, Ribavirin treated"	"Huh7.5.1 cell line, PBS treated"
p_23035_1	"U2OS cell, BAP1 depleted"	"U2OS cell, control"
p_23066_1	"human fibroblast, non small cell lung cancer (NSCLC) tissue"	"human fibroblast, normal bronchial fibroblast"
p_23102_1	"HEK293 cell, WT, tetracycline treated"	"HEK293 cell, WT, control"
p_23102_2	"HEK293 cell, TRPM7 overexpressed, tetracycline treated"	"HEK293 cell, TRPM7 overexpressed, control"
p_23103_1	"HeLa cell line,SCY1-like 1 esiRNA"	"HeLa cell line, control esiRNA"
p_23117_1	"non SS gland, advanced"	"SS gland, control"
p_23117_2	"SS gland, advanced"	"SS gland, control"
p_23117_3	"SS gland, early"	"SS gland, control"
p_23117_4	"SS gland, moderate"	"SS gland, control"
p_23183_1	"CD8+ cell, no soluble CD8 suppress"	"CD8+ cell, soluble CD8 suppress"
p_23183_2	"CD8+ cell, HIV infected"	"CD8+ cell, soluble CD8 suppress"
p_23205_1	"peripheral blood mononuclear cells, risk haplotype"	"peripheral blood mononuclear cells, proteictive haplotype"
p_23206_1	"H322c cells, cultured in gefitinib, 1uM, 4 days"	"H322c cells, cultured in DMSO, 4 days"
p_23295_1	"colon cancer SW620 cell line, CD133+"	"colon cancer SW620 cell line, CD133-"
p_23332_1	"T cell, acute GvHD"	"T cell, no GvHD"
p_23332_3	"T cell, GvHD"	"T cell, no GvHD"
p_23360_1	"Human BLM (Bowes Lung Metastases) melanoma cells, P-cadherin overexpression"	"Human BLM (Bowes Lung Metastases) melanoma cells, control"
p_23366_1	"Unrestricted Somatic Stem Cells (USSC), co-cultured with Dendritic cells"	"Unrestricted Somatic Stem Cells (USSC), control"
p_23371_1	"Dendritic cell, Mature"	"Dendritic cell, Immature"
p_23371_2	"Dendritic cell, Activated tolerogenic"	"Dendritic cell, Tolerogenic"
p_23391_1	Serous ovarian cancer epithelia	Ovarian surface epithelia
p_23399_1	"Breast cancer associatd fibroblasts (BCAFs), paclitaxol treated, collect RNA at day1"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23399_2	"Breast cancer associatd fibroblasts (BCAFs), paclitaxol treated, collect RNA at day3"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23399_3	"Breast cancer associatd fibroblasts (BCAFs), paclitaxol treated, collect RNA at day7"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23399_4	"Breast cancer associatd fibroblasts (BCAFs), Doxorubicin treated, collect RNA at day1"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23399_5	"Breast cancer associatd fibroblasts (BCAFs), Doxorubicin treated, collect RNA at day3"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23399_6	"Breast cancer associatd fibroblasts (BCAFs), Doxorubicin treated, collect RNA at day7"	"Breast cancer associatd fibroblasts (BCAFs), untreated"
p_23405_1	"U937 cells, treated with heat stress (42C), 0h"	"U937 cells, control"
p_23405_4	"U937 cells, treated with heat stress (42C), 6h"	"U937 cells, control"
p_23405_5	"U937 cells, treated with heat stress (44C), 0h"	"U937 cells, control"
p_23405_6	"U937 cells, treated with heat stress (44C), 1h"	"U937 cells, control"
p_23427_1	"MzChA1, felodipine, 20uM, 24h"	"MzChA1, control"
p_23450_1	"Huh7 cell, CD133+"	"Huh7 Cell, CD133-"
p_23451_1	"PLC8024 cell, CD133 +"	"PLC8024 cell, CD133 -"
p_23494_1	"HK2 cells, PCB153 treated, 70uM, 0.5h"	"HK2 cells, PCB153 treated, 70uM, 0h"
p_23494_2	"HK2 cells, PCB153 treated, 70uM, 6h"	"HK2 cells, PCB153 treated, 70uM, 0h"
p_23494_3	"HK2 cells, PCB153 treated, 70uM, 24h"	"HK2 cells, PCB153 treated, 70uM, 0h"
p_23494_4	"HK2 cells, PCB77 treated, 40uM, 0.5h"	"HK2 cells, PCB77 treated, 40uM, 0h"
p_23494_5	"HK2 cells, PCB77 treated, 40uM, 6h"	"HK2 cells, PCB77 treated, 40uM, 0h"
p_23494_6	"HK2 cells, PCB77 treated, 40uM, 24h"	"HK2 cells, PCB77 treated, 40uM, 0h"
p_23501_1	"diffuse large B cell lymphoma, activated B-cell like (ABC)"	"pooled normal cells (breast, gastric, lymph node, spleen and tonsil), from patients of free of DLBCL after initial treatment"
p_23501_2	"diffuse large B cell lymphoma,germinal center B cell-like (GCB)"	"pooled normal cells (breast, gastric, lymph node, spleen and tonsil), from patients of free of DLBCL after initial treatment"
p_23579_1	"Human cerebral cortex, Ethanol treated"	"Human cerebral cortex, control"
p_23583_1	"iPSC derived from dH1CF fibroblast, viral derived iPS"	"dH1F fibroblast, untransfected"
p_23583_10	"RNA iPS cells derived from BJ fibroblast, RNA derived iPS"	"pooled human ESC (H1, H9)"
p_23583_11	"iPS cells derived from MRC5 fibroblast, viral derived iPS"	"pooled human ESC (H1, H9)"
p_23583_12	"RNA iPS cells derived from MRC5 fibroblast, RNA derived iPS"	"pooled human ESC (H1, H9)"
p_23583_2	"RNA iPSC derived from dH1F fibroblast, RNA deribed iPS"	"dH1F fibroblast, untransfected"
p_23583_3	"iPS cells derived from BJ fibroblast, viral derived iPS"	"BJ fibroblast, untransfected"
p_23583_4	"RNA iPS cells derived from BJ fibroblast, RNA derived iPS"	"BJ fibroblast, untransfected"
p_23583_5	"iPS cells derived from MRC5 fibroblast, viral derived iPS"	"MRC5 fibroblast, untransfected"
p_23583_6	"RNA iPS cells derived from MRC5 fibroblast, RNA derived iPS"	"MRC5 fibroblast, untransfected"
p_23583_7	"iPSC derived from dH1CF fibroblast, viral derived iPS"	"pooled human ESC (H1, H9)"
p_23583_8	"RNA iPSC derived from dH1F fibroblast, RNA deribed iPS"	"pooled human ESC (H1, H9)"
p_23583_9	"iPS cells derived from BJ fibroblast, viral derived iPS"	"pooled human ESC (H1, H9)"
p_23586_1	"Gingiva cell, Periodontitis affected"	"Gingiva cell, healthy state"
p_23593_1	"Breast tumor core needle biopsy, ER positive"	"Breast tumor core needle biopsy, ER negative"
p_23593_2	"Breast tumor core needle biopsy, PR positive"	"Breast tumor core needle biopsy, PR negative"
p_23597_1	"colonic biopsy, infliximab treated, 5mg/kg, week 0"	"colonic biopsy, placebo treated, 5mg/kg, week 0"
p_23597_2	"colonic biopsy, infliximab treated, 5mg/kg, week 8"	"colonic biopsy, placebo treated, 5mg/kg, week 8"
p_23597_3	"colonic biopsy, infliximab treated, 5mg/kg, week 30"	"colonic biopsy, placebo treated, 5mg/kg, week 30"
p_23597_4	"colonic biopsy,  infliximab treated, 10mg/kg, week 0"	"colonic biopsy, infliximab treated, 5mg/kg, week 0"
p_23597_5	"colonic biopsy, infliximab treated, 10mg/kg, week 8"	"colonic biopsy, infliximab treated, 5mg/kg, week 8"
p_23597_6	"colonic biopsy, Infliximab treated, 10mg/kg, week 30"	"colonic biopsy, infliximab treated, 5mg/kg, week 30"
p_23603_1	"A2008 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"A2008 cell line, untreated control"
p_23603_10	"A2780CP cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780CP cell line, untreated control"
p_23603_11	"A2780CP cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780CP cell line, untreated control"
p_23603_12	"A2780CP cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780CP cell line, untreated control"
p_23603_13	"A2780S cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780S cell line, untreated control"
p_23603_14	"A2780S cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780S cell line, untreated control"
p_23603_15	"A2780S cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780S cell line, untreated control"
p_23603_16	"A2780S cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780S cell line, untreated control"
p_23603_17	"A2780S cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780S cell line, untreated control"
p_23603_18	"A2780S cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780S cell line, untreated control"
p_23603_19	"C13 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"C13 cell line, untreated control"
p_23603_2	"A2008 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"A2008 cell line, untreated control"
p_23603_20	"C13 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"C13 cell line, untreated control"
p_23603_21	"C13 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"C13 cell line, untreated control"
p_23603_22	"C13 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"C13 cell line, untreated control"
p_23603_23	"C13 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"C13 cell line, untreated control"
p_23603_24	"C13 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"C13 cell line, untreated control"
p_23603_25	"IGROV1 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"IGROV1 cell line, untreated control"
p_23603_26	"IGROV1 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"IGROV1 cell line, untreated control"
p_23603_27	"IGROV1 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"IGROV1 cell line, untreated control"
p_23603_28	"IGROV1 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"IGROV1 cell line, untreated control"
p_23603_29	"IGROV1 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"IGROV1 cell line, untreated control"
p_23603_3	"A2008 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"A2008 cell line, untreated control"
p_23603_30	"IGROV1 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"IGROV1 cell line, untreated control"
p_23603_31	"OV2008 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"OV2008 cell line, untreated control"
p_23603_32	"OV2008 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"OV2008 cell line, untreated control"
p_23603_33	"OV2008 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"OV2008 cell line, untreated control"
p_23603_34	"OV2008 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"OV2008 cell line, untreated control"
p_23603_35	"OV2008 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"OV2008 cell line, untreated control"
p_23603_36	"OV2008 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"OV2008 cell line, untreated control"
p_23603_37	"OVCAR5 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"OVCAR5 cell line, untreated control"
p_23603_38	"OVCAR5 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"OVCAR5 cell line, untreated control"
p_23603_39	"OVCAR5 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"OVCAR5 cell line, untreated control"
p_23603_4	"A2008 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"A2008 cell line, untreated control"
p_23603_40	"OVCAR5 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"OVCAR5 cell line, untreated control"
p_23603_41	"OVCAR5 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"OVCAR5 cell line, untreated control"
p_23603_42	"OVCAR5 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"OVCAR5 cell line, untreated control"
p_23603_43	"T8 cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"T8 cell line, untreated control"
p_23603_44	"T8 cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"T8 cell line, untreated control"
p_23603_45	"T8 cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"T8 cell line, untreated control"
p_23603_46	"T8 cell line, treatment schedule: B, cisplatin treated, 4ug/ml,treatment/expansion cycle number within schedule: 6"	"T8 cell line, untreated control"
p_23603_47	"T8 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"T8 cell line, untreated control"
p_23603_48	"T8 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"T8 cell line, untreated control"
p_23603_5	"A2008 cell line, treatment schedule: C, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 3"	"A2008 cell line, untreated control"
p_23603_6	"A2008 cell line, treatment schedule: C, cisplatin treated, 5ug/ml,treatment/expansion cycle number within schedule: 6"	"A2008 cell line, untreated control"
p_23603_7	"A2780CP cell line, treatment schedule: A, cisplatin treated, 1ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780CP cell line, untreated control"
p_23603_8	"A2780CP cell line, treatment schedule: A, cisplatin treated, 3ug/ml,treatment/expansion cycle number within schedule: 6"	"A2780CP cell line, untreated control"
p_23603_9	"A2780CP cell line, treatment schedule: B, cisplatin treated, 2ug/ml,treatment/expansion cycle number within schedule: 3"	"A2780CP cell line, untreated control"
p_23610_1	"MCF-7 cell, Estradiol 0.1uM treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_2	"MCF-7 cell, Ferulic acid 0.1uM treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_3	"MCF-7 cell, Ferulic acid 1uM treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_4	"MCF-7 cell, Ferulic acid 10uM treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_5	"MCF-7 cell, Si-Wu-Tang 0.0256mg/ml treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_6	"MCF-7 cell, Si-Wu-Tang 0.256mg/ml treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23610_7	"MCF-7 cell, Si-Wu-Tang 2.56mg/ml treated"	"MCF-7 cell, 0.001% DMSO treated"
p_23614_1	"UOK257-2 cell, FLCN silenced"	"UOK257-2 cell, scrambled"
p_23614_2	"UOK257-2 cell, TFE3 silenced"	"UOK257-2 cell, scrambled"
p_23614_3	"UOK257-2 cell, FLCN, TFE3 silenced"	"UOK257-2 cell, scrambled"
p_23627_1	RCC Lung metastatic Genration 1	RCC parental cell line
p_23627_2	RCC Lung metastatic Genration 2	RCC parental cell line
p_23630_1	"Intestinal colon cell, Frozen"	"Intestinal colon cell, control"
p_23630_2	"Intestinal colon cell, PMA/IO"	"Intestinal colon cell, control"
p_23630_3	"Intestinal colon cell, PMA/IO, BL23 treated"	"Intestinal colon cell, control"
p_23630_4	"Intestinal colon cell, PMA/IO, LP299v treated"	"Intestinal colon cell, control"
p_23630_5	"Intestinal colon cell, PMA/IO, LP299v (A-) treated"	"Intestinal colon cell, control"
p_23704_1	"BAL cells, inflammatory lung disease, liposomal ATRA treated, 5uM"	"BAL cells, untreated"
p_23741_1	"normal dermal fibroblast, rottlerin treated, 50ug/ml, 24h"	"normal dermal fibroblast, untreated"
p_23741_2	"systemic sclerosis fibroblast, rottlerin treated, 50ug/ml, 24h"	systemic sclerosis fibroblast
p_23741_3	systemic sclerosis fibroblast	"normal dermal fibroblast, untreated"
p_23741_4	"systemic sclerosis fibroblast, rottlerin treated, 50ug/ml, 24h"	"normal dermal fibroblast, rottlerin treated, 50ug/ml, 24h"
p_23764_1	"A375M2, thin rigid collagen"	"A375M2, thick deformable collagen"
p_23764_2	"A375P, thick deformable collagen"	"A375M2, thick deformable collagen"
p_23764_3	"A375M2, thick deformable collagen, blebbistatin"	"A375M2, thick deformable collagen"
p_23764_4	"A375M2, thick deformable collagen, Y27632"	"A375M2, thick deformable collagen"
p_23764_5	"A375M2, thick deformable collagen, H1152"	"A375M2, thick deformable collagen"
p_23849_1	"293T cell, EerI treated"	"293T cell, control"
p_23849_2	"293T cell, CBU-028 treated"	"293T cell, control"
p_23849_3	"293T cell, 5-NA treated"	"293T cell, control"
p_23878_1	"colon, tumour"	"colon, paired normal tissue"
p_23882_1	"HCT116 cell, T1G1A expressed"	"HCT116 cell, control"
p_23882_2	"HCT116 cell, T1G1B expressed"	"HCT116 cell, control"
p_23906_1	"MAQC sample B, i.e., Ambion Human Brain Reference RNA (HBRR, Catalog #6050)"	"MAQC sample A, i.e., Stratagene Universal Human Reference RNA (UHRR, Catalog #740000)"
p_23935_1	"Glioblastoma, LY2109761 treated, 2mM, 3h"	"Glioblastoma, untreated"
p_23952_1	"pancreatic cancer cell (Panc-1 cells), TGF Treated, 48 hr"	"panceratic cnacer cell (Panc-1 cells), untreated"
p_23968_1	MRC5-derived iPSC	MRC5 fibroblasts
p_23968_2	BJ1-derived iPSC	BJ1 fibroblasts
p_23968_3	hFib2-derived iPSC line	hFib2 fibroblasts
p_23968_4	MRC5-derived iPSC	"pooled human ESC (H9, BG01)"
p_23968_5	BJ1-derived iPSC	"pooled human ESC (H9, BG01)"
p_23968_6	hFib2-derived iPSC line	"pooled human ESC (H9, BG01)"
p_23973_1	"hFib2-iPS5 cell, lincRNA-ST8SIA3 targeting siRNA treated"	"hFib2-iPS5 cell, control"
p_23984_1	"CD3+ T lymphocytes, TX527 treated, 10nM"	"CD3+ T lymphocytes, EtOH treated, control"
p_23994_1	"LiFraumeni syndrome, epithelial"	Normal epithelial
p_23994_2	"LiFraumeni syndrome, stromal"	Normal stromal
p_24027_1	"MCF-7 cells, VLX50 treated, 6h"	"MCF-7 cells, control"
p_24044_1	"GC B cell, transfected with KDM6B"	"GC B cell, control vector"
p_24089_1	"Carcinoma cell , HPV infected"	"Carcinoma cell , control"
p_24091_1	"SCC cell line, HPV positive"	"SCC cell line, HPV negative"
p_24093_1	"Endothelial cell, Akt activated"	"Endothelial cell, GFP infected"
p_24093_2	"Endothelial cell, PymT activated"	"Endothelial cell, GFP infected"
p_24093_3	"Endothelial cell, MAPK activated"	"Endothelial cell, GFP infected"
p_24132_1	"adult peripheral Dendritic cell, RSV infected"	"adult peripheral Dendritic cell, mock infected"
p_24132_2	"Cord blood Dendritic cell, RSV infected"	"Cord blood Dendritic cell, mock infected"
p_24150_1	"MCF-7 cells, b-AP15 treated, 6h"	"MCF-7 cells, control"
p_24170_1	"U2OS cell, Wt-Set8b transfected"	"U2OS cell, empty vector transfected"
p_24170_2	"U2OS cell, Set8b_deltaPIP2 transfected"	"U2OS cell, empty vector transfected"
p_24188_1	"hepatocyte, atorvastatin treated, 24h"	"hepatocyte, untreated"
p_24188_2	"hepatocyte, atorvastatin treated, 48h"	"hepatocyte, untreated"
p_24188_3	"hepatocyte, Rifampicin treated, 24h"	"hepatocyte, untreated"
p_24188_4	"hepatocyte, Rifampicin treated, 48h"	"hepatocyte, untreated"
p_24188_5	"hepatocyte, Rosuvastatin treated, 24h"	"hepatocyte, untreated"
p_24188_6	"hepatocyte, Rosuvastatin treated, 48h"	"hepatocyte, untreated"
p_24199_1	"soft-tissue sarcoma, Non-side population"	"soft-tissue sarcoma, Side population"
p_24223_11	"CD14 cell, 8 week after kidney transplant"	"CD14 cell, kidney transplant, day 0"
p_24223_14	"CD19 cell, 2 week after kidney transplant"	"CD19 cell, kidney transplant, day 0"
p_24223_15	"CD19 cell, 12 week after kidney transplant"	"CD19 cell, kidney transplant, day 0"
p_24223_18	"CD4 cell, 2 week after kidney transplant"	"CD4 cell, kidney transplant, day 0"
p_24223_2	"whole blood, 1 week after kidney transplant"	"whole blood, kidney transplant, day 0"
p_24223_20	"CD4 cell, 8 week after kidney transplant"	"CD4 cell, kidney transplant, day 0"
p_24223_23	"CD8 cell, 2 week after kidney transplant"	"CD8 cell, kidney transplant, day 0"
p_24223_24	"CD8 cell, 8 week after kidney transplant"	"CD8 cell, kidney transplant, day 0"
p_24223_26	"CD56 cell, 2 week after kidney transplant"	"CD56 cell, kidney transplant, day 0"
p_24223_27	"CD56 cell, 12 week after kidney transplant"	"CD56 cell, kidney transplant, day 0"
p_24223_5	"whole blood, 8 week after kidney transplant"	"whole blood, kidney transplant, day 0"
p_24223_8	"CD14 cell, 1 week after kidney transplant"	"CD14 cell, kidney transplant, day 0"
p_24224_1	"HL60 cell, decitabine"	"HL60 cell, control"
p_24244_1	"CD133+, CD144+ cell, Brain GBM tumor"	"CD133-, CD144- cell, Brain GBM tumor"
p_24249_1	"MDA-MB-231 cell, GATA3 expressed"	"MDA-MB-231 cell, control"
p_24259_1	"A375SM cells, transduced with PAR-1 shRNA"	"A375SM cells, transduced with NT shRNA, control"
p_2435_1	"Awells cell line, autophagy, 6h"	"Awells cell line, control, 6h"
p_2435_2	"Awells cell line, autophagy, 24h"	"Awells cell line, control, 24h"
p_24362_1	"LCL , EBNA3CHT permissive"	"LCL, control"
p_24362_2	"LCL , EBNA3CHT non-permissive"	"LCL, control"
p_24468_1	"mammary epithelial cell,  R5020 treated, 10nM, 16h"	"mammary epithelial cell, vehicle, 16h"
p_24473_1	"T47D cell, RASSF1C over-expression"	"T47D cell, control"
p_24487_1	HGPS (Hutchinson-Gilford progeria syndrom) Fibroblast	BJ (CRL-2522) fibroblasts
p_24487_2	"BJ-iPSC, iPSC from normal human fibroblast (CRL-2522)"	H9 ESC
p_24487_3	"HGPS-iPSC, iPSC from HGPS (Hutchinson-Gilford progeria syndrom) Fibroblast"	H9 ESC
p_24493_1	"KCL-22 cell, Imatinib treated"	"KCL-22 cell, control"
p_24493_2	"KU-812 cell, Imatinib treated"	"KU-812 cell, control"
p_24493_3	"JURL-MK1 cell, Imatinib treated"	"JURL-MK1 cell, control"
p_24522_1	"MMS1 cell, miR16 knock-out"	"MMS1 cell, control"
p_24522_2	"RPMI cell, miR16 knock-out"	"RPMI cell, control"
p_24530_1	"H1 hESC, FACs sorted small subpopulation"	"H1 hESC, FACs sorted large subpopulation"
p_24547_1	"MCF7 cells, Danusertib treated, 24h"	"MCF7 cells, untreated, 24h"
p_24547_2	"MDA-MB-468 cell, Danusertib treated, 24 h"	"MDA-MB-468 cell, untreated, 24 h"
p_24547_3	"HCT-116 cells, Danusertib treated, 24h"	"HCT-116 cells, untreated, 24h"
p_24547_4	"Colo205 cell, Danusertib treated, 24 h"	"Colo205 cell, untreated, 24 h"
p_24547_5	"A2780 cell, Danusertib treated, 24 h"	"A2780 cell, untreated, 24 h"
p_24553_1	"Thyroid cell, SAGM treated"	"Thyroid cell, control"
p_24584_1	"CL1-5 cells, Analogue 3, 4-iodo-3,3,5-tripropyl-4-methoxy treated"	"CL1-5 cells, DMSO treated"
p_24612_1	"Human synovial MSC, co-culture"	"Human synovial MSC, mono-culture"
p_24733_1	"293T cells, transfected with pCMV-Aire expression vector"	"293T cell, control"
p_24736_1	"Mature naive B cell, Allele C/T"	"Mature naive B cell, Allele C/C"
p_24736_2	"Mature naive B cell, Allele T/T"	"Mature naive B cell, Allele C/C"
p_24739_1	"CD34+ G0 cell, CML patient"	"CD34+ G0 cell, normal"
p_24739_2	"CD34+ G1 cell, CML patient"	"CD34+ G1 cell, normal"
p_24743_1	"U937 cells, treated with shikonin"	"U937 cells, treated with DMSO"
p_24783_1	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (42C), 0h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24783_2	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (42C), 6h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24783_3	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (42C), 12h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24783_4	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (44C), 0h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24783_5	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (44C), 6h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24783_6	"Human oral squamous carcinoma cell line (HSC-3), treated with heat stress (44C), 12h"	"Human oral squamous carcinoma cell line (HSC-3), control"
p_24824_1	"liver metastasis sample, anti-miR-182 treated"	"liver metastasis sample, control"
p_24849_1	"CD34+-derived Hematopoietic stem cells, Day10, Plasmodium falciparum (3D7) infection (GenePattern)"	"CD34+-derived Hematopoietic stem cells , Day10, uninfected (GenePattern)"
p_24849_2	"CD34+-derived Hematopoietic stem cells, Plasmodium falciparum (3D7) infection, Day14 (GenePattern)"	"CD34+-derived Hematopoietic stem cells, uninfected, Day14 (GenePattern)"
p_24849_3	"CD34+-derived Hematopoietic stem cells,  Plasmodium falciparum (3D7) infection, Day10 (dChip)"	"CD34+-derived Hematopoietic stem cells, uninfected,  Day10 (dChip)"
p_24849_4	"CD34+-derived Hematopoietic stem cells, Plasmodium falciparum (3D7) infection, Day14 (dChip)"	"CD34+-derived Hematopoietic stem cells, uninfected, Day14 (dChip)"
p_24868_1	PC-3/S cell line	PC-3/Mc cell line
p_24869_1	"monocyte, LTB4 treated, 30 min"	"monocyte, control"
p_24897_1	"Macrophage, treated P.gingivalis, control"	"Macrophage, treated saline, control"
p_24897_2	"Macrophage, treated PG-LPS, control"	"Macrophage, treated saline, control"
p_24897_3	"Macrophage, treated PG-fimbriae, control"	"Macrophage, treated saline, control"
p_25012_1	"GBM cells, transplantation into zebrafish, 24 hours post"	"GBM cells, transplantation into zebrafish, 4 hours post"
p_25012_2	"GBM cells, transplantation into zebrafish, 48 hours post"	"GBM cells, transplantation into zebrafish, 4 hours post"
p_25014_1	"PMVEC, 5 mM heme treated"	"PMVEC, vehicle, control"
p_25014_2	"PAEC, 5 mM heme treated"	"PAEC, vehicle, control"
p_25085_1	Thymocyte from Adult BM HSC	Thymocyte from Fetal BM HSC
p_25085_2	Thymocyte from Fetal Liver HSC	Thymocyte from Fetal BM HSC
p_25086_1	"MIAPaCa-2 cells, NDRG1 transfected"	"MIAPaCa-2 cells, control vector"
p_25087_1	"Naive CD4+ T cells, adult"	"Naive CD4+ T cells, fetal"
p_25087_2	"CD4+CD25+ Treg, adult"	"CD4+CD25+ Treg, fetal"
p_25090_1	iPS from CD34 cell	hESCs
p_25090_2	hESCs	CD34 cells
p_25118_1	"NCI-H2228 xenograft, CH5424802 4mg treated"	"NCI-H2228 xenograft, vehicle"
p_25118_2	"NCI-H2228 xenograft, CH5424802 20mg treated"	"NCI-H2228 xenograft, vehicle"
p_25127_1	"TC32 cell, mithramycin"	"TC32 cell, control"
p_25127_2	"TC71 cell, mithramycin"	"TC71 cell, control"
p_25146_1	"AGS cell, LPS treated"	"AGS cell, control"
p_25147_1	"MKN45 cell, LPS treated"	"MKN45 cell, control"
p_25148_1	"HEK-TLR2 cell, LPS treated 2h"	"HEK-TLR2 cell, control 2h"
p_25148_2	"HEK-TLR2 cell, LPS treated 4h"	"HEK-TLR2 cell, control 4h"
p_25148_3	"HEK-TLR2 cell, LPS treated 8h"	"HEK-TLR2 cell, control 8h"
p_25148_4	"HEK-TLR2 cell, LPS treated 24h"	"HEK-TLR2 cell, control 24h"
p_25148_5	"HEK-TLR2 cell, LPS treated 48h"	"HEK-TLR2 cell, control 48h"
p_25156_1	"HRP1 cell, permissive to hcv"	"Huh7 cell, non-permissive to hcv"
p_25157_1	"HCV Replicon containing Huh7-K2040 cells, transfected with pTracer-CREB3L1"	"HCV Replicon containing Huh7-K2040 cells, transfected with pTracer, control"
p_25162_1	"MCF7 cell, overexpressing miR-210"	"MCF7 cell, control"
p_25162_2	"MDA-MB-231 cell, overexpressing miR-210"	"MDA-MB-231 cell, control"
p_25191_1	"IGROV1 cells, side population"	"IGROV1 cells, non-side population"
p_25251_1	"primary lung cancer, Tumor cell line"	"pulmonary lymph node, cell line"
p_25251_2	"primary lung cancer, Tumor tissue"	"pulmonary lymph node, tissue"
p_25269_1	"HUVEC cell, Dexamethasone, 4h"	"HUVEC cell, control, 4h"
p_25269_2	"HUVEC cell, Dexamethasone, 16h"	"HUVEC cell, control, 16h"
p_25300_1	"Bone marrow cells, Evolution in AML"	"Bone marrow cells, MDS patients at diagnosis"
p_25311_1	"Huh7 cell, FH HDL treated"	"Huh7 cell, Normal HDL treated"
p_25320_1	"HMC-1 cell, exosome"	"HMC-1 cell, control"
p_25330_1	"C2M cell, Lactobacillus salivarius treated"	"C2M cell, control"
p_25330_2	"C2M cell, E.coli treated"	"C2M cell, control"
p_25330_3	"C2M cell, Bacteroides fragilis treated"	"C2M cell, control"
p_25330_4	"C2M cell, polystyrene beads treated"	"C2M cell, control"
p_25332_1	"Hec50 cell, empty vector"	"Hec50 cell, control"
p_25332_2	"Hec50 cell, miR-200C treated"	"Hec50 cell, control"
p_25336_1	"Olfactory MSC, Transdifferentiated to Hematopoietic SC"	Olfactory MSC
p_25407_1	"breast tumor, stage I, explant"	breast reduction mammoplasty tissue explant
p_25417_1	"H9 cell, hepatic differentiated, 5d"	"H9 cell, hepatic differentiated, 20d, HNF4a knockdown"
p_25417_2	"H9 cell, hepatic differentiated, 10d"	"H9 cell, hepatic differentiated, 20d, HNF4a knockdown"
p_25417_3	"H9 cell, hepatic differentiated, 15d"	"H9 cell, hepatic differentiated, 20d, HNF4a knockdown"
p_25427_1	"normal ovarian surface epithelium, pooled from five individuals, 5-AzaC treated, 5uM, 72h"	"normal ovarian surface epithelium, pooled from five individuals, mock treated"
p_25427_2	"serous borderline ovarian cells, treated with 5-AzaC"	"serous borderline ovarian cells, mock treated"
p_25427_3	"serous epithelial ovarian cancer cells, 5-AzaC treated, 5uM, 72h"	"serous epithelial ovarian cancer cells, mock treated"
p_25429_1	"normal ovarian surface epithelium, 5-AzaC treated, 72h"	"normal ovarian surface epithelium, mock treated"
p_25429_2	"serous borderline ovarian cells, treated with 5-AzaC"	"serous borderline ovarian cells, mock treated"
p_25429_3	"serous epithelial ovarian cancer cells, treated with 5-AzaC"	"serous epithelial ovarian cancer cells, mock treated"
p_25436_1	"Melanoma cell line, M202R1 cell lines, V600E BRAF mutant, PLX4032 resistant"	"M202 cells, V600E BRAF mutant, PLX4032 sensitive"
p_25458_1	"Ishikawa cell, metastin-10 treated"	"Ishikawa cell, control"
p_25458_2	"Ishikawa cell, GPR54 suppressed, metastin-10 treated"	"Ishikawa cell, GPR54 suppressed"
p_25471_1	"HEK293T, ZAPS expression, 48h"	"HEK293T, control"
p_25507_1	"lymphocyte, autism"	"lymphocyte, healthy control"
p_25518_1	"testicular biopsies, cryptorchidism"	"contralateral descended testes, control"
p_25547_1	"HepG2 cell, GW7647 treated, 6h"	"HepG2 cell, control"
p_25547_2	"HepG2 cell, GW7647 treated, 24h"	"HepG2 cell, control"
p_25550_1	"MALT lymphoma, t(11;18)-negative"	normal spleen tissue
p_25550_2	"MALT lymphoma, t(11;18)-positive"	normal spleen tissue
p_25550_3	"MALT lymphoma, t(11;18)-positive"	"MALT lymphoma, t(11;18)-negative"
p_2555_1	"HEK293 cells, HCaRG transfected"	"HEK293 cells, control"
p_25571_1	"PBMC, mononuclear cells, FISH (del 13q14)"	"PBMC, mononuclear cells, FISH (no del 13q14, no del 11q22-23, no del 17p13, no trisomy 12)"
p_25571_2	"PBMC, mononuclear cells, FISH (del 11q22-23)"	"PBMC, mononuclear cells, FISH (no del 13q14, no del 11q22-23, no del 17p13, no trisomy 12)"
p_25571_3	"PBMC, mononuclear cells, FISH (del 17q13)"	"PBMC, mononuclear cells, FISH (no del 13q14, no del 11q22-23, no del 17p13, no trisomy 12)"
p_25571_4	"PBMC, mononuclear cells, FISH (trisomy 12)"	"PBMC, mononuclear cells, FISH (no del 13q14, no del 11q22-23, no del 17p13, no trisomy 12)"
p_25613_1	"Mantel cell lymphoma cell line, resistant to ABT-737"	"Mantel cell lymphoma cell line, sensitive to ABT-737"
p_25619_1	"mammary fibroblast, granulin treated"	"mammary fibroblast, control"
p_25634_1	"second trimester amniotic fluid, trisomy 18"	"second trimester amniotic fluid, euploid control"
p_25638_1	MALT lymphoma	"naive B cells, tonsil, healthy control"
p_25638_10	"Diffuse large B cell lymphoma (DLBCL), frozen biopsy"	"IgM+IgD+CD27+ cells, Peripheral Blood, healthy control"
p_25638_11	"Follicular B cell lymphoma (FCL), frozen biopsy"	"IgM+IgD+CD27+ cells, Peripheral Blood, healthy control"
p_25638_12	"Splenic Marginal B Cell lymphoma, frozen biopsy"	"IgM+IgD+CD27+ cells, Peripheral Blood, healthy control"
p_25638_13	MALT lymphoma	"CD19+ cells, Peripheral Blood, healthy control"
p_25638_14	"Diffuse large B cell lymphoma (DLBCL), frozen biopsy"	"CD19+ cells, Peripheral Blood, healthy control"
p_25638_15	"Follicular B cell lymphoma (FCL), frozen biopsy"	"CD19+ cells, Peripheral Blood, healthy control"
p_25638_16	"Splenic Marginal B Cell lymphoma, frozen biopsy"	"CD19+ cells, Peripheral Blood, healthy control"
p_25638_17	MALT lymphoma	"CD19+ cells, Peripheral blood, activated, healthy control"
p_25638_18	"Diffuse large B cell lymphoma (DLBCL), frozen biopsy"	"CD19+ cells, Peripheral blood, activated, healthy control"
p_25638_19	"Follicular B cell lymphoma (FCL), frozen biopsy"	"CD19+ cells, Peripheral blood, activated, healthy control"
p_25638_2	"Diffuse large B cell lymphoma (DLBCL), frozen biopsy"	"naive B cells, tonsil, healthy control"
p_25638_20	"Splenic Marginal B Cell lymphoma, frozen biopsy"	"CD19+ cells, Peripheral blood, activated, healthy control"
p_25638_3	"Follicular B cell lymphoma (FCL), frozen biopsy"	"naive B cells, tonsil, healthy control"
p_25638_4	"Splenic Marginal B Cell lymphoma, frozen biopsy"	"naive B cells, tonsil, healthy control"
p_25638_5	MALT lymphoma	"Memory B cells, tonsil, healthy control"
p_25638_6	"Diffuse large B cell lymphoma (DLBCL), frozen biopsy"	"Memory B cells, tonsil, healthy control"
p_25638_7	"Follicular B cell lymphoma (FCL), frozen biopsy"	"Memory B cells, tonsil, healthy control"
p_25638_8	"Splenic Marginal B Cell lymphoma, frozen biopsy"	"Memory B cells, tonsil, healthy control"
p_25638_9	MALT lymphoma	"IgM+IgD+CD27+ cells, Peripheral Blood, healthy control"
p_25725_1	"HEL cell, CEP701 treated"	"HEL cell, DMSO treated"
p_25725_2	"HEL cell, shPRMT5 treated"	"HEL cell, shControl treated"
p_25743_1	"Hs578T cell, EpCAM expressed"	"Hs578T cell, control"
p_25861_1	"endothelial cells, Intra Uterine Growth Restriction"	"endothelial cells, Preterm labour, control"
p_25941_1	"Muscle cell, Old, male"	"Muscle cell, Young, male"
p_25941_2	"Muscle cell, Old, Female"	"Muscle cell, Young, Female"
p_25986_1	Hodgkin lymphoma cell	Germinal center
p_25987_1	"KM-H2 cells, CIITA-BX648577 knockdown"	"KM-H2 cells, Non-silencing control"
p_2600_1	"NB4 cells, Anaplasma phagocytophilum infected"	"NB4 cells, control"
p_26027_1	"Rectum tumor, one hour after a dose of 7.2 Gy (4th fraction) during radiotherapy"	"Rectum tumor, before radiotherapy"
p_26049_1	"whole blood, Essential Thronbocythemia, RMA"	"whole blood, control, RMA"
p_26049_2	"whole blood, Polycythemia Vera, RMA"	"whole blood, control, RMA"
p_26049_3	"whole blood, Primary Myelofibrosis, RMA"	"whole blood, control, RMA"
p_26049_4	"whole blood, Essential Thronbocythemia, dChip"	"whole blood, control, dChip"
p_26049_5	"whole blood, Polycythemia Vera, dChip"	"whole blood, control, dChip"
p_26049_6	"whole blood, Primary Myelofibrosis, dChip"	"whole blood, control, dChip"
p_26050_1	"Peripheral Blood Mononuclear Cell, FHL, WT"	"Peripheral Blood Mononuclear Cell, no-FHL, control"
p_26050_2	"Peripheral Blood Mononuclear Cell, FHL, PRF"	"Peripheral Blood Mononuclear Cell, no-FHL, control"
p_26077_1	"PDL cell, mechanical stress 48h"	"PDL cell, control"
p_26114_1	"MV4-11, ABT-869"	"MV4-11, Control"
p_26114_2	"MV4-11, SAHA"	"MV4-11, Control"
p_26114_3	"MV4-11, ABT-869 + SAHA"	"MV4-11, Control"
p_26114_4	"MOLM-14, ABT-869"	"MOLM-14, Control"
p_26114_5	"MOLM-14, SAHA"	"MOLM-14, Control"
p_26114_6	"MOLM-14, ABT-869 + SAHA"	"MOLM-14, Control"
p_26146_1	Human vascular adventital fibroblast	Human lung cell derived fibroblast
p_26156_1	Double Positive CD4 T cells	Single Positive CD4 T cells
p_26176_1	"W12 cervical ectokeratinocyte, passage 22"	"W12 cervical ectokeratinocyte, passage 19"
p_26213_1	"early human hypertrophic scar, white, neck, 6.7 mpi, 19 yr"	"early human hypertrophic scar, black, upper extremity, 10.8 mpi, 54 yr"
p_26272_1	"MSC, ZNF145 overexpressed"	"MSC, control"
p_26298_1	"MCF-7 cell, scramble siRNA, 100nM 4-hydroxytamoxifen treated"	"MCF-7 cell, scramble siRNA, vehicle"
p_26298_2	"MCF-7 cell, scramble siRNA, 500nM 4-hydroxytamoxifen treated"	"MCF-7 cell, scramble siRNA, vehicle"
p_26298_3	"MCF-7 cell, ER siRNA, vehicle"	"MCF-7 cell, scramble siRNA, vehicle"
p_26298_4	"MCF-7 cell, RARalpha siRNA, vehicle"	"MCF-7 cell, scramble siRNA, vehicle"
p_26308_1	"Xenograft, treated"	"Xenograft, untreated"
p_26308_2	A375 cell RNA on mouse	A375 cell RNA on human
p_26332_1	"C4-2 cell, miR-99a transfected"	"C4-2 cell, control"
p_2634_1	African green monkey whole blood	human whole blood
p_2634_2	Rhesus monkey whole blood	human whole blood
p_2634_3	cynomologus macaque whole blood	human whole blood
p_26351_1	"mobilized peripheral blood CD34+ cell, BIO treated"	"mobilized peripheral blood CD34+ cell, control"
p_26351_2	"mobilized peripheral blood CD34+ cell, BMP4 treated"	"mobilized peripheral blood CD34+ cell, control"
p_26378_1	"whole blood, septic shock patients"	"whole blood, normal control"
p_26440_1	"whole blood, septic shock patients"	"whole blood, normal control"
p_26451_1	HES-3	FORESKIN
p_26451_2	"ES4SKIN, induced pluripotent stem cells"	HES-3
p_26453_1	HES-3	IMR90
p_26453_2	"ESIMR90, induced pluripotent stem cells"	HES-3
p_26459_1	"MCF7 cell, estrogen treated, Tamoxifen sensitive"	"MCF7 cell, control, Tamoxifen sensitive"
p_26459_2	"MCF7 cell, 4-OHT treated, Tamoxifen sensitive"	"MCF7 cell, control, Tamoxifen sensitive"
p_26459_3	"MCF7 cell, estrogen+4-OHT treated, Tamoxifen sensitive"	"MCF7 cell, control, Tamoxifen sensitive"
p_26459_4	"MCF7 cell, estrogen treated, Tamoxifen resistant"	"MCF7 cell, control, Tamoxifen resistant"
p_26459_5	"MCF7 cell, 4-OHT treated, Tamoxifen resistant"	"MCF7 cell, control, Tamoxifen resistant"
p_26459_6	"MCF7 cell, estrogen+4-OHT treated, Tamoxifen resistant"	"MCF7 cell, control, Tamoxifen resistant"
p_26462_1	"MDA-MB-231 cell, WASF3 knockdown"	"MDA-MB-231 cell, control"
p_26484_1	"PBMC, MS patient, low Sema4A"	"PBMC, healthy, low Sema4A"
p_26484_2	"PBMC, MS patient, high Sema4A"	"PBMC, MS patient, low Sema4A"
p_26495_1	PD-1 high CD8+ CD3+ T cells	Naive CD8+ CD3+ T cells
p_26495_2	PD-1 low CD8+ CD3+ T cells	Naive CD8+ CD3+ T cells
p_26525_1	"A549 cell, Geld IC50 treated, 24h"	"A549 cell, DMSO treated, 24h"
p_26525_2	"A549 cell, Geld IC20 treated, 48h"	"A549 cell, DMSO treated, 48h"
p_26525_3	"A549 cell, Geld IC50 treated, 48h"	"A549 cell, DMSO treated, 48h"
p_26526_1	"flow-sorted CD19+ cells, peripheral blood,chronic lymphocytic leukemia patient, del11q present"	"flow-sorted CD19+ cells, peripheral blood,chronic lymphocytic leukemia patient, non-del11q"
p_26541_1	"HMEC, shp53 , Ras, Epi treated"	"HMEC, shp53 treated"
p_26541_2	"HMEC, shp53 , Ras, Mes treated"	"HMEC, shp53 treated"
p_26567_1	"mouse lung, LPS-exposed, MSC treated"	"mouse lung, LPS-exposed, PBS treated"
p_26567_2	"mouse lung, LPS-exposed, MSC treated"	"mouse lung, PBS-exposed, MSC treated"
p_26567_3	"mouse lung, LPS-exposed, MSC in vitro mix"	"mouse lung, PBS-exposed, MSC in vitro mix"
p_26569_1	"G3361 cell, ABCB5 negative"	"G3361 cell, ABCB5 positive"
p_26569_2	"A375 cell, ABCB5 negative"	"A375 cell, ABCB5 positive"
p_26569_3	"Melanoma cell, ABCB5 negative"	"Melanoma cell, ABCB5 positive"
p_26594_1	"FS087 cell, Fas stimulated"	"FS087 cell, control"
p_26594_2	"MRC5 cell, Fas stimulated"	"MRC5 cell, control"
p_26594_3	"N78 cell, Fas stimulated"	"N78 cell, control"
p_26599_1	"HB4a, Doxorubicin treated"	"HB4a, DMSO treated"
p_26599_2	"HB4a, Rapamycin treated"	"HB4a, DMSO treated"
p_26599_3	"HB4a, Doxorubicin, Rapamycin treated"	"HB4a, DMSO treated"
p_26599_4	"C5.2 cell, Doxorubicin treated"	"C5.2 cell, DMSO treated"
p_26599_5	"C5.2 cell, Rapamycin treated"	"C5.2 cell, DMSO treated"
p_26599_6	"C5.2 cell, Doxorubicin, Rapamycin treated"	"C5.2 cell, DMSO treated"
p_26599_7	"SKBR3, Doxorubicin treated"	"SKBR3, DMSO treated"
p_26599_8	"SKBR3, Rapamycin treated"	"SKBR3, DMSO treated"
p_26599_9	"SKBR3, Doxorubicin, Rapamycin treated"	"SKBR3, DMSO treated"
p_26603_1	"M14 cell, ARHGAP8 activated, 2d"	"M14 cell, GFP activated, 2d"
p_26603_2	"M14 cell, ARHGAP8 activated, 3d"	"M14 cell, GFP activated, 3d"
p_26622_1	Liver biopsy after immunosuppressive therapy	Liver biopsy before immunosuppressive therapy
p_26626_1	"ADSC, PUM2 repressed"	"ADSC, control"
p_26637_1	"Adipose cell, Fasting, Insulin resistant"	"Adipose cell, Fasting, Insulin sensitive"
p_26637_2	"Adipose cell, Hyperinsulinemic, Insulin resistant"	"Adipose cell, Hyperinsulinemic, Insulin sensitive"
p_26656_1	"A375 melanoma cell-line, Wnt-1 overexpressed"	"A375 melanoma cell-line, control"
p_26656_2	"A375 melanoma cell-line, treated CsA, Wnt-1 overexpressed"	"A375 melanoma cell-line, treated CsA"
p_26656_3	"M24met melanoma cell-line, Wnt-1 overexpressing"	"M24met melanoma cell-line, control"
p_26661_1	"BC-3 cell, treated si463"	"BC-3 cell, treated siN, control"
p_26661_2	"BC-3 cell, treated si716s"	"BC-3 cell, treated siN, control"
p_26673_1	"Immunodeficiency associated Burkitt lymphoma, HIV-infected European adult"	"Burkitt lymphoma, African children"
p_26704_1	"H460 cell line, wild type, CCDP treated, 1h"	"H460 cell line, wild type, control"
p_26704_10	"H460 cell line, DUSP1 knockdown, CCDP treated, 6h"	"H460 cell line, wild type, CCDP treated, 6h"
p_26704_3	"H460 cell line, wild type, CCDP treated, 6h"	"H460 cell line, wild type, control"
p_26704_4	"H460 cell line, DUSP1 knockdown, CCDP treated, 1h"	"H460 cell line, DUSP1 knockdown, control"
p_26704_6	"H460 cell line, DUSP1 knockdown, CCDP treated, 6h"	"H460 cell line, DUSP1 knockdown, control"
p_26704_8	"H460 cell line, DUSP1 knockdown, CCDP treated, 1h"	"H460 cell line, wild type, CCDP treated, 1h"
p_26725_1	"peripheral blood, B-CLL patients"	"peripheral blood, control"
p_26748_1	"SiHa cells, cidofovir treated, 50g/ml, 24h growth"	"SiHa cells, 24h growth"
p_26748_2	"SiHa cells, cidofovir treated, 50g/ml, 48h growth"	"SiHa cells, 48h growth"
p_26748_3	"SiHa cells, cidofovir treated, 50g/ml, 72h growth"	"SiHa cells, 72h growth"
p_26748_4	"SiHa cells, cidofovir treated, 50g/ml, 72h growth"	"SiHa cells, cidofovir resistant, 72h growth"
p_2677_1	"peripheral blood, CG treated, 6h"	"peripheral blood, CG untreated, 0h"
p_2677_2	"peripheral blood, CG treated, 8h"	"peripheral blood, CG untreated, 0h"
p_2677_3	"peripheral blood, CG treated, 24h"	"peripheral blood, CG untreated, 0h"
p_26828_1	"UROtsa cell, Cadmium-transformed"	"UROtsa cells, control"
p_26862_1	"H9 cell, SOX17 treated, stage 1"	"H9 cell, control"
p_26862_2	"H9 cell, SOX17 treated, stage 2"	"H9 cell, control"
p_26868_1	"HeLa cells, TNF-alpha treated, 10ng/mL, 2h"	"HeLa cells, control"
p_26868_2	"THP1 cells, TNF-alpha treated, 10ng/mL, 2h"	"THP1 cells, control"
p_26878_1	"acute lymphoblastic leukemia, subtype: High Hyperploidy"	"acute lymphoblastic leukemia, subtype: dic(9;20)"
p_26878_10	"acute lymphoblastic leukemia, subtype: T-cell lineage ALL (T-ALL)"	"acute lymphoblastic leukemia, subtype: t(9;22) BCR-ABL1"
p_26878_2	"acute lymphoblastic leukemia, subtype: t(12;21) ETV6-RUNX1"	"acute lymphoblastic leukemia, subtype: dic(9;20)"
p_26878_3	"acute lymphoblastic leukemia, subtype: t(9;22) BCR-ABL1"	"acute lymphoblastic leukemia, subtype: dic(9;20)"
p_26878_4	"acute lymphoblastic leukemia, subtype: T-cell lineage ALL (T-ALL)"	"acute lymphoblastic leukemia, subtype: dic(9;20)"
p_26878_5	"acute lymphoblastic leukemia, subtype: t(12;21) ETV6-RUNX1"	"acute lymphoblastic leukemia, subtype: High Hyperploidy"
p_26878_6	"acute lymphoblastic leukemia, subtype: t(9;22) BCR-ABL1"	"acute lymphoblastic leukemia, subtype: High Hyperploidy"
p_26878_7	"acute lymphoblastic leukemia, subtype: T-cell lineage ALL (T-ALL)"	"acute lymphoblastic leukemia, subtype: High Hyperploidy"
p_26878_8	"acute lymphoblastic leukemia, subtype: t(9;22) BCR-ABL1"	"acute lymphoblastic leukemia, subtype: t(12;21) ETV6-RUNX1"
p_26878_9	"acute lymphoblastic leukemia, subtype: T-cell lineage ALL (T-ALL)"	"acute lymphoblastic leukemia, subtype: t(12;21) ETV6-RUNX1"
p_26884_1	"MCF 10 cell, 10uM BPA treated"	"MCF 10 cell, DMSO treated"
p_26884_2	"MCF 10 cell, 1uM BPA treated"	"MCF 10 cell, DMSO treated"
p_26886_1	esophageal adenocarcinoma	Barrett's esophagus
p_26886_2	esophageal squamous cell carcinoma	esophageal squamous epithelium
p_26890_1	"Peripheral CD8+ T cells, cell phenotype: CXCR1+CD27-CD28-"	"Peripheral CD8+ T cells, cell phenotype: CXCR1-CD27-CD28-"
p_26910_1	"Breast cell, tumor"	"Breast cell, normal"
p_26910_2	"Prostate cell, tumor"	"Prostate cell, normal"
p_26920_1	"DMS-53 cell, DFO treated"	"DMS-53 cell, control"
p_26920_2	"DMS-53 cell, Dp44mT treated"	"DMS-53 cell, control"
p_26921_1	"NCI-H929 cells, DZNep treated, 0.5uM, 48h"	"NCI-H929 cells, DMSO treated, control"
p_26921_2	"MM.1S cells, DZNep treated, 0.5uM, 48h"	"MM.1S cells, DMSO treated, control"
p_26921_3	"KMS18 cells, DZNep treated, 0.5uM, 48h"	"KMS18 cells, DMSO treated, control"
p_26921_4	"OPM-2 cells, DZNep treated, 0.5uM, 48h"	"OPM-2 cells, DMSO treated, control"
p_26966_1	Gonadotrope tumor	Normal pituitary
p_26969_1	"arterial tissue, unruptured aneurysm"	"arterial tissue, normal"
p_26994_1	"HeLa cells,, treated with TNF-alpha, 10ng/mL, 2h"	"HeLa cells, untreated control"
p_26994_2	"THP1 cells, treated with TNF-alpha, 10ng/mL, 2h"	"THP1 cells, untreated control"
p_27018_1	"Breast cancer tumor, tumor sample histological grade: low, co-cultured with fibroblast, 3 days"	"Breast cancer tumor, tumor sample histological grade: low, untreated, 3 days"
p_27018_2	"Breast cancer tumor, tumor sample histological grade: high, co-cultured with fibroblast, 3 days"	"Breast cancer tumor, tumor sample histological grade: high, untreated, 3 days"
p_27071_1	"Monocyte cell, serum, treated"	"Monocyte cell, control"
p_27071_2	"Monocyte cell, serum, U0126 treated"	"Monocyte cell, control"
p_27120_1	"Fibroblast, co-cultured with: BT474"	"Fibroblast, co-cultured with: n/a"
p_27120_10	"MSC, co-cultured with: MCF7"	"MSC, co-cultured with: n/a"
p_27120_11	"MSC, co-cultured with: MDA-MB-231"	"MSC, co-cultured with: n/a"
p_27120_12	"MSC, co-cultured with: MDA-MB-361"	"MSC, co-cultured with: n/a"
p_27120_13	"MSC, co-cultured with: SKBR3"	"MSC, co-cultured with: n/a"
p_27120_14	"MSC, co-cultured with: T47D"	"MSC, co-cultured with: n/a"
p_27120_15	"Myoepithelial, co-cultured with: BT474"	"Myoepithelial, co-cultured with: n/a"
p_27120_16	"Myoepithelial, co-cultured with: LY2"	"Myoepithelial, co-cultured with: n/a"
p_27120_17	"Myoepithelial, co-cultured with: MCF7"	"Myoepithelial, co-cultured with: n/a"
p_27120_18	"Myoepithelial, co-cultured with: MDA-MB-231"	"Myoepithelial, co-cultured with: n/a"
p_27120_19	"Myoepithelial, co-cultured with: MDA-MB-361"	"Myoepithelial, co-cultured with: n/a"
p_27120_2	"Fibroblast, co-cultured with: LY2"	"Fibroblast, co-cultured with: n/a"
p_27120_20	"Myoepithelial, co-cultured with: SKBR3"	"Myoepithelial, co-cultured with: n/a"
p_27120_21	"Myoepithelial, co-cultured with: T47D"	"Myoepithelial, co-cultured with: n/a"
p_27120_3	"Fibroblast, co-cultured with: MCF7"	"Fibroblast, co-cultured with: n/a"
p_27120_4	"Fibroblast, co-cultured with: MDA-MB-231"	"Fibroblast, co-cultured with: n/a"
p_27120_5	"Fibroblast, co-cultured with: MDA-MB-361"	"Fibroblast, co-cultured with: n/a"
p_27120_6	"Fibroblast, co-cultured with: SKBR3"	"Fibroblast, co-cultured with: n/a"
p_27120_7	"Fibroblast, co-cultured with: T47D"	"Fibroblast, co-cultured with: n/a"
p_27120_8	"MSC, co-cultured with: BT474"	"MSC, co-cultured with: n/a"
p_27120_9	"MSC, co-cultured with: LY2"	"MSC, co-cultured with: n/a"
p_27128_1	"Human airway epithelial Calu-3 cells, strained at 30%, 24h"	"Human airway epithelial Calu-3 cells, non strained"
p_27157_1	"tumor tissue, p53 mutant"	"tumor tissue, p53 wild type"
p_27160_1	"HUVEC cell, matrigel 8h"	"HUVEC cell, matrigel 0.5h"
p_27160_2	"HUVEC cell, matrigel 18h"	"HUVEC cell, matrigel 0.5h"
p_27186_1	Induced pluripotent stem cells from umbilical cord blood	Umbilical cord blood
p_27186_2	Induced pluripotent stem cell from keratinocyte	Keratinocyte
p_27187_1	"AML-M5 patients, DNMT3A mutation"	"AML-M5 patients, DNMT3A wild type"
p_27206_1	"iPS cells, SMA patient"	"iPS cells, 19.9 control"
p_27206_2	"Fibroblast, SMA patient"	"Fibroblast, healthy"
p_27220_1	"breast cancer, vitaminD, 0.5nM, 24h"	"breast cancer, control, 24h"
p_27220_2	"breast cancer, vitaminD, 100nM, 24h"	"breast cancer, control, 24h"
p_27224_1	iPSC derived from Cord Blood	Cord Blood
p_27224_2	iPSC derived from Keratinocyte	Keratinocyte
p_27263_1	"nasal biopsy, after inhalation (0.7 ppm Formaldehyde), 0h"	"nasal biopsy, before inhalation"
p_27263_2	"nasal biopsy, after inhalation (0.7 ppm Formaldehyde), 24h"	"nasal biopsy, before inhalation"
p_27263_3	"nasal biopsy, after inhalation (0.7 ppm Formaldehyde), 72h"	"nasal biopsy, before inhalation"
p_27263_4	"Blood, after inhalation (0.7 ppm Formaldehyde), 0h"	"Blood, before inhalation"
p_27263_5	"Blood, after inhalation (0.7 ppm Formaldehyde), 24h"	"Blood, before inhalation"
p_27263_6	"Blood, after inhalation (0.7 ppm Formaldehyde), 72h"	"Blood, before inhalation"
p_27263_7	"Blood cells, exposed to 200uM Formaldehyde, 4h"	"Blood cells, before exposure"
p_27280_1	"iPSC, Pompe disease"	"Human fibroblast, Pompe disease"
p_27280_2	"CMLC derived from iPSC, Pompe disease"	CMLC derived from hESC
p_27313_1	"hMSC, WNT3a treated, 6h"	"hMSC, control"
p_27313_2	"hMSC, WNT3a treated, 24h"	"hMSC, control"
p_27316_1	"HEK293 cell, MosIR plasmid"	"HEK293 cell, control plasmid"
p_27316_2	"Hela cell, MosIR plasmid"	"Hela cell, control plasmid"
p_27318_1	"NPC 5-8F cells, NESG1 overexpression"	"NPC 5-8F cells, NESG1-negative expression"
p_27328_1	"SKOV3 cell, express LHR"	"SKOV3 cell, control"
p_27328_2	"SKOV3 cell, express LHR, LH treated, 1h"	"SKOV3 cell, control"
p_27328_3	"SKOV3 cell, express LHR, LH treated, 4h"	"SKOV3 cell, control"
p_27328_4	"SKOV3 cell, express LHR, LH treated, 8h"	"SKOV3 cell, control"
p_27328_5	"SKOV3 cell, express LHR, LH treated, 20h"	"SKOV3 cell, control"
p_27372_1	"HOB-01 pre-osteocytes cells, transwell JJN3"	"HOB-01 pre-osteocytes cells, control"
p_27424_1	"Kelatinocytes, Notch3 shRNA, low"	"Kelatinocytes, scramble shRNA, low"
p_27424_2	"Kelatinocytes, Notch3 shRNA, high"	"Kelatinocytes, scramble shRNA, high"
p_27431_1	"ovarian cancer cell, miR-7 treated"	"ovarian cancer cell, control miRNA treated"
p_27431_2	"ovarian cancer cell, miR-128 treated"	"ovarian cancer cell, control miRNA treated"
p_27444_1	"MCF7 cells, retroviral transduction: ZF-TF 115, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_10	"MCF7 cells, retroviral transduction: ZF-TF 70, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27444_11	"MCF7 cells, retroviral transduction: ZF-TF 7, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27444_12	"MCF7 cells, retroviral transduction: ZF-TF 83, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27444_2	"MCF7 cells, retroviral transduction: ZF-TF 19, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_3	"MCF7 cells, retroviral transduction: ZF-TF 64, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_4	"MCF7 cells, retroviral transduction: ZF-TF 70, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_5	"MCF7 cells, retroviral transduction: ZF-TF 7, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_6	"MCF7 cells, retroviral transduction: ZF-TF 83, 1st infection"	"MCF7 cells, 1st infection, control"
p_27444_7	"MCF7 cells, retroviral transduction: ZF-TF 115, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27444_8	"MCF7 cells, retroviral transduction: ZF-TF 19, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27444_9	"MCF7 cells, retroviral transduction: ZF-TF 64, 2nd infection"	"MCF7 cells, 2nd infection, control"
p_27473_1	"MCF-7 cells, silenced Estrogen Receptor"	"MCF-7 cells, control"
p_27489_1	"ELF cell, contralateral site"	"ELF cell, nodule site"
p_27515_1	MDA231 cell	"B6TC cell, hybrided MDA231,ZR75"
p_27515_2	ZR75 cell	"B6TC cell, hybrided MDA231,ZR75"
p_27526_1	"A2780 cell, TGF - beta treated, SMAD4 stimulated"	"A2780 cell, TGF - beta treated"
p_27529_1	"L428 cells, miR-9 LNA treatead"	"L428 cells, scrambled LNA treated"
p_27554_1	"endobronchial epithelial lining fluid, nodule site, adenocarcinoma"	"endobronchial epithelial lining fluid, nodule site, control patients"
p_27554_2	"endobronchial epithelial lining fluid, nodule site, squamous cell carcinoma"	"endobronchial epithelial lining fluid, nodule site, control patients"
p_27554_3	"endobronchial epithelial lining fluid, contralateral site, adenocarcinoma"	"endobronchial epithelial lining fluid, contralateral site, control patients"
p_27554_4	"endobronchial epithelial lining fluid, contralateral site, squamous cell carcinoma"	"endobronchial epithelial lining fluid, contralateral site, control patients"
p_27562_1	"PBMCs, patients with diagnosis of invasive breast cancer, confirmed by diagnostic biopsy"	"PBMCs, patients with normal mammogram"
p_27562_2	"PBMCs, patients with benign diagnosis, confirmed by diagnostic biopsy"	"PBMCs, patients with normal mammogram"
p_27562_3	"PBMCs, patients with other cancer types (e.g., gastrointestinal and brain"	"PBMCs, patients with normal mammogram"
p_27631_1	"HUVEC, BMP6 treated, 6h"	"HUVEC, control"
p_27631_2	"HUVEC, BMP6 treated, 24h"	"HUVEC, control"
p_27631_3	"HUVEC, BMP9 treated, 6h"	"HUVEC, control"
p_27631_4	"HUVEC, BMP9 treated, 24h"	"HUVEC, control"
p_27651_1	Serous borderline ovarian tumor cell	"Human ovrian surface epithelia cell, control"
p_27651_2	"Serous borderline ovarian carcinoma, low grade serous"	"Human ovrian surface epithelia cell, control"
p_27651_3	"Serous borderline ovarian carcinoma, high grade serous"	"Human ovrian surface epithelia cell, control"
p_27657_1	Perithyroid adipose tissue	Subcutaneous adipose tissue
p_27659_1	"serous borderline tumors, BRAF mutation"	"serous borderline tumors, wild type"
p_27670_1	"GC B cell, pcDNA3.1-pRDM1A transfected"	"GC B cell, empty vector"
p_27670_2	"GC B cell, pcDNA3.1-LMP1 transfected"	"GC B cell, empty vector"
p_27718_1	"4L melanoma cell, miR-30d treated"	"4L melanoma cell, scrambled miR treated"
p_27718_2	"5B1 melanoma cell, miR-30d treated"	"5B1 melanoma cell, scrambled miR treated"
p_27820_1	"HUMSC, active"	"HUMSC, inactive"
p_27820_2	"HUMSC, active, culture in hypoxia condition"	"HUMSC, inactive"
p_27854_1	"colorectal cancer, metastasis"	"colorectal cancer, non-metastasis"
p_27909_1	"Trophoblast, side population"	"Trophoblast, non-side population"
p_27914_1	"LNCaP cell, COP1 siRNA"	"LNCaP cell, control siRNA"
p_27914_2	"LNCaP cell, COP1, ETV1 siRNA"	"LNCaP cell, control siRNA"
p_27914_3	"LNCaP cell, COP1, c-JUN siRNA"	"LNCaP cell, control siRNA"
p_27914_4	"LNCaP cell, COP1, ETV1, c-JUN siRNA"	"LNCaP cell, control siRNA"
p_27928_1	"CD4 cell, Tonsil patient"	"CD4 cell, FL patient"
p_27928_2	"CD8 cell, Tonsil patient"	"CD8 cell, FL patient"
p_27931_1	"GBM cell, TRRAP knockdown"	"GBM cell, control"
p_28050_1	"HEK 293T cells, esiRNA targeting BACH1, 24h"	"HEK 293T cells, mock transfection, 24h"
p_28050_2	"HEK 293T cells, siRNA1 targeting BACH1, 24h"	"HEK 293T cells, mock transfection, 24h"
p_28050_3	"HEK 293T cells, siRNA2 targeting BACH1, 24h"	"HEK 293T cells, mock transfection, 24h"
p_28050_4	"HEK 293T cells, esiRNA targeting BACH1, 72h"	"HEK 293T cells, mock transfection, 72h"
p_28050_5	"HEK 293T cells, siRNA1 targeting BACH1, 72h"	"HEK 293T cells, mock transfection, 72h"
p_28050_6	"HEK 293T cells, siRNA2 targeting BACH1, 72h"	"HEK 293T cells, mock transfection, 72h"
p_28053_1	"HEK293T cell, BACH1 esiRNA treated, 24h"	"HEK293T cell, control"
p_28053_2	"HEK293T cell, BACH1 siRNA treated, 24h"	"HEK293T cell, control"
p_28053_3	"HEK293T cell, BACH1 esiRNA treated, 72h"	"HEK293T cell, control"
p_28053_4	"HEK293T cell, BACH1 siRNA treated, 72h"	"HEK293T cell, control"
p_28057_1	"Huh7 cell, CD24 knock down"	"Huh7 cell, control"
p_28059_1	"Huh7 cell, DEGS1 silenced"	"Huh7 cell, control silenced"
p_28059_2	"Huh7 cell, SPTLC123 silenced"	"Huh7 cell, control silenced"
p_28160_1	"Brain cell, Untreated HAND"	"Brain cell, control"
p_28160_2	"Brain cell, treated HAND"	"Brain cell, control"
p_2816_1	"primary human monocyte, cMyb virus-infected"	"primary human monocyte, control virus-infected"
p_2816_2	"primary human monocyte, vMyb virus-infected"	"primary human monocyte, control virus-infected"
p_28167_1	"Brain U251MG glioma cells, cultured on highly-aligned electrospun nanofibers of poly-caprolactone"	"Brain U251MG glioma cells, cultured on randomly-oriented electrospun nanofibers of poly-caprolactone"
p_2817_1	alive glioma; brain cancer	recurrent glioma
p_28177_1	"jejunum, HIV-infected"	"jejunum, uninfected control"
p_28274_1	"MCF7 cell, glycolysis induced"	"MCF7 cell, control"
p_28274_2	"MCF7 cell, beginning of death"	"MCF7 cell, control"
p_28304_1	Human dermal microvascular endothelial cell si-GATA2	Human dermal microvascular endothelial cell
p_28305_1	"MDA-MB-453 cell, DHT treated, 4h"	"MDA-MB-453 cell, vehicle"
p_28305_2	"MDA-MB-453 cell, DHT treated, 16h"	"MDA-MB-453 cell, vehicle"
p_28305_3	"MDA-MB-453 cell, DHT treated, 48h"	"MDA-MB-453 cell, vehicle"
p_28317_1	"CD34+ cell, MIGR1, AML1, ETO infected"	"CD34+ cell, MIGR1 infected"
p_28317_2	"CD34+ cell, MIGR1, AML1, ETOdNHR1 infected"	"CD34+ cell, MIGR1 infected"
p_28331_1	Myeloma tumor	"Endothelial progenitor cell, Advanced multiple myeloma"
p_28335_1	"Melanoma, invasive"	"Melanoma, proliferative"
p_28339_1	"HeLa cell, Cyclin T1 shRNA"	"HeLa cell, control"
p_28339_2	"HeLa cell, Cyclin T2 shRNA"	"HeLa cell, control"
p_28359_1	"Hematopoietic stem cell (HSC), SR1 treated, 30nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_2	"Hematopoietic stem cell (HSC), SR1 treated, 100nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_3	"Hematopoietic stem cell (HSC), SR1 treated, 300nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_4	"Hematopoietic stem cell (HSC), SR1 treated, 1000nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_5	"Hematopoietic stem cell (HSC), LGC006 treated, 30nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_6	"Hematopoietic stem cell (HSC), LGC006 treated, 300nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28359_7	"Hematopoietic stem cell (HSC), LGC006 treated, 1000nM, 24h"	"Hematopoietic stem cell (HSC), SR1 treated, 0nM, 24h"
p_28392_1	"vastus lateralis muscle, Young Female, trained"	"vastus lateralis muscle, Young Female, untrained"
p_28392_2	"vastus lateralis muscle, Old Female, trained"	"vastus lateralis muscle, Old Female, untrained"
p_28406_1	induced pluripotency cells from DPC	dermal papilla cells (DPC)
p_28406_2	induced pluripotency cells from granulosa cells	primary granulosa cells
p_28406_3	induced pluripotency cells from foreskin cells	primary foreskin cells
p_28413_1	"MCF7VP cells, etoposide-resistant"	"MCF-7 cells, control"
p_28414_1	"MCF7VP cell, RUNX2 knockdown"	"MCF7VP cell, control"
p_2842_1	acute lymphoblastic leukemia (ALL)-6h GC treated; time course	acute lymphoblastic leukemia (ALL)-0h
p_2842_2	acute lymphoblastic leukemia (ALL)-24h GC treated; time course	acute lymphoblastic leukemia (ALL)-0h
p_2842_3	S-Line-6h GC treated; time course	S-Line-6h EtOH
p_2842_4	S-Line-24h GC treated; time course	S-Line-6h EtOH
p_2842_5	C-Line-6h GC treated; time course	C-Line-6h EtOH
p_2842_6	C-Line-24h GC treated; time course	C-Line-24h EtOH
p_2842_7	R-Line-6h GC treated; time course	R-Line-6h EtOH
p_2842_8	R-Line-24h GC treated; time course	R-Line-6h EtOH
p_28442_1	"lymphnode, metastatic"	"lymphnode, negative"
p_28448_1	"HMEC-TR cell, scrambbled siRNA, TGF B+"	"HMEC-TR cell, scrambbled siRNA, TGF B-"
p_28448_2	"HMEC-TR cell, Smad4 silenced with siRNA, TGF B+"	"HMEC-TR cell, Smad4 silenced with siRNA, TGF B-"
p_28448_3	"HMEC-TR cell, T1F1y silenced with siRNA, TGF B+"	"HMEC-TR cell, T1F1y silenced with siRNA, TGF B-"
p_28460_1	"acute lymphoblastic leukemia (ALL), late relapse"	"acute lymphoblastic leukemia (ALL), early relapse"
p_28460_2	"Bone marrow cell, diagnosis, late"	"Bone marrow cell, relapse, late"
p_28476_1	"Adrenocortical adenoma, CTNNB1 mutation"	"Adrenocortical adenoma, wt"
p_28502_1	"HUVSMC cell line, Triptolide treated, 24h"	"HUVSMC cell line, control"
p_28503_1	"MCF7 cells, POLRMT knockdown"	"MCF7 cells, non-targeting siRNA, control"
p_28503_2	"MCF7 cells, PolII knockdown"	"MCF7 cells, non-targeting siRNA, control"
p_28548_1	"HEK293 cell, stimulated with TNF alpha"	"HEK293 cell, control"
p_28548_2	"HEK293 cell, sirtuin 6 transfected"	"HEK293 cell, control"
p_28548_3	"HEK293 cell, stimulated with TNF alpha + sirtuin 6 transfected"	"HEK293 cell, control"
p_28548_4	"HEK293 cell, mutant sirtuin 6 transfected"	"HEK293 cell, control"
p_28548_5	"HEK293 cell, stimulated with TNF alpha + mutant sirtuin 6 transfected"	"HEK293 cell, control"
p_28548_6	"HEK293 cell, pCDNA3 transfected"	"HEK293 cell, control"
p_28548_7	"HEK293 cell, stimulated with TNF alpha + pCDNA3 transfected"	"HEK293 cell, control"
p_28583_1	"breast tumor biopsy, Postchemotherapy"	"breast tumor biopsy, Prechemotherapy"
p_28590_1	"HepG2 cell, siHNF4a, 0h"	"HepG2 cell, siControl, 0h"
p_28590_2	"HepG2 cell, siHNF4a, TGF-beta treated, 1.5h"	"HepG2 cell, siControl, TGF-beta treated, 1.5h"
p_28590_3	"HepG2 cell, siHNF4a, TGF-beta treated, 24h"	"HepG2 cell, siControl, TGF-beta treated, 24h"
p_28603_1	"SGBS cell, hypoxia, 3h"	"SGBS cell, control"
p_28603_2	"SGBS cell, hypoxia, 6h"	"SGBS cell, control"
p_28603_3	"SGBS cell, hypoxia, 9h"	"SGBS cell, control"
p_28618_1	"U87 cells, HOXD9 siRNA"	"U87 cells, control siRNA"
p_28619_1	"Liver, Alcoholic hepatitis"	"Liver, control"
p_2864_1	"SH-SY5Y/TrkA cells, dnEgr (dominant negative Egr)/EGFP infected"	"SH-SY5Y/TrkA cells, EGFP infected"
p_28645_1	"LYC2 cell, SRC1 siRNA, control"	"LYC2 cell, control siRNA, control"
p_28645_2	"LYC2 cell, SRC1 siRNA, tamoxifen treated"	"LYC2 cell, control siRNA, tamoxifen treated"
p_28646_1	CP70 cells	A2780 cells
p_28646_2	"CP70 cells, Decitabine treated"	CP70 cells
p_28646_3	"CP70 cells, Decitabine+PXD101 treated"	CP70 cells
p_28646_4	"CP70 cells, PXD101 treated"	CP70 cells
p_28681_1	"HMLE cells, mesenchymal subpopulation"	"HMLE cells, epithelial subpopulation"
p_28694_1	"breast tumor biopsy, Postchemotherapy"	"breast tumor biopsy, Prechemotherapy"
p_28698_1	"CD34+ HSC, TEL-PDGFRb oncogene expression, Glivec treatead, 4h"	"CD34+ HSC, TEL-PDGFRb oncogene expression"
p_28715_1	"HEK293T cell, siRNA Med26"	"HEK293T cell, wt"
p_28726_1	"CD4 cell, stimulated, after 18d"	"CD4 cell, stimulated, after 3d"
p_28726_2	"NKT cell, stimulated, after 18d"	"NKT cell, stimulated, after 3d"
p_28726_3	"Va24 cell, stimulated, after 18d"	"Va24 cell, stimulated, after 3d"
p_28750_1	"whole blood cell, Sepsis patient"	"whole blood cell, healthy"
p_28750_2	"whole blood cell, post surgical , sepsis patient"	"whole blood cell, healthy"
p_28789_1	"MDA-MB-453 cells, 5a-dihydrotestosterone (DHT) treated, 10nM, 4h"	"MDA-MB-453 cells, vehicle treated"
p_28789_2	"MDA-MB-453 cells, 5a-dihydrotestosterone (DHT) treated, 10nM, 16h"	"MDA-MB-453 cells, vehicle treated"
p_28789_3	"MDA-MB-453 cells, 5a-dihydrotestosterone (DHT) treated, 10nM, 48h"	"MDA-MB-453 cells, vehicle treated"
p_28792_1	"Caco-2 cell, 100mM Nacl"	"Caco-2 cell, control"
p_28792_2	"Caco-2 cell, 5mM butyrate"	"Caco-2 cell, control"
p_28792_3	"Caco-2 cell, 0% polydextrose"	"Caco-2 cell, control"
p_28792_4	"Caco-2 cell, 1% polydextrose"	"Caco-2 cell, control"
p_28792_5	"Caco-2 cell, 2% polydextrose"	"Caco-2 cell, control"
p_28799_1	OVCAR-3 derived stem cell-like cells	parental OVCAR-3 cells
p_28807_1	"primary Wilms tumor cells (ws568li), ATRA treated"	"primary Wilms tumor cells (ws568li), untreated"
p_28810_1	"U251, miR-31 over-expression"	"U251, control"
p_28815_1	"hiPSC conventional, from IMR-90 cell"	IMR-90 cell
p_28815_2	"hiPSC SMC4, from IMR-90 cell"	IMR-90 cell
p_28815_3	"hiPSC conventional, from FTC1 Foreskin Fibroblast cell"	FTC1 Foreskin Fibroblast cell
p_28815_4	"hiPSC SMC4, from FTC1 Foreskin Fibroblast cell"	FTC1 Foreskin Fibroblast cell
p_28842_1	"PBMC, non inmunotolerant patients"	"PBMC, inmunetolerant patients"
p_28842_2	"PBMC, non inmunotolerant patients, a year after weaning"	"PBMC, inmunetolerant patients, a year after weaning"
p_28846_1	"231MFP cells, aggressive breast cancer cell type"	"MCF7 cells, non-agressive breast cancer cell type"
p_28846_2	"SKOV3 cells, agressive ovarian cancer cell type"	"OVCAR3 cells, non-agressive ovarian cancer cell type"
p_28846_3	"C8161 cells, agressive melanoma cancer cell type"	"MUM2C cells, non-agressive melanoma cancer cell type"
p_28846_4	"DU145 cells, agressive prostate cancer cell type"	"LNCaP, non-agressive prostate cancer cell type"
p_28846_5	PC3 cellsm agressive prostate cancer cell type	"LNCaP, non-agressive prostate cancer cell type"
p_28847_1	"PASMC, BMP4 treated, 2h"	"PASMC, control"
p_28847_2	"PASMC, BMP4 treated, 24h"	"PASMC, control"
p_28882_1	"HeLa, ip antibody: rabbit anti-DZIP1 polyclonal"	"HeLa, ip antibody: rabbit IgG, control"
p_28914_1	"Skin cell, acute wound"	"Skin cell, intact"
p_28914_2	"Skin cell, 3rd post-operative day"	"Skin cell, intact"
p_28914_3	"Skin cell, 7th post-operative day"	"Skin cell, intact"
p_28995_1	"Myeloid cell, RA treated"	"Myeloid cell, control"
p_28995_2	"Myeloid cell, TNF alpha treated"	"Myeloid cell, control"
p_28995_3	"Myeloid cell, RA, TNF alpha treated"	"Myeloid cell, control"
p_28995_4	"Myeloid cell, RA treated 2h"	"Myeloid cell, control"
p_28995_5	"Myeloid cell, RA treated 6h"	"Myeloid cell, control"
p_28995_6	"Myeloid cell, RA treated 16h"	"Myeloid cell, control"
p_28995_7	"Myeloid cell, RA treated 40h"	"Myeloid cell, control"
p_28998_1	"Biceps, trained"	"Biceps, untrained"
p_29008_1	"Hct8 cell, TcdA treated, 2h"	"Hct8 cell, control , 2h"
p_29008_2	"Hct8 cell, TcdB treated, 2h"	"Hct8 cell, control , 2h"
p_29008_3	"Hct8 cell, TcdA treated, 6h"	"Hct8 cell, control , 6h"
p_29008_4	"Hct8 cell, TcdB treated, 6h"	"Hct8 cell, control , 6h"
p_29008_5	"Hct8 cell, TcdA treated, 24h"	"Hct8 cell, control , 24h"
p_29008_6	"Hct8 cell, TcdB treated, 24h"	"Hct8 cell, control , 24h"
p_29060_1	"HT-29 cell, Aza treated"	"HT-29 cell, control"
p_29061_1	Huh7 cells transduced with Ad-HEV ORF2	"Huh7 cells, transduced with Ad-GFP"
p_29084_1	"HepG2 cells, HNF4a RNAi treated"	"HepG2 cells, control"
p_29115_1	"H9 cell, diff, KDR, CD31, sorted, 4d"	"H9 cell, undiff, unsorted, 0d"
p_29115_2	"H9 cell, diff, KDR, CD31, sorted, 6d"	"H9 cell, undiff, unsorted, 0d"
p_29115_3	"H9 cell, diff, KDR, CD31, sorted, 8d"	"H9 cell, undiff, unsorted, 0d"
p_29133_1	"human distal lung, Alveolar epithelial type II, COPD"	"human distal lung, Alveolar epithelial type II, non COPD"
p_29137_1	"MCF7 cells, GFP-Numb4 transfected"	"MCF7 cells, GFP vector control"
p_29137_2	"MCF7 cells, GFP-Numb5 transfected"	"MCF7 cells, GFP vector control"
p_29137_3	"MCF7 cells, GFP-Numb6 transfected"	"MCF7 cells, GFP vector control"
p_29137_4	"MDA-MB-231 cells, GFP-Numb4 transfected"	"MDA-MB-231 cells, GFP vector control"
p_29137_5	"MDA-MB-231 cells, GFP-Numb5 transfected"	"MDA-MB-231 cells, GFP vector control"
p_29137_6	"MDA-MB-231 cells, GFP-Numb6 transfected"	"MDA-MB-231 cells, GFP vector control"
p_29220_1	"Ovarian cancer, 3C stage"	"Healthy, control"
p_29220_2	"Ovarian cancer, 3B stage"	"Healthy, control"
p_29232_1	"RWPE-1 AR cell, R1881 treated, 3h"	"RWPE-1 AR cell, control, 3h"
p_29232_2	"RWPE-1 AR cell, R1881 treated, 24h"	"RWPE-1 AR cell, control, 24h"
p_29237_1	"retinal progenitor cells, derived from human embryonic stem cells"	"forebrain progenitor cells, derived from human embryonic stem cells"
p_29246_1	"macrophages, infected with Leishmania donovani, monastrol treated"	"macrophages, infected with Leishmania donovani"
p_29297_1	"HEK-293 cells with inducible LMP1 TES2+IkBa super-repressor, 0hours doxycycline/4HT"	"HEK-293 cells, inducible LMP1 TES2, 0hours doxycyline/4HT"
p_29297_2	"HEK-293 cells with inducible LMP1 TES2+IkBa super-repressor, 6hours doxycycline/4HT"	"HEK-293 cells, inducible LMP1 TES2, 6hours doxycyline/4HT"
p_29297_3	"HEK-293 cells with inducible LMP1 TES2+IkBa super-repressor, 9hours doxycycline/4HT"	"HEK-293 cells, inducible LMP1 TES2, 9hours doxycyline/4HT"
p_29297_4	"HEK-293 cells with inducible LMP1 TES2+IkBa super-repressor, 12hours doxycycline/4HT"	"HEK-293 cells, inducible LMP1 TES2, 12hours doxycyline/4HT"
p_29297_5	"HEK-293 cells with inducible LMP1 TES2+IkBa super-repressor, 24hours doxycycline/4HT"	"HEK-293 cells, inducible LMP1 TES2, 24hours doxycyline/4HT"
p_29301_1	"Lymphoblastoid Cell Line, EBV-infected, monoclonal"	"Purified B Cells, from negative selection of PBMCs"
p_29313_1	"HeLa cell, EWS inhibited"	"HeLa cell, control"
p_29313_2	"Whole cell, EWS inhibited"	"Whole cell, control"
p_29316_1	"CCD-18Co, SHH treated"	"CCD-18Co, untreated"
p_29327_1	"MCF10A cells, miR-221/222"	"MCF10A cells, miR-control"
p_29367_1	"HARA cell, highly bone metastatic subline"	"HARA cell, control"
p_29368_1	"GPC, CD140a positive"	"GPC, CD140a negative"
p_29375_1	"HepG2 cell, APRIL treated, 2h"	"HepG2 cell, APRIL treated, 0h"
p_29375_2	"HepG2 cell, APRIL treated, 6h"	"HepG2 cell, APRIL treated, 0h"
p_29375_3	"HepG2 cell, APRIL treated, 12h"	"HepG2 cell, APRIL treated, 0h"
p_29384_1	"LN229 cells, Cyr61 expression"	"LN229 cells, control"
p_29402_1	Cornea	Conjunctiva
p_29410_1	omental adipose tissue	subcutaneous adipose tissue
p_29431_1	"Breast tumor tissue, with HER2 IHC3+ score"	"Normal breast tissue, from breast cancer patients"
p_29431_2	"Breast tumor tissue, with HER2 IHC3+ score and proved amplification"	"Normal breast tissue, from breast cancer patients"
p_29431_3	"Breast tumor tissue, with HER2 IHC2+ score and proved amplification"	"Normal breast tissue, from breast cancer patients"
p_29431_4	"Breast tumor tissue, with HER2 IHC2+ score and proved no-amplification"	"Normal breast tissue, from breast cancer patients"
p_29431_5	"Breast tumor tissue, with HER2 IHC0/1 score and proved no-amplification"	"Normal breast tissue, from breast cancer patients"
p_29431_6	"Breast tumor tissue, with HER2 IHC0/1 score"	"Normal breast tissue, from breast cancer patients"
p_29431_7	"Breast tumor tissue, with HER2 IHC3+ score and proved amplification"	"Normal breast tissue, from breast cancer patients"
p_29435_1	"IKPRAB36 cell line, cultured in 1nm MPA, 48h"	"IKPRAB36 cell line, cultured in absence of 1nm MPA, 48h"
p_29436_1	"Endometrial Cancer Specimen, Progressive"	"Endometrial Cancer Specimen, Non-progressive"
p_29450_1	Primary tumors from clear cell ovarian cancer	Normal ovarian surface epithelium
p_29459_1	"CD34+ cells, GAR-treated, 7 days"	"CD34+ cells, DMSO-treated, 7 days"
p_29523_1	"CD34+CD45RA+Lin- HPCs, transduced with A2M"	"CD34+CD45RA+Lin- HPCs, empty vector"
p_29524_1	"CD34+CD45RA+Lin- HPCs, empty vector, Delta1ext-IgG cultured , 2g"	"CD34+CD45RA+Lin- HPCs, empty vector, BSA cultured"
p_29524_2	"CD34+CD45RA+Lin- HPCs, A2M transduced, Delta1ext-IgG cultured, 2g"	"CD34+CD45RA+Lin- HPCs, A2M transduced, BSA cultured"
p_29524_3	"CD34+CD45RA+Lin- HPCs, empty vector, Delta1ext-IgG cultured , 5g"	"CD34+CD45RA+Lin- HPCs, empty vector, Delta1ext-IgG cultured , 2g"
p_29524_4	"CD34+CD45RA+Lin- HPCs, A2M transduced, Delta1ext-IgG cultured, 5g"	"CD34+CD45RA+Lin- HPCs, A2M transduced, BSA cultured"
p_29539_1	"OECM1, transfected with pmCherry-let7i"	"OECM1, pmR-mCherry empty vector"
p_29544_1	"CUTLL1 cell, GSI treated"	"CUTLL1 cell, DMSO treated"
p_29544_2	"CUTLL1 cell, GSI treated, 3day"	"CUTLL1 cell, DMSO treated"
p_29544_3	"CUTLL1 cell, wash 2h, +CHX treated"	"CUTLL1 cell, wash 2h, -CHX treated"
p_29544_4	"CUTLL1 cell, wash 4h, +CHX treated"	"CUTLL1 cell, wash 4h, -CHX treated"
p_29544_5	"CUTLL1 cell, GSI-mockwah-CHX2h treated"	"CUTLL1 cell, DMSO treated"
p_29544_6	"CUTLL1 cell, GSI-mockwah-CHX4h treated"	"CUTLL1 cell, DMSO treated"
p_29544_7	"CUTLL1 cell, MigR1 GSI"	"CUTLL1 cell, DNMAML1, GSI"
p_29544_8	"CUTLL1 cell, MigR1 GSI , wash 2h"	"CUTLL1 cell, DNMAML1, GSI, wash 2h"
p_29544_9	"CUTLL1 cell, MigR1 GSI , wash 4h"	"CUTLL1 cell, DNMAML1, GSI, wash 4h"
p_29605_1	"CLL B cell, low miR-155, unmutated IgVH"	"CLL B cell, high miR-155, unmutated IgVH"
p_29605_2	"CLL B cell, low miR-155, mutated IgVH"	"CLL B cell, high miR-155, mutated IgVH"
p_29619_1	"Peripheral blood mononuclear cells, vaccinated with Influenza vaccine , day 3"	"Peripheral blood mononuclear cells, vaccinated with Influenza vaccine , day 0"
p_29619_2	"Peripheral blood mononuclear cells, vaccinated with Influenza vaccine , day 7"	"Peripheral blood mononuclear cells, vaccinated with Influenza vaccine , day 0"
p_29630_1	"gastric cancer cell line (AGS), galectin-3 silenced"	"gastric cancer cell line (AGS), control"
p_29639_1	"AT2 cell, shG1 treated"	"AT2 cell, control"
p_29639_2	"REH cell, shG1 treated"	"REH cell, control"
p_29652_1	"Astrocyte, Braak 1-2 stage, APOE e4-"	"Astrocyte, Braak 1-2 stage, APOE e4+"
p_29652_2	"Astrocyte, Braak 3-4 stage, APOE e4-"	"Astrocyte, Braak 3-4 stage, APOE e4+"
p_29652_3	"Astrocyte, Braak 5-6 stage, APOE e4-"	"Astrocyte, Braak 5-6 stage, APOE e4+"
p_29700_1	"BL-2 cell line, LPS treated, 6h"	"BL-2 cell line, control"
p_29721_1	Hepatocellular carcinoma (HCC)	normal liver
p_29807_1	"Umblical Cord Blood cell, LBW newborn"	"Umblical Cord Blood cell, NBW newborn"
p_29850_1	"HUVEC, transduced with N1IC"	"HUVEC, control vector"
p_29868_1	"Primary human hepatocytes, atorvastatin treated, 6h"	"Primary human hepatocytes, DMSO, 6h"
p_29868_2	"Primary human hepatocytes, atorvastatin treated, 12h"	"Primary human hepatocytes, DMSO, 12h"
p_29868_3	"Primary human hepatocytes, atorvastatin treated, 24h"	"Primary human hepatocytes, DMSO, 24h"
p_29868_4	"Primary human hepatocytes, atorvastatin treated, 48h"	"Primary human hepatocytes, DMSO, 48h"
p_29868_5	"Primary human hepatocytes, atorvastatin treated, 72h"	"Primary human hepatocytes, DMSO, 72h"
p_29881_1	"HUAEC cell, Estradiol treated"	"HUAEC cell, control"
p_29881_2	"HUAEC cell, oxLDL treated"	"HUAEC cell, control"
p_29881_3	"HUAEC cell, Estradiol + oxLDL treated"	"HUAEC cell, control"
p_29883_1	"mononuclear cells from bone marrow, inv(16)/t(16;16)"	"mononuclear cells from bone marrow, t(8;21)"
p_29908_1	"peripheral blood mononuclear cell, after AHST treatment, 6 month"	"peripheral blood mononuclear cell, before AHST treatment"
p_29981_1	"Human endometrium, days from lh peak: -14"	"Human endometrium, days from lh peak: -1"
p_29986_1	"Bone marrow cell, ALL patient"	"Bone marrow cell, common"
p_29986_2	"Biopsy, lymphoblastic tumor"	"Bone marrow cell, common"
p_30010_1	"human breast biopsy, parous"	"human breast biopsy, nulliparous"
p_30063_1	"small airway epithelium, smokers with Chronic Obstructive Lung Disease"	"small airway epithelium, healthy non-smokers"
p_30063_2	"small airway epithelium, healthy smokers"	"small airway epithelium, healthy non-smokers"
p_30161_1	"ovarian cancer cells, formalin-fixed paraffin embedded (FFPE) tissue, complete response to Carboplatin/Taxol"	"ovarian cancer cells, formalin-fixed paraffin embedded (FFPE) tissue, partial response to Carboplatin/Taxol"
p_30174_1	"white blood cells, non-metastatic prostate cancer, baseline"	"white blood cells, healthy matched control"
p_30174_2	"white blood cells, non-metastatic prostate cancer, external beam radiation therapy (EBRT) treated, time of wbc and fatigue score collection: D1"	"white blood cells, healthy matched control"
p_30174_3	"white blood cells, non-metastatic prostate cancer, external beam radiation therapy (EBRT) treated, time of wbc and fatigue score collection: D7"	"white blood cells, healthy matched control"
p_30174_4	"white blood cells, non-metastatic prostate cancer, external beam radiation therapy (EBRT) treated, time of wbc and fatigue score collection: D14"	"white blood cells, healthy matched control"
p_30174_5	"white blood cells, non-metastatic prostate cancer,external beam radiation therapy (EBRT) treated,  time of wbc and fatigue score collection: D21"	"white blood cells, healthy matched control"
p_30174_6	"white blood cells, non-metastatic prostate cancer, external beam radiation therapy (EBRT) treated, time of wbc and fatigue score collection: D42"	"white blood cells, healthy matched control"
p_30174_7	"white blood cells, non-metastatic prostate cancer, external beam radiation therapy (EBRT) treated, time of wbc and fatigue score collection: D72 (30days post-EBRT)"	"white blood cells, healthy matched control"
p_30201_1	"Hematopoietic stem cells, low risk myelodysplastic syndrome"	"Hematopoietic stem cells, healthy control"
p_30296_1	"SKOV3 cell , BRCA1 stable expression"	"SKOV3 cell, neo clone"
p_30304_1	"RWPE-1 cell, 3D cultured"	"RWPE-1 cell, 2D cultured"
p_30304_2	"LNCaP cell, 3D cultured"	"LNCaP cell, 2D cultured"
p_30355_1	Normal keratinocyte	Normal skin epidermal cell
p_30355_2	Sorted keratinocyte	Normal skin epidermal cell
p_30391_1	"Umbilical cord Wharton's jelly stem cells , passage 2"	"Umbilical cord Wharton's jelly stem cells , passage 1"
p_30391_9	"Umbilical cord Wharton's jelly stem cells , passage 10"	"Umbilical cord Wharton's jelly stem cells , passage 1"
p_30423_1	"hypopharyngeal cancer cell line (FADU), rCTFG treated"	"hypopharyngeal cancer cell line (FADU), citric buffer treated"
p_30439_1	CFBE41o-  F508-CFTR	CFBE41o- wt-CFTR
p_30439_2	"CFBE41o-  F508-CFTR, exposed to PA01"	"CFBE41o- wt-CFTR, exposed to PA01"
p_30442_1	"mononuclear cells, AML, BCOR mutation"	"mononuclear cells, AML, BCOR wild type"
p_30478_1	"HCT116 cell, UHRF-1 shRNA treated"	"HCT116 cell, control"
p_30494_1	"A549 cell, siFFluc"	"A549 cell, siEGFP"
p_30494_2	"A549 cell, siKDM3A"	"A549 cell, siEGFP"
p_30494_3	"SW780 cell, siFFluc"	"SW780 cell, siEGFP"
p_30494_4	"SW780 cell, siKDM3A"	"SW780 cell, siEGFP"
p_30499_13	"U2OScells, hypoxia, 4.5 h"	"U2OS cells, control, 4.5 h"
p_30499_14	"U2OScells, tunicamycin treated, 4.5 h"	"U2OS cells, control, 4.5 h"
p_30499_15	"U2OScells, emetine treated, 4.5 h"	"U2OS cells, control, 4.5 h"
p_30499_16	"U2OScells, shRent1 treated, 4.5 h"	"U2OS cells, control, 4.5 h"
p_30501_1	"TOV21G cell, PLKO-1 shRNA treated"	"TOV21G cell, non-target shRNA treated"
p_30501_2	"TOV21G cell, PAX shRNA treated"	"TOV21G cell, non-target shRNA treated"
p_30516_1	"BT20 cells, erlotinib treated, 10uM, 0.5h"	"BT20 cells, erlotinib treated, 10uM, 0h"
p_30516_2	"BT20 cells, erlotinib treated, 10uM, 6h"	"BT20 cells, erlotinib treated, 10uM, 0h"
p_30516_3	"BT20 cells, erlotinib treated, 10uM, 24h"	"BT20 cells, erlotinib treated, 10uM, 0h"
p_30516_4	"MDA-MB-453 cells, erlotinib treated, 10uM, 24h"	"MDA-MB-453 cells, erlotinib treated, 10uM, 0h"
p_30516_5	"MCF cells, erlotinib treated, 10uM, 24h"	"MCF cells, erlotinib treated, 10uM, 0h"
p_30522_1	"Prostate tissue, cancer"	"Prostate tissue, normal"
p_30522_2	Bladder cancer-associated stromal cells	Normal bladder stromal cells
p_30522_3	Embryonal carcinoma cell line NCCIT	Normal bladder basal cells
p_30524_1	"RPMI 8266 cell, PPP 6h treated"	"RPMI 8266 cell, untreated"
p_30524_2	"RPMI 8266 cell, PPP 24h treated"	"RPMI 8266 cell, untreated"
p_30524_3	"RPMI 8266 cell, LBH 6h treated"	"RPMI 8266 cell, untreated"
p_30524_4	"RPMI 8266 cell, LBH 24h treated"	"RPMI 8266 cell, untreated"
p_30524_5	"RPMI 8266 cell, PPP+LBH 6h treated"	"RPMI 8266 cell, untreated"
p_30524_6	"RPMI 8266 cell, PPP+LBH 24h treated"	"RPMI 8266 cell, untreated"
p_30531_1	"A375 cells, MLN4924 treated, 650nM, 1h"	"A375 cells, DMSO treated,1h"
p_30531_2	"A375 cells, MLN4924 treated, 650nM, 2h"	"A375 cells, DMSO treated,2h"
p_30531_3	"A375 cells, MLN4924 treated, 650nM, 4h"	"A375 cells, DMSO treated,4h"
p_30531_4	"A375 cells, MLN4924 treated, 650nM, 8h"	"A375 cells, DMSO treated,8h"
p_30531_5	"A375 cells, MLN4924 treated, 650nM, 24h"	"A375 cells, DMSO treated,24h"
p_30563_1	"Human brain tumor, glioblastoma"	Human normal brain
p_30563_2	"Human brain tumor, ganglioglioma"	Human normal brain
p_30563_3	"Human brain tumor, schwannoma"	Human normal brain
p_30585_1	"CD34+ cord blood cell, CID -"	"CD34+ cord blood cell, CID +"
p_30585_2	"CD34+ cord blood cell, Tpo +"	"CD34+ cord blood cell, CID +"
p_30585_3	"CD34+ cord blood cell, Epo +"	"CD34+ cord blood cell, CID +"
p_30589_1	"Vero E6 cells, infected with SARS-CoV (WT), 7hpi"	"Vero E6 cells, mock-infected, 7hpi"
p_30589_2	"Vero E6 cells, infected with SARS-CoV-DeltaE, 7hpi"	"Vero E6 cells, mock-infected, 7hpi"
p_30589_7	"MA-104 cells, infected with SARS-CoV (WT), 65hpi"	"MA-104 cells, mock-infected, 0hpi"
p_30589_8	"MA-104 cells, infected with SARS-CoV-DeltaE, 65hpi"	"MA-104 cells, mock-infected, 0hpi"
p_30599_1	"mononuclear cells, T-cell ALL, PICALM-MLLT10 fusion"	"mononuclear cells, T-cell ALL, No PICALM-MLLT10 fusion"
p_30644_1	"MM1S cell, Salmeterol treated"	"MM1S cell, untreated"
p_30644_2	"MM1S cell, Low dose Dexomethasone treated"	"MM1S cell, untreated"
p_30644_3	"MM1S cell, High dose Dexomethasone treated"	"MM1S cell, untreated"
p_30644_4	"MM1S cell, Low dose Dexomethasone + Salmeterol treated"	"MM1S cell, untreated"
p_30644_5	"MM1S cell, CGS-21680 treated"	"MM1S cell, untreated"
p_30644_6	"MM1S cell, Low dose Dexomethasone + CGS-21680 treated"	"MM1S cell, untreated"
p_30660_1	"LEC, smoker"	"LEC, control"
p_30775_1	"MDA-MB-231 cells, siRNA targeting LSD1"	"MDA-MB-231 cells, control siRNA"
p_30781_1	"HCEC, Cyclin treated"	"HCEC, control"
p_30781_2	"HCEC, Cyclin E6/E7 treated"	"HCEC, control"
p_30784_1	oral squamous cell carcinoma	normal oral tissue
p_30784_2	dysplasia	normal oral tissue
p_30792_1	Wild-type iPSCs	SNCA triplication iPSCs
p_30806_1	"muscle Vastus lateralis, IBMPFD affected"	"muscle Vastus lateralis, normal"
p_30807_1	osteosarcoma U2OS derived cell line UT2	bone marrow mesenchymal stem cells
p_30807_2	osteosarcoma U2OS cells	bone marrow mesenchymal stem cells
p_30903_1	"AML blast cell, ATP treated"	"AML blast cell, untreated"
p_30950_1	"Natural killer cell, IL-2 + BCG treated"	"Natural killer cell, IL-2 treated"
p_30950_2	"Natural killer cell, IL-2 + H37Rv treated"	"Natural killer cell, IL-2 treated"
p_30950_3	"Natural killer cell, IL-12 + BCG treated"	"Natural killer cell, IL-12 treated"
p_30950_4	"Natural killer cell, IL-12 + H37Rv treated"	"Natural killer cell, IL-12 treated"
p_30985_1	"HCT116 cell, DAC 5um treated"	"HCT116 cell, DMSO treated"
p_30985_10	"HCT116 cell, Aza_G669043 1500nm treated"	"HCT116 cell, DMSO treated"
p_30985_2	"HCT116 cell, DAC 120nm treated"	"HCT116 cell, DMSO treated"
p_30985_3	"HCT116 cell, Aza 1500nm treated"	"HCT116 cell, DMSO treated"
p_30985_4	"HCT116 cell, Aza 150nm treated"	"HCT116 cell, DMSO treated"
p_30985_5	"HCT116 cell, Ester_G668684 7um treated"	"HCT116 cell, DMSO treated"
p_30985_6	"HCT116 cell, Ester_G668684 150nm treated"	"HCT116 cell, DMSO treated"
p_30985_7	"HCT116 cell, phos_G669071 6um treated"	"HCT116 cell, DMSO treated"
p_30985_8	"HCT116 cell, phos_G669071 63um treated"	"HCT116 cell, DMSO treated"
p_30985_9	"HCT116 cell, Aza_G669043 150nm treated"	"HCT116 cell, DMSO treated"
p_30988_1	"Hela cell, Doxorubicin treated, 24h"	"Hela cell, control, 24h"
p_30988_2	"Hela cell, Doxorubicin treated, 48h"	"Hela cell, control, 48h"
p_30999_1	"Skin biopsy, moderate-to-severe psoriasis, psoriasis lesion"	"Skin biopsy, moderate-to-severe psoriasis, non-lesion"
p_31040_1	"cultured lymphoblastoid cells, young, starvation"	"cultured lymphoblastoid cells, young, basal"
p_31040_2	"cultured lymphoblastoid cells, centenarian, starvation"	"cultured lymphoblastoid cells, centenarian, basal"
p_31084_1	"HCT116 cell, wt, high glucose"	"HCT116 cell, wt, low glucose"
p_31084_2	"HCT116 G13D cell, wt, high glucose"	"HCT116 G13D cell, wt, low glucose"
p_31122_1	"BT12 cells, treated with IC25 of SNDX275"	"BT12 cells, not treated"
p_31122_2	"BT16 cells, treated with IC25 of SNDX275"	"BT16 cells, not treated"
p_31138_1	"blood vessels, invasiave ductal carcinoma breast tissue"	"blood vessels, Normal breast tissue"
p_31172_1	"HeLa cell, S34F mutant"	"HeLa cell, mock"
p_31172_2	"TF1 cell, S34F mutant"	"TF1 cell, mock"
p_31180_1	"MCF7 cell line, transfected with SNCA"	"MCF-7 cells,transfected with GFP"
p_31189_1	cancer urothelia	non-cancer urothelia
p_31193_1	"liver, IFN, 6hr"	"liver, control"
p_31193_2	"liver, IFN, 24hr"	"liver, control"
p_31193_3	"liver, IL28B, 6hr"	"liver, control"
p_31193_4	"liver, IL28B, 24hr"	"liver, control"
p_31210_1	"primary lung tumor, gene alteration status: EGFR/KRAS/ALK -"	"normal lung tissue, control"
p_31210_2	"primary lung tumor, gene alteration status: EGFR mutation"	"normal lung tissue, control"
p_31210_3	"primary lung tumor, gene alteration status KRAS mutation"	"normal lung tissue, control"
p_31210_4	"primary lung tumor, gene alteration status: EML4-ALK fusion"	"normal lung tissue, control"
p_31215_1	"hpMSCs, EWS-FLI-1 overexpression"	"hpMSCs, empty vector"
p_31229_1	"CLB-GA cell, DAC treated"	"CLB-GA cell, untreated"
p_31229_2	"IMR-32 cell, DAC treated"	"IMR-32 cell, untreated"
p_31229_3	"SH-SY5Y cell, DAC treated"	"SH-SY5Y cell, untreated"
p_31229_4	"N206 cell, DAC treated"	"N206 cell, untreated"
p_31229_5	"CHP-902R cell, DAC treated"	"CHP-902R cell, untreated"
p_31229_6	"LAN-2 cell, DAC treated"	"LAN-2 cell, untreated"
p_31229_7	"SK-N-AS cell, DAC treated"	"SK-N-AS cell, untreated"
p_31229_8	"SJNB-1 cell, DAC treated"	"SJNB-1 cell, untreated"
p_31255_1	"Normal human mucosa, EPHB2-low"	"Normal human mucosa, EPHB2 neg"
p_31255_2	"Normal human mucosa, EPHB2-medium"	"Normal human mucosa, EPHB2 neg"
p_31255_3	"Normal human mucosa, EPHB2-high"	"Normal human mucosa, EPHB2 neg"
p_31264_1	"Primary hepatocyte, IFNalpha treated, 6h"	"Primary hepatocyte, control"
p_31264_2	"Primary hepatocyte, IFNalpha treated, 24h"	"Primary hepatocyte, control"
p_31264_3	"Primary hepatocyte, IL28B treated, 6h"	"Primary hepatocyte, control"
p_31264_4	"Primary hepatocyte, IL28B treated, 24h"	"Primary hepatocyte, control"
p_31264_5	"Primary hepatocyte, T Poly IC treated, 24h"	"Primary hepatocyte, control"
p_31264_6	"primary hepatocyte, JFH1 recombinant, MOI of 5 treated, 36h"	"Primary hepatocyte, control"
p_31264_7	"primary hepatocyte, IL28B recombinant, 24h"	"primary hepatocyte, untreated"
p_31287_1	"SCCHN cell, after figitumumab"	"SCCHN cell, before figitumumab"
p_31315_1	"A549 cells, non-side population, anti-EpCAM treated"	"A549 cells, non-side population, control"
p_31315_2	"A549 cells, side population, anti-EpCAM treated"	"A549 cells, side population, control"
p_31323_1	"Epithelium cell , Benign Prostatic Hyperplasia"	"Stromal cell , Benign Prostatic Hyperplasia"
p_31348_1	"Blood, Tuberculosis, conventional combination therapy (2HRZE/4HR), week 1"	"Blood, Tuberculosis, at the day of diagnosis (week 0)"
p_31348_2	"Blood, Tuberculosis, conventional combination therapy (2HRZE/4HR), week 2"	"Blood, Tuberculosis, at the day of diagnosis (week 0)"
p_31348_3	"Blood, Tuberculosis, conventional combination therapy (2HRZE/4HR), week 4"	"Blood, Tuberculosis, at the day of diagnosis (week 0)"
p_31348_4	"Blood, Tuberculosis, conventional combination therapy (2HRZE/4HR), week 26"	"Blood, Tuberculosis, at the day of diagnosis (week 0)"
p_31355_1	"CLB-GA neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"CLB-GA neuroblastoma cell line, control"
p_31355_2	"IMR-32 neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"IMR-32 neuroblastoma cell line, control"
p_31355_3	"SH-SY5Y neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"SH-SY5Y neuroblastoma cell line, control"
p_31355_4	"N206 neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"N206 neuroblastoma cell line, control"
p_31355_5	"CHP-902R neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"CHP-902R neuroblastoma cell line, control"
p_31355_6	"LAN-2 neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"LAN-2 neuroblastoma cell line, control"
p_31355_7	"SK-N-AS neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"SK-N-AS neuroblastoma cell line, control"
p_31355_8	"SJNB-1 neuroblastoma cell line, DAC (2'-deoxy-5'-cytydine) treated"	"SJNB-1 neuroblastoma cell line, control"
p_31397_1	"MCF-7 cell, miR-101 transfected"	"MCF-7 cell, scramble control"
p_31412_1	"HeLa cells, siRNA against HCFC1, control"	"HeLa cells, siRNA against Luciferase, control"
p_31434_1	"Hela cell, SLC44A5 transfected"	"Hela cell, Negative control"
p_31434_2	"Hela cell, siSLC44A5 transfected"	"Hela cell, Negative control"
p_31440_1	"Colon cancer cell, SPARCL1 transfected , on Plastic"	"Colon cancer cell, control on Plastic"
p_31440_2	"Colon cancer cell, SPARCL1 transfected , on Matrigel"	"Colon cancer cell, control on Matrigel"
p_31447_1	"LCL cells, Thapsigargin treated, 24h"	"LCL cells, DMSO treated, 24h, control"
p_31447_2	"LCL cells, Salubrinal treated, 24h"	"LCL cells, DMSO treated, 24h, control"
p_31447_3	"LCL cells, Thapsigargin+Salubrinal treated, 24h"	"LCL cells, DMSO treated, 24h, control"
p_31469_1	"A549 cell, H1N1 infected, 2h"	"A549 cell, control"
p_31469_2	"A549 cell, H1N1 infected, 4h"	"A549 cell, control"
p_31469_3	"A549 cell, H1N1 infected, 6h"	"A549 cell, control"
p_31470_1	"A549 cells,H1N1 infected, 10hpi"	"A549 cells, mock infected"
p_31471_1	"A549, H9N2 infected, 2H"	"A549, H9N2 infected, 0H"
p_31471_2	"A549, H9N2 infected, 4H"	"A549, H9N2 infected, 0H"
p_31471_3	"A549, H9N2 infected, 6H"	"A549, H9N2 infected, 0H"
p_31471_4	"A549, H9N2 infected, 8H"	"A549, H9N2 infected, 0H"
p_31471_5	"A549, H9N2 infected, 10H"	"A549, H9N2 infected, 0H"
p_31472_1	"A549, H5N2 infected, 2H"	"A549, H5N2 infected, 0H"
p_31472_2	"A549, H5N2 infected, 4H"	"A549, H5N2 infected, 0H"
p_31472_3	"A549, H5N2 infected, 6H"	"A549, H5N2 infected, 0H"
p_31472_4	"A549, H5N2 infected, 8H"	"A549, H5N2 infected, 0H"
p_31472_5	"A549, H5N2 infected, 10H"	"A549, H5N2 infected, 0H"
p_31518_1	"A549, pH1N1 infected, 2H"	"A549, pH1N1 infected, 0H"
p_31518_2	"A549, pH1N1 infected, 4H"	"A549, pH1N1 infected, 0H"
p_31518_3	"A549, pH1N1 infected, 6H"	"A549, pH1N1 infected, 0H"
p_31518_4	"A549, pH1N1 infected, 8H"	"A549, pH1N1 infected, 0H"
p_31518_5	"A549, pH1N1 infected, 10H"	"A549, pH1N1 infected, 0H"
p_31641_1	"human melanocytes, 4TBP treated, 3h"	"human melanocytes, untreated"
p_31641_2	"human melanocytes, 4TBP treated, 6h"	"human melanocytes, untreated"
p_31641_3	"human melanocytes, 4TBP treated, 24h"	"human melanocytes, untreated"
p_31641_4	"human melanocytes, MBEH treated, 3h"	"human melanocytes, untreated"
p_31641_5	"human melanocytes, MBEH treated, 6h"	"human melanocytes, untreated"
p_31641_6	"human melanocytes, MBEH treated, 24h"	"human melanocytes, untreated"
p_31681_1	"Cumulus cell, stage metaphase I"	"Cumulus cell, Germinal vesicle"
p_31681_2	"Cumulus cell, stage metaphase II"	"Cumulus cell, Germinal vesicle"
p_31683_1	"Human endometrial stromal cell, nontarget silenced"	"Human endometrial stromal cell, empty vector"
p_31683_2	"Human endometrial stromal cell, KLF9 , silenced"	"Human endometrial stromal cell, empty vector"
p_31683_3	"Human endometrial stromal cell, PGR, silenced"	"Human endometrial stromal cell, empty vector"
p_31683_4	"Human endometrial stromal cell, KLF9 + PGR, silenced"	"Human endometrial stromal cell, empty vector"
p_31735_1	"Lung cancer cell, Nugen FF method"	"Lung cancer cell, AFFY method"
p_31735_2	"Lung cancer cell, Nugen Pico method"	"Lung cancer cell, AFFY method"
p_31735_3	"Lung cancer cell, Nugen V2 method"	"Lung cancer cell, AFFY method"
p_31782_1	"MDA-MB231, JMJD6 Knock-down"	"MDA-MB231, JMJD6 control (scrambled siRNA)"
p_31782_2	"MCF-7, JMJD6 Knock-down"	"MCF-7, JMJD6 control (scrambled siRNA)"
p_31782_3	"MCF-7, JMJD6 over-expressed"	"MCF-7, JMJD6 control (scrambled siRNA)"
p_31787_1	"Gastric cancer, Epstein-Barr virus treated"	"Gastric cancer, Epstein-Barr virus minus"
p_31831_1	"MCF7, tamoxifen-resistant, tamoxifen treated"	"MCF7 cells, tamoxifen-sensitive, tamoxifen treated"
p_31831_2	"MCF7 cells, tamoxifen-resistant, AMD3100 + tamoxifen treated"	"MCF7 cells, tamoxifen-sensitive, AMD3100 + tamoxifen treated"
p_31831_3	"MCF7, tamoxifen-resistant, estrogen treated"	"MCF7 cells, tamoxifen-sensitive, estrogen treated"
p_31831_4	"MCF7 cells, tamoxifen-resistant, AMD3100 + estrogen treated"	"MCF7 cells, tamoxifen-sensitive, AMD3100 + estrogen treated"
p_31864_1	"Human bladder carcinoma, relatively fast grow"	"Urothelial cell, normal"
p_31864_2	"Human bladder carcinoma, fast grow"	"Urothelial cell, normal"
p_31879_1	melanoma tumor	"melanocyte, normal"
p_31908_1	"lung adenocarcinoma, EGFR mutation"	"lung adenocarcinoma, EGFR wild type"
p_31912_1	"MCF-7 cells, siRNA targeting ABL1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_10	"MCF-7 cells, siRNA targeting CCNA2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_11	"MCF-7 cells, siRNA targeting CCNB1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_12	"MCF-7 cells, siRNA targeting CCND3, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_13	"MCF-7 cells, siRNA targeting CCNG2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_14	"MCF-7 cells, siRNA targeting CDC16, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_15	"MCF-7 cells, siRNA targeting CDC2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_16	"MCF-7 cells, siRNA targeting CDC20, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_17	"MCF-7 cells, siRNA targeting CDC25A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_18	"MCF-7 cells, siRNA targeting CDC25B, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_19	"MCF-7 cells, siRNA targeting CDC34, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_2	"MCF-7 cells, siRNA targeting AKT1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_20	"MCF-7 cells, siRNA targeting CDK2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_21	"MCF-7 cells, siRNA targeting CDK4, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_22	"MCF-7 cells, siRNA targeting CDKN2A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_23	"MCF-7 cells, siRNA targeting CEBPA, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_24	"MCF-7 cells, siRNA targeting CEBPB, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_25	"MCF-7 cells, siRNA targeting CEBPD, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_26	"MCF-7 cells, siRNA targeting CENPE, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_27	"MCF-7 cells, siRNA targeting CENPF, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_28	"MCF-7 cells, siRNA targeting CHEK1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_29	"MCF-7 cells, siRNA targeting CREBBP, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_3	"MCF-7 cells, siRNA targeting ARHGEF1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_30	"MCF-7 cells, siRNA targeting CTNNB1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_31	"MCF-7 cells, siRNA targeting E2F1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_32	"MCF-7 cells, siRNA targeting E2F5, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_33	"MCF-7 cells, siRNA targeting ERBB2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_34	"MCF-7 cells, siRNA targeting ERF, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_35	"MCF-7 cells, siRNA targeting ESR1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_36	"MCF-7 cells, siRNA targeting ESRRA, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_37	"MCF-7 cells, siRNA targeting FOS, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_38	"MCF-7 cells, siRNA targeting FOXC1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_39	"MCF-7 cells, siRNA targeting FOXJ2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_4	"MCF-7 cells, siRNA targeting ATR, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_40	"MCF-7 cells, siRNA targeting FOXO1A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_41	"MCF-7 cells, siRNA targeting FOXO3A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_42	"MCF-7 cells, siRNA targeting FOXP1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_43	"MCF-7 cells, siRNA targeting GATA3, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_44	"MCF-7 cells, siRNA targeting HDAC3, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_45	"MCF-7 cells, siRNA targeting HDAC5, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_46	"MCF-7 cells, siRNA targeting HIF1A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_47	"MCF-7 cells, siRNA targeting HOXB7, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_48	"MCF-7 cells, siRNA targeting HSF2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_49	"MCF-7 cells, siRNA targeting ID1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_5	"MCF-7 cells, siRNA targeting BCL2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_50	"MCF-7 cells, siRNA targeting JUN, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_51	"MCF-7 cells, siRNA targeting JUND, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_52	"MCF-7 cells, siRNA targeting MAPK1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_53	"MCF-7 cells, siRNA targeting MAPK14, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_54	"MCF-7 cells, siRNA targeting MAX, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_55	"MCF-7 cells, siRNA targeting MCM2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_56	"MCF-7 cells, siRNA targeting MYBL2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_57	"MCF-7 cells, siRNA targeting MYC, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_58	"MCF-7 cells, siRNA targeting NCOR2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_59	"MCF-7 cells, siRNA targeting NFKB1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_6	"MCF-7 cells, siRNA targeting BCL6, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_60	"MCF-7 cells, siRNA targeting NMI, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_61	"MCF-7 cells, siRNA targeting PAX3, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_62	"MCF-7 cells, siRNA targeting PCNA, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_63	"MCF-7 cells, siRNA targeting PIAS, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_64	"MCF-7 cells, siRNA targeting POLR2A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_65	"MCF-7 cells, siRNA targeting RB1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_66	"MCF-7 cells, siRNA targeting RBL2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_67	"MCF-7 cells, siRNA targeting RELA, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_68	"MCF-7 cells, siRNA targeting SKP2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_69	"MCF-7 cells, siRNA targeting SLC2A3, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_7	"MCF-7 cells, siRNA targeting BRCA1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_70	"MCF-7 cells, siRNA targeting SMAD7, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_71	"MCF-7 cells, siRNA targeting SP100, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_72	"MCF-7 cells, siRNA targeting STAT1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_73	"MCF-7 cells, siRNA targeting STAT5B, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_74	"MCF-7 cells, siRNA targeting TCEA1, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_75	"MCF-7 cells, siRNA targeting TEL2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_76	"MCF-7 cells, siRNA targeting TOP2A, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_77	"MCF-7 cells, siRNA targeting TP53, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_8	"MCF-7 cells, siRNA targeting BRCA2, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31912_9	"MCF-7 cells, siRNA targeting CCL5, 48h"	"MCF-7 cells, control siRNA, 48h"
p_31980_1	"synovial MSC-aggregates, MSC-aggregates"	"synovial MSCs, MSCs in a monolayer"
p_3202_1	"H720 cell line, MK886 1 uM, 24h, serum free"	"H720 cell line, control"
p_3202_2	"A549 cell line, MK886 1 uM, 24h, serum free"	"A549 cell line, control"
p_3202_3	"A549 cell line, treated by HNRPA2B1, silenced"	"A549 cell line,  treated by HNRPA2B1 construct, control"
p_3202_4	"H720 treated by HNRPA2B1 construct, silenced"	"H720 cell line, treated by HNRPA2B1, control"
p_3202_5	"H209 treated by HNRPA2B1 construct, silenced"	"H209 cell line, treated by HNRPA2B1, control"
p_3202_6	"A549 cell line,treated by FLAP (ALOX5AP) siRNA, sielnced"	"A549 cell line, treated by FLAP (ALOX5AP) siRNA, control"
p_32052_1	"MDA-MB 231 cells, S100A7 overexpression"	"MDA-MB 231 cells, control vector"
p_32056_1	"HSC-3 cell, trypsin-2 over-expressed, 48h"	"HSC-3 cell, control vector, 48h"
p_32108_1	"HeLa cell, siRNA CDK8-1"	"HeLa cell, control"
p_32108_2	"HeLa cell, siRNA CDK8-2"	"HeLa cell, control"
p_32108_3	"HeLa cell, siRNA CDK19-1"	"HeLa cell, control"
p_32108_4	"HeLa cell, siRNA CDK19-2"	"HeLa cell, control"
p_32142_1	"Human oral squamous cell carcinoma cell, HAI-1 knock down"	"Human oral squamous cell carcinoma cell, control"
p_32158_1	"HuBEC,1uM BPA treated"	"HuBEC, control"
p_32158_2	"HuBEC,10uM BPA treated"	"HuBEC, control"
p_32161_1	"MCF-7 cell, tRA treated , 12h"	"MCF-7 cell, DMSO treated , 12h"
p_32161_2	"MCF-7 cell, tRA + H treated , 12h"	"MCF-7 cell, DMSO treated , 12h"
p_32169_1	"trabecular meshwork cells, E. coli, 5% oxygen"	"trabecular meshwork cells, 5% oxygen"
p_32169_2	"trabecular meshwork cells, Pigment, 5% oxygen"	"trabecular meshwork cells, 5% oxygen"
p_32169_3	"trabecular meshwork cells, E. coli, 40% oxygen"	"trabecular meshwork cells, 40% oxygen"
p_32169_4	"trabecular meshwork cells, Pigment, 40% oxygen"	"trabecular meshwork cells, 40% oxygen"
p_32171_1	"hMSC, co-culture with rat neonatal cardiomyocyte, 4 days"	"hMSC, control"
p_32175_1	"saliva, lung cancer"	"saliva, healthy control"
p_32178_1	"Myometrium cell, Dystocia"	"Myometrium cell, control"
p_32374_1	congenital GBM tumor	pediatric GBM tumor
p_32374_2	congenital GBM tumor	adult GBM tumor
p_32448_1	"Homoprostate tumor, well defferentiaed"	"Homoprostate normal, well defferentiaed"
p_32448_2	"Homoprostate tumor, partially defferentiaed"	"Homoprostate normal, partially defferentiaed"
p_32482_1	"Human glioblastoma stem cell, ALK suppress"	"Human glioblastoma stem cell, control"
p_32482_2	"Human glioblastoma stem cell, PTN suppress"	"Human glioblastoma stem cell, control"
p_32496_1	"A549 cells, Aza-dC treated"	"A549 cells, untreated"
p_32496_2	"A549 cells, Aza-dC/TSA treated"	"A549 cells, untreated"
p_32496_3	"H1993 cells, Aza-dC treated"	"H1993 cells, untreated"
p_32496_4	"H1993 cells, Aza-dC/TSA treated"	"H1993 cells, untreated"
p_32496_5	"H2073 cells, Aza-dC treated"	"H2073 cells, untreated"
p_32496_6	"H2073 cells, Aza-dC/TSA treated"	"H2073 cells, untreated"
p_32523_1	"Human T-cell Acute Lymphoblastic Leukemia cell line (CEM), shRNA against ZMIZ1"	"Human T-cell Acute Lymphoblastic Leukemia cell line (CEM), scrambled shRNA"
p_32526_1	"S2N cell, sphere type"	"S2 cell, sphere type"
p_32526_2	"S2N cell, monolayer type"	"S2 cell, monolayer type"
p_32534_1	"peritumoral cortex, ganglioglioma, Epilepsy"	"peritumoral cortex, ganglioglioma, no epilepsy"
p_32540_1	"Gastric tubular adenocarcinoma cell, CDH1 overexpressed"	"Gastric tubular adenocarcinoma cell, empty vector"
p_32547_1	"HUVEC, statin treated, 4h"	"HUVEC, control"
p_32666_1	"T47D cell, Ethanol"	"T47D cell, control"
p_32666_2	"T47D cell, Estradiol"	"T47D cell, control"
p_32666_3	"T47D cell, E2-BSA"	"T47D cell, control"
p_32666_4	"T47D cell, ICI"	"T47D cell, control"
p_32666_5	"T47D cell, G15"	"T47D cell, control"
p_32666_6	"T47D cell, E2-BSA + ICI"	"T47D cell, control"
p_32666_7	"T47D cell, E2-BSA + G15"	"T47D cell, control"
p_32666_8	"T47D cell, BSA"	"T47D cell, control"
p_32667_1	"MCF-7 cell, Estradiol"	"MCF-7 cell, control"
p_32667_2	"MCF-7 cell, E2-BSA"	"MCF-7 cell, control"
p_32667_3	"MCF-7 cell, E2-BSA + ICI"	"MCF-7 cell, control"
p_32667_4	"MCF-7 cell, E2-BSA + G15"	"MCF-7 cell, control"
p_32667_5	"MCF-7 cell, BSA"	"MCF-7 cell, control"
p_32668_1	"MDA-MB-231 cell, Ethanol"	"MDA-MB-231 cell, control"
p_32668_2	"MDA-MB-231 cell, Estradiol"	"MDA-MB-231 cell, control"
p_32668_3	"MDA-MB-231 cell, E2-BSA"	"MDA-MB-231 cell, control"
p_32668_4	"MDA-MB-231 cell, ICI"	"MDA-MB-231 cell, control"
p_32668_5	"MDA-MB-231 cell, G15"	"MDA-MB-231 cell, control"
p_32668_6	"MDA-MB-231 cell, E2-BSA+ICI"	"MDA-MB-231 cell, control"
p_32668_7	"MDA-MB-231 cell, E2-BSA+G15"	"MDA-MB-231 cell, control"
p_32668_8	"MDA-MB-231 cell, BSA"	"MDA-MB-231 cell, control"
p_32669_1	"SKBR3 cell, Ethanol treated"	"SKBR3 cell, control"
p_32669_2	"SKBR3 cell, Estradiol treated"	"SKBR3 cell, control"
p_32669_3	"SKBR3 cell, E2-BSA treated"	"SKBR3 cell, control"
p_32669_4	"SKBR3 cell, E2-BSA + ICI treated"	"SKBR3 cell, control"
p_32669_5	"SKBR3 cell, BSA treated"	"SKBR3 cell, control"
p_32669_6	"SKBR3 cell, G15 treated"	"SKBR3 cell, control"
p_32669_7	"SKBR3 cell, E2-BSA + G15 treated"	"SKBR3 cell, control"
p_32676_1	pancreatic cancer	"pancreas, non-malignant"
p_32685_1	"Keratinocyte, KLF4 induced"	"Keratinocyte, control"
p_32685_2	"Keratinocyte, ZNF750 induced"	"Keratinocyte, control"
p_32693_1	"HUVEC, siRNA targeting KLF4, statin treated"	"HUVEC, siRNA targeting KLF2, statin treated"
p_32725_1	"Bone marrow cell, eldery"	"Bone marrow cell, Young"
p_32727_1	"HMEC, hTert, transduced with Twist1+Ras"	"HMEC, hTert, control"
p_32727_2	"HMEC, hTert, transduced with Zeb1+Ras"	"HMEC, hTert, control"
p_32727_3	"HMEC, hTert, transduced with Zeb2+Ras"	"HMEC, hTert, control"
p_32727_4	"HMEC, hTert, transduced with Twist1+Ras+TGF"	"HMEC, hTert, control"
p_32727_5	"HMEC, hTert, transduced with Zeb2+Ras+TGF"	"HMEC, hTert, control"
p_32727_6	"HMEC, hTert, transduced with Ras"	"HMEC, hTert, control"
p_32727_7	"HMEC, hTert, transduced with Zeb1"	"HMEC, hTert, control"
p_32727_8	"HMEC, hTert, transduced with Zeb2"	"HMEC, hTert, control"
p_32727_9	"HMEC, hTert, transduced with Twist1"	"HMEC, hTert, control"
p_3284_1	blood cells after LPS 2 h (gpl570);  treated	blood cells after before LPS (gpl570)
p_3284_2	blood cells after LPS 6 h (gpl570);  treated	blood cells after before LPS (gpl570)
p_32876_1	"Neurosphere cell, miR124 transfected"	"Neurosphere cell, control"
p_32876_2	"Neurosphere cell, miR132 transfected"	"Neurosphere cell, control"
p_32876_3	"Neurosphere cell, miR380 transfected"	"Neurosphere cell, control"
p_32876_4	"Neurosphere cell, miR433 transfected"	"Neurosphere cell, control"
p_32876_5	"Neurosphere cell, miR448 transfected"	"Neurosphere cell, control"
p_32893_1	"BEAS2-B cells, exposed to A.alternata spores"	"BEAS2-B cells, negative control"
p_32911_1	"HT1080 cell, normal growth condition + compound C 18h"	"HT1080 cell, normal growth condition"
p_32911_2	"HT1080 cell, normal growth condition + versipelostatin 18h"	"HT1080 cell, normal growth condition"
p_32911_3	"HT1080 cell, normal growth condition + phenformin 18h"	"HT1080 cell, normal growth condition"
p_32911_4	"HT1080 cell, 10mM 2-deoxyglucose + compound C 18h"	"HT1080 cell, 10mM 2-deoxyglucose 18h"
p_32911_5	"HT1080 cell, 10mM 2-deoxyglucose + versipelostatin 18h"	"HT1080 cell, 10mM 2-deoxyglucose 18h"
p_32911_6	"HT1080 cell, 10mM 2-deoxyglucose + phenformin 18h"	"HT1080 cell, 10mM 2-deoxyglucose 18h"
p_3292_1	"HNCCC, HPV+;  treated"	"HNCCC, HPV-"
p_32939_1	"Human peripheral blood monocytes, sMHC II treated, 3h"	"Human peripheral blood monocytes, medium only treated"
p_32959_10	"CD4+ T cell, after treat + IL-4 24h"	"CD4+ T cell , no treat"
p_32959_12	"CD4+ T cell, after treat + IL-4 72h"	"CD4+ T cell , no treat"
p_32959_2	"CD4+ T cell , after treat 24h"	"CD4+ T cell , no treat"
p_32959_4	"CD4+ T cell , after treat 72h"	"CD4+ T cell , no treat"
p_32959_6	"CD4+ T cell, after treat + IL-12 24h"	"CD4+ T cell , no treat"
p_32959_8	"CD4+ T cell, after treat + IL-12 72h"	"CD4+ T cell , no treat"
p_32962_1	"Primary infant ALL cells, resistant to prednosolone"	"Primary infant ALL cells, sensitive to prednosolone"
p_32982_1	prostate cancer tissue from radical prostatectomy specimen	prostate tissue from castrated subject
p_32982_2	prostate benign tissue from radical prostatectomy specimen	prostate tissue from castrated subject
p_32984_1	"HUVEC cell, Erg antisence treated , 24h"	"HUVEC cell, untreated , 0h"
p_32984_2	"HUVEC cell, Erg antisence treated , 24h"	"HUVEC cell, control antisence treated , 24h"
p_32984_3	"HUVEC cell, Erg antisence treated , 48h"	"HUVEC cell, control antisence treated , 48h"
p_33006_1	hepatocellular carcinoma (HCC)	Adjacent normal liver
p_33050_1	"HeLa cell, cultured without glucose"	"HeLa cell, cultured with FBS"
p_33050_2	"HeLa cell, cultured with High glucose"	"HeLa cell, cultured with FBS"
p_33051_1	"Hela Cell, cultured without glucose"	"Hela Cell, cultured with FBS"
p_33051_2	"Hela Cell, cultured with High glucose"	"Hela Cell, cultured with FBS"
p_33066_1	"HUF-1, SSEA3-Pos"	"HUF-1, SSEA3-Neg"
p_33109_1	"Human Neural cell, expose to VS 0.1um 6h"	"Human Neural cell, control, 0h"
p_33109_2	"Human Neural cell, expose to VS 0.1um 6h"	"Human Neural cell, control, 6h"
p_33109_3	"Human Neural cell, expose to VS 0.1um 24h"	"Human Neural cell, control, 24h"
p_33109_4	"Human Neural cell, expose to VS 0.1um 72h"	"Human Neural cell, control, 72h"
p_33109_5	"Human Neural cell, expose to VS 6um 6h"	"Human Neural cell, control, 6h"
p_33109_6	"Human Neural cell, expose to VS 6um 24h"	"Human Neural cell, control, 24h"
p_33109_7	"Human Neural cell, expose to VS 6um 72h"	"Human Neural cell, control, 72h"
p_33112_1	"Colo200 cells, Low Wnt responsive contstuct"	"Colo200 cells, High Wnt responsive contstuct"
p_33112_2	"LM003 cells, Low Wnt responsive contstuct"	"LM003 cells, High Wnt responsive contstuct"
p_33112_3	"LM23 cells, Low Wnt responsive contstuct"	"LM23 cells, High Wnt responsive contstuct"
p_33112_4	"co108 cells, Low Wnt responsive contstuct"	"co108 cells, High Wnt responsive contstuct"
p_33112_5	"Colo100.1 cells, Low Wnt responsive contstuct"	"Colo100.1 cells, High Wnt responsive contstuct"
p_33113_1	primary tumor resection	normal colon mucosa
p_33135_1	"peripheral blood mononuclear cells, dexamethasone treated, 6h, Unmutated IGHV gene / high ZAP-70 expresssion"	"peripheral blood mononuclear cells, untreated, Unmutated IGHV gene / high ZAP-70 expresssion"
p_33135_2	"peripheral blood mononuclear cells, dexamethasone treated, 6h, Mutated IGHV gene / low ZAP-70 expresssion"	"peripheral blood mononuclear cells, untreated, Mutated IGHV gene / low ZAP-70 expresssion"
p_33143_1	"DLD1 cells, SAH-BCL9B treated"	"DLD1 cells, vehicle"
p_33145_1	HMEC cell	DKAT cell
p_33145_2	MDA-MB-231 cell	DKAT cell
p_33146_1	"Human breast cancer-derived cell line (DKAT), cultured in SCGM, 14 days"	"Human breast cancer-derived cell line (DKAT), cultured in MEGM, 14 days"
p_33169_1	"intact skin, negative pressure treated, 0d"	"intact skin, control, 0d"
p_33169_2	"intact skin, negative pressure treated, 7d"	"intact skin, 7d"
p_33182_1	"PC3 cells, COUP-TFII siRNA, 48h"	"PC3 cells, control siRNA, 48h"
p_33243_1	"AML cell, Fenretinide treated , 6h"	"AML cell, control"
p_33243_2	"AML cell, Fenretinide treated , 12h"	"AML cell, control"
p_3325_1	Clinically localized primary prostate cancer	Benign Prostate tissue
p_3325_2	Metastatic prostate cancer	Benign Prostate tissue
p_33316_1	androgen-deprived LuCaP35 cell	"LuCaP35 cell, control"
p_33325_1	"cardiomyocyte cell, expose to VX 0.1um, 6h"	"cardiomyocyte cell, control 0h"
p_33325_2	"cardiomyocyte cell, expose to VX 0.1um, 6h"	"cardiomyocyte cell, control 6h"
p_33325_3	"cardiomyocyte cell, expose to VX 0.1um, 24h"	"cardiomyocyte cell, control 24h"
p_33325_4	"cardiomyocyte cell, expose to VX 0.1um, 72h"	"cardiomyocyte cell, control 72h"
p_33325_5	"cardiomyocyte cell, expose to VX 6um, 6h"	"cardiomyocyte cell, control 6h"
p_33325_6	"cardiomyocyte cell, expose to VX 6um, 24h"	"cardiomyocyte cell, control 24h"
p_33325_7	"cardiomyocyte cell, expose to VX 6um, 72h"	"cardiomyocyte cell, control 72h"
p_33356_1	"lung tissue, primary tumor"	"lung tissue, paired normal adjacent"
p_33358_1	"U937 cell, Tan IIA treated, 12h"	"U937 cell, DMSO treated"
p_33358_2	"U937 cell, Tan IIA treated, 24h"	"U937 cell, DMSO treated"
p_33363_1	microdissected non-small cell lung cancer tissue	non-small cell lung cancer tissue
p_33371_1	Adrenocortical Adenoma	Normal Adrenal Cortex
p_33371_2	Adrenocortical Carcinoma	Normal Adrenal Cortex
p_33374_1	CD161++CD8ab T cells	CD161++CD8aa T cells
p_33420_1	"DLD-1, miR-143"	"DLD-1, mock treated"
p_33424_1	"T cell, CD8+ , CD161 +"	"T cell, CD8+ , CD161 -"
p_33424_2	"T cell, CD8+ , CD161 ++"	"T cell, CD8+ , CD161 -"
p_33455_1	"DU-145 cell, docetaxel resistant"	"DU-145 cell, control"
p_33455_2	"PC3 cell, docetaxel resistant"	"PC3 cell, control"
p_33458_1	"143B cell, TIC"	"143B cell, non-TIC"
p_33458_2	"MNNG/HOS cell, TIC"	"MNNG/HOS cell, non-TIC"
p_33495_1	"primary neonatal keratinocytes, TP63 knock down"	"primary neonatal keratinocytes, control"
p_33495_2	"rimary neonatal keratinocytes, Np63(I482T) Overexpression"	"primary neonatal keratinocytes, control"
p_33495_3	"rimary neonatal keratinocytes, Np63(R500P) Overexpression"	"primary neonatal keratinocytes, control"
p_33495_4	"rimary neonatal keratinocytes, Np63 Overexpression"	"primary neonatal keratinocytes, control"
p_33504_1	"HMC1 cells, CD2+ expression"	"HMC1 cells, CD2- expression"
p_33539_1	"ALLSIL cell line, TLX1 knockdown"	"ALLSIL cell line, control"
p_33540_1	"HPBALL cell line, TLX3 knockdown"	"HPBALL cell line, control"
p_33562_1	"CUTLL1 cell, 1uM PF-03084014 treated"	"CUTLL1 cell, DMSO treated"
p_33562_2	"CUTLL1 cell, 1uM dexamethasone treated"	"CUTLL1 cell, DMSO treated"
p_33562_3	"CUTLL1 cell, 1uM dexamethasone + PF-03084014 treated"	"CUTLL1 cell, DMSO treated"
p_33572_1	"primary neonatal keratinocytes, TP63 knock down"	"primary neonatal keratinocytes, control siRNA"
p_33572_2	"primary neonatal keratinocytes, Np63(I482T) Overexpression"	"primary neonatal keratinocytes, control siRNA"
p_33572_3	"primary neonatal keratinocytes, Np63(R500P) Overexpression"	"primary neonatal keratinocytes, control siRNA"
p_33572_4	"primary neonatal keratinocytes, Np63(Wild type) Overexpression"	"primary neonatal keratinocytes, control siRNA"
p_33577_1	"MM.1S cell, MLN4924 treated,8h"	"MM.1S cell, control"
p_33577_2	"MM.1S cell, MLN4924 treated,16h"	"MM.1S cell, control"
p_33577_3	"MM.1S cell, MLN4924 treated,24h"	"MM.1S cell, control"
p_33580_1	"whole blood, HIV resistant women"	"whole blood, HIV negative women"
p_33585_1	THP1-cells stimulated with Infliximab for 6h	"THP1-cells, unstimulated, 0h"
p_33585_2	THP1-cells stimulated with Infliximab for 24h	"THP1-cells, unstimulated, 0h"
p_33585_3	THP1-cells stimulated with CDP870 for 6h	"THP1-cells, unstimulated, 0h"
p_33585_4	THP1-cells stimulated with CDP870 for 24h	"THP1-cells, unstimulated, 0h"
p_33606_1	"hNHEP cell, 0.1uM, 6h"	"hNHEP cell, control, 6h"
p_33606_2	"hNHEP cell, 10uM, 6h"	"hNHEP cell, control, 6h"
p_33630_1	anaplastic thyroid carcinomas (ATC)	non-tumoral thyroid tissues
p_33630_2	papillary thyroid carcinomas (PTC)	non-tumoral thyroid tissues
p_33780_1	"A1555G cell, hyper-methylated overexpressed"	"A1555G cell, control"
p_33780_2	"Hela cell, mtTFB1 overexpressed, hyper-methylated"	"Hela cell, mtTFB1 overexpressed"
p_33810_1	"Esophagus cell, tumor"	"Esophagus cell, non-tumor"
p_33810_2	"Esophagus cell, tumor with familly history"	"Esophagus cell, non-tumor"
p_33827_1	"MDA-MB-231 cell, T2 tumor, treated SM-164"	"MDA-MB-231 cell, parental, treated SM-164"
p_33827_2	"MDA-MB-231 cell, T3 tumor, treated SM-164"	"MDA-MB-231 cell, parental, treated SM-164"
p_33827_3	"MDA-MB-231 cell, T6 tumor, treated SM-164"	"MDA-MB-231 cell, parental, treated SM-164"
p_33827_4	"MDA-MB-231 cell, T8 tumor, treated SM-164"	"MDA-MB-231 cell, parental, treated SM-164"
p_33831_1	"Mesenchymal stem cell, 6h"	"Mesenchymal stem cell, 0h"
p_33831_2	"Mesenchymal stem cell, 12h"	"Mesenchymal stem cell, 0h"
p_33831_3	"Mesenchymal stem cell, 24h"	"Mesenchymal stem cell, 0h"
p_33831_4	"Mesenchymal stem cell, 48h"	"Mesenchymal stem cell, 0h"
p_33845_1	"Lung cancer, low invasive, Electric Fields"	"Lung cancer, low invasive, control"
p_33845_2	"Lung cancer, High invasive, Electric Fields"	"Lung cancer, High invasive, control"
p_33864_1	"HSF-6 cell, Butyrate, DZNep treated"	"HSF-6 cell, control"
p_33870_1	"HEK293 cell, FTO overexpressed, 0h"	"HEK293 cell, control, 0h"
p_33870_2	"HEK293 cell, FTO overexpressed, 1d"	"HEK293 cell, control, 1d"
p_33870_3	"HEK293 cell, FTO overexpressed, 2d"	"HEK293 cell, control, 2d"
p_33870_4	"HEK293 cell, FTO knockout"	"HEK293 cell, control"
p_33939_1	Polymorphonuclear leukocyte cell control time : 30	"Polymorphonuclear leukocyte cell, PVL treated time : 30"
p_33939_2	Polymorphonuclear leukocyte cell control time : 60	"Polymorphonuclear leukocyte cell, PVL treated time : 60"
p_33939_3	Polymorphonuclear leukocyte cell control time : 180	"Polymorphonuclear leukocyte cell, PVL treated time : 180"
p_33939_4	Polymorphonuclear leukocyte cell control time : 30	Polymorphonuclear leukocyte cell + iPVL treated time : 30
p_33939_5	Polymorphonuclear leukocyte cell control time : 60	Polymorphonuclear leukocyte cell + iPVL treated time : 60
p_33939_6	Polymorphonuclear leukocyte cell control time : 180	Polymorphonuclear leukocyte cell + iPVL treated time : 180
p_33950_1	"MDA-MB-231 cell, shHIF treated"	"MDA-MB-231 cell, shGFP, control"
p_33950_2	"MDA-MB-231 cell, Sharp1 overexpressed"	"MDA-MB-231 cell, shGFP, control"
p_33984_1	"EAHY cells, HSHV-infected"	"EAHY cells, non-infected control"
p_34022_1	"Huh-7 cell, IFN alpha treated"	"Huh-7 cell, control"
p_34025_1	"Monocyte, DEP treated"	"Monocyte, control"
p_34027_1	"TC-71 cell, expose to AEW"	"TC-71 cell, control"
p_34027_2	"TC-71 cell, expose to AVE"	"TC-71 cell, control"
p_34027_3	"TC-71 cell, expose to CP"	"TC-71 cell, control"
p_34042_1	"M12 cell, 5-AZA treated"	"M12 cell, control"
p_34042_2	"P69 cell, 5-AZA treated"	"P69 cell, control"
p_34042_3	"RD cell, 5-AZA treated"	"RD cell, control"
p_34042_4	"Rh30 cell, 5-AZA treated"	"Rh30 cell, control"
p_34053_1	"Carcinoma cell, CD133-"	Carcinoma associated fibroblast
p_34053_2	"Carcinoma cell, CD133+"	Carcinoma associated fibroblast
p_34055_1	"HMEC, Myc overexpressed"	"HMEC, control"
p_34055_2	"HMEC, SUMO depleted"	"HMEC, control"
p_34055_3	"HMEC, Myc overexpressed, SUMO depleted"	"HMEC, control"
p_34112_1	"PC3 cells, hypoxia, sulindac treated"	"PC3 cells, hypoxia, DMSO treated"
p_34112_2	"PC3 cells, hypoxia, NO-sulindac treated"	"PC3 cells, hypoxia, DMSO treated"
p_34112_3	"PC3 cells, normoxia, sulindac treated"	"PC3 cells, nomroxia, DMSO treated"
p_34112_4	"PC3 cells, normoxia, NO-sulindac treated"	"PC3 cells, normoxia, DMSO treated"
p_34200_1	"ESC, UNDIFF LINE (BG02), PASSAGE 50"	UniRef Processing Control
p_34200_3	"ESC UNDIFF LINE (ES02), PASSAGE 45"	UniRef Processing Control
p_34200_5	"ESC UNDIFF LINE (TE03), PASSAGE 66"	UniRef Processing Control
p_34200_7	"ESC UNDIFF LINE (UC01), PASSAGE 56"	UniRef Processing Control
p_34200_9	"ESC UNDIFF LINE (WA01), PASSAGE 52"	UniRef Processing Control
p_34205_1	"PBMC, infected by influenze"	"PBMC, no-infection, control"
p_34205_2	"PBMC, infected by acute RSV"	"PBMC, no-infection, control"
p_34298_1	"K562 cells, Shikonin resistant"	"K562 cells, control"
p_34299_1	"HT29RC cell, PLX4720 resistant"	"HT29 parental cell, control"
p_34299_2	"Colo 205 cell, PLX4720 resistant"	"Colo 205 parental cell, control"
p_34308_1	"dermal fibroblast, CCALD patient"	"dermal fibroblast, healthy control"
p_34331_1	"MCF-7 cells, F05 5 M, 6h"	"MCF-7 cells, DMSO 0.05%, 6h"
p_34339_1	"Diffuse Large B-cell Lymphoma, Swedish"	"Diffuse Large B-cell Lymphoma, Egyptian"
p_34407_1	"Human peripheral monocyte, toxin treated"	"Human peripheral monocyte, control"
p_34454_1	"SW1783 cell, miR-376a*A treated, 24h"	"SW1783 cell, control , 24h"
p_34454_2	"SW1783 cell, miR-376a*G treated, 24h"	"SW1783 cell, control , 24h"
p_34455_1	"U87 cell, miR-376a*A treated, 24h"	"U87 cell, control , 24h"
p_34455_2	"U87 cell, miR-376a*G treated, 24h"	"U87 cell, control , 24h"
p_34456_1	"U87 cell, miR-376a*A treated, 72h"	"U87 cell, control , 72h"
p_34456_2	"U87 cell, miR-376a*G treated, 72h"	"U87 cell, control , 72h"
p_34482_1	"SW1783 cells, transfected with miR-376a*A, 24h"	"SW1783 cells, control miRNA, 24h"
p_34482_2	"SW1783 cells, transfected with miR-376a*G, 24h"	"SW1783 cells, control miRNA, 24h"
p_34482_3	"U87 cells, transfected with miR-376a*A, 24h"	"U87 cells, control miRNA, 24h"
p_34482_4	"U87 cells, transfected with miR-376a*G, 24h"	"U87 cells, control miRNA, 24h"
p_34482_5	"U87 cells, transfected with miR-376a*A, 72h"	"U87 cells, control miRNA, 72h"
p_34482_6	"U87 cells, transfected with miR-376a*G, 72h"	"U87 cells, control miRNA, 72h"
p_34489_1	"colorectal cancer tissue, chromosome instability (cin) phenotype: CIN-high"	"colorectal cancer tissue, chromosome instability (cin) phenotype: CIN-low"
p_34512_1	"HMVEC-LBI, siRNA targeting PBEF treated"	"primary HMVEC-LBI, scrambled siRNA treated"
p_34514_1	"Sperm cell, Normal"	"Sperm cell, Asthenozoospemic patient"
p_34515_1	"HBMCS, cd16 positive"	"HBMCS, cd16 negative"
p_34515_2	"HBMCS, cd1c positive"	"HBMCS, cd16 negative"
p_34526_1	"granulosa cells, PCOS women"	"granulosa cells, normal women"
p_34528_1	"Keratinocyte, ANCR silenced"	"Keratinocyte, siRNA control"
p_34573_1	"NPC biopsy, nasopharyngeal carcinoma"	normal nasopharyngeal biopsy
p_34602_1	"Mino cell, GSI treated"	"Mino cell, mock treated"
p_34602_2	"Rec-1 cell, GSI treated"	"Rec-1 cell, mock treated"
p_34602_3	"SP-49 cell, GSI treated"	"SP-49 cell, mock treated"
p_34628_1	"primary human umbilical vein endothelial cells, DV infected"	"primary human umbilical vein endothelial cells, control"
p_34635_1	"bronchioepithelial cells (BEAS-2B), N-OH-PhIP treatead, 500nM, 24h"	"bronchioepithelial cells (BEAS-2B), DMSO treatead, 24h, control"
p_34635_4	"bronchioepithelial cells (BEAS-2B), N-OH-PhIP treatead, 50nM, 24h"	"bronchioepithelial cells (BEAS-2B), DMSO treatead, 24h, control"
p_34635_6	"bronchioepithelial cells (BEAS-2B), N-OH-PhIP treatead, 5nM, 24h"	"bronchioepithelial cells (BEAS-2B), DMSO treatead, 24h, control"
p_34635_8	"bronchioepithelial cells (BEAS-2B), N-OH-PhIP treatead, 500pM, 24h"	"bronchioepithelial cells (BEAS-2B), DMSO treatead, 24h, control"
p_34715_1	"HEK293cell, dox treated"	"HEK293cell, dox untreated"
p_34776_1	"lymphoblast tissue, Nicotine dependent"	"lymphoblast tissue, control"
p_34781_1	"white blood cell of venous blood, unstable angina"	"white blood cell of venous blood, control"
p_34789_1	"Calu-3 cell, stretched"	"Calu-3 cell, non-stretched"
p_34846_1	"RPE1 cell, transfected with M129 oligo, 72h"	"RPE1 cell, transfected with control oligo, 72h"
p_34880_1	"Reh cells, vorinostat treated, 0.5uM"	"Reh cells, control"
p_34880_2	"Reh cells, vorinostat treated, 1uM"	"Reh cells, control"
p_34880_3	"Reh cells, vorinostat treated, 2.5M"	"Reh cells, control"
p_34880_4	"RS4 cells, vorinostat treated, 1uM"	"RS4 cells, control"
p_34880_5	"MV4 cells, vorinostat treated, 1uM"	"MV4 cells, control"
p_34880_6	"ALL patients, vorinostat treated, 1uM"	"ALL patients, control"
p_34972_1	"HPSCs, 12h"	"HPSCs, 0 day"
p_34972_2	"HPSCs, 2 weeks"	"HPSCs, 0 day"
p_34972_3	"HPSCs, 5 weeks"	"HPSCs, 0 day"
p_35014_1	"bladder cancer cells (UM-UC-3), transfected with GFP-tagged RhoGDI2"	"bladder cancer cells (UM-UC-3), transfected with GFP (control)"
p_35082_1	"Mononuclear cells, Splenic Marginal Zone Lymphoma patient, 7q32 deleted"	"Mononuclear cells, Splenic Marginal Zone Lymphoma patient"
p_35084_1	"HEK293 cells, LPA treated"	"HEK293 cells, untreated"
p_35169_1	"U87-2M1 cell, hypoxia"	"U87-2M1 cell, control"
p_35170_1	"U87-2M1 cell, miR-10b silencing"	"U87-2M1 cell, control"
p_35249_1	"Fibroblast cell, CAF patient"	"Fibroblast cell, aNOF patient"
p_35250_1	"Fibroblast cell, coCAF patient"	"Fibroblast cell, NOF patient"
p_35251_1	"Normal omental fibroblast transfected with 3 miRNAs (miR-155, anti-miR-31 and anti-miR-214), 2d"	Normal omental fibroblast
p_35252_1	"Normal omental fibroblast, transfected with 3 miRNAs (miR-155, anti-miR-31 and anti-miR-214), 4d"	normal omental fibroblast
p_35324_1	"C4-2B cell, B-DIM treated, 6h"	"C4-2B cell, control"
p_35324_2	"C4-2B cell, B-DIM treated, 48h"	"C4-2B cell, control"
p_35324_3	"C4-2B cell, Isoflavone treated, 6h"	"C4-2B cell, control"
p_35324_4	"C4-2B cell, Isoflavone treated, 72h"	"C4-2B cell, control"
p_35330_1	"primary natural killer (NK) cells, anti-CD158d mAb, 4 hr"	"primary natural killer (NK) cells, 4 hr, control"
p_35330_2	"primary natural killer (NK) cells, anti-CD158d mAb, 16 hr"	"primary natural killer (NK) cells, 16 hr, control"
p_35330_3	"primary natural killer (NK) cells, anti-CD158d mAb, 64 hr"	"primary natural killer (NK) cells, 64 hr, control"
p_35331_1	"Bone-Marrow Mesenchymal Stromal Cells, Follicular Lymphoma patient, untreated"	"Bone-Marrow Mesenchymal Stromal Cells, healthy donors, untreated"
p_35331_2	"Bone-Marrow Mesenchymal Stromal Cells, healthy donors, Stimulated by TNF+LT, 3 days"	"Bone-Marrow Mesenchymal Stromal Cells, healthy donors, untreated"
p_35340_1	"CD207+, CD1a+ LCH (Langerhans cell histiocytosis) cells"	epidermal Langerhans cells
p_35340_2	"CD207+, CD1a+ LCH (Langerhans cell histiocytosis) cells"	myeloid dendritic cells (mDC1)
p_35340_3	"CD207+, CD1a+ LCH (Langerhans cell histiocytosis) cells"	plasmacytoid dendritic cells (pDC)
p_35369_1	"Gene expression in gastric epithelial cells: CDX1 induction -, 24 h"	"Gene expression in gastric epithelial cells: control induction -, 24 h"
p_35369_2	"Gene expression in gastric epithelial cells: CDX1 induction +, 24 h"	"Gene expression in gastric epithelial cells: control induction -, 24 h"
p_35374_1	"Cord blood CD45RAlow+CD34+CD38-CD90+ cells, SCF+CCL28 treated, 18h"	"Cord blood CD45RAlow+CD34+CD38-CD90+ cells, SCF treated, 18h"
p_35383_1	"Mononuclear cells, splenic marginal zone lymphoma, without 7q32 deletion"	"Mononuclear cells, splenic marginal zone lymphoma, 7q32 deletion"
p_35388_1	"A375 cell, exosome"	"A375 cell, normal"
p_35388_2	"HEMa-LP cell, exosome"	"HEMa-LP cell, normal"
p_35414_1	"Human Multiple Myeloma cell line MM1S, FK866 at concentration of 10nM , 6h"	"Human Multiple Myeloma cell line MM1S, untreated"
p_35414_2	"Human Multiple Myeloma cell line MM1S, FK866 at concentration of 10nM , 24h"	"Human Multiple Myeloma cell line MM1S, untreated"
p_35428_1	"MCF-7 cells, co-treatment: E2_ethanol"	"MCF-7 cells, co-treatment: ethanol_ethanol"
p_35428_2	"MCF-7 cells, co-treatment: E2_4OHT"	"MCF-7 cells, co-treatment: ethanol_4OHT"
p_35428_3	"MCF-7 cells, co-treatment: E2_ICI 182,780"	"MCF-7 cells, co-treatment: ethanol_ICI 182,780"
p_35428_4	"MCF-7 cells, co-treatment: E2_Bazedoxifene"	"MCF-7 cells, co-treatment: ethanol_Bazedoxifene"
p_35428_5	"MCF-7 cells, co-treatment: E2_Raloxifene"	"MCF-7 cells, co-treatment: ethanol_Raloxifene"
p_35452_1	"rectal cancer, response to preoperative chemoradiotherapy: Responder"	"rectal cancer, response to preoperative chemoradiotherapy: Non-responder"
p_35493_1	"brain tumor, atypical teratoid / rhabdoid tumor"	"brain tumor, glioblastoma"
p_35493_2	"brain tumor, atypical teratoid / rhabdoid tumor"	"brain tumor, medulloblastoma, large-cell"
p_35493_3	"brain tumor, atypical teratoid / rhabdoid tumor"	"brain tumor, primitive neuroectodermal tumor"
p_35493_4	"brain tumor, atypical teratoid / rhabdoid tumor"	"normal brain control, cerebellum, pediatric"
p_35493_5	"brain tumor, atypical teratoid / rhabdoid tumor"	"normal brain control, frontal, pediatric"
p_35493_6	"brain tumor, atypical teratoid / rhabdoid tumor"	"normal brain control, occipital, pediatric"
p_35493_7	"brain tumor, atypical teratoid / rhabdoid tumor"	"normal brain control, parietal, pediatric"
p_35493_8	"brain tumor, atypical teratoid / rhabdoid tumor"	"normal brain control, temporal, pediatric"
p_35503_1	"hMSC, GW9662 treated, 1wk"	"hMSC, DMSO treated, 1wk"
p_35503_2	"hMSC, GW9662 treated, 2wk"	"hMSC, DMSO treated, 2wk"
p_35511_1	"MDA-MB-231, transfected with pcDNA6/V5-His-ZNF217 plasmid"	"MDA-MB-231 cells, transfected with pcDNA6/V5-His plasmid"
p_35546_1	"MSC cell, Kartogenin 1nm treated , 6h"	"MSC cell, DMSO treated"
p_35546_2	"MSC cell, Kartogenin 1nm treated , 24h"	"MSC cell, DMSO treated"
p_35546_3	"MSC cell, Kartogenin 10nm treated , 6h"	"MSC cell, DMSO treated"
p_35546_4	"MSC cell, Kartogenin 10nm treated , 24h"	"MSC cell, DMSO treated"
p_35546_5	"MSC cell, Kartogenin 100nm treated , 6h"	"MSC cell, DMSO treated"
p_35546_6	"MSC cell, Kartogenin 100nm treated , 24h"	"MSC cell, DMSO treated"
p_35551_1	SD8 skin fibro blast	"human Skin fibroblasts, control"
p_35551_2	SD60 skin fibro blast	"human Skin fibroblasts, control"
p_35554_1	"skin fibroblast, chimke immuno-osseous dysplasia"	"skin fibroblast, control"
p_35620_1	"human skin fibroblast cells, transfected with miR-941 mimics-Lipofectamine 2000 complexes"	"human skin fibroblast cells, mock treated"
p_35620_2	"human embryonic kidney cells (HEK cells), ransfected with miR-941 mimics-Lipofectamine 2000 complexes"	"human embryonic kidney cells (HEK cells), mock treated"
p_35620_3	"human embryonic kidney cells (293T cell), transfected with mock oligonucleotides"	"human embryonic kidney cells (293T cell), transfected with mock oligonucleotides"
p_35620_4	"LLCM2 cells, transfected with miR-941 mimics-Lipofectamine 2000 complexes"	"LLCM2 cells, transfected with mock oligonucleotides"
p_35620_5	"fetal rhesus monkey kidney (FRhK-4) cells, transfected with miR-941 mimics-Lipofectamine 2000 complexes"	"fetal rhesus monkey kidney (FRhK-4) cells, transfected with mock oligonucleotides"
p_35620_6	"MSF cells, transfected with miR-941 mimics-Lipofectamine 2000 complexes"	"MSF cells, transfected with mock oligonucleotides"
p_35621_1	"293T cells, transfected with Synthetic miR-941"	"293T cells, transfected with scrambled oligonucleotide, control"
p_35683_1	"Umbilical Cord blood Monocytes, LPS+DEX"	"Umbilical Cord blood Monocytes, LPS"
p_35683_2	"Umbilical Cord blood Monocytes, LPS+IL-10"	"Umbilical Cord blood Monocytes, LPS"
p_35683_3	"Umbilical Cord blood Polymorphonucler cells, LPS+DEX"	"Umbilical Cord blood Polymorphonucler cells, LPS"
p_35683_4	"Umbilical Cord blood Polymorphonucler cells, LPS+IL-10"	"Umbilical Cord blood Polymorphonucler cells, LPS"
p_35696_1	"MCF7 cell, RL silenced , LIF treated"	"MCF7 cell, RL silenced , NS"
p_35696_2	"MCF7 cell, SIN3a silenced, LIF treated"	"MCF7 cell, SIN3a silenced, NS"
p_35809_1	"Gastric Cancer cell, proliferative"	"Gastric Cancer cell, metabolic"
p_35809_2	"Gastric Cancer cell, Invasive"	"Gastric Cancer cell, metabolic"
p_35830_1	"Ect1 cell, 10% seminal plasma treated"	"Ect1 cell, control"
p_35830_2	"Ect1 cell, TGFB treated"	"Ect1 cell, control"
p_35864_1	"Brain white matter, HIV infected"	"Brain white matter, control"
p_35864_2	"Brain white matter, HIV inefected with neurocognitive impairment"	"Brain white matter, control"
p_35864_3	"Brain white matter, HIV infected with both neurocognitive impairment and encephalitis patients"	"Brain white matter, control"
p_35864_4	"Brain white matter, HIV infected"	Brain frontal cortex
p_35864_5	"Brain white matter, HIV inefected with neurocognitive impairment"	Brain frontal cortex
p_35864_6	"Brain white matter, HIV infected with both neurocognitive impairment and encephalitis patients"	Brain frontal cortex
p_35864_7	"Brain white matter, HIV infected"	Brain basal ganglia
p_35864_8	"Brain white matter, HIV inefected with neurocognitive impairment"	Brain basal ganglia
p_35864_9	"Brain white matter, HIV infected with both neurocognitive impairment and encephalitis patients"	Brain basal ganglia
p_35955_1	"Mesenchymal stem cell, bone marrow, from elderly-aged donor"	"Mesenchymal stem cell, bone marrow, from middle-aged donor"
p_35957_1	"Mesenchymal stem cell, bone marrow, cellular senescence state"	"Mesenchymal stem cell, bone marrow, control"
p_35958_1	"Mesenchymal stem cell, bone marrow, from old donor with primary osteoporosis"	"Mesenchymal stem cell, bone marrow, from old donor, control"
p_35972_1	"TOV112D cells, NSC319726 treated"	"TOV112D cells, untreated"
p_35973_1	"DKS5 cell, hyposia, 12h"	"DKS5 cell, normoxia"
p_35973_2	"DKO3 cell, hyposia, 12h"	"DKO3 cell, normoxia"
p_36083_1	"placenta, 8 weeks, antiphospholipid antibody"	"placenta, 8 weeks, control"
p_36098_1	"HIDEMs (human iPS cell-derived mesoangioblasts), Limb-girdle muscular dystrophy 2D (LGMD2D) derived"	"human mesoangioblasts, wild type adult skeletal muscle derived, control"
p_36098_2	"HIDEMs (human iPS cell-derived mesoangioblasts), Wild-type"	"human mesoangioblasts, wild type adult skeletal muscle derived, control"
p_36135_1	"DU145 cell, Docetaxel resistant"	"DU145 cell, parental sensitive"
p_36135_2	"22Rv1 cell, Docetaxel resistant"	"22Rv1 cell, parental sensitive"
p_36149_1	"Acute Lymphoblastic Leukemia cell line RS4:11, obatoclax, 72h EC50"	"Acute Lymphoblastic Leukemia cell line RS4:11, control"
p_36149_2	"Acute Lymphoblastic Leukemia cell line RS4:11, obatoclax, 3x 72h EC50"	"Acute Lymphoblastic Leukemia cell line RS4:11, control"
p_36149_3	"Acute Lymphoblastic Leukemia cell line SEM-K2, obatoclax, 72h EC50"	"Acute Lymphoblastic Leukemia cell line SEM-K2, control"
p_36149_4	"Acute Lymphoblastic Leukemia cell line SEM-K2, obatoclax, 3x 72h EC50"	"Acute Lymphoblastic Leukemia cell line SEM-K2, control"
p_36222_1	"primary neonatal keratinocytes, ACTL6a knock down"	"primary neonatal keratinocytes, control"
p_36238_1	"Blood, Tuberculosis patients, Week 26"	"Blood, Tuberculosis patients, at diagnosis (Week0)"
p_36287_1	"primary keratinocytes, IFNa-treated"	"primary keratinocytes, untreated control"
p_36287_2	"primary keratinocytes, IFNg-treated"	"primary keratinocytes, untreated control"
p_36287_3	"primary keratinocytes, IL13-treated"	"primary keratinocytes, untreated control"
p_36287_4	"primary keratinocytes, IL17-treated"	"primary keratinocytes, untreated control"
p_36287_5	"primary keratinocytes, IL4-treated"	"primary keratinocytes, untreated control"
p_36287_6	"primary keratinocytes, TNF-treated"	"primary keratinocytes, untreated control"
p_36547_1	"CD34+ cell, prostaglandin treated, 4deg, 1h"	"CD34+ cell, vehicle treated, 4deg, 1h"
p_36547_2	"CD34+ cell, prostaglandin treated, 37deg, 2h"	"CD34+ cell, vehicle treated, 37deg, 2h"
p_36609_1	"H181 cell, without bFGF"	"H181 cell, with bFGF"
p_36609_2	"H181 cell, without bFGF, NO treated"	"H181 cell, with bFGF"
p_36666_1	"HCT116 cell, wt, spheroid type"	"HCT116/GFP cell, wt, spheroid type"
p_36666_2	"HCT116 cell, wt, monolayer type"	"HCT116/GFP cell, wt, monolayer type"
p_36667_1	100-01#16 iPSC	201B7 iPSC
p_36668_1	"Ovary cell, borderline tumor"	"Ovary cell, normal"
p_36668_2	"Ovary cell, carcinoma"	"Ovary cell, normal"
p_36701_1	"Rectal colon biopsy, IBS-C (Constipation predominant IBS subjects)"	"Rectal colon biopsy, healthy control"
p_36701_2	"Rectal colon biopsy, IBS-D (Constipation predominant IBS subjects)"	"Rectal colon biopsy, healthy control"
p_36701_3	"Rectal colon biopsy, PIBD (post Campylobacter infection with IBS (within 6 months))"	"Rectal colon biopsy, healthy control"
p_36701_4	"Rectal colon biopsy, PIBS (post infection IBS (unknown time point and organism))"	"Rectal colon biopsy, healthy control"
p_36701_5	"Rectal colon biopsy, PINIBS (post Campylobacter infection with no resulting IBS)"	"Rectal colon biopsy, healthy control"
p_36754_1	"Shef3 cell line, hESCs differentiating in the presence of FGF3 and 10, day 14"	"Shef3 cell line, hESC"
p_36754_2	"H14 cell line, hESCs differentiating in the presence of FGF3 and 10, day 14"	"H14 cell line, hESC"
p_36754_3	"Shef1 cell line, hESCs differentiating in the presence of FGF3 and 10, day 14"	"Shef1 cell line, hESC"
p_36771_1	"Primary breast tumor, erstrogen receptor status: ER+"	"Primary breast tumor, erstrogen receptor status: ER-"
p_36771_2	"Primary breast tumor, progesterone receptor status: PgR+"	"Primary breast tumor, progesterone receptor status: PgR-"
p_36771_3	"Primary breast tumor, lymph node metastasis LN+"	"Primary breast tumor, lymph node metastasis: LN-"
p_36771_4	"Primary breast tumor, Tumor histological grade: 3"	"Primary breast tumor, Tumor histological grade: 2"
p_3678_1	thyroid containing tumor cells	"human thyroid, control"
p_36809_1	"white blood cell, hours since injury<12h"	"white blood cell, control"
p_36809_2	"white blood cell, 12h<hours since injury<1 day"	"white blood cell, control"
p_36809_3	"white blood cell, 1day <hours since injury<4 day"	"white blood cell, control"
p_36809_4	"white blood cell, 4day <hours since injury<7 day"	"white blood cell, control"
p_36809_5	"white blood cell, 7day <hours since injury<14 day"	"white blood cell, control"
p_36809_6	"white blood cell, 14day <hours since injury"	"white blood cell, control"
p_36821_1	"A549 cells, main population"	"A549 cells, side population"
p_36821_2	"H1650 cells, main population"	"H1650 cells, side population"
p_36821_3	"H460 cells, main population"	"H460 cells, side population"
p_36830_1	"UT cell, CRSsNP patient"	"UT cell, control"
p_36830_2	"UT cell, CRSwNP patient"	"UT cell, control"
p_36830_3	"UT cell, CRSwNP patient"	"polyp cell, CRSwNP patient"
p_36895_1	clear-cell renal cell carcinoma (ccRCC) primary tumors	"Normal cortex, clear-cell renal cell carcinoma"
p_36901_1	"U87MG cell, Medium EGFRvIII"	"U87MG cell, Dead EGFRvIII"
p_36901_2	"U87MG cell, High EGFRvIII"	"U87MG cell, Dead EGFRvIII"
p_36901_3	"U87MG cell, Super-high EGFRvIII"	"U87MG cell, Dead EGFRvIII"
p_36953_1	"TNBC cell line MDA-MB-231, breast adenocarcinoma, seeded in 6-well plates"	"TNBC cell line MDA-MB-231, breast adenocarcinoma, tumor xenograft model"
p_36953_2	"TNBC cell line MDA-MB-231, plated in 6-well plates precoated with Matrigel"	"TNBC cell line MDA-MB-231, breast adenocarcinoma, tumor xenograft model"
p_36953_3	"TNBC cell line Hs578T, breast carcinoma, seeded in 6-well plates"	"TNBC cell line Hs578T, breast carcinoma, tumor xenograft model"
p_36953_4	"TNBC cell line Hs578T, breast carcinoma, plated in 6-well plates precoated with Matrigel"	"TNBC cell line Hs578T, breast carcinoma, tumor xenograft model"
p_36970_1	"Mesenchymal stem cells; KDM4B knockdown, BMP 0hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 0h"
p_36970_2	"hmesenchymal stem cells; KDM6B knockdown, BMP 0hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 0h"
p_36970_3	"Mesenchymal stem cells; KDM4B knockdown, BMP 4hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 4h"
p_36970_4	"hmesenchymal stem cells; KDM6B knockdown, BMP 4hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 4h"
p_36970_5	"Mesenchymal stem cells; KDM4B knockdown, BMP 24hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 24h"
p_36970_6	"hmesenchymal stem cells; KDM6B knockdown, BMP 24hr"	"bone marrow derived mesenchymal stem cells, Scramble shRNA, BMP4/7 treated, 24h"
p_36995_1	wound macrophages	blood monocyte derived macrophage
p_37059_1	"Melanoma cell, Sox10 Knockdown, 48h"	"Melanoma cell, control, 48h"
p_37059_2	"Melanoma cell, Sox10 Knockdown, 96h"	"Melanoma cell, control, 96h"
p_37132_1	"Colo829 cells, BANCR shRNA"	"Colo829 cells, control shRNA"
p_37136_1	"WM115 cells, transduced with HOXA1"	"WM115 cells, transduced with GFP control"
p_37157_1	"PBMC, asymptomatic group, polinization period"	"PBMC, non-allergic subject, polinization period"
p_37157_2	"PBMC, asymptomatic group, post-polinization period"	"PBMC, non-allergic subject, post-polinization period"
p_37157_3	"PBMC, asymptomatic group, polinization period"	"PBMC, non-related to olive allergic group, polinization period"
p_37157_4	"PBMC, asymptomatic group, post-polinization period"	"PBMC, non-related to olive allergic group, post-polinization period"
p_37157_5	"PBMC, treated allergic subject, polization period"	"PBMC, non-treated allergic subject, polization period"
p_37157_6	"PBMC, treated allergic subject, post-polization period"	"PBMC, non-treated allergic subject, post-polization period"
p_37169_1	"Colo829 melanoma cells, BANCR knockdown"	"Colo829 melanoma cells, control"
p_37208_1	"HCCLM3 cells, CTHRC1 siRNA"	"HCCLM3 cells, scramble siRNA control"
p_37253_1	"Jurkat T cell, FOXP3, rest"	"Jurkat T cell, GFP, rest"
p_37253_2	"Jurkat T cell, FOXP3, PMA/iono exposure, 4h"	"Jurkat T cell, GFP, PMA/iono exposure, 4h"
p_37290_1	"RMG2 cell, HNF1b shRNA treated"	"RMG2 cell, control"
p_37355_1	"BCBL1 cell, K13-ER expressed"	"BCBL1 cell, empty vector"
p_37355_2	"BCBL1 cell, 4OHT treated, empty vector"	"BCBL1 cell, empty vector"
p_37355_3	"BCBL1 cell, K13-ER expressed, 4OHT treated"	"BCBL1 cell, empty vector"
p_37416_1	"PMN, LVS treated"	"PMN, control"
p_37427_1	"fibroblast-like synoviocytes, transfected with mimic-miR-23b"	"fibroblast-like synoviocytes, transfected with mimic-NC"
p_3744_1	"Breast cell, tumor"	"Breast cell, normal"
p_3744_10	ER (+) breast cancer	ER (-) breast cancer
p_3744_11	HER2 (+) breast cancer	HER2 (-) breast cancer
p_3744_2	BRCA IF Positive breast cancer	BRCA IF Negative breast cancer
p_3744_3	BRCA mutation (+) breast cancer	BRCA mutation (-) breast cancer
p_3744_4	Xist staining (+) breast cancer	Xist staining (-) breast cancer
p_3744_5	H3mK27 staining (+) breast cancer	H3mK27 staining (-) breast cancer
p_3744_6	ch14 iso (+) breast cancer	ch14 iso (-) breast cancer
p_3744_7	ch17 iso (+) breast cancer	ch17 iso (-) breast cancer
p_3744_8	X methylation assay (+) breast cancer	X methylation assay (-) breast cancer
p_3744_9	PR (+) breast cancer	PR (-) breast cancer
p_37474_1	"trabecular meshwork and corneoscleral tissue, dexamethasone treated, 100nM"	"trabecular meshwork and corneoscleral tissue, control"
p_37552_1	"OS cell, non-metastatic, SaOS-2/LM7, subline"	"OS cell, non-metastatic, SaOS-2, parental line"
p_37552_2	"OS cell, non-metastatic, HOS/143B, subline"	"OS cell, non-metastatic, HOS, parental line"
p_37567_1	"Peripheral blood mononuclear cell , 10 mkM lead acetate treated, 1d"	"Peripheral blood mononuclear cell , control, 1d"
p_37567_2	"Peripheral blood mononuclear cell , wash and RPMI"	"Peripheral blood mononuclear cell , control, 2d"
p_37580_1	"HL60 cell, Eltrombopag 3ug/ml treated"	"HL60 cell, control"
p_37588_1	"monocytes, stimulated with LPS"	"monocyte, normal"
p_37595_1	"KG1-cells, siRNA-Tbet transfected, IL-18 stimulated"	"KG1-cells, siRNAc transfected, IL-18 stimulated"
p_37629_1	"NCI-H226 cells, Spheroid"	"NCI-H226 cells, monolayer"
p_37637_1	"keratinocyte, EXOSC9 Knocked down"	"keratinocyte , coltrol"
p_37637_2	"keratinocyte, EXOSC9 + GRHL3i Knocked down"	"keratinocyte , coltrol"
p_37645_1	"Pancreatic ductal adenocarcinoma tumor xenograft, sensitive to MRK-003"	"Pancreatic ductal adenocarcinoma tumor xenograft, non-sensitive to MRK-003"
p_37659_1	"THP1 cells, IL17RC+"	"THP1 cells, IL17RC-"
p_37667_1	"Blood cell, Prolonged wakefulness"	"Blood cell, control"
p_37667_2	"Blood cell, Sleep recovery"	"Blood cell, control"
p_37715_1	"human hepatocytes, interferon-alpha (IFN-) treated"	"human hepatocytes, control"
p_37715_2	"human hepatocytes, hepatitis C virus (HCV) treated"	"human hepatocytes, control"
p_37715_3	"human hepatocytes, hepatitis C virus (HCV) and interferon-alpha (IFN-)"	"human hepatocytes, control"
p_37768_1	"Lung tissue, smoker"	"Lung tissue, non-smoker"
p_37768_2	"Lung tissue, COPD patient"	"Lung tissue, non-smoker"
p_37796_1	"LNCaP-abl cell, n=8 treated"	"LNCaP-abl cell, empty vehicle"
p_37796_2	"LNCaP-abl cell, cyc treated"	"LNCaP-abl cell, empty vehicle"
p_37796_3	"LNCaP-abl cell, C3 treated"	"LNCaP-abl cell, empty vehicle"
p_37812_1	"PC-3 cell, RD treated"	"PC-3 cell, control"
p_37820_1	"MCF-7 cells, transfected by siRNA targeting estrogen receptor alpha (ESR1)."	"MCF-7 cells, transfected by control siRNA"
p_37838_1	"Renal allograft biopsy, diagnosis: Bad"	"Renal allograft biopsy, diagnosis: Good"
p_37842_1	"DMC driven PCMDM, Passage 30"	"DMC driven PCMDM, Passage 8"
p_37868_1	"CL1-0 cells, FDFT overexpression"	"CL1-0 cells, control vector"
p_37896_1	human iPSC	human embryonic stem cell
p_37896_2	human iPSC	human Adipose stem cell
p_37903_1	"CL1-0 cell, AK4 expressed"	"CL1-0 cell, control"
p_37903_2	"CL1-5 cell, AK4 shRNA vector"	"CL1-5 cell, control"
p_37934_1	SKOV3.ip1-S116D cells	SKOV3.ip1-S116A cells
p_37955_1	"MCF-7/LTED, breast cancer, fulvestrant"	"MCF-7/LTED, breast cancer, ethanol"
p_37955_2	"HCC-1428/LTED, breast cancer, fulvestrant"	"HCC-1428/LTED, breast cancer, ethanol"
p_37964_1	"dnTCF-1E cell, wt, doxycycline treated, 1ug"	"dnTCF-1E cell, wt, water treated"
p_37964_2	"dnTCF-1E cell, wt, doxycycline treated, 6x10E-4ug"	"dnTCF-1E cell, wt, water treated"
p_37964_3	"dnTCF-1E cell, mutant, doxycycline treated, 1ug"	"dnTCF-1E cell, mutant, water treated"
p_37964_4	"dnLEF-1 cell, 1ug doxycycline treated"	"dnLEF-1 cell, water treated"
p_37964_5	"mock cell, 1ug doxycycline treated"	"mock cell, water treated"
p_37982_1	"iPS cells, derived from CML (chronic myelogenous leukemia) patients sample"	"iPS cells, derived from normal cord blood"
p_38010_1	"Brain cell, active plaque"	"Brain cell, control"
p_38010_2	"Brain cell, chronic plaque"	"Brain cell, control"
p_38010_3	"Brain cell, chronic active plaque"	"Brain cell, control"
p_38027_1	"THP-1 cell, Pam3CSK4 treated"	"THP-1 cell, control"
p_38027_2	"THP-1 cell, MP_13 treated"	"THP-1 cell, control"
p_38027_3	"THP-1 cell, MP_25 treated"	"THP-1 cell, control"
p_38043_1	"Treg, metastatic castration-resistant prostate cancer patient"	"Treg, Healthy donor"
p_38058_1	"HSC-3 cells, treated with siRNA for HSF1"	"HSC-3 cells, treated with siRNA for luciferase"
p_38069_1	"reprogrammed iPSCs (chiPS),chips transplanted into HuSCID mice"	"reprogrammed iPSCs (chiPS),chips transplanted into SCID mice"
p_38080_1	"HepG2 cell, Hsp shRNA transfected"	"HepG2 cell, control vector"
p_38080_2	"HepG2 cell, Hsp ORF vector transfected"	"HepG2 cell, control vector"
p_38121_1	"HCC827 cell, resistant to Erlotinib treatment"	"HCC827 cell, sensitive to Erlotinib treatment"
p_38177_1	"heart Right ventricle biopsy, patient with a diagnosis of cyanotic Tetralogy of Fallot congenital heart disease, corrective surgery using controlled reoxygenation cardiopulmonary bypass"	"heart Right ventricle biopsy, patient with a diagnosis of cyanotic Tetralogy of Fallot congenital heart disease, hyperoxic/standard cardiopulmonary bypass"
p_38190_1	Cornea tissue	limbus tissue
p_38190_2	conjunctiva tissue	limbus tissue
p_38312_1	melanoma cell	normal melanocyte
p_38351_1	"Monocytes, healthy donor, stimulated with TNF,1.5 hour"	"Monocytes, healthy donor, isolated immediately after drawing blood"
p_38351_2	"Monocytes, healthy donor, stimulated with IFN2a,1.5 hour"	"Monocytes, healthy donor, isolated immediately after drawing blood"
p_38351_3	"Monocytes, healthy donor, stimulated with IFN,1.5 hour"	"Monocytes, healthy donor, isolated immediately after drawing blood"
p_38351_4	"Monocytes, healthy donor, stimulated with TNF,1.5 hour"	"Monocytes, healthy donor, incubated for 1.5h, without stimulation"
p_38351_5	"Monocytes, healthy donor, stimulated with IFN2a,1.5 hour"	"Monocytes, healthy donor, incubated for 1.5h, without stimulation"
p_38351_6	"Monocytes, healthy donor, stimulated with IFN,1.5 hour"	"Monocytes, healthy donor, incubated for 1.5h, without stimulation"
p_38396_1	"Human dermal microvascular lymphatic endothelial cells (HDLEC), type 2 diabetic adult, undergoing leg amputation"	"Human dermal microvascular lymphatic endothelial cells (HDLEC),healthy adults, undergoing abdominoplasty"
p_38408_1	"A549 cells, TIMP-2 transfected"	"A549 cells, EV control"
p_38408_2	"A549 cells, Ala+TIMP-2 transfected"	"A549 cells, EV control"
p_38408_3	"A549 cells, tumor xenograft, TIMP-2 transfected"	"A549 cells, EV control, tumor xenograft"
p_38408_4	"A549 cells, tumor xenograft, Ala+TIMP-2 transfected"	"A549 cells, EV control, tumor xenograft"
p_38422_1	"HEK293T cell, transfected, GFP positive"	"HEK293T cell, control"
p_38422_2	"HEK293T cell, untransfected"	"HEK293T cell, control"
p_38453_1	"nasopharyngeal carcinoma cells (NA), TPA/SB combined MNNG (TS-MG) treated, passage 10"	"nasopharyngeal carcinoma cells (NA), mock-treated, passage 1"
p_38506_1	"mammary fibroblast, high mammographic density (MD)"	"mammary fibroblast, low mammographic density (MD)"
p_38583_1	"UM-SCC-81B, low glucose(0.1mM), 4hrs"	"UM-SCC-81B, without glucose deprivation treatment"
p_38583_2	"UM-SCC-81B, low glucose(0.1mM), 24hrs"	"UM-SCC-81B, without glucose deprivation treatment"
p_38597_2	"liver, acute hepatitis C"	"liver, healthy"
p_38598_1	"liver biopsy, acute hepatitis C"	"liver biopsy, healthy control"
p_38663_1	"Liver biopsy, IFN treated"	"Liver biopsy, control"
p_38663_2	"Liver biopsy, RBV treated"	"Liver biopsy, control"
p_38663_3	"Liver biopsy, IFN + RBV treated"	"Liver biopsy, control"
p_38680_1	"Biceps muscle, Pompe patient"	"Biceps muscle, Control patients"
p_38680_2	"Quadriceps muscle, Pompe patient, rhGAA treatment, 0week"	"Quadriceps muscle, Control patients"
p_38680_3	"Quadriceps muscle, Pompe patient, rhGAA treatment, 12week"	"Quadriceps muscle, Control patients"
p_38680_4	"Quadriceps muscle, Pompe patient, rhGAA treatment, 52week"	"Quadriceps muscle, Control patients"
p_38692_1	"Normal CD34+ Cord Blood, transfected with ASXL1-shRNA"	"Normal CD34+ Cord Blood, transfected with vector control"
p_38697_1	"Germinal center B cells (CD19+CD38+IgD-), human tonsil dark zone"	"Germinal center B cells (CD19+CD38+IgD-), human tonsil light zone"
p_38718_1	"Muscle biopsy, young men"	"Muscle biopsy, young women"
p_38718_2	"Muscle biopsy, old men"	"Muscle biopsy, old women"
p_38749_1	"Gastric adenoma, less than 24 months of survival"	"Gastric adenoma, more than 24 months of survival"
p_38772_1	"Panc-1 controls cells (siCtrl), incubated for 7 hrs before TGF1 treatment"	"Panc-1 controls cells (siCtrl), incubated without TGF1 (Mock)"
p_38772_2	"Panc-1 controls cells (siCtrl), incubated for 24 hrs before TGF1 treatment"	"Panc-1 controls cells (siCtrl), incubated without TGF1 (Mock)"
p_38772_3	"Panc-1 Nupr1-depleted cells (sip8), incubated for 7 hrs before TGF1 treatment"	"Panc-1 Nupr1-depleted cells (sip8), incubated without TGF1 (Mock)"
p_38772_4	"Panc-1 Nupr1-depleted cells (sip8), incubated for 24 hrs before TGF1 treatment"	"Panc-1 Nupr1-depleted cells (sip8), incubated without TGF1 (Mock)"
p_38780_1	"Extraocular muscle, strabismus"	"Extraocular muscle, normal"
p_38816_1	"Follicular Lymphoma B-cells, high expression of CD20"	"Follicular Lymphoma B-cells, intermediate expression of CD20"
p_38833_1	"Caco-2 cell, 10uM EHTy treated"	"Caco-2 cell, control"
p_38833_2	"Caco-2 cell, 10uM HTy treated"	"Caco-2 cell, control"
p_38836_1	"T cell, activated in micro Gravity"	"T cell, control"
p_38836_2	"T cell, activated in 1 Gravity"	"T cell, control"
p_38885_1	"post-transplant lymphoma, EBV positive"	"post-transplant lymphoma, EBV negative"
p_38885_2	"post-transplant lymphoma, EBV negative"	"immunocompetent lymphoma, EBV negative"
p_38934_1	"Lung emphysematous lesion, CPFE patient"	"Lung fibrous lesion, CPFE patient"
p_38972_1	"PC3 cell, Wee1 inhibitor treated"	"PC3 cell, control"
p_38972_2	"PC3 cell, Hsp90 inhibitor treated"	"PC3 cell, control"
p_38972_3	"PC3 cell, Hsp90 inhibitor, Wee1 inhibitor treated"	"PC3 cell, control"
p_39042_1	"MDA-MB-231 cell, hypoxia, control (CTL)"	"MDA-MB-231 cell, normoxia ,control (CTL)"
p_39042_2	"MDA-MB-231 cell, hypoxia, paclitaxel (TAX)"	"MDA-MB-231 cell, normoxia, paclitaxel (TAX)"
p_39042_3	"MDA-MB-231 cell, hypoxia epirubicin (EPI)"	"MDA-MB-231 cell, normoxia, epirubicin (EPI)"
p_39177_1	"Hs68 cell, heat stress, 0h"	"Hs68 cell, control"
p_39177_2	"Hs68 cell, heat stress, 1h"	"Hs68 cell, control"
p_39177_3	"Hs68 cell, heat stress, 3h"	"Hs68 cell, control"
p_39178_1	"OUMS-36 cell, heat stress, 0h"	"OUMS-36 cell, control"
p_39178_2	"OUMS-36 cell, heat stress, 1h"	"OUMS-36 cell, control"
p_39178_3	"OUMS-36 cell, heat stress, 3h"	"OUMS-36 cell, control"
p_39204_1	"Ovarian cancer, ascites_cytology:negative"	"Ovarian cancer, ascites_cytology:positive"
p_39218_1	"IMR32 cells, shMYCN virus, 24h"	"IMR32 cells, control virus, 24h"
p_39218_2	"IMR32 cells, shMYCN virus, 48h"	"IMR32 cells, control virus, 48h"
p_39218_3	"IMR32 cells, shMYCN virus, 72h"	"IMR32 cells, control virus, 72h"
p_39227_1	"293T cell, miR-941 overexpression"	"293T cell, control"
p_39335_1	"Bone marrow cells, Philadelphia positive ALL, good-risk, after treatment (day17)"	"Bone marrow cells, Philadelphia positive ALL, good-risk, before treatment (day0)"
p_39335_2	"Bone marrow cells, Philadelphia positive ALL, poor-risk, after treatment (day17)"	"Bone marrow cells, Philadelphia positive ALL, poor-risk, before treatment (day0)"
p_39339_1	"CCRF-CEM-C7-14 cell line, dexamethasone treatment, 2h"	"CCRF-CEM-C7-14 cell line, before dexamethasone treatment (0 h)"
p_39339_2	"CCRF-CEM-C7-14 cell line, dexamethasone treatment, 10h"	"CCRF-CEM-C7-14 cell line, before dexamethasone treatment (0 h)"
p_39353_1	"RWPE-1 cell, ETV-1 overexpressed"	"RWPE-1 cell, control"
p_39353_2	"RWPE-1 cell, ERG overexpressed"	"RWPE-1 cell, control"
p_39354_1	"VCaP cells, siRNA targeting ERG, EtOH treated"	"VCaP cells, control siRNA, EtOH treated"
p_39354_2	"VCaP cells, siRNA targeting ERG, DHT treated, 10nM"	"VCaP cells, control siRNA, DHT treated, 10nM"
p_39354_3	"LNCaP cells, shRNA targeting ETV1, EtOH treated"	"LNCaP cells, control shRNA, EtOH treated"
p_39354_4	"LNCaP cells, shRNA targeting ETV1, DHT treated"	"LNCaP cells, control shRNA, DHT treated"
p_39388_1	"RWPE-1 cell, ETV1 activated"	"RWPE-1 cell, control"
p_39388_2	"RWPE-1 cell, ERG activated"	"RWPE-1 cell, control"
p_39388_3	"VCaP cell, siERG, EtOH treated"	"VCaP cell, siControl, EtOH treated"
p_39388_4	"VCaP cell, siERG, DHT treated"	"VCaP cell, siControl, DHT treated"
p_39388_5	"LNCaP cell, shETV1, EtOH treated"	"LNCaP cell, shControl, EtOH treated"
p_39388_6	"LNCaP cell, shETV1, DHT treated"	"LNCaP cell, shControl, DHT treated"
p_39394_1	"CCD-Co-18 cell, TGF- beta treated"	"CCD-Co-18 cell, contol"
p_39409_1	pancreatic adenocarcinomas	ampullary adenocarcinomas
p_39409_2	duodenal adenocarcinomas	ampullary adenocarcinomas
p_39409_3	extrahepatic biliary adenocarcinomas	ampullary adenocarcinomas
p_39452_1	"LNCaP-abl cell, EZH2 silenced, VEH"	"LNCaP-abl cell, control, VEH"
p_39452_2	"LNCaP-abl cell, EZH2 silenced, DHT"	"LNCaP-abl cell, control, DHT"
p_39461_1	"LNCaP-abl (abl) cells, depleted of EZH2, hormone depleted"	"LNCaP-abl (abl) cells, transfected with control siRNA, hormone depleted"
p_39461_2	"LNCaP cells, depleted of EZH2, 10nM DHT"	"LNCaP cells, transfected with control siRNA, 10nM DHT"
p_39503_1	"Lymph node biopsy, IL10R2 patient"	"Tonsil cell, control"
p_39503_2	"Human blood cell, IL10R2 patient"	"Tonsil cell, control"
p_39504_1	"FlpIn T-Rex Human embryonic kidney 293 stable cell line, Immunoprecipitate"	"FlpIn T-Rex Human embryonic kidney 293 stable cell line, lysate"
p_39508_1	Low IL-2 IFN:index derived CD8+ T cell	High IL-2:IFN index derived CD8+ T cell
p_39730_1	"mononuclear cell from bone marrow, p53-miR-34a treated"	mononuclear cell from peripheral blood
p_39733_1	"A549 cell, FAM60A silenced"	"A549 cell, control"
p_39733_2	"A549 cell, SDS3 silenced"	"A549 cell, control"
p_39744_1	"HeLa cell, EHMT1 siRNA treated"	"HeLa cell, control siRNA treated"
p_39744_2	"HeLa cell, EHMT1 siRNA + TNF treated"	"HeLa cell, control siRNA + TNF treated"
p_39763_1	"Endothelial progenitor cells, peripheral blood"	"Endothelial progenitor cells, Cord blood"
p_39839_1	"c-kit-positive cells, Amniotic fluid-derived, late passage"	"c-kit-positive cells, Amniotic fluid-derived cells, early passage"
p_39840_1	"Monocyte, LPS treated"	"Monocyte, PBS, control"
p_39840_2	"Polymorphonuclear cell, LPS treated"	"Polymorphonuclear cell, PBS, control"
p_39889_1	"Neutrophil cell, smooth mab exposured"	"Neutrophil cell, saline mab exposured"
p_39889_2	"Neutrophil cell, S.aureus exposured"	"Neutrophil cell, saline mab exposured"
p_39889_3	"Neutrophil cell, rough mab exposured"	"Neutrophil cell, saline mab exposured"
p_39890_1	"KGN cell, FOXL2 silenced"	"KGN cell, control"
p_39890_2	"COV434, pFOXL2 mutant"	"COV434, control"
p_39902_1	"MCF10-T1k (MII), APC siRNA"	"MCF10-T1k (MII), control siRNA"
p_39902_2	"MCF10-T1k (MII), APC siRNA+TAZ siRNA"	"MCF10-T1k (MII), control siRNA"
p_39902_3	"MCF10-T1k (MII), beta-catenin siRNA"	"MCF10-T1k (MII), control siRNA"
p_39902_4	"MCF10-T1k (MII), beta-catenin siRNA+TAZ siRNA"	"MCF10-T1k (MII), control siRNA"
p_39904_1	"SW480 cell, siTAZ treated"	"SW480 cell, siGFP treated"
p_39904_2	"SW480 cell, sibcat treated"	"SW480 cell, siGFP treated"
p_39904_3	"SW480 cell, APC treated"	"SW480 cell, siGFP treated"
p_39999_1	"immature dendritic cells (iDCs), 1 mg/l human recombinant interleukin 8(IL-8)"	immature dendritic cells (iDCs)
p_39999_2	"immature dendritic cells (iDCs), recombinant Brugia malayi asparaginyl t RNA synthetase(AsnRS)"	immature dendritic cells (iDCs)
p_40051_1	"U87 glioma cell, transfected with FOXM1 siRNA"	"U87 glioma cell, transfected with none target siRNA"
p_40122_1	"Organotypic human epidermis, Staufen1 Knock down"	"Organotypic human epidermis, Control Staufen1"
p_40122_2	"Organotypic human epidermis, TINCR Knock down"	"Organotypic human epidermis, Control TINCR (terminal differentiation-induced ncRNA)"
p_40123_1	"Organotypic human epidermis, siSTAU treated"	"Organotypic human epidermis, control"
p_40123_2	"Organotypic human epidermis, siTINCR treated"	"Organotypic human epidermis, control"
p_40160_1	Cultured classical Hodgkin lymphoma (cHL) cells	Primary mediastinal B-cell lymphoma
p_40182_1	"Preeclampsia trophoblasts, 0h"	"Preterm labor trophoblasts, 0h"
p_40182_2	"Preeclampsia trophoblasts, 12h"	"Preterm labor trophoblasts, 12h"
p_40182_3	"Preeclampsia trophoblasts, 24h"	"Preterm labor trophoblasts, 24h"
p_40182_4	"Preeclampsia trophoblasts, 48h"	"Preterm labor trophoblasts, 48h"
p_40215_1	"HeLaS3 cells, transducd with shNF-YA"	"HeLaS3 cells, transducd with scSCM, control"
p_4030_1	"Schwann cells, heregulin + forskolin treated, passage 3"	"Schwann cells, heregulin + forskolin treated, passage 1"
p_40301_1	"Renal cell carcinoma , rhTimp1 treated"	"Renal cell carcinoma , empty vector"
p_40301_2	"Renal cell carcinoma ,TMIP-1-GPI 7ng treated"	"Renal cell carcinoma , empty vector"
p_40301_3	"Renal cell carcinoma ,TIMP-1-GPI 14ng treated"	"Renal cell carcinoma , empty vector"
p_40349_1	"IMR90, senescent, infected with Ras and control hairpin (shLuciferase)"	"IMR90, growing"
p_40349_2	"IMR90, senescent, infected with Ras and RB hairpin"	"IMR90, growing"
p_40349_3	"IMR90, senescent, infected with Ras and E2F7 hairpin"	"IMR90, growing"
p_40349_4	"IMR90, senescent, infected with Ras and RB and E2F7 hairpins"	"IMR90, growing"
p_4036_1	"cerebellar tissue, Schizophrenia patients"	"cerebellar tissue, matched control"
p_40404_1	"human fibroblasts, overexpressing prelamin A"	"human fibroblasts, control"
p_40404_2	"human fibroblasts, overexpressing prelamin A and ZMPSTE24"	"human fibroblasts, control"
p_40404_3	"human fibroblasts, treated with FTI"	"human fibroblasts, control"
p_40404_4	"human fibroblasts, overexpressing progerin"	"human fibroblasts, control"
p_40404_5	"human fibroblasts, overexpressing progerin treated with FTI"	"human fibroblasts, control"
p_40422_1	"SkMel30 cells, transduced HOXA1"	"SkMel30 cells, transduced with GFP control"
p_40424_1	"A549 cells, transfected by hMOF siRNA"	"A549 cells, transfected by scramble siRNA"
p_40424_2	"H1299 cells, transfected by hMOF siRNA"	"H1299 cells, transfected by scramble siRNA"
p_40438_1	"Lumbar spinal motor neurons, vulnerable to amyotrophic lateral sclerosis"	"Oculomotor neurons, resistant to amyotrophic lateral sclerosis"
p_40444_1	"H9-hESC cell, control"	"HUF1 skin fibroblasts, control"
p_40444_2	"HUF1 skin fibroblasts, OCT4 treated"	"HUF1 skin fibroblasts, control"
p_40444_3	"HUF1 skin fibroblasts, OCT4, BAY11 treated"	"HUF1 skin fibroblasts, control"
p_40512_1	"KOPTK1 cell, treated with CDK4/6 inhibitor PD 0332991"	"KOPTK1 cell, control"
p_40564_1	"H69, PIK75"	"H69, none"
p_40564_2	"H69, TGX221"	"H69, none"
p_40567_1	"U-2 OS cells, expressing full-length SV40 LT"	"U-2 OS cells, control"
p_40567_2	"U-2 OS cells, expressing SV40 LT fragment T6"	"U-2 OS cells, control"
p_40567_3	"U-2 OS cells, expressing SV40 LT fragment T8"	"U-2 OS cells, control"
p_40567_4	"U-2 OS cells, expressing SV40 LT fragment T16"	"U-2 OS cells, control"
p_40580_1	"HepG2, PADMA28 treated"	"HepG2, EtOH treated, control"
p_40611_1	"parotid tissue, primary Sjogren syndrome patient"	"parotid tissue, control"
p_40611_2	"parotid tissue, sicca patient"	"parotid tissue, control"
p_40613_1	"MSCs, co-cultured with PECs+FACS separated"	"MSCs, cultured alone"
p_40635_1	"CEM cells, PD-0332991 treated, 1uM, 15h"	"CEM cells, DMSO treated, 15h, control"
p_40635_2	"CUTL1 cells, PD-0332991 treated, 1uM, 15h"	"CUTL1 cells, DMSO treated, 15h, control"
p_40635_3	"DND41 cells, PD-0332991 treated, 1uM, 15h"	"DND41 cells, DMSO treated, 15h, control"
p_40635_4	"Jurkat cells, PD-0332991 treated, 1uM, 15h"	"Jurkat cells, DMSO treated, 15h, control"
p_40709_1	"hESC, Insulin negative"	Human Islet cell
p_40709_2	"hESC, Insulin positive"	Human Islet cell
p_40830_1	"CFU-M cell, 0d"	"Megakaryocyte cell, 0d"
p_40830_2	"CFU-M cell, 4d"	"Megakaryocyte cell, 4d"
p_40831_1	"CD34-CD41+CD61+CD45- megakaryocytes, umbilical cord blood, 0 Day"	"CD34-CD33+CD13+ colony forming unit-monocytes, 0 day"
p_40831_2	"CD34-CD41+CD61+CD45- megakaryocytes, 4 days"	"CD34-CD33+CD13+ colony forming unit-monocytes, 4 days"
p_40837_1	"Human breast tumor, post sorafenib treatment"	"Human breast tumor, pre sorafenib treatment"
p_4086_1	"P493-6 cells, hypoxia"	"P493-6 cells, non-hypoxia"
p_40885_1	"alveolar macrophage, LPS treated"	"alveolar macrophage, saline treated, control"
p_40893_1	CD105-positive erythroid cells	CD14-positive cells
p_40893_2	CD34-positive common precursor cells	CD14-positive cells
p_40893_3	CD105-positive erythroid cells	CD34-positive common precursor cells
p_40960_1	"cultured passage-3 human dermal microvascular endothelial cells (HMVEC-D),BMP9 treated"	"cultured passage-3 human dermal microvascular endothelial cells (HMVEC-D), control"
p_40968_1	"MCF-7 Tet-On cells, breast cancer, ACSL4-induced"	"MCF-7 Tet-On cells, breast cancer, control"
p_40968_2	"MCF-7, breast cancer, ACSL4-transfected"	"MCF-7, breast cancer, control"
p_40968_3	"SKBr3, breast cancer, ACSL4-transfected"	"SKBr3, breast cancer, control"
p_40971_1	"Pfeiffer cell, GSK126 treated"	"Pfeiffer cell, vehicle"
p_40971_10	"Toledo cell, GSK126 treated"	"Toledo cell, vehicle"
p_40971_2	"WSU-DLCL2 cell, GSK126 treated"	"WSU-DLCL2 cell, vehicle"
p_40971_3	"KARPAS-422 cell, GSK126 treated"	"KARPAS-422 cell, vehicle"
p_40971_4	"SU-DHL-10 cell, GSK126 treated"	"SU-DHL-10 cell, vehicle"
p_40971_5	"HT cell, GSK126 treated"	"HT cell, vehicle"
p_40971_6	"SU-DHL-6 cell, GSK126 treated"	"SU-DHL-6 cell, vehicle"
p_40971_7	"DB cell, GSK126 treated"	"DB cell, vehicle"
p_40971_8	"OCI-LY-19 cell, GSK126 treated"	"OCI-LY-19 cell, vehicle"
p_40971_9	"SU-DHL-4 cell, GSK126 treated"	"SU-DHL-4 cell, vehicle"
p_40988_1	"L-428 cells, knock-down of PRAME"	"L-428 cells, control vector"
p_41035_1	"RT112 cells, FGFR3 shRNA, no doxycycline"	"RT112 cells, EGFP shRNA, no doxycycline"
p_41035_2	"RT112 cells, FGFR3 shRNA, doxycycline treated"	"RT112 cells, EGFP shRNA, doxycycline treated"
p_4107_1	early onset colorectal cancer; colon	healthy control
p_41137_12	"VHL Clear Cell Renal Cell Carcinoma, stored at 37C, frozen at 60min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41137_13	"VHL Clear Cell Renal Cell Carcinoma, stored at 37C, frozen at 120min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41137_3	"VHL Clear Cell Renal Cell Carcinoma, stored at 4C, frozen at 60min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41137_4	"VHL Clear Cell Renal Cell Carcinoma, stored at 4C, frozen at 120min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41137_8	"VHL Clear Cell Renal Cell Carcinoma, stored at 22C, frozen at 60min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41137_9	"VHL Clear Cell Renal Cell Carcinoma, stored at 22C, frozen at 120min"	"VHL Clear Cell Renal Cell Carcinoma, snap frozen"
p_41239_1	"KARPAS-422 cell, EZH2 inhibited"	"KARPAS-422 cell, coltrol"
p_41239_2	"Pfeiffer cell, EZH2 inhibited"	"Pfeiffer cell, control"
p_41315_1	Diffusued large B cell lymphomas + EZH2i 1d	Diffusued large B cell lymphomas + DMSO 1d
p_41315_2	Diffusued large B cell lymphomas + EZH2i 2d	Diffusued large B cell lymphomas + DMSO 2d
p_41315_3	Diffusued large B cell lymphomas + EZH2i 3d	Diffusued large B cell lymphomas + DMSO 3d
p_41315_4	Diffusued large B cell lymphomas + EZH2i 6d	Diffusued large B cell lymphomas + DMSO 6d
p_41326_1	"HepG2, transfected with RNF43 siRNA"	"HepG2, transfected with negative control siRNA"
p_41328_1	Colorectal adenocarcinomas	Normal colonic tissues
p_41386_1	"myometrial smooth muscle cell, siREST treated, 48h"	"myometrial smooth muscle cell, the scrambled siRNA treated, 48h"
p_41386_2	"Leiomyoma smooth muscle cell, the scrambled siRNA treated, 48h"	"myometrial smooth muscle cell, the scrambled siRNA treated, 48h"
p_41459_1	"trophoblast, shRNA targeting PRR15 mRNA"	"trophoblast, control"
p_41469_1	CD56-NKp46lowCD117brightCD127bright cells	"CD56+NKp46+CD117-CD127- cells, control"
p_41498_1	"benign_serous tumor, cyst"	"serous tumor, control"
p_41498_2	"benign_serous tumor, cystadenoma"	"serous tumor, control"
p_41498_3	"benign_serous tumor, cystadenofibroma"	"serous tumor, control"
p_41571_1	"Macrophages, LMDed from Ruptured Carotid Atheromatous Plaque"	"Macrophages, LMDed from Stable Carotid Atheromatous Plaque"
p_41600_1	"BEAS-2B cell, DMSO, Elastase, 3h"	"BEAS-2B cell, DMSO, NaOAC, 3h"
p_41600_2	"BEAS-2B cell, symplostatin 5, Elastase, 3h"	"BEAS-2B cell, symplostatin 5, NaOAC, 3h"
p_41627_1	"Light polyribosome, MCF10A, genotype: wild type, exposed to 10Gy of IR"	"Light polyribosome, MCF10A, genotype: wild type, mock treated"
p_41627_2	"Heavy polyribosome, MCF10A, genotype: wild type, exposed to 10Gy of IR"	"Heavy polyribosome, MCF10A, genotype: wild type, mock treated"
p_41627_3	"Light polyribosome, MCF10A, eIF4G1 knock down, exposed to 10Gy of IR"	"Light polyribosome, MCF10A, eIF4G1 knock down, mock treated"
p_41627_4	"Heavy polyribosome, MCF10A, genotype: eIF4G1 knock down, exposed to 10Gy of IR"	"Heavy polyribosome, MCF10A, genotype: eIF4G1 knock down, mock treated"
p_41627_5	"Total lysate, MCF10A, genotype: wild type, exposed to 10Gy of IR"	"Total lysate, MCF10A, genotype: wild type, mock treated"
p_41627_6	"Total lysate, MCF10A, genotype: eIF4G1 knock down, exposed to 10Gy of IR"	"Total lysate, MCF10A, genotype: eIF4G1 knock down, mock treated"
p_41627_7	"Light polyribosome, MCF10A, eIF4G1 knock down, exposed to 10Gy of IR"	"Light polyribosome, MCF10A, genotype: wild type, exposed to 10Gy of IR"
p_41627_8	"Heavy polyribosome, MCF10A, genotype: eIF4G1 knock down, exposed to 10Gy of IR"	"Heavy polyribosome, MCF10A, genotype: wild type, exposed to 10Gy of IR"
p_41635_1	"MCF-7 cell, ALK over-expressed"	"MCF-7 cell, Control"
p_41662_1	skin lesional	"skin, non-lesional"
p_41663_1	"Skin cell, psoriasis lesional skin"	"Skin cell, non-lesional"
p_41663_2	"Skin cell, Etanercept treated, 1w"	"Skin cell, non-lesional"
p_41663_3	"Skin cell, Etanercept treated, 2w"	"Skin cell, non-lesional"
p_41663_4	"Skin cell, Etanercept treated, 4w"	"Skin cell, non-lesional"
p_41663_5	"Skin cell, Etanercept treated, 12w"	"Skin cell, non-lesional"
p_41802_1	"HCT116 cells, IDH1 mutation (IDH1 R132H/+)"	"HCT116 cells, wild type"
p_41802_2	"HCT116 cells, IDH1 mutation (IDH1 R132C/+)"	"HCT116 cells, wild type"
p_41802_3	"HCT116 cells, IDH2 mutation (IDH2 R140Q/+)"	"HCT116 cells, wild type"
p_41802_4	"HCT116 cells, IDH2 mutation (IDH2 R172K/+)"	"HCT116 cells, wild type"
p_4182_1	Polygenic neural tube defect; tissue	Controls
p_41827_1	"HeLa, treated with Cas-II-gly"	"HeLa, control"
p_4183_1	"colon, adenoma"	"colon, normal"
p_4183_2	"colon, colorectal carcinomas (CRC)"	"colon, normal"
p_4183_3	"colon, inflammatory bowel diseases (IBD)"	"colon, normal"
p_41855_1	"Human B lymphoid RL cell line (ATCC: CRL-2261), MALC, 14 days, quiescent cells"	"Human B lymphoid RL cell line (ATCC: CRL-2261), MALC, 14 days, cycling cells"
p_41856_1	"Human B lymphoid RL cell line, suspension cells, exponential"	"Human B lymphoid RL cell line, MALC, 10 days"
p_41856_2	"Human B lymphoid RL cell line (ATCC: CRL-2261), MALC, 14 days, cycling cells"	"Human B lymphoid RL cell line, MALC, 14 days, quiescent cells"
p_41972_1	"MCF7 cell, DCTP treated"	"MCF7 cell, AS1411 aptamer"
p_42058_1	"CD11c+ cells, HIV infected"	"CD11c+ cells, HIV uninfected"
p_42088_1	"Dendritic Cell, leishmania major infected, 2hrs"	"Dendritic Cell, uninfected 2hrs"
p_42088_2	"Dendritic Cell, leishmania major infected, 4hrs"	"Dendritic Cell, uninfected 2hrs"
p_42088_3	"Dendritic Cell, leishmania major infected, 8hrs"	"Dendritic Cell, uninfected 2hrs"
p_42088_4	"Dendritic Cell, leishmania major infected, 24hrs"	"Dendritic Cell, uninfected 2hrs"
p_4217_1	"HFF2, Spheroid"	"HFF2, Monolayer"
p_4217_2	"HFF2, Spheroid recovery"	"HFF2, Monolayer"
p_4217_3	"HFF2, Monolayer recovery"	"HFF2, Monolayer"
p_42174_1	"DLBCL cell line RL, transfected with a tetracycline-inducible LITAF"	"DLBCL cell line RL, transfected with a tetracycline-inducible LITAF expression vector, absence of doxycycline"
p_42174_2	"DLBCL cell line SC-1, transfected with a tetracycline-inducible LITAF"	"DLBCL cell line SC-1, transfected with a tetracycline-inducible LITAF expression vector, absence of doxycycline"
p_42174_3	"DLBCL cell line KARPAS-231, transfected with a LITAF-specific siRNA"	"KARPAS-231 cells, non-targeting siRNA"
p_42174_4	"VAL cells, siRNA targeting LITAF"	"VAL cells, non-targeting siRNA"
p_4218_1	"T98G, Spheroid"	"T98G, Monolayer"
p_4218_2	"T98G, Spheroid recovery"	"T98G, Monolayer"
p_4218_3	"T98G, Monolayer recovery"	"T98G, Monolayer"
p_4219_1	"HFF2, Spheroid"	"HFF2, Monolayer"
p_4219_2	"HFF2, Spheroid recovery"	"HFF2, Monolayer"
p_4219_3	"HFF2, Monolayer recovery"	"HFF2, Monolayer"
p_4219_4	"T98G, Spheroid"	"T98G, Monolayer"
p_4219_5	"T98G, Spheroid recovery"	"T98G, Monolayer"
p_4219_6	"T98G, Monolayer recovery"	"T98G, Monolayer"
p_42253_1	"CD4 T cells, Hsp90 inhibitor"	"CD4 T cells, control"
p_42253_2	"CD8 T cells, Hsp90 inhibitor"	"CD8 T cells, control"
p_42253_3	"CD8 T cells, Hsp90 inhibitor"	"NK cells, control"
p_42259_1	"THP cell line, Dll4-Fc treated"	"THP cell line, untreated"
p_42291_1	"HUVEC, CRL-2615 infected by HIV"	"HUVEC, control"
p_42320_1	"Ovcar5 cells, ShRNA tageted to IKKe (B2)"	"Ovcar5 cells, control shRNA"
p_42344_1	"Leukemia cell, JS-K treated, 1.5h"	"Leukemia cell , JS-K untreated"
p_42344_2	"Leukemia cell, JS-K treated, 4h"	"Leukemia cell , JS-K untreated"
p_42344_3	"Leukemia cell, JS-K treated, 24h"	"Leukemia cell , JS-K untreated"
p_42363_1	"EAC primary tumor, moderate grade"	"EAC primary tumor, poor grade"
p_4237_1	"Pituitary adenoma, invasive"	"Pituitary adenoma, non-invasive"
p_4237_2	"Pituitary adenoma, recurrent"	"Pituitary adenoma, non-recurrent"
p_42407_1	"Lung adenocarcinoma (CL1-5), highly invasive"	"Lung adenocarcinoma (CL1-0), poorly invasive"
p_4250_1	Hereditary gingival fibromatosis(HGF) patient; tissue	Normal Gingiva
p_42672_1	HUVEC	Fibroblast
p_42672_2	Induced endothelial cell from CRL-2097	Fibroblast
p_42672_3	Induced endothelial cell from BJ	Fibroblast
p_42733_1	CD14 monocyte	Nurse-like cell (NLC)
p_42743_1	oral cancer samples	matched normal samples
p_42802_1	"293T cell, stimulated with recombinant IFNbeta, 12h"	"293T cells, unstimulated"
p_42853_1	"PBMC, Tetanus toxoid+"	"PBMC, CMV+"
p_42853_2	"PBMC, Candida Albicans+"	"PBMC, CMV+"
p_42867_1	"Awia-BL, EBV positive, Latency I clones"	"Awia-BL, EBV negative clones"
p_42867_2	"Awia-BL, EBV positive, Wp-restricted clones"	"Awia-BL, EBV negative clones"
p_42989_1	"293T cell, tRNA vector"	"293T cell, empty vector"
p_42989_2	"293T cell, hairpin vector"	"293T cell, empty vector"
p_43017_1	Adult T-cell leukemia (ATL) cells	"CD4+ T lymphocytes, healthy control"
p_4302_1	"airway epithelial brushing, Asthmatics"	"airway epithelial brushing, healthy control"
p_4302_2	"airway epithelial brushing, Smoker"	"airway epithelial brushing, healthy control"
p_4302_3	"airway epithelial brushing, Asthmatics after fluticasone treatment"	"airway epithelial brushing, no treat"
p_43124_1	"CD34+, from patients post-G-CSF+Cytoxan therapy"	"CD34+ cells, patients post DoVeD therapy"
p_43179_1	"peripheral blood T cell, patients"	"peripheral blood T cell, control"
p_43210_1	"PBMC, anti-CD3/CD28 treated"	"PBMC, untreated donor"
p_43210_2	"PBMC, anti-CD3/CD28 treated, CRAC inhibitor"	"PBMC, untreated donor"
p_43210_3	"PBMC, anti-CD3/CD28 treatead, CsA inhibitor"	"PBMC, untreated donor"
p_43210_4	"PBMC, anti-CD3/CD28 treatead, FK506 inhibitor"	"PBMC, untreated donor"
p_43257_1	RPE derived from 253G1 iPSC	Primary RPE (Retinal Pigment Epithelium)
p_43608_1	"HCT116, hypoxia, 3 days"	"HCT116, normoxia, 3 days"
p_43653_1	"ECC, DEHP treated"	"ECC, control"
p_43700_1	"peripheral blood nmonuclear cells, stimulated with IL-10, 10ng/ml, 24h"	"peripheral blood mononuclear cells, stimulated with media alone, 24h"
p_43701_1	"Hela cell, MHT treated, 0h"	"Hela cell, control"
p_43701_2	"Hela cell, MHT treated, 1h"	"Hela cell, control"
p_43701_3	"Hela cell, MHT treated, 3h"	"Hela cell, control"
p_43762_1	"GBM, Sphere, after 7day"	"GBM, Sphere, after 2day"
p_43762_2	"GBM, Differentiation, after 7day"	"GBM, Differentiation, after 2day"
p_43777_1	PBMC. dengue hemorrhagic fever	"PBMC, dengue fever"
p_43862_1	"HSC-3 cell, MHT treated, 0h"	"HSC-3 cell, control"
p_43862_2	"HSC-3 cell, MHT treated, 1h"	"HSC-3 cell, control"
p_43862_3	"HSC-3 cell, MHT treated, 3h"	"HSC-3 cell, control"
p_43881_1	"LNCaP-abl, siRNA targeting HIPK2"	"LNCaP-abl, control"
p_43881_2	"LNCaP-abl, siRNA targeting MED19"	"LNCaP-abl, control"
p_43884_1	"A2780 cells, shRNA targeting UCHL1"	"A2780 cells, non-target shRNA"
p_43923_1	Osteophytic cartilage	Articular cartilage
p_44029_1	"Sw480 cell line, treated with shRNA against gankyrin, 4 days"	"SW480 cell line, treated with non targeting shRNA, 4 days"
p_44335_1	"HMLER, retroviral vector expressing FOXC2"	"HMLER, control vector"
p_44337_1	human diffuse large B cells (DLBCL)	human peripheral blood B-cells
p_44541_1	"BE(2)-C neuronal cells, Antimycin A1a treated"	"BE(2)-C neuronal cells, DMSO treated"
p_44541_2	"BE(2)-C neuronal cells, Unfractionated antimycin A treated"	"BE(2)-C neuronal cells, DMSO treated"
p_44740_1	"gastric myofibroblasts, cancer associated, non-regulated exocytosis in response to acute stimulation with IGF"	"gastric myofibroblasts, cancer associated, regulated exocytosis in response to acute stimulation with IGF"
p_44740_2	"gastric myofibroblasts, Adjacent tissue associated, non-regulated exocytosis in response to acute stimulation with IGF"	"gastric myofibroblasts, Adjacent tissue, regulated exocytosis in response to acute stimulation with IGF"
p_44740_3	"gastric myofibroblasts, pernicious anaemia patient, non-regulated exocytosis in response to acute stimulation with IGF"	"gastric myofibroblasts, pernicious anaemia patient, regulated exocytosis in response to acute stimulation with IGF"
p_44841_1	"Glioblastoma multiforme cells, differentiation, 4 days"	"Glioblastoma multiforme cells, neurosphere, 4days"
p_44857_1	"AML xenografts, DAC treated"	"AML xenografts, control"
p_44857_2	"AML xenografts, Ara-C treated"	"AML xenografts, control"
p_44857_3	"AML xenografts, Ara-C, DAC treated"	"AML xenografts, control"
p_4527_1	"TH cells, UBD-transformed"	"TH cells, control vector"
p_4536_2	"NBE-cultured GBMs, passage 8; brain cancer"	"serum-cultured GBMs, passage 8"
p_4536_3	"NBE-cultured GBMs, passage 13; brain cancer"	"serum-cultured GBMs, passage 13"
p_4536_4	"NBE-cultured GBMs, passage 20; brain cancer"	"serum-cultured GBMs, passage 20"
p_4536_5	"NBE-cultured GBMs, passage 35; brain cancer"	"serum-cultured GBMs, passage 35"
p_4567_1	"human pulmonary artery endothelial cell,  Ultrafine particle treated, 100ug/ml"	"human pulmonary artery endothelial cell, control"
p_4600_1	"SH-SY5Y cell, undifferentiated, PMA treated"	"SH-SY5Y cell, undifferentiated, control"
p_4600_2	"SH-SY5Y cell, differentiated, MeCP2 treated"	"SH-SY5Y cell, differentiated, control"
p_4600_3	48 h differentiated and Control decoy transfected cells; treated	Undifferentiated SH-SY5Y cells
p_4737_1	"HEK293 cells, HCaRG overexpression"	HEK293 cells
p_4757_1	"Brain, entorhinal cortex, tangle"	"Brain, entorhinal cortex, normal"
p_4773_1	"SK-N-MC neuroblastoma cells, rotenone, 1 week"	"SK-N-MC neuroblastoma cells, control, 1 week"
p_4773_2	"SK-N-MC neuroblastoma cells, rotenone, 2 week"	"SK-N-MC neuroblastoma cells, control, 2 week"
p_4773_3	"SK-N-MC neuroblastoma cells, rotenone, 4 week"	"SK-N-MC neuroblastoma cells, control, 4 week"
p_4780_1	"Meningioma, Grade2"	"Meningioma, Grade1"
p_4883_1	"microphage, Simvastatin treated, 12h"	"microphage, control"
p_4883_2	"microphage, Simvastatin treated, 24h"	"microphage, control"
p_4888_1	"endometrium, ESE; tissue"	"endometrium, PE"
p_4888_2	"endometrium, MSE; tissue"	"endometrium, PE"
p_4888_3	"endometrium, LSE; tissue"	"endometrium, PE"
p_4984_1	"monocyte derived dendritic cells(MDDC), LPS matured MDDCs"	"monocyte derived dendritic cells, vehicle treated"
p_4984_2	"monocyte derived dendritic cells(MDDC), galectin-1 matured matured MDDCs"	"monocyte derived dendritic cells, vehicle treated"
p_5040_1	"GM15850 patient cells, untreated"	"GM15851 control cells, untreated, normal control"
p_5040_2	"GM15850 patients cells, FA1 treated, 1uM."	"GM15851 control cells, FA1 treated, 1uM."
p_5040_3	"GM15850 patients cells, FA1 treated, 2uM."	"GM15851 control cells, FA1 treated, 2uM."
p_5040_4	"GM15850 patients cells, FA2 treated, 2uM."	"GM15851 control cells, treated with FA2 at 2uM."
p_5040_5	patient cells treated with FA1 at 2uM	patient cells untreated
p_5040_6	patient cells treated with FA2 at 2uM	patient cells untreated
p_5058_1	"small airways, smoker; tissue"	"small airways, non-smoker"
p_5058_2	"small airways, chronic obstructive pulmonary disease (COPD); tissue"	"small airways, non-smoker"
p_5109_1	"Human muscle, vastus laterlis, Time of Surgery, Post"	"Human muscle, vastus laterlis, Time of Surgery, Pre"
p_5110_1	"Human skeletal muscle, limb immobilization, 48h"	"Human skeletal muscle, control"
p_5116_1	trMCF	"MCF-10F, control"
p_5116_2	bcMCF	"MCF-10F, control"
p_5116_3	caMCF	"MCF-10F, control"
p_5145_1	"human bronchial smooth muscle cell, Vitamin D treated, 100nM, 24h"	"human bronchial smooth muscle cell, vehicle, 24h"
p_5231_1	"Mammary gland, IGF1R-overexpressed"	"Mammary gland, control"
p_5231_2	"Mammary gland, LPS-treated"	"Mammary gland, control"
p_5231_3	"Mammary gland, 12G FEZL overexpressed"	"Mammary gland, control"
p_5264_2	"Bronchial epithelial cells, air-liquid interface, day 2"	"Bronchial epithelial cells, air-liquid interface, day 0"
p_5264_4	"Bronchial epithelial cells, air-liquid interface, day 8"	"Bronchial epithelial cells, air-liquid interface, day 0"
p_5264_6	"Bronchial epithelial cells, air-liquid interface, day 14"	"Bronchial epithelial cells, air-liquid interface, day 0"
p_5264_7	"Bronchial epithelial cells, air-liquid interface, day 21"	"Bronchial epithelial cells, air-liquid interface, day 0"
p_5281_1	"Entorhinal Cortex, Alzheimer disease; brain tissue"	"Entorhinal Cortex, control"
p_5281_2	"Hippocampus, Alzheimer disease; brain tissue"	"Hippocampus, control"
p_5281_3	"Medial Temporal Gyrus, Alzheimer disease; brain tissue"	"Medial Temporal Gyrus, control"
p_5281_4	"Posterior Singulate, Alzheimer disease; brain tissue"	"Posterior Singulate, control"
p_5281_5	"Superior Frontal Gyrus, Alzheimer disease; brain tissue"	"Superior Frontal Gyrus, control"
p_5281_6	"Primary Visual Cortex, Alzheimer disease; brain tissue"	"Primary Visual Cortex, control"
p_5372_1	"airway epithelial cell, non-smoker, after airway brushing, day 7"	"airway epithelial cell, non-smoker, before airway brushing"
p_5372_2	"airway epithelial cell, non-smoker, after airway brushing, day 14"	"airway epithelial cell, non-smoker, before airway brushing"
p_5372_3	"airway epithelial cell, smoker, after airway brushing, day 7"	"airway epithelial cell, smoker, before airway brushing"
p_5372_4	"airway epithelial cell, smoker, after airway brushing, day 14"	"airway epithelial cell, smoker, before airway brushing"
p_5486_3	LS180_Em; treated	LS180_Con
p_5486_4	SW480_Caff+Act; treated	SW480_Con
p_5486_5	SW480_Caff+Act/Caff; treated	SW480_Con
p_5486_6	SW480_Em; treated	SW480_Con
p_5547_1	infected_skin_biopsy; treated	unifected_Skin_biopsy
p_5547_2	infected_DC; treated	uninfected_DC
p_5563_1	vulva biopsy of vulvar intraepithelial neoplasia; tissue	vulva biopsy of normal tissue
p_5579_1	"Lymphatic endothelial cells, hypoxia"	"Lymphatic endothelial cells, normoxia"
p_5579_2	"Lymphatic endothelial cells, conditioned medium from NSCLC hypoxia, 24 h"	"Lymphatic endothelial cells, conditioned medium from NSCLC, 24 h"
p_5679_1	"Human Dendrite cell, RSG treated"	"Human Dendrite cell, control"
p_5679_2	"Human Dendrite cell, AM treated"	"Human Dendrite cell, control"
p_5679_3	"Human Dendrite cell, RSG, AGN treated"	"Human Dendrite cell, control"
p_5741_1	"APRE-19 cells, LDL treated"	"APRE-19 cells, untreated"
p_5741_2	"APRE-19 cells, OX-LDL treated"	"APRE-19 cells, untreated"
p_5764_1	tumor_ductal; breast cancer	normal_ductal
p_5764_2	tumor_lobular; breast cancer	normal_lobular
p_5790_3	"Blood cell, LCMV-WE infected monkey, 3d"	"Blood cell, not infected, 0d"
p_5790_6	"Blood cell, LCMV-WE infected monkey, 7d"	"Blood cell, not infected, 0d"
p_5790_7	"Blood cell, LCMV-Armstrong infected monkey, 3d"	"Blood cell, not infected, 0d"
p_5790_9	"Blood cell, LCMV-Armstrong infected monkey, 7d"	"Blood cell, not infected, 0d"
p_5809_1	Endometrium in trophoblast conditioned medium for 3 hours; treated; time course	Endometrium in control conditioned medium for 3 hours
p_5809_2	Endometrium in trophoblast conditioned medium for 12 hours; treated; time course	Endometrium in control conditioned medium for 12 hours
p_5816_1	"H2347 cell, 5-AZA treated, 100nM"	"H2347 cell, DMSO control"
p_5816_10	"A549 cell, 5-AZA treated, 1000nM"	"A549 cell, DMSO control"
p_5816_11	"HBEC2 cell, 5-AZA treated, 100nM"	"HBEC2 cell, DMSO control"
p_5816_12	"HBEC2 cell, 5-AZA treated, 1000nM"	"HBEC2 cell, DMSO control"
p_5816_13	"HBEC3 cell, 5-AZA treated, 100nM"	"HBEC3 cell, DMSO control"
p_5816_14	"HBEC3 cell, 5-AZA treated, 1000nM"	"HBEC3 cell, DMSO control"
p_5816_15	"HBEC4 cell, 5-AZA treated, 100nM"	"HBEC4 cell, DMSO control"
p_5816_16	"HBEC4 cell, 5-AZA treated, 1000nM"	"HBEC4 cell, DMSO control"
p_5816_17	"H157 cell, 5-AZA treated, 100nM"	"H157 cell, DMSO control"
p_5816_18	"H157 cell, 5-AZA treated, 1000nM"	"H157 cell, DMSO control"
p_5816_19	"H1819 cell, 5-AZA treated, 100nM"	"H1819 cell, DMSO control"
p_5816_2	"H2347 cell, 5-AZA treated, 1000nM"	"H2347 cell, DMSO control"
p_5816_20	"H1819 cell, 5-AZA treated, 1000nM"	"H1819 cell, DMSO control"
p_5816_21	"H526 cell, 5-AZA treated, 1000nM"	"H526 cell, DMSO control"
p_5816_22	"MCF7 cell, 5-AZA treated, 1000nM"	"MCF7 cell, DMSO control"
p_5816_23	"HCT116 cell, 5-AZA treated, 1000nM"	"HCT116 cell, DMSO control"
p_5816_3	"H1993 cell, 5-AZA treated, 100nM"	"H1993 cell, DMSO control"
p_5816_4	"H1993 cell, 5-AZA treated, 1000nM"	"H1993 cell, DMSO control"
p_5816_5	"H1299 cell, 5-AZA treated, 100nM"	"H1299 cell, DMSO control"
p_5816_6	"H1299 cell, 5-AZA treated, 1000nM"	"H1299 cell, DMSO control"
p_5816_7	"H460 cell, 5-AZA treated, 100nM"	"H460 cell, DMSO control"
p_5816_8	"H460 cell, 5-AZA treated, 1000nM"	"H460 cell, DMSO control"
p_5816_9	"A549 cell, 5-AZA treated, 100nM"	"A549 cell, DMSO control"
p_5823_1	"BT-474 cells, RNAi targeting c-MYC"	"BT-474 cells, control"
p_5823_2	"MCF-7 cells, RNAi targeting c-MYC"	"MCF-7 cells, control"
p_5823_3	"MDA-MB-231 cells, RNAi targeting c-MYC"	"MDA-MB-231 cells, control"
p_5823_4	"HeLa cells, RNAi targeting c-MYC"	"HeLa cells, control"
p_5850_1	"MII arrested oocyte, PCOS women"	"MII arrested oocyte, normal women"
p_5868_1	"Tumor driven by SV7tert AML cells, oestrogen-treated"	"Tumor driven by SV7tert AML cells, control"
p_5968_1	"HepG2 cells, PGC-1 mutant"	"HepG2 cells, BGAL"
p_5968_2	"HepG2 cells, PGC-1 mutant"	"HepG2 cells, L2L3 mutant"
p_5968_3	"HepG2 cells, PGC-1 mutant"	"HepG2 cells, wt PGC-1"
p_5993_1	"ME180 cells, shRNA targeting p63, p63-depleted"	"ME180 cells, empty vector"
p_6004_1	Thyroid cancer center	Normal thyroid
p_6004_2	Thyroid cancer invasive area	Normal thyroid
p_6013_1	"A549 cell, asbestos exposed, 1h"	"A549 cell, control, 1h"
p_6013_10	"Met5A cell, asbestos exposed, 1h"	"Met5A cell, control, 1h"
p_6013_11	"Met5A cell, asbestos exposed, 48h"	"Met5A cell, control, 48h"
p_6013_4	"A549 cell, asbestos exposed, 2d"	"A549 cell, control, 2d"
p_6013_6	"Beas2B cell, asbestos exposed, 1h"	"Beas2B cell, control, 1h"
p_6013_9	"Beas2B cell, asbestos exposed, 2d"	"Beas2B cell, control, 2d"
p_6021_1	"HeLa cell, immunoprecipitated cDNA extract from immunoprecipitation experiment (PTB)"	"HeLa cell, total cDNA extract from immunoprecipitation experiment (PTB)"
p_6022_1	"HeLa cell, immunoprecipitated cDNA extract from immunoprecipitation experiment (U2AF65)"	"HeLa cell, total cDNA extract from immunoprecipitation experiment (U2AF65)"
p_6034_1	"ATL cell line(TaY), Bortezomib treated, 5nM, 24h"	"ATL cell line(TaY), mock treated"
p_6034_2	"ATL cell line(TaY), Bortezomib treated, 15nM, 24h"	"ATL cell line(TaY), mock treated"
p_6034_3	"ATL cell line(MT-2), Bortezomib treated, 5nM, 24h"	"ATL cell line(MT-2), mock treated"
p_6034_4	"ATL cell line(MT-4), Bortezomib treated, 5nM, 24h"	"ATL cell line(MT-4), mock treated"
p_6043_1	HMEC/hTERT/eIF4E/polysomal	HMEC/hTERT/polysomal
p_6043_2	HMEC/hTERT/eIF4E/Total	HMEC/hTERT/Total
p_6054_1	"monocyte, heterozygote FH"	"monocyte, normal people"
p_6054_2	"monocyte, homozygote FH"	"monocyte, normal people"
p_6075_1	"HOK/BM-1 cell, E6 treated"	"HOK/BM-1 cell, LXSN treated"
p_6075_2	"HOK/BM-1 cell, E6(Delta)118-122 treated"	"HOK/BM-1 cell, LXSN treated"
p_6088_1	"T cell, heterozygote FH"	"T cell, normal people"
p_6088_2	"T cell, homozygote FH"	"T cell, normal people"
p_6090_1	"primary dendritic cells,stimulated using plate bound anti-DC-SIGN antibody, 2h"	"primary dendritic cells, unstimulated"
p_6092_1	"HUVEC, stimulated with Borrelia burgdorferi"	"HUVEC, unstimulated"
p_6092_2	"HUVEC, stimulated with IFN-g"	"HUVEC, unstimulated"
p_6092_3	"HUVEC, stimulated with Borrelia burgdorferi+IFN-g"	"HUVEC, unstimulated"
p_6140_1	"A2780 ovarian carcinoma cell line, exposed to cell cycle inhibitor, 6h"	"A2780 cells, untreated, 6h"
p_6207_1	"HepG2 cell line, miR-124 transfection, 4h"	"HepG2 cell line, negativecontrol transfection, 4h"
p_6207_2	"HepG2 cell line, miR-124 transfection, 8h"	"HepG2 cell line, negativecontrol transfection, 8h"
p_6207_3	"HepG2 cell line, miR-124 transfection, 16h"	"HepG2 cell line, negativecontrol transfection, 16h"
p_6207_4	"HepG2 cell line, miR-124 transfection, 24h"	"HepG2 cell line, negativecontrol transfection, 24h"
p_6207_5	"HepG2 cell line, miR-124 transfection, 32h"	"HepG2 cell line, negativecontrol transfection, 32h"
p_6207_6	"HepG2 cell line, miR-124 transfection, 72h"	"HepG2 cell line, negativecontrol transfection, 72h"
p_6207_7	"HepG2 cell line, miR-124 transfection, 120h"	"HepG2 cell line, negativecontrol secondtransfection, 120h"
p_6222_1	"Huh4, hepatocellular carcinoma line"	"human liver tissue, normal"
p_6222_2	"hepatocellular carcinoma line, stage 1"	"human liver tissue, normal"
p_6222_3	"hepatocellular carcinoma line, stage 3"	"human liver tissue, normal"
p_6233_1	"EC109 cell line, ezrin-knockdown"	"EC109 cell line, control"
p_6241_1	"HUVEC, SAA treated, 20ug/ml, 4h"	"HUVEC, no stimulation"
p_6241_2	"HUVEC, SAA treated, 20ug/ml, 24h"	"HUVEC, no stimulation"
p_6241_3	"HUVEC, SAA treated, 20ug/ml, 48h"	"HUVEC, no stimulation"
p_6257_1	"Human lymphatic endothelial cells, TNFa treatment"	"Human lymphatic endothelial cells, without TNFa, control"
p_6276_1	"HEK289 cells, hIMP1 wt over-expression"	"HEK289 cells, empty vector"
p_6276_2	"HEK289 cells, hIMP Dmut expression"	"HEK289 cells, empty vector"
p_6281_1	"Skin biopsy, upper nates, nickel allergic, no nickel exposure"	"Skin biopsy, upper nates, non-nickel allergic, no nickel exposure"
p_6281_2	"Skin biopsy, upper nates, nickel allergic, exposed to 5% nickel sulfate, 7h"	"Skin biopsy, upper nates, non-nickel allergic, exposed to 5% nickel sulfate, 7h"
p_6281_3	"Skin biopsy, upper nates, nickel allergic, exposed to 5% nickel sulfate, 48h"	"Skin biopsy, upper nates, non-nickel allergic, exposed to 5% nickel sulfate, 48h"
p_6281_4	"Skin biopsy, upper nates, nickel allergic, exposed to 5% nickel sulfate, 96h"	"Skin biopsy, upper nates, non-nickel allergic, exposed to 5% nickel sulfate, 96h"
p_6283_1	"amniocytes, trisomy 21"	"amniocytes, normal karyotype"
p_6283_2	"amniocytes, trisomy 13"	"amniocytes, normal karyotype"
p_6283_3	"chorion villus cells, trisomy 21"	"chorion villus cells, normal karyotype"
p_6283_4	"chorion villus cells, trisomy 18"	"chorion villus cells, normal karyotype"
p_6338_1	Peripheral T-cell lymphoma unspecified (PTCL/U)	normal T cells
p_6338_2	Angioimmunoblastic T-cell Lymphoma (AITL)	normal T cells
p_6338_3	anaplastic large cell lymphoma (ALCL)	normal T cells
p_6351_1	"peripheral blood, Acromegaly case"	"peripheral blood, healthy normal"
p_6364_1	Proliferative endometrium from patient with endometriosis; tissue	Proliferative endometrium from normal patient
p_6364_2	Early secretory endometrium from patient with endometriosis; tissue	Early secretory endometrium from normal patient
p_6364_3	Mid secretory endometrium from patient with endometriosis; tissue	Mid secretory endometrium from normal patient
p_6369_1	"prostate cancer, metastatic"	"Human Prostate Cancer, Non-metastatic, control"
p_6400_1	"A549 cell, Actinomycin D treated"	"A549 cell, Mannitol treated, control"
p_6400_2	"A549 cell, 1.25uM sapphyrin PCI-2050 treated"	"A549 cell, Mannitol treated, control"
p_6400_3	"A549 cell, 2.5uM sapphyrin PCI-2050 treated"	"A549 cell, Mannitol treated, control"
p_6406_1	"Human pancreatic xenograft, siRNA treatment"	"Human pancreatic xenograft, saline treatment, control"
p_6406_2	"Human pancreatic xenograft, siLNA treatment"	"Human pancreatic xenograft, saline treatment, control"
p_6451_1	"IMR-32 cell, DPP3 overexpressed"	"IMR-32 cell, control"
p_6451_2	"IMR-32 cell, SQSTM1 overexpressed"	"IMR-32 cell, control"
p_6460_1	"hMSC, bFGF treated"	"hMSC, control"
p_6460_2	"hMSC, TGFbeta treated"	"hMSC, control"
p_6460_3	"hMSC, PDGF-BB treated"	"hMSC, control"
p_6465_1	"HCC cells, Xenograft"	"HCC cells, Primary"
p_6465_2	"HCC cells, Xenograft, bevacizumab treated"	"HCC cells, Xenograft, control"
p_6465_3	"HCC cells, Xenograft, rapamycin treated"	"HCC cells, Xenograft, control"
p_6465_4	"HCC cells, Xenograft, bevacizumab+rapamycin treated"	"HCC cells, Xenograft, control"
p_6489_1	"HMVEC-L, HHV8 infected"	"HMVEC-L, Mock infected"
p_6495_1	"MOLT4 cell line, treated with GSI"	"MOLT4 cell line, untreated"
p_6518_1	"Caco-2 cell, trans-10+cis-12 CLA treated."	"Caco-2 cell, linoleic acid"
p_6518_2	"Caco-2 cell, trans-11+cis-9 CLA treated."	"Caco-2 cell, linoleic acid"
p_6519_1	"precentral gyrus brain, 1 LCPUFA (0.33%DHA-0.67%ARA)"	"precentral gyrus brain, control"
p_6519_2	"precentral gyrus brain, 3X LCPUFA (1.00%DHA-0.67%ARA)"	"precentral gyrus brain, control"
p_6521_14	"MCF-7 cells, U0126 treated, 90min"	"MCF-7 cells, control"
p_6521_16	"MCF-7 cells, AG1478 treated, 10min"	"MCF-7 cells, control"
p_6521_2	"MCF-7 cells, HRG treated, 10min"	"MCF-7 cells, control"
p_6521_21	"MCF-7 cells, AG1478 treated, 90min"	"MCF-7 cells, control"
p_6521_23	"MCF-7 cells, HRG+AG1478 treated, 10min"	"MCF-7 cells, control"
p_6521_28	"MCF-7 cells, HRG+AG1478 treated, 90min"	"MCF-7 cells, control"
p_6521_7	"MCF-7 cells, HRG treated, 90min"	"MCF-7 cells, control"
p_6521_9	"MCF-7 cells, U0126 treated, 10min"	"MCF-7 cells, control"
p_6548_1	"HMECs , E2 treated"	"HMECs , Fulvestrant treated"
p_6551_1	"Intracranial artery, aneurysm"	"Intracranial artery, non-aneurysm"
p_6561_1	"H14 cell, hsr containing"	"H14 cell, not hsr containing"
p_6566_1	"dendritic cell, high DC strength"	"dendritic cell, low DC strength"
p_6573_1	"Decidua, Preeclampsia"	"decidua, control"
p_6573_2	"Placenta, Preeclampsia"	"Placenta, Control"
p_6573_3	"Fat, Preeclampsia"	"Fat, Control"
p_6575_1	"whole blood, Autism spectrum disorder"	"whole blood, General population"
p_6575_2	"whole blood, Autism spectrum disorder"	"whole blood, Mental retardation or developmental delay"
p_6575_3	Blood of mental retardation or developmental delay; tissue	Blood of general population
p_6653_1	"IOSE cells, TGFb treated ,3hr"	"IOSE cells, TGFb treated ,0hr"
p_6653_2	"IOSE cells, TGFb treated ,6hr"	"IOSE cells, TGFb treated ,0hr"
p_6653_3	"IOSE cells, TGFb treated ,12hr"	"IOSE cells, TGFb treated ,0hr"
p_6679_1	"HeLa cell, siRNA Stau1 treated"	"HeLa cell, control"
p_6695_1	"H157 cell line, low dose (5-aza-2'deoxycytidine) treatment, 100nM, 6 days"	"H157 cell line, control"
p_6695_2	"H157 cell line, high dose (5-aza-2'deoxycytidine) treatment, 1000nM, 6 days"	"H157 cell line, control"
p_6695_3	"H1819 cell line, low dose (5-aza-2'deoxycytidine) treatment, 100nM, 6 days"	"H1819 cell line, control"
p_6695_4	"H1819 cell line, high dose (5-aza-2'deoxycytidine) treatment, 1000nM, 6 days"	"H1819 cell line, control"
p_6728_1	"Granta-519 cell line, emetine treated"	"Granta-519 cell line, mock treated"
p_6728_10	"JEKO-1 cell line, treated with emetine followed by actinomycin D treatment"	"JEKO-1 cell line, mock treated"
p_6728_2	"Granta- 519 cell line, treated with emetine followed by actinomycin D treatment"	"Granta-519 cell line, mock treated"
p_6728_3	"REC-1 cell line, emetine treated"	"REC-1 cell line, mock treated"
p_6728_4	"REC-1 cell line, treated with emetine followed by actinomycin D treatment"	"REC-1 cell line, mock treated"
p_6728_5	"UPN-1 cell line, emetine treated"	"UPN-1 cell line, mock treated"
p_6728_6	"UPN-1 cell line, treated with emetine followed by actinomycin D treatment"	"UPN-1 cell line, mock treated"
p_6728_7	"HBL-2 cell line, emetine treated"	"HBL-2 cell line, mock treated"
p_6728_8	"HBL-2 cell line, treated with emetine followed by actinomycin D treatment"	"HBL-2 cell line, mock treated"
p_6728_9	"JEKO-1 cell line, emetine treated"	"JEKO-1 cell line, mock treated"
p_6743_1	"peripheral naive T cells, Retinoid Acid stimulated"	"peripheral naive T cells, unstimulated"
p_6743_2	"peripheral naive T cells, IL-12 stimulated"	"peripheral naive T cells, unstimulated"
p_6743_3	"peripheral naive T cells, 1,25(OH)2 vitamin D3 stimulated"	"peripheral naive T cells, unstimulated"
p_6743_4	"peripheral naive T cells, 1,25(OH)2 vitamin D3 + IL-12 stimulated CCR10-positive CLA-positive T cells"	"peripheral naive T cells, unstimulated"
p_6743_5	"peripheral naive T cells, 1,25(OH)2 vitamin D3 + IL-12 stimulated CCR10-negative CLA-positive T cells"	"peripheral naive T cells, unstimulated"
p_6751_1	"PBMC, periodontal therapy, 1w"	"PBMC, periodontal therapy, 0w"
p_6751_2	"PBMC, periodontal therapy, 6w"	"PBMC, periodontal therapy, 0w"
p_6751_3	"PBMC, periodontal therapy, 10w"	"PBMC, periodontal therapy, 0w"
p_6764_1	cirrhotic liver tissue	normal liver tissue
p_6764_2	low-grade dysplastic liver tissue	normal liver tissue
p_6764_3	high-grade dysplastic liver tissue	normal liver tissue
p_6764_4	very early HCC (hepatocellular carcinoma)	normal liver tissue
p_6764_5	early HCC (hepatocellular carcinoma)	normal liver tissue
p_6764_6	advanced HCC (hepatocellular carcinoma)	normal liver tissue
p_6764_7	very advanced HCC (hepatocellular carcinoma)	normal liver tissue
p_6764_8	very advanced HCC; liver cancer	Normal Liver Tissue
p_6767_1	"HeLa cell, sidroshaB transfected"	"HeLa cell, siGFP transfected, control"
p_6767_2	"HeLa cell, sidroshaC transfected"	"HeLa cell, siGFP transfected, control"
p_6791_1	Cervical cancer	normal cervix
p_6791_2	head-neck cancer	head-neck normal
p_6791_3	HPV+ cervical cancer	HPV- cervical cancer
p_6791_4	HPV+ head-neck cancer	HPV- head-neck cancer
p_6798_1	"Vastus lateralis muscle, polycystic ovary syndrome (PCOS)"	"Vastus lateralis muscle, normal"
p_6800_1	"MCF-7, Cimicifuga treated, 24h"	"MCF-7 cell, DMSO, control, 24h"
p_6800_2	"MCF-7, Estradiol treated, 24h"	"MCF-7 cell, DMSO, control, 24h"
p_6800_3	"MCF-7, Tamoxifen treated, 24h"	"MCF-7 cell, DMSO, control, 24h"
p_6803_1	"MCF-7 cells, 24h, Estradiol treated"	"MCF-7 cells, 24h, DMSO control"
p_6803_2	"MCF-7 cells, 24h, Leuzea treated"	"MCF-7 cells, 24h, DMSO control"
p_6803_3	"MCF-7 cells, 24h, Tamoxifen treated"	"MCF-7 cells, 24h, DMSO control"
p_6816_1	"SK-N-MC Cell Line, Human Melanotransferrin inserted"	SK-N-MC Cell Line
p_6817_1	"SK-Mel-28, Melanotransferrin siRNA inserted"	"SK-Mel-28, Scrambled Control"
p_6819_1	"HeLa, treated with siRNA specific for optineurin mRNA"	"HeLa, treated with water (mock)"
p_6833_1	"SK-Mel-28 cells, Human Melanotransferrin siRNA treatead"	"SK-Mel-28 cells, Scrambled control"
p_6833_2	"SK-Mel-28, MTF; treated"	"SK-Mel-28, control"
p_6863_1	"iDCs, hypoxia"	"iDCs, normoxia"
p_6872_1	"Sperm cell, Teratozoospemic"	"Sperm cell, Normospemic"
p_6878_2	"HepG2 cell, PCB153 treated 0.5h"	"HepG2 cell, control"
p_6878_4	"HepG2 cell, PCB153 treated 6h"	"HepG2 cell, control"
p_6878_7	"HepG2 cell, PCB77 treated 0.5h"	"HepG2 cell, control"
p_6878_8	"HepG2 cell, PCB77 treated 6h"	"HepG2 cell, control"
p_6885_1	BPLER	BPE
p_6885_2	HMLER	HME
p_6920_1	Primary T-ALL cells	"CD8 cells, from normal donor"
p_6920_2	"Human T-ALL cells, from patient propagated in NOD/SCID mice"	"CD8 cells, from normal donor"
p_6960_1	"A549 cell, Zinc treated"	"A549 cell, control"
p_6960_2	"A549 cell, PCI 5002 treated"	"A549 cell, control"
p_6960_3	"A549 cell, Zinc, PCI 5002 treated"	"A549 cell, control"
p_6962_1	"A549 cell, PCI 5002 treated"	"A549 cell, control"
p_6962_2	"A549 cell, PCI 5003 treated"	"A549 cell, control"
p_6965_1	"dendritic cells, cultivated together with Aspergillus fumigatus germ tubes, 6h"	"dendritic cells, cultivated in medium, 6h"
p_6972_1	"non-cycling plateau phase A549 lung cancer cell culture, ZnOAc2 treated"	"non-cycling plateau phase A549 lung cancer cell culture, control"
p_6972_2	"non-cycling plateau phase A549 lung cancer cell culture, PCI-5002 treated"	"non-cycling plateau phase A549 lung cancer cell culture, control"
p_6972_3	"non-cycling plateau phase A549 lung cancer cell culture, ZnOAc2+PCI-5002 treated"	"non-cycling plateau phase A549 lung cancer cell culture, control"
p_6972_4	"A549 cell, Xenograft, PCI 5002 treated"	"A549 cells, Xenograft Control"
p_6972_5	"A549 cell, Xenograft, PCI 5003 treated"	"A549 cells, Xenograft Control"
p_7011_1	"Human CD34+ cord blood cells, MLL-AF9, grown serum-free"	"Human CD34+ cord blood cells, AML1-ETO, grown serum-free"
p_7011_2	"Human CD34+ cord blood cells, MLL-AF9 , grown serum-free"	"Human CD34+ cord blood cells, CBFbeta-MYH11, grown serum-free"
p_7011_3	"Human CD34+ cord blood cells, MLL-AF9, grown with serum"	"Human CD34+ cord blood cells, AML1-ETO, grown with serum"
p_7011_4	"Human CD34+ cord blood cells, MLL-AF9 , grown serum-free"	"Human CD34+ cord blood cells, MLL-AF9, grown with serum"
p_7014_1	"Skeletal muscle, myotonic dystrophy type 1"	"Skeletal muscle, normal adult patient"
p_7014_2	"Skeletal muscle, myotonic dystrophy type 2"	"Skeletal muscle, normal adult patient"
p_7023_3	Renal Cancer Papillary Type 2A; kidney cancer	normal kidney
p_7023_4	Renal Cancer Papillary Type 2B; kidney cancer	normal kidney
p_7036_1	"Trasnsformed Lymphocytes, Bipolar Disorder Affected"	"Trasnsformed Lymphocytes, Unaffected"
p_7047_1	"HeLa cells, infected"	"HeLa cells, uninfected"
p_7117_1	"Liver sample, diet intervention group"	"Liver sample, control subject"
p_7152_1	p14ARF mutant Melanoma cell lines	p14ARF WT
p_7153_1	metastatic melanoma cell lines	"Melanoma cell line, primary nodular melanoma"
p_7158_1	Monocyte High PBM; tissue	Monocyte Low PBM
p_7161_1	"HCT116 cell, TOP1 silenced"	"HCT116 cell, Control"
p_7161_2	"MCF7 cell, TOP1 silenced"	"MCF7 cell, Control"
p_7181_1	"Neurosphere-like glioma Cell Line R11, CD133+ cancer stem cells,"	"Adherent glioma cell line R43, CD133- cancer stem cells, control"
p_7213_1	"HIV1, VLP"	"HIV1, cellular"
p_7216_1	"Normal human epidermal keratinocytes, Treated with IL19"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_2	"Normal human epidermal keratinocytes, Treated with IL20"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_3	"Normal human epidermal keratinocytes, Treated with IL22"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_4	"Normal human epidermal keratinocytes, Treated with IL24"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_5	"Normal human epidermal keratinocytes, Treated with IL26d"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_6	"Normal human epidermal keratinocytes, Treated with KGF"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_7	"Normal human epidermal keratinocytes, Treated with IFNg"	"Normal human epidermal keratinocytes, untreated, control"
p_7216_8	"Normal human epidermal keratinocytes, Treated with IL1b"	"Normal human epidermal keratinocytes, untreated, control"
p_7223_1	"LNCaP cell, RSL1 treated, 6h"	"LNCaP cell, control"
p_7223_2	"LNCaP cell, RSL1 treated, 24h"	"LNCaP cell, control"
p_7224_1	Gingival Epithelium	Tonsil Epithelium
p_7234_1	Human embryonic carcinoma cell	Human embryonic stem cell
p_7234_2	complex karytoype ESC; stem cell	normal karyotype ESC
p_7234_3	carcinoma cells	normal karyotype ESC
p_7247_1	DC_mRNA	DC_unloaded
p_7247_2	DC_lysate	DC_unloaded
p_7247_3	DC_double_matched	DC_unloaded
p_7247_4	DC_double_mismatched	DC_unloaded
p_7268_1	"ileal mucosa, C.hominis infected"	"ileal mucosa, uninfected"
p_7268_2	"ileal mucosa, C.parvum infected"	"ileal mucosa, uninfected"
p_7305_1	Endometrium/Ovary-Disease	"Endometrium, normal"
p_7307_1	accumbens PD; tissue	accumbens normal
p_7307_10	breast cancer	breast normal
p_7307_11	caudate PD; tissue	caudate normal
p_7307_12	endometriosis; tissue	endometrium normal
p_7307_13	globus pallidus PD; tissue	globus pallidus normal
p_7307_14	myometrium adenomyosis; tissue	myometrium normal
p_7307_15	myometrium uterine fibroid; tissue	myometrium normal
p_7307_2	putamen PD; tissue	putamen normal
p_7307_3	skin melanoma	skin normal
p_7307_4	substantia nigra_pars compacta PD; tissue	substantia nigra_pars compacta normal
p_7307_5	substantia nigra_reticulata PD; tissue	substantia nigra_reticulata normal
p_7307_6	synovial membrane rheumatoid arthritis; tissue	synovial membrane normal
p_7307_7	thalamus_lateral nuclei PD; tissue	thalamus_lateral nuclei normal
p_7307_8	myometrium endometriosis; tissue	myometrium normal
p_7307_9	thalamus_subthalamic nucleus PD; tissue	thalamus_subthalamic nucleus normal
p_7327_1	"MCF7 xenografts, E2-treated"	"MCF7 xenografts, Tam-treated"
p_7345_1	"PBMCs, ALPS 1A, 0h after IL-2 withdrawal"	"PBMCs, Normal control, 0h after IL-2 withdrawal"
p_7345_2	"PBMCs, P58, 0h after IL-2 withdrawal"	"PBMCs, Normal control, 0h after IL-2 withdrawal"
p_7345_3	"PBMCs, ALPS 1A, 24h after IL-2 withdrawal"	"PBMCs, Normal control, 24h after IL-2 withdrawal"
p_7345_4	"PBMCs, P58, 24h after IL-2 withdrawal"	"PBMCs, Normal control, 24h after IL-2 withdrawal"
p_7364_1	Neuroblastoma cell; tissue	peripheral blood mononuclear cell
p_7368_1	"BAL (bronchoalveolar lavage) cells, Steroid Resistant"	"BAL (bronchoalveolar lavage) cells, Steroid Sensitive"
p_7382_1	"MCF7 cell, High LMO4"	"MCF7 cell, low LMO4"
p_7392_1	"renal tissue, Subclinical interstitial fibrosis, T=0"	"renal tissue, normal, T=0"
p_7392_2	"renal tissue, Subclinical interstitial fibrosis , T=12m"	"renal tissue, normal, T=12m"
p_7400_1	"peripheral blood, post G-CSF"	"peripheral blood, pre G-CSF"
p_7434_1	"Placenta cell, smoking"	"Placenta cell, non-smoking"
p_7440_1	SER; acute lymphoblastic leukemia (ALL); blood cancer	RER
p_7440_2	Relapse; acute lymphoblastic leukemia (ALL); blood cancer	RER
p_7440_3	CCr; acute lymphoblastic leukemia (ALL); blood cancer	RER
p_7451_1	whole saliva pSS patient; tissue	whole saliva control
p_7454_1	"U-2OS cell, decitabine treated"	"U-2OS cell, control"
p_7462_1	"PBMC, exposed to diesel exhaust, 200ug, 4h"	"PBMC, exposed to diesel exhaust, 200ug, 0h"
p_7462_2	"PBMC, exposed to diesel exhaust, 200ug, 22h"	"PBMC, exposed to diesel exhaust, 200ug, 0h"
p_7462_3	"PBMC, exposed to diesel exhaust, 200ug, 4h"	"PBMC, exposed to filtered air, 4h"
p_7462_4	"PBMC, exposed to diesel exhaust, 200ug, 22h"	"PBMC, exposed to filtered air, 22h"
p_7476_1	"Bladder cell, low grade superfical tumor"	"Bladder cell, normal"
p_7476_2	"Bladder cell, high grade superfical tumor"	"Bladder cell, normal"
p_7476_3	"Bladder cell, high grade muscle invasive tumor"	"Bladder cell, normal"
p_7486_1	LCL Discordant twin pair; tissue	LCL Unaffected MZ twin pair
p_7486_2	LCL Concordant for Epilepsy twin pair; tissue	LCL Unaffected MZ twin pair
p_7500_1	scramble siRNA with RA; siRNA treatment	scramble siRNA no RA
p_7500_2	RISC-free siRNA treated with RA; siRNA treatment	RISC-free siRNA no RA
p_7500_3	siRNA for RIP140 with RA; siRNA treatment	siRNA for RIP140 no RA
p_7500_4	siRNA for RIP140 no RA; siRNA treatment	scramble siRNA no RA
p_7500_5	siRNA for RIP140 with RA; siRNA treatment	scramble siRNA with RA
p_7508_1	"Jurkat cell, LEDGF knockdown"	"Jurkat cell, control"
p_7509_1	"Dendritic cell, immature, IFN alpha treatment, 24h"	"Immature Dendritic cell, without IFN alpha treatment, 24h"
p_7509_2	"Dendritic cell, immature,  anti-FcgRIIB antibody treated, 24h"	"Immature Dendritic cell, isotype antibody treated, 24h"
p_7509_3	"Dendritic cell, immature, inflammatory cytokines treated, 24h"	"Immature Dendritic cell, isotype antibody treated, 24h"
p_7509_4	"monocyte, antiFcgRIIB antibody treated, 24h"	"monocyte, isotype control antibody treated, 24h"
p_7509_5	"Dendritic cell, anti-FcgRIIB antibody treated, 24h"	"Dendritic cell, isotype antibody treated, 24h"
p_7509_6	"Dendritic cell, inflammatory cytokines treated, 24h"	"Dendritic cell, isotype antibody treated, 24h"
p_7510_1	"peripheral blood, GVHD"	"peripheral blood, control"
p_7510_2	related GVHD; tissue	related Ctrl
p_7513_1	"breast tumor, non-CD44+/CD24-"	"breast tumor,CD44+/CD24-"
p_7515_1	Cancer mammospheres	primary breast cancer
p_7538_1	CD34 acute myeloid leukemia (AML)_PTL_6 h; treated	CD34 acute myeloid leukemia (AML)_UT_6 h
p_7553_1	basal cell carcinoma; skin cancer	normal skin
p_7553_2	melanoma in situ; skin cancer	normal skin
p_7553_3	metastatic melanoma; skin cancer	normal skin
p_7553_4	primary melanoma; skin cancer	normal skin
p_7553_5	squamous cell carcinoma; skin cancer	normal skin
p_7554_1	"HEK293 cells, expressing 10 KSHV encoded miRNAs"	"HEK293 cells, control vector"
p_7556_1	SKVCR 2.0 cell	SKOV3 cell
p_7562_1	"A431 cell, PTEN RNAi treated"	"A431 cell, wt"
p_7562_2	"HCC827 cell, PTEN RNAi treated"	"HCC827 cell, wt"
p_7562_3	"SKBR3 cell, PTEN RNAi treated"	"SKBR3 cell, wt"
p_7568_1	"Macrophage, differenciated in the presence of IL-4, 5 days, then stimulated with TGF-beta,24h"	"Macrophage, differenciated in the presence of IL-4, 5 days"
p_7568_2	"Macrophage, differenciated in the presence of IL-4+dexamethasone, 5 days, then stimulated with TGF-beta,3h"	"Macrophage, differenciated in the presence of IL-4+dexamethasone, 5 days"
p_7568_3	"Macrophage, differenciated in the presence of IL-4+dexamethasone, 5 days, then stimulated with TGF-beta,24h"	"Macrophage, differenciated in the presence of IL-4+dexamethasone, 5 days"
p_7578_1	"DAOY cell line, Bmi1 shRNA"	"DAOY cell line, wt"
p_7578_2	"DAOY cell line, Mel18 shRNA"	"DAOY cell line, wt"
p_7578_3	"DAOY cell line, Bmi1 Mel18 shRNA"	"DAOY cell line, wt"
p_7578_4	Alk shRNA; treated	Wild Type
p_7621_1	"Substantia nigra cell, Parkinson's disease"	"Substantia nigra cell, normal"
p_7678_1	"SW480 cell, GFP treated, Dox treated"	"SW480 cell, GFP treated, control"
p_7678_2	"SW480 cell, miRNA34a treated, Dox treated"	"SW480 cell, miRNA34a treated, control"
p_7678_4	SW480_miRNA34a_with_Dox; treated	SW480_GFP_with_Dox
p_7696_1	"GBM, radiotherapy; treated"	"non-tumor, epilepsy"
p_7696_2	"GBM, TMZ/radiotherapy; treated"	"non-tumor, epilepsy"
p_7696_3	"Recurrent GBM, TMZ/radiotherapy; treated"	"non-tumor, epilepsy"
p_7700_1	"MDA MB231 cell, YAP knock down"	"MDA MB231 cell, control"
p_7700_2	"Normal luminal cell, YAP knock down"	"Normal luminal cell, control"
p_7708_1	"LNCaP cells, stimulated with DHT"	"LNCaP cells, not stimulated with DHT"
p_7708_2	"LNCaP cells, Bicalutamide treated, not stimulated with DHT"	"LNCaP cells, not stimulated with DHT"
p_7708_3	"LNCaP cells, control polyamide treated, not stimulated with DHT"	"LNCaP cells, not stimulated with DHT"
p_7708_4	"LNCaP cells, Polyamide targeting ARE treated, not stimulated with DHT"	"LNCaP cells, not stimulated with DHT"
p_7741_1	"Liver cell, HCV infected, stage 0 Fibrosis"	"Liver cell, control"
p_7741_2	"Liver cell, HCV infected, Advance Fibrosis"	"Liver cell, control"
p_7745_1	"Caco-2 cell, differentiated"	"Caco-2 cell, undifferentiated"
p_7753_1	"PBMC, new onset sJIA"	"PBMC, normal control"
p_7754_1	"HCT116 cells, miR-34a expression"	"HCT116 cells, empty vector"
p_7757_1	acute lymphoblastic leukemia (ALL) with hyperdiploid karyotype; blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_2	acute lymphoblastic leukemia (ALL) with t(1;19); blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_3	acute lymphoblastic leukemia (ALL) with t(12;21); blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_4	c-acute lymphoblastic leukemia (ALL)/Pre-B-acute lymphoblastic leukemia (ALL) without t(9;22); blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_5	c-acute lymphoblastic leukemia (ALL)/Pre-B-acute lymphoblastic leukemia (ALL) with t(9;22); blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_6	pro-B-acute lymphoblastic leukemia (ALL) with t(11q23)/MLL; blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7757_7	T-acute lymphoblastic leukemia (ALL); blood cancer	acute myeloid leukemia (AML) with normal kartyotype + other abnormalities
p_7788_1	NLPHL_lymph_node; cancer	Normal_reactive_lymph_node
p_7788_2	THRBL_lymph_node; cancer	Normal_reactive_lymph_node
p_7807_1	"Human elutriated monocytes, stimulated with LTD4, 100nM, 30 min"	"Human elutriated monocytes, vehicle control (EtOH)"
p_7808_1	"epididimus, tail segment, 26 years-old"	"epididimus, corpus segment, 26 years-old"
p_7808_2	"epididimus, head segment, 26 years-old"	"epididimus, corpus segment, 26 years-old"
p_7808_3	"epididimus, tail segment, 26 years-old"	"epididimus, head segment, 26 years-old"
p_7808_4	"epididimus, tail segment, 47 years-old"	"epididimus, corpus segment, 47 years-old"
p_7808_5	"epididimus, head segment, 47 years-old"	"epididimus, corpus segment, 47 years-old"
p_7808_6	"epididimus, tail segment, 47 years-old"	"epididimus, head segment, 47 years-old"
p_7808_7	"epididimus, tail segment, 50 years-old"	"epididimus, corpus segment, 50 years-old"
p_7821_1	"intestinal mucosa, dizygotic twin; tissue"	"intestinal mucosa, monozytotic twin"
p_7824_1	"tumor, periphral"	"tumor, center"
p_7835_1	"U251 cells, stimulated with DFO"	"U251 cells, not stimulated with DFO"
p_7835_2	"U251 cells, siRNA against HIF-1a treated, stimulated with DFO"	"U251 cells, stimulated with DFO"
p_7835_3	"U251 cells, polyamide targeting the HRE treated, stimulated with DFO"	"U251 cells, stimulated with DFO"
p_7835_4	"U251 cells, Echinomycin treated, stimulated with DFO"	"U251 cells, stimulated with DFO"
p_7845_1	"Human airway cells, 1 ng/mL ricin, 24 h"	"Human airway cells, untreated, 24 h"
p_7846_1	"endometrial endothelial cell from eutopic endometrium, patient with endometriosis"	"endometrial endothelial cell from eutopic endometrium, normal control"
p_7868_1	"LNCaP cells, DHT treated, 4h"	"LNCaP cells, DHT untreated"
p_7868_2	"LNCaP cells, DHT treated, 16h"	"LNCaP cells, DHT untreated"
p_7869_1	"PKD1 cell, small cyst"	"PKD1 cell, control"
p_7869_2	"PKD1 cell, medium cyst"	"PKD1 cell, control"
p_7869_3	"PKD1 cell, large cyst"	"PKD1 cell, control"
p_7869_4	Minimally cystic tissue	"PKD1 cell, control"
p_7874_1	"CD34+ hematopoietic progenitor cells, in EST condition"	"CD34+ hematopoietic progenitor cells, subjected to EPO"
p_7879_1	"hES, SA01 expressed"	"hES, VUB01 expressed"
p_7879_2	"MSC, SA01 expressed"	"MSC, VUB01 expressed"
p_7888_2	"mesenchymal stem cells, lot#4F1127, 9th passage"	"mesenchymal stem cells, lot#4F1127, 4th passage"
p_7888_3	"mesenchymal stem cells, lot#4F1127, 22nd passage"	"mesenchymal stem cells, lot#4F1127, 4th passage"
p_7890_1	"dermal fibroblasts from keloid, treated with 1.5uM hydrocortisone"	"dermal fibroblasts from keloid, untreated control"
p_7890_2	"dermal fibroblasts from normal scar, treated with 1.5uM hydrocortisone"	"dermal fibroblasts from normal scar, untreated control"
p_7890_3	keloid treated with hydrocortisone	normal scar treated with hydrocortisone
p_7890_4	keloid with no hydrocortisone treatment	normal with no hydrocortisone treatment
p_7896_1	"Sheff 4 hESC, S1P treated"	Sheff4 hESC
p_7896_2	"Sheff 4 hESC, grown upon matrigel"	Sheff4 hESC
p_7904_1	"breast tissue, basal-like cancer (BLC)"	"breast tissue, normal"
p_7904_2	"breast tissue, non-basal-like cancer (non-BLC)"	"breast tissue, normal"
p_7904_3	Non-basal-like cancers	Normal breast
p_7964_1	"SEG1 cells, HDAC42 pretreated+acid pulsed"	"SEG1 cells, vehicle pretreated+acid pulsed"
p_7967_1	arsenic exposure > 1	arsenic exposure < 1
p_8023_1	"AML1-ETO expressing cord blood cell, grown serum-free, CD34"	"Cord blood cells, grown serum-free, CD34 purified"
p_8023_2	"AML1-ETO expressing cord blood cell, clone 13.2"	Cord blood cells
p_8023_3	"AML1-ETO expressing cord blood cell, clone 9"	Cord blood cells
p_8045_1	"A549 cells, siRNA targeting ALDH1A1+ALDH3A1 (Lenti 1+3 cells)"	"A549 cells, control siRNA"
p_8045_2	"A549 cells, siRNA targeting ALDH1A1+ALDH3A1 (Lenti 1+3 cells)"	"A549 cells, wild type"
p_8049_1	"GSf cell line, glioblastoma derived neurosphere cultures"	"GSr cell line, glioblastoma derived neurosphere cultures"
p_8050_1	"RCC099 cell, tumor"	"RCC099 cell, normal"
p_8050_2	"RCC110 cell, tumor"	"RCC110 cell, normal"
p_8052_1	Asthma	control
p_8056_1	"Burn wound margin of human skin, 0-3 days post-thermal injury"	"Normal human skin, no thermal injury"
p_8056_2	"Burn wound margin of human skin, 4-7 days post-thermal injury"	"Normal human skin, no thermal injury"
p_8056_3	"Burn wound margin of human skin, >7 days post-thermal injury"	"Normal human skin, no thermal injury"
p_8059_1	"Natural killer cells, stimulated by IL2, 100IU/ml, 2h"	"Natural Killer cells, heathy control"
p_8059_2	"Natural killer cells, stimulated by IL2, 100IU/ml, 8h"	"Natural Killer cells, heathy control"
p_8059_3	"Natural killer cells, stimulated by IL2, 100IU/ml, 24h"	"Natural Killer cells, heathy control"
p_8066_1	"SKNAS cell, NmycER expressed"	"SKNAS cell, Control"
p_8066_10	"SHEP-21N, t=8 hrs; time course"	"SHEP-21N, t=0"
p_8066_12	"SHEP-21N, t=120 hrs; time course"	"SHEP-21N, t=0"
p_8066_3	"SHEP-21N cell, MYCN expressed"	"SHEP-21N cell, control"
p_8066_4	"IMR32-DKK1 c63, t=24 hrs; time course"	"IMR32-DKK1 c63, t=0"
p_8066_6	"IMR32-DKK1 c63, t=288 hrs; time course"	"IMR32-DKK1 c63, t=0"
p_8066_7	"IMR32-DKK1 c66, t=24 hrs; time course"	"IMR32-DKK1 c66, t=0"
p_8066_9	"IMR32-DKK1 c66, t=288 hrs; time course"	"IMR32-DKK1 c66, t=0"
p_8121_1	Septic Shock 1 day	Normal
p_8121_2	Septic Shock 3 day	Normal
p_8140_1	"MCF7 cell, Fulv treated"	"MCF7 cell, E2+G treated"
p_8140_2	"MCF7 cell, ED treated"	"MCF7 cell, E2+G treated"
p_8140_3	"MCF7 cell, Tam+G treated"	"MCF7 cell, E2+G treated"
p_8141_1	"MCF7, E2+G treated"	"MCF7, Fulv treated"
p_8141_10	"MCF7/HER2-18, E2+G treated"	"MCF7/HER2-18, E2 treated"
p_8141_11	"MCF7/HER2-18, ED+G treated"	"MCF7/HER2-18, ED treated"
p_8141_12	"MCF7/HER2-18, Tam+G treated"	"MCF7/HER2-18, Tam treated"
p_8141_13	"MCF7/HER2-18, E2+Tam treated"	"MCF7/HER2-18, E2 treated"
p_8141_14	"MCF7/HER2-18, E2+Tam treated"	"MCF7/HER2-18, Tam treated"
p_8141_2	"MCF7, ED treated"	"MCF7, Fulv treated"
p_8141_3	"MCF7, Tam+G treated"	"MCF7, Fulv treated"
p_8141_4	"MCF/HER2-18, late E2 treated"	"MCF7/HER2-18, early E2 treated"
p_8141_5	"MCF7/HER2-18, res ED treated"	"MCF7/HER2-18, sen ED treated"
p_8141_6	"MCF7/HER2-18, late E2+G treated"	"MCF7/HER2-18, small E2+G treated"
p_8141_7	"MCF7/HER2-18, res ED+G treated"	"MCF7/HER2-18, sen ED+G treated"
p_8141_8	"MCF7/HER2-18, late Tam treated"	"MCF7/HER2-18, early Tam treated"
p_8141_9	"MCF7/HER2-18, res Tam+G treated"	"MCF7/HER2-18, sen Tam+G treated"
p_8157_1	"skeletal muscle of PCOS, pioglitazone treated"	"skeletal muscle of PCOS, pioglitazone not treated"
p_8157_2	"skeletal muscle of PCOS, pioglitazone not treated"	"skeletal muscle, healthy control"
p_8157_3	"Muscle PCOS, case"	"Muscle PCOS, control"
p_8166_1	HUVEC vs CAN34 3hr exposure ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8166_2	HUVEC vs SC5314 3hr exposure ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8166_3	HUVEC vs TNF   -alpha 3hr ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8166_4	HUVEC vs CAN34 8hr exposure ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8166_5	HUVEC vs SC5314 8hr exposure ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8166_6	HUVEC vs TNF -alpha 8hr ; time course	HUVEC vs M199 3hr exposure (U133P2)
p_8167_1	Kit mutation GIST	Kit wild type GIST
p_8192_10	"HeLa, shLuc-, 30min"	"HeLa, shLuc-, 0min"
p_8192_13	"HeLa, shLuc-, 120min"	"HeLa, shLuc-, 0min"
p_8192_15	"HeLa, shLuc+, 30min"	"HeLa, shLuc+, 0min"
p_8192_18	"HeLa, shLuc+, 120min"	"HeLa, shLuc+, 0min"
p_8192_2	"HeLa, shRHAU-,30min"	"HeLa, shRHAU-, 0min"
p_8192_4	"HeLa, shRHAU-, 120 min"	"HeLa, shRHAU-, 0min"
p_8192_6	"HeLa, shRHAU+, 30min"	"HeLa, shRHAU+, 0min"
p_8192_8	"HeLa, shRHAU+, 120min"	"HeLa, shRHAU+, 0min"
p_8289_1	"HEK293 cell line, induced HNF4a2 WT"	"HEK293 cell line, noninduced HNF4a2 WT"
p_8289_2	"HEK293 cell line, induced HNF4a2 mutant C106R"	"HEK293 cell line, noninduced HNF4a2 mutant C106R"
p_8289_3	"HEK293 cell line, induced HNF4a2 mutant R154X"	"HEK293 cell line, noninduced HNF4a2 mutant R154X"
p_8302_1	"hepatocyte, WY14643 treated, 12h"	"hepatocyte, control"
p_8316_1	human_hepatocytes_WY12h	human_hepatocytes_control
p_8331_1	"Left ventricle myocytes, isolated from congestive heart failure patient"	Left Ventricle Myocytes. isolated from high ejection fraction patient
p_8437_1	"HEK293 cells, Staufen2-HA (59kDa) over-expression"	"HEK293 cells, mock-transfected"
p_8437_2	"HEK293 cells, Staufen2-HA (62kDa) over-expression"	"HEK293 cells, mock-transfected"
p_8438_1	"HEK293 cells, Staufen1-HA over-expression"	"HEK293 cells, mock-transfected"
p_8442_1	Angiotensin II	Basal
p_8442_2	Angiotensin II	Angiotensin II + cycloheximide
p_8471_1	"MCF-7 cell, heregulin, 2h"	"MCF-7 cell, control"
p_8507_1	PMN_LB_180_min	PMN_control_180_min
p_8507_2	PMN_LB_360_min	PMN_control_360_min
p_8507_3	MO_LB_180_min	MO_control_180_min
p_8514_1	Aldosterone-producing adenoma	"adrenal gland, normal"
p_8527_1	"Detroit 562 cells, infected with D39WT"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_2	"Detroit 562 cells, infected with D39delta-cps"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_3	"Detroit 562 cells, infected with G54delta-cps"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_4	"Detroit 562 cells, infected with G54WT"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_5	"Detroit 562 cells, infected with TIGR4WT"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_6	"Detroit 562 cells, infected with TIGR4delta-cps"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_7	"Detroit 562 cells, infected with D39delta-cps_low"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8527_8	"Detroit 562 cells, infected with Type2cps"	"Detroit 562 cells (Pharyngeal epithelial cells), uninfected"
p_8537_1	"T98G cells, G0 arrested"	"T98G cells, actively growing"
p_8537_2	"T98G cells, G1 stage"	"T98G cells, G0 arrested"
p_8537_3	"T98G cells, S phase"	"T98G cells, G1 stage"
p_8545_1	"Small Airway, smoker"	"Small Airway, non-smoker"
p_8545_2	"Small Airway, smoker with chronic obstructive pulmonary disease (COPD)"	"Small Airway, non-smoker"
p_8565_1	"MCF-7 cells, bortezomib treated, 14h"	"MCF-7 cells, untreated"
p_8565_3	"MCF-7 cells, bortezomib treated, 48h"	"MCF-7 cells, untreated"
p_8565_4	"MCF-7 cells, Argyrin A treated, 12h"	"MCF-7 cells, untreated"
p_8565_7	"MCF-7 cells, Argyrin A treated, 48h"	"MCF-7 cells, untreated"
p_8581_1	"Lung, chronic obstructive pulmonary disease (COPD)"	"Lung, control"
p_8586_1	"umbilical cord tissue, BPD (bronchopulmonary dysplasia), low gestational age"	"umbilical cord tissue, no BPD (bronchopulmonary dysplasia), low gestational age"
p_8586_2	"umbilical cord tissue, BPD (bronchopulmonary dysplasia), high gestational age"	"umbilical cord tissue, no BPD (bronchopulmonary dysplasia), high gestational age"
p_8588_1	"H295R cell, 2OHBDE47"	"H295R cell, control"
p_8588_2	"H295R cell, 2OHBDE85"	"H295R cell, control"
p_8597_1	"MCF7, CHE, E2 treated, 24h"	"MCF7, E2 treated, 24h"
p_8597_2	"MCF7, CHE, EtOH treated, 24h"	"MCF7, EtOH treated, 24h"
p_8597_3	MCF7_CHX_E2_24h	MCF7_E2_24h
p_8597_4	MCF7_CHX_EtOH_24h	MCF7_EtOH_24h
p_8608_1	"monocyte-derived macrophages, COPD patients, LPS treated"	"monocyte-derived macrophages, COPD patients, untreated"
p_8608_2	humanMDM_Healthy_Particles	humanMDM_Healthy_untreated
p_8615_1	"post ILI, ADH-1 4hr; time course"	"post ILI, saline 4hr"
p_8615_2	"post ILI, ADH-1 24hr; time course"	"post ILI, saline 24hr"
p_8615_3	"post ILI, ADH-1 48hr; time course"	"post ILI, saline 48hr"
p_8640_1	"MCF7 cell, siRNA TFAP2A treated, Estrogen"	"MCF7 cell, control, Estrogen"
p_8640_2	"MCF7 cell, siRNA TFAP2C treated, Estrogen"	"MCF7 cell, control, Estrogen"
p_8640_3	"MCF7 cell, siRNA TFAP2A treated, noEstrogen"	"MCF7 cell, control, noEstrogen"
p_8640_4	"MCF7 cell, siRNA TFAP2C treated, noEstrogen"	"MCF7 cell, control, noEstrogen"
p_8640_5	MCF7_TFAP2AsiRNA_noEstrogen	MCF7_nosiRNA_Estrogen
p_8646_1	"H1299 cells, TAp63 alpha 24h induction"	"H1299 cells, TAp63 alpha 24h without induction"
p_8646_2	"H1299 cells, TAp63 alpha Q540L 24h induction"	"H1299 cells, TAp63 alpha Q540L 24h without induction"
p_8646_3	TAp63 alpha Q540L 24h induction	TAp63 alpha Q540L 24h without induction
p_8646_4	TAp63 alpha 24h induction	TAp63 alpha 24h without induction
p_8658_1	"Monocyte derived dendritic cells, rosiglitazone (RSG) treated, 1uM, 6h"	"Monocyte derived dendritic cells, vehicle treated, 6h"
p_8658_2	"Monocyte derived dendritic cells, cultured in human AB serum, 6h"	"Monocyte derived dendritic cells, vehicle treated, 6h"
p_8658_3	"Monocyte derived dendritic cells, rosiglitazone (RSG) treated, 1uM, 5d"	"Monocyte derived dendritic cells, vehicle treated, 5d"
p_8658_4	"Monocyte derived dendritic cells, cultured in human AB serum, 5d"	"Monocyte derived dendritic cells, vehicle treated, 5d"
p_8658_5	5d DC RSG	5d DC
p_8658_6	5d DC HS	5d DC
p_8665_1	UET-13TR-EWS/FLI1 24hr tet+; time course	UET-13TR-EWS/FLI1 24hr
p_8665_2	UET-13TR-EWS/FLI1 48hr tet+; time course	UET-13TR-EWS/FLI1 48hr
p_8665_3	UET-13TR-EWS/FLI1 72hr tet+; time course	UET-13TR-EWS/FLI1 72hr
p_8665_4	UET-13TR-EWS/ERG 24hr tet+; time course	UET-13TR-EWS/ERG 24hr
p_8665_5	UET-13TR-EWS/ERG 48hr tet+; time course	UET-13TR-EWS/ERG 48hr
p_8665_6	UET-13TR-EWS/ERG 72hr tet+; time course	UET-13TR-EWS/ERG 72hr
p_8668_1	"Neutrophils, after 30min bout of exercise"	"Neutrophils, before exercise"
p_8671_1	Colorectal adenoma	Normal mucosa of the colon
p_8685_1	"Sez-4 cells, starved of IL-2, activated with IL-2"	"Sez-4 cells, starved of IL-2"
p_8685_2	"Sez-4 cells, starved of IL-2, activated with IL-15"	"Sez-4 cells, starved of IL-2"
p_8685_3	"Sez-4 cells, starved of IL-2, activated with IL-21"	"Sez-4 cells, starved of IL-2"
p_8687_1	"Sez-4 cell line, starved of IL-2, activated with IL-2"	"Sez-4 cell line, starved of IL-2"
p_8687_2	"Sez-4 cell line, starved of IL-2, pre-treated with pan-Jak inhibitor, activated with IL-2"	"Sez-4 cell line, starved of IL-2"
p_8687_3	"Sez-4 cell line, starved of IL-2, pre-treated with Jak3 inhibitor, activated with IL-2"	"Sez-4 cell line, starved of IL-2"
p_8699_1	"HUVEC, co-cultured with 1205Lu melanoma cells, RFP-labeled"	"HUVEC, grown alone, RFP-labeled"
p_8699_2	"1205Lu melanoma cells, co-cultured with HUVEC cells, GFP-labeled"	"1205Lu melanoma cells, grown alone, GFP-labeled"
p_8702_3	LNCaP_AndrogenDeprived_5month	LNCaP_Control_5month
p_8702_4	LNCaP_AndrogenDeprived_12month	LNCaP_Control_12month
p_8702_5	LNCaP_AndrogenDeprived_11month	LNCaP_Control_12month
p_8717_1	90-8_Infect	90-8_Mock
p_8717_2	S462_Infect	S462_Mock
p_8717_3	malignant peripheral nerve sheath tumor (MPNST) 26T cells infected with G207 and oncolytic HSV	26T_Mock
p_8717_4	T265_Infect	T265_Mock
p_8730_1	1h TGF-beta treated odontoblasts; time course	1h -TGF-beta odontoblasts
p_8730_2	24h TGF-beta treated odontoblasts; time course	24h -TGF-beta odontoblasts
p_8742_1	"SK-MEL-5 cells, PEP008 treated, 24h"	"SK-MEL-5 cells, mock treated, control"
p_8742_2	"SK-MEL-5 cells, PEP008 treated 24h+drug removed+ recovery of drug at 72h"	"SK-MEL-5 cells, mock treated, control"
p_8742_3	"MCF7 cells, PEP008 treated, 24h"	"MCF7 cells, mock treated, control"
p_8742_4	"MCF7 cells, PEP008 treated 24h+drug removed+ recovery of drug at 72h"	"MCF7 cells, mock treated, control"
p_8742_5	"COLO-205 cells, PEP008 treated, 24h"	"COLO-205 cells, mock treated, control"
p_8742_6	"COLO-205 cells, PEP008 treated 24h+drug removed+ recovery of drug at 72h"	"COLO-205 cells, mock treated, control"
p_8742_7	"SK-MEL-5 cells, TPA treated, 24h"	"SK-MEL-5 cells, mock treated, control"
p_8762_1	lymphocytes_HD_F	lymphocytes_ctl_F
p_8762_2	lymphocytes_HD_M	lymphocytes_ctl_M
p_8764_1	"Parotid people, female"	"Parotid people, male"
p_8764_2	"Parotid, female"	"Parotid, male"
p_8772_1	"melanoma cells, KINK-1, 12hrs"	"melanoma cells, control"
p_8772_2	"melanoma cells, KINK-1, 24hrs"	"melanoma cells, control"
p_8784_1	"HeLa cells, induced with doxycycline+exposed to TNF-alpha (40ng/ml)"	"HeLa cells, no doxycycline"
p_8784_2	"HeLa cells bearing the delta CS construct , induced with doxycycline+exposed to TNF-alpha (40ng/ml)"	"HeLa cells, no doxycycline"
p_8823_1	"alveolar macrophage, smoker"	"alveolar macrophage, non-smoker"
p_8832_1	"K562 cells, 1R-Chl treated, 250nM, 24h"	"K562 cells, no treatment control, 24h"
p_8837_1	"normal human bronchial epithelial (NHBE) , siRhoBTG2.1"	"normal human bronchial epithelial (NHBE) , siCyclophilin"
p_8837_2	"normal human bronchial epithelial (NHBE) , siRhoBTG2.1"	"normal human bronchial epithelial (NHBE) , Lamin"
p_8837_3	"normal human bronchial epithelial (NHBE) , siRhoBTG2.2"	"normal human bronchial epithelial (NHBE) , sicyclophilin"
p_8837_4	"normal human bronchial epithelial (NHBE) , siRhoBTG2.2"	"normal human bronchial epithelial (NHBE) , Lamin"
p_8840_1	alveolar rhabdomyosarcoma cell line	embryonal rhabdomyosarcoma cell line
p_8853_1	"Esophageal cell, IL-13 treated"	"Esophageal cell, control"
p_8866_1	"IMR-32 cells, ccnd1 siRNA transfected, 48hr"	"IMR-32 cells, 0hr"
p_8866_2	"IMR-32 cells, cdk siRNA transfected, 48hr"	"IMR-32 cells, 0hr"
p_8866_3	"IMR-32 cells, ccnd1 siRNA transfected, 48hr"	"IMR-32 cells, GFP siRNA transfected, 48hr"
p_8866_4	"IMR-32 cells, cdk siRNA transfected, 48hr"	"IMR-32 cells, GFP siRNA transfected, 48hr"
p_8928_1	"MonoMac6 cell line, stimulated with leukotriene"	"MonoMac6 cell line, unstimulated"
p_8928_2	"MonoMac6 cell line, stimulated with lipoxin A4"	"MonoMac6 cell line, unstimulated"
p_8928_3	"MonoMac6, lipoxin A4"	"MonoMac6, unstimulated"
p_8928_4	"MonoMac6, lipoxin B4"	"MonoMac6, unstimulated"
p_8961_1	"A549 cell, hMPV infected, 6h"	"A549 cell, control"
p_8961_2	"A549 cell, hMPV infected, 12h"	"A549 cell, control"
p_8961_3	"A549 cell, hMPV infected, 24h"	"A549 cell, control"
p_8961_4	"A549 cell, hMPV infected, 48h"	"A549 cell, control"
p_8961_5	"A549 cell, hMPV infected, 72h"	"A549 cell, control"
p_8977_1	Stroma tumor	Stroma normal breast
p_9008_1	"A549, 25 mM resveratrol, 48 h"	"A549 cell, ethanol control, 48 h"
p_9031_1	Lymphoma cell line	Myeloma cell line
p_9031_2	Mantle cell lymphoma	Myeloma
p_9055_16	"HUVEC, TNFa treated, 4h00m"	"HUVEC, TNFa treated, 0h00m"
p_9055_2	"HUVEC, TNFa treated, 0h30m"	"HUVEC, TNFa treated, 0h00m"
p_9055_24	"HUVEC, TNFa treated, 8h00m"	"HUVEC, TNFa treated, 0h00m"
p_9055_8	"HUVEC, TNFa treated, 2h00m"	"HUVEC, TNFa treated, 0h00m"
p_9077_1	"TERT5-71, TERT transfected"	"TIG-1-45, parent"
p_9093_1	"MCF-7 cells, transfected with pIRES-TGFBR1*6A-HA-FLAG (6A-SA5)"	"MCF-7 cells, transfected with pIRES-TGFBR1-HA-FLAG (WT-WB1)"
p_9101_1	"Human THP-1 macrophages, stimulated with HDL"	"Human THP-1 macrophages, unstimulated"
p_9101_2	"Human THP-1 macrophages, stimulated with VLDL"	"Human THP-1 macrophages, unstimulated"
p_9101_3	"Human THP-1 macrophages, stimulated with LDL"	"Human THP-1 macrophages, unstimulated"
p_9103_1	"Vastus Lateralis muscle,old trained subject"	"Vastus Lateralis muscle,old sedentary subject"
p_9103_2	"Vastus Lateralis muscle,young trained subject"	"Vastus Lateralis muscle,young sedentary subject"
p_9103_3	Old trained subject	Young trained subject
p_9103_4	Old sedentary subject	Young sedentary subject
p_9119_1	"Primary peripheral blood B cell, antiIgM, 1hr"	Primary peripheral blood B cell
p_9119_2	"Primary peripheral blood B cell, antiIgM, 3hr"	Primary peripheral blood B cell
p_9150_1	"nasal epithelial cells, house dust mite exposed, 24h"	"nasal epithelial cells, saline exposed, 24h, control"
p_9150_2	"Control, house dust mite"	"Control, saline"
p_9150_3	"Allergic, house dust mite"	"Control, house dust mite"
p_9150_4	"Allergic, saline"	"Control, saline"
p_9151_1	"epithelial cell line, house dust mite exposed, 24h"	"epithelial cell line, saline exposed, 24h"
p_9159_1	Myometrium_term no labor	Myometrium_term labor
p_9159_2	Myometrium_preterm no labor	Myometrium_preterm labor
p_9169_12	"SH-SY5Y(ECACC) cell, RA treated, 5d"	"SH-SY5Y(ECACC) cell, RA inhibited, 5d"
p_9169_13	"SH-SY5Y(ECACC) cell, BDNF treated, 6h"	"SH-SY5Y(ECACC) cell, RA treated, 6h"
p_9169_16	"SH-SY5Y(ECACC) cell, BDNF treated, 3d"	"SH-SY5Y(ECACC) cell, RA treated, 3d"
p_9169_17	"SK-N-SH cell, BDNF treated, 6h"	"SK-N-SH cell, RA treated, 6h"
p_9169_2	"SH-SY5Y(ATCC) cell, RA treated, 6h"	"SH-SY5Y(ATCC) cell, RA inhibited, 6h"
p_9169_20	"SK-N-SH cell, BDNF treated, 3d"	"SK-N-SH cell, RA treated, 3d"
p_9169_6	"SH-SY5Y(ATCC) cell, RA treated, 5d"	"SH-SY5Y(ATCC) cell, RA inhibited, 5d"
p_9169_8	"SH-SY5Y(ECACC) cell, RA treated, 6h"	"SH-SY5Y(ECACC) cell, RA inhibited, 6h"
p_9195_1	PgR+ breast cancer	PgR- breast cancer
p_9195_2	Node + breast cancer	Node - breast cancer
p_9196_1	H1 undifferentiated embryonic stem cells	bulk normal breast or normal breast organoid
p_9196_10	H9 undifferentiated embryonic stem cells	"CD31+ cell, normal prostate, endothelial study"
p_9196_11	H9 day3.5 embryoid bodies	"CD31+ cell, normal prostate, endothelial study"
p_9196_12	H9 blast cells	"CD31+ cell, normal prostate, endothelial study"
p_9196_13	H1 undifferentiated embryonic stem cells	"CD49a+ cell, normal prostate, stromal study"
p_9196_14	H1 day3.5 embryoid bodies	"CD49a+ cell, normal prostate, stromal study"
p_9196_15	H1 blast cells	"CD49a+ cell, normal prostate, stromal study"
p_9196_16	H9 undifferentiated embryonic stem cells	"CD49a+ cell, normal prostate, stromal study"
p_9196_17	H9 day3.5 embryoid bodies	"CD49a+ cell, normal prostate, stromal study"
p_9196_18	H9 blast cells	"CD49a+ cell, normal prostate, stromal study"
p_9196_19	H1 undifferentiated embryonic stem cells	"whole blood, leukocyte study"
p_9196_2	H1 day3.5 embryoid bodies	bulk normal breast or normal breast organoid
p_9196_20	H1 day3.5 embryoid bodies	"whole blood, leukocyte study"
p_9196_21	H1 blast cells	"whole blood, leukocyte study"
p_9196_22	H9 undifferentiated embryonic stem cells	"whole blood, leukocyte study"
p_9196_23	H9 day3.5 embryoid bodies	"whole blood, leukocyte study"
p_9196_24	H9 blast cells	"whole blood, leukocyte study"
p_9196_3	H1 blast cells	bulk normal breast or normal breast organoid
p_9196_4	H9 undifferentiated embryonic stem cells	bulk normal breast or normal breast organoid
p_9196_5	H9 day3.5 embryoid bodies	bulk normal breast or normal breast organoid
p_9196_6	H9 blast cells	bulk normal breast or normal breast organoid
p_9196_7	H1 undifferentiated embryonic stem cells	"CD31+ cell, normal prostate, endothelial study"
p_9196_8	H1 day3.5 embryoid bodies	"CD31+ cell, normal prostate, endothelial study"
p_9196_9	H1 blast cells	"CD31+ cell, normal prostate, endothelial study"
p_9200_1	Glioblastoma tumor	Glioblastoma cell line
p_9212_1	"Lung cell, PAX9 overexpressed"	"Lung cell, control"
p_9212_2	"Lung cell, TTF1 overexpressed"	"Lung cell, control"
p_9212_3	"Lung cell, NKX2-8 overexpressed"	"Lung cell, control"
p_9234_1	"HT29 cell lines, hypoxia"	"HT29 cell lines, normoxia"
p_9250_1	"chronic lymphocytic leukemia (CLL), 13q deletion"	"chronic lymphocytic leukemia (CLL), no 13q deletion"
p_9253_1	"MCF7 cells, 17beta-estradiol (E2) treated"	"MCF7 cells, EtOH treated, control"
p_9254_1	"Colorectal mucosa, Ascending segment"	"Colorectal mucosa, Cecum"
p_9254_2	"Colorectal mucosa, Transverse segment"	"Colorectal mucosa, Cecum"
p_9254_3	"Colorectal mucosa, Sigmoid"	"Colorectal mucosa, Cecum"
p_9254_4	"Colorectal mucosa, Rectum"	"Colorectal mucosa, Cecum"
p_9254_5	"Colorectal mucosa, Distal part"	"Colorectal mucosa, Proximal part"
p_9264_1	"Human embryonic kidney cell, miR-155"	"Human embryonic kidney cell, control"
p_9264_2	"Human embryonic kidney cell, miR-K12-11"	"Human embryonic kidney cell, control"
p_9339_1	"SJNB8-MSX1 cells(clone K5) , 24h"	"SJNB8-MSX1 cells(clone K5) , 0h"
p_9339_2	"SJNB8-MSX1 cells(clone K5) , 48h"	"SJNB8-MSX1 cells(clone K5) , 0h"
p_9339_3	"SJNB8-MSX1 cells(clone K5) , 192h"	"SJNB8-MSX1 cells(clone K5) , 0h"
p_9348_1	early stage CRC patient's tumor	healthy control
p_9350_1	"FG cell, hypoxic, control"	"FG cell, normoxic, control"
p_9350_2	"L3.6pl cell, hypoxic, control"	"L3.6pl cell, normoxic, control"
p_9361_1	"HEK293 cells, StarPap specific siRNA"	"HEK293 cells, control siRNA"
p_9361_2	"HEK293 cells, PIPKIalpha specific siRNA"	"HEK293 cells, control siRNA"
p_9390_1	"CD14+ cell, cultured in conditioned medium (collected from HS5), 48h"	"CD14+ cells, freshly isolated"
p_9390_2	"CD14+ cell, cultured in conditioned medium (collected from HS27a), 48h"	"CD14+ cells, freshly isolated"
p_9419_1	"vastus lateralis, old protein 0.50g/kg"	"vastus lateralis, young protein 0.50g/kg"
p_9419_2	"vastus lateralis, old protein 0.75g/kg"	"vastus lateralis, young protein 0.75g/kg"
p_9419_3	"vastus lateralis, old protein 1.00g/kg"	"vastus lateralis, young protein 1.00g/kg"
p_9437_1	"human B-LCL cell line, TAP1/2 +/+ (TAP expressing)"	"human B-LCL cell line, TAP1/2 -/- (TAP deficient )"
p_9438_1	"Brain meningioma cell, ER treated"	"Brain meningioma cell, control"
p_9438_2	"Brain meningioma cell, PR treated"	"Brain meningioma cell, control"
p_9438_3	"Brain meningioma cell, PR,ER treated"	"Brain meningioma cell, control"
p_9440_1	hES-T3 derived embryoid bodies	Human embryonic stem cell line T3ES
p_9440_2	Human fibroblast-like cells	Human embryonic stem cell line T3ES
p_9451_1	chondrocyte	adipocyte
p_9451_10	fibroblast	iliac MSC
p_9451_2	osteoblast	adipocyte
p_9451_3	iliac MSC	adipocyte
p_9451_4	fibroblast	adipocyte
p_9451_5	osteoblast	chondrocyte
p_9451_6	iliac MSC	chondrocyte
p_9451_7	fibroblast	chondrocyte
p_9451_8	iliac MSC	osteoblast
p_9451_9	fibroblast	osteoblast
p_9452_1	"Ulcerative colitis patient, descending colon, macroscopic inflammation vissible"	"Colonic mucosal endoscopic pinch biopsy, Ulcerative colitis patient, no macroscopic signs of inflammation"
p_9452_2	UC smaples without macroscopic signs of inflammation	control subjects
p_9481_1	"Overian cancer, IFN-alpha treated Side Population"	"Ovarian cancer, untreated Side Population"
p_9489_1	"renal graft, AR IA"	"kidney, control"
p_9489_10	"renal graft, CAN I"	"kidney, control"
p_9489_11	"renal graft, CAN II"	"kidney, control"
p_9489_12	"renal graft, CAN III"	"kidney, control"
p_9489_13	"renal graft, non-rejecting"	"kidney, control"
p_9489_14	"renal graft, AR & CAN"	"kidney, control"
p_9489_2	"renal graft, AR IB"	"kidney, control"
p_9489_3	"renal graft, AR & CAN"	"renal graft, AR"
p_9489_4	"renal graft, AR & CAN"	"renal graft, CAN"
p_9489_5	"kidney, without clamping"	"kidney, with clamping"
p_9489_6	"kidney, cortex & medulla"	"kidney, cortex"
p_9489_7	"renal graft, AR IIA"	"kidney, control"
p_9489_8	"renal graft, AR IIB"	"kidney, control"
p_9489_9	"renal graft, borderline changes"	"kidney, control"
p_9492_1	"Chronic allograft nephropathy biopsy, grade I"	"adult kidney sample, control"
p_9492_2	"Chronic allograft nephropathy biopsy, grade I"	Biopsy from non-rejecting human kidney allograft
p_9517_1	"HepG2/C3A cells, cys depletion followed by 6 h +Cys (Short +Cys)"	"HepG2/C3A cells, cysteine depletion for 42 h (long -Cys)"
p_9517_2	"HepG2/C3A cells, complete medium followed by 6 h of cysteine deprivation (Short -Cys)"	"HepG2/C3A cells, control medium for 42 h (Long +Cys)"
p_9520_1	"human MSC, grown for 7 days, passage2"	"human MSC, grown for 2 days, passage2"
p_9526_1	"cumulus cells, late cleavage"	"cumulus cells, early cleavage"
p_9576_1	Scraped off mucosal layer	Normal Ileum Mucosa
p_9576_2	Midgut carinoid Liver Metastasis	Midgut carinoid primary tumor
p_9593_1	"BM-mesenchymal stem cells (MSC), passage 3"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_2	"BM-mesenchymal stem cells (MSC), passage 4"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_3	"BM-mesenchymal stem cells (MSC), passage 5"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_4	"BM-mesenchymal stem cells (MSC), passage 6"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_5	"BM-mesenchymal stem cells (MSC), passage 7"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_6	"BM-mesenchymal stem cells (MSC), passage 8"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9593_7	"BM-mesenchymal stem cells (MSC), passage 10"	"BM-mesenchymal stem cells (MSC), passage 2"
p_9599_1	"pancreatic tumor, resistant to EGFR"	"pancreatic tumor, sensitive to EGFR"
p_9600_1	"FFPE cell, normal adjacent epithelia"	"FFPE cell, HNSCC"
p_9600_2	"FFPE cell, HNSCC, radiation, treated"	"FFPE cell, HNSCC"
p_9600_3	"FFPE cell, HNSCC, radiation, cetuximab treated"	"FFPE cell, HNSCC"
p_9600_4	"FFPE cell, HNSCC, radiation, cetuximab treated, AMG 479 treated"	"FFPE cell, HNSCC"
p_9613_1	HeLa CTCF RNAi	HeLa Control RNAi
p_9613_2	HeLa hScc1 RNAi	HeLa Control RNAi
p_9624_1	"Omental adipose tissue, obese"	"Omental adipose tissue, control"
p_9647_1	"HUVEC, exposed to dp3.9 apple procyanidins extract, 4h"	"HUVEC, DMSO treated, 4h, control"
p_9647_2	"HUVEC, exposed to dp3.9 apple procyanidins extract+TNF- treated, 4h"	"HUVEC, DMSO+TNF- treated, 6h, control"
p_9647_3	HUVEC_DMSO+TNF  _6h	HUVEC_DMSO_4h
p_9649_1	"Human Mammary Epithelial Cell, media with 25mM lactic acidosis, normoxia"	"Human Mammary Epithelial Cell, normoxia, control media"
p_9649_2	"Human Mammary Epithelial Cell, hypoxia"	"Human Mammary Epithelial Cell, normoxia, control media"
p_9649_3	"Human Mammary Epithelial Cell, media with 25mM lactic acidosis, hypoxia"	"Human Mammary Epithelial Cell, hypoxia, control media"
p_9649_4	"Human Mammary Epithelial Cell, media with 25mM sodium lactate, normoxia"	"Human Mammary Epithelial Cell, normoxia, control media"
p_9649_5	"Human Mammary Epithelial Cell, acidosis media, normoxia"	"Human Mammary Epithelial Cell, normoxia, control media"
p_9666_1	"LNCaP cells, Androgen independent-fiber model"	"LNCaP cells, Androgen dependent-fiber model"
p_9666_2	"LNCaP cells, Androgen ablation-fiber model"	"LNCaP cells, Androgen dependent-fiber model"
p_9677_1	"HUVEC, stimulated with Angiopoietin, 1h"	"HUVEC, unstimulated"
p_9677_2	Angiopoietin-1(sparse)	unstimulated(sparse)
p_9686_1	Crohn Disease Colon	Normal Colon
p_9686_2	Treated Crohn Disease Colon	Normal Colon
p_9686_3	Ulcerative Colitis Colon	Normal Colon
p_9692_1	Septic Shock	Control
p_9709_1	"Human iPSC, cultured in mTeSR1"	Human neonatal dermal fibroblast
p_9709_2	"Human iPSC, cultured in MEF"	Human neonatal dermal fibroblast
p_9709_3	"Human iPSC, cultured in ESM"	Human neonatal dermal fibroblast
p_9709_4	"Human iPSC, cultured in mTeSR1, freeze-thaw treated"	Human neonatal dermal fibroblast
p_9709_5	Human induced pluripotent stem cell clone 2-4 cultured in mTeSR1 on Matrigel	Human neonatal dermal fibroblast
p_9709_6	Human induced pluripotent stem cell clone 2-4 cultured in ESM on MEF	Human neonatal dermal fibroblast
p_9709_7	Human induced pluripotent stem cell clone 3-2 cultured in mTeSR1 on Matrigel	Human neonatal dermal fibroblast
p_9731_1	"Vasectomised epididimus, 45 years-old, corpus segment"	"Vasectomised epididimus, 1980, corpus segment"
p_9731_2	"Vasectomised epididimus, 47 years-old, corpus segment"	"Vasectomised epididimus, 1980, corpus segment"
p_9731_3	"Vasectomised epididimus, 45 years-old, caput segment"	"Vasectomised epididimus, 1980, caput segment"
p_9731_4	"Vasectomised epididimus, 47 years-old, caput segment"	"Vasectomised epididimus, 1980, caput segment"
p_9731_5	"Vasectomised epididimus, 45 years-old, cauda segment"	"Vasectomised epididimus, 1980, cauda segment"
p_9731_6	"Vasectomised epididimus, 47 years-old, cauda segment"	"Vasectomised epididimus, 1980, cauda segment"
p_9747_1	"MDA-MB-231 cells, vector containing PARVB, 2D, bovine type I collagen"	"MDA-MB-231 cells, vector control, 2D, bovine type I collagen"
p_9747_2	"MDA-MB-231 cells, vector containing PARVB, 3D, 40% Matrigel"	"MDA-MB-231 cells, vector control, 3D, 40% Matrigel"
p_9747_3	"MDA-MB-231 cells, vector containing PARVB, 3D, bovine type I collagen"	"MDA-MB-231 cells, vector control, 3D, bovine type I collagen"
p_9757_1	"MDA-MB-231 cells, Era infected"	"MDA-MB-231 cells, CMV infected"
p_9758_1	"MDA-MB-231 cells, Era3411 infected"	"MDA-MB-231 cells, CMV infected"
p_9759_1	"MDA-MB-231 cells, infected with recombinant adenovirus bearing cDNA for ERbeta"	"MDA-MB-231 cells, infected with the recombinant adenovirus bearing no cDNA (CMV)"
p_9759_2	"MDA-MB-231 cells, infected with recombinant adenovirus bearing cDNA for ERbeta mutant defective in"	"MDA-MB-231 cells, infected with the recombinant adenovirus bearing no cDNA (CMV)"
p_9762_1	"fibroblast, trisomy 21 fibroblast"	"fibroblast, eupliod fibroblast"
p_9762_2	monosomy 21 cells	control cells
p_9764_1	"hMSCs, exposed to 5-Azacytidine"	"hMSC, control DMEM media"
p_9764_2	"hMSCs, exposed to breast cancer condition media"	"hMSC, control DMEM media"
p_9764_3	"hMSCs, exposed to 5-Azacytidine"	"hMSCs, control alpha MEM media"
p_9764_4	"hMSCs, exposed to breast cancer condition media"	"hMSCs, control alpha MEM media"
p_9768_1	"CP-A hTERT Barrett's oesophagus cell line, deoxycholic acid pH 4.5, 2h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9768_2	"CP-A hTERT Barrett's oesophagus cell line, deoxycholic acid pH 4.5, 6h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9768_3	"CP-A hTERT Barrett's oesophagus cell line, primary bile mixture pH 4.5, 2h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9768_4	"CP-A hTERT Barrett's oesophagus cell line, primary bile mixture pH 4.5, 6h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9768_5	"CP-A hTERT Barrett's oesophagus cell line, acid pH 4.5, 2h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9768_6	"CP-A hTERT Barrett's oesophagus cell line, acid pH 4.5, 6h"	"CP-A hTERT Barrett's oesophagus cell line, control"
p_9770_1	"hippocampus, non-demented individual with intermediate Alzheimer's pathologies"	"entorhinal cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_10	"posterior cingulate cortex, non-demented individual with intermediate Alzheimer's pathologies"	"middle temporal gyrus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_11	"primary visual cortex, non-demented individual with intermediate Alzheimer's pathologies"	"middle temporal gyrus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_12	"superior frontal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"middle temporal gyrus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_13	"primary visual cortex, non-demented individual with intermediate Alzheimer's pathologies"	"posterior cingulate cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_14	"superior frontal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"posterior cingulate cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_15	"superior frontal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"primary visual cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_2	"middle temporal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"entorhinal cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_3	"posterior cingulate cortex, non-demented individual with intermediate Alzheimer's pathologies"	"entorhinal cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_4	"superior frontal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"entorhinal cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_5	"primary visual cortex, non-demented individual with intermediate Alzheimer's pathologies"	"entorhinal cortex, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_6	"middle temporal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"hippocampus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_7	"posterior cingulate cortex, non-demented individual with intermediate Alzheimer's pathologies"	"hippocampus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_8	"primary visual cortex, non-demented individual with intermediate Alzheimer's pathologies"	"hippocampus, non-demented individual with intermediate Alzheimer's pathologies"
p_9770_9	"superior frontal gyrus, non-demented individual with intermediate Alzheimer's pathologies"	"hippocampus, non-demented individual with intermediate Alzheimer's pathologies"
p_9807_1	"SH-SY5Y cells, siRNA targeting SNCA"	"SH-SY5Y cells, control siRNA"
p_9826_1	compound A 1 hr; time course	control 1 hr
p_9826_12	compound B 6 hr; time course	control 6 hr
p_9826_6	compound A 6 hr; time course	control 6 hr
p_9826_7	compound B 1 hr; time course	control 1 hr
p_9832_1	dH1f - iPS	dH1f fibroblast
p_9832_2	dH1f - iPS	H1-OGN hES
p_9832_3	MRC5 - iPS	MRC5 fibroblast
p_9832_4	MRC5 - iPS	H1-OGN hES
p_9832_5	BJ1 - iPS	BJ1 fibroblast
p_9832_6	BJ1 - iPS	H1-OGN hES
p_9834_1	"Normal Human Astrocytes (NHA), Baculoviral Vector Transduction"	"Normal Human Astrocytes (NHA), control"
p_9835_1	"neuronal cells, Baculoviral Vector Transduction"	"neuronal cells, control"
p_9843_1	TP53 mutation + HCC	TP53 mutation - HCC
p_9843_2	CTNNB1 mutation + HCC	CTNNB1 mutation - HCC
p_9843_3	pRPS56 + HCC	pRPS56 - HCC
p_9843_4	pIGFR1 + HCC	pIGFR1 - HCC
p_9843_5	pAkT + HCC	pAkT - HCC
p_9843_6	CTNNB1 + HCC	CTNNB1 - HCC
p_9844_1	Oral Tongue Squamous Cell Carcinoma	Tongue Squamous Cells from control subjects
p_9865_1	Human Embryonic Stem Cells passage 49 HSF1	Human embryonic stem cell line H9
p_9865_10	Partially reprgrammed clone Hips24	Human embryonic stem cell line H9
p_9865_11	Partially reprogrammed clone Clone100	Human embryonic stem cell line H9
p_9865_12	Partially reprogrammed clone Hips29	Human embryonic stem cell line H9
p_9865_2	Human embryonic stem cell line H9	Fibroblasts with GFP virus NHDF1 + GFP
p_9865_3	Human embryonic stem cell line H9	Fibroblasts NHDF1
p_9865_4	Reprogrammed clone Hips1	Human embryonic stem cell line H9
p_9865_5	Fibroblasts and 5 factors after 18 days NHDF1 +5V	Human embryonic stem cell line H9
p_9865_6	Reprogrammed clone 5 hips5	Human embryonic stem cell line H9
p_9865_7	Reprogrammed clone 2 Hips2	Human embryonic stem cell line H9
p_9865_8	Reprogrammed clone 7 Hips7	Human embryonic stem cell line H9
p_9865_9	Reprogrammed Clone54	Human embryonic stem cell line H9
p_9890_1	"Carcinoma of ovary, stroma"	"Carcinoma of ovary, epithelial cell"
p_9894_1	CD235a+ cells	bone marrow MSC
p_9894_2	CD11b+ cells	bone marrow MSC
p_9894_3	CD45+ cells	bone marrow MSC
p_9916_1	"Human Mononuclear cell, Heat shock treated"	"Human Mononuclear cell, control"
p_9916_2	"Human Mononuclear cell, LPS treated"	"Human Mononuclear cell, control"
p_9916_3	"Human Mononuclear cell, Heat shock, LPS treated"	"Human Mononuclear cell, control"
p_9927_1	"CD4+ T-cells, HIV+ donor"	"CD4+ T-cells, normal HIV- donor"
p_9940_1	"hESC, H9 derived day 6 EBs pool from H9p27, H9p28, H9p31"	"a pool of hESCs from H9p27, H9p28, H9p31"
p_9940_2	H9 hES cell derived day 10 primitive neural epithelial pool	"a pool of hESCs from H9p27, H9p28, H9p31"
p_9940_3	"H9 hES cell derived day 10 primitive neural epithelial pool, treated with bFGF"	"a pool of hESCs from H9p27, H9p28, H9p31"
p_9940_4	H9 hES cell derived day 17 definitive neural epithelial pool	"a pool of hESCs from H9p27, H9p28, H9p31"
p_9940_5	"H9 hES cell derived day 17 primitive neural epithelial pool, treated with bFGF"	"a pool of hESCs from H9p27, H9p28, H9p31"
p_9941_2	"transduced hMSC with lentivirus, low signal"	"hMSC, control"
p_9947_3	"transduced hMSC with lentivirus, high signal"	"hMSC, control"
p_9951_1	"Prostate tissue,exposed to Cadmium, 2.5uM, 0h"	"Prostate tissue, control, 0h"
p_9951_2	"Prostate tissue, exposed to Cadmium, 2.5uM, 4h"	"Prostate tissue, control, 4h"
p_9951_3	"Prostate tissue,exposed to Cadmium, 2.5uM, 8h"	"Prostate tissue, control, 8h"
p_9951_4	"Prostate tissue,exposed to Cadmium, 2.5uM, 16h"	"Prostate tissue, control, 16h"
p_9951_5	"Prostate tissue,exposed to Cadmium, 2.5uM, 32h"	"Prostate tissue, control, 32h"
p_9960_1	"Circulating mononuclear cells, Spesis"	"Circulating mononuclear cells, control"
p_9960_2	"Circulating mononuclear cells, Spesis, Gram-negative"	"Circulating mononuclear cells, Spesis, Gram-positive"
p_9960_3	"critically ill patients, sepsis gram-negative"	"critically ill patients, control"
p_9960_4	"critically ill patients, sepsis mixed infection"	"critically ill patients, control"
p_9960_5	"critically ill patients, sepsis gram-positive"	"critically ill patients, sepsis gram-negative"
p_9973_1	Burkitt lymphoma (BL41) 60 min nt treated; time course	BL41 60 min tc
p_9973_2	Burkitt lymphoma (BL41) 60 min p treated; time course	BL41 60 min tc
p_9974_1	"SEG-1 cell line, OSU-HDAC42 pretreated, acid pulsed, 3 hr"	"SEG-1 cell line, vehicle pretreated, acid pulsed, 3 hr"
p_9974_2	"SEG-1 cell line, OSU-HDAC42 pretreated, acid pulsed, 6 hr"	"SEG-1 cell line, vehicle pretreated, acid pulsed, 6 hr"
p_9974_3	"SEG-1 cell line, OSU-HDAC42 pretreated, acid pulsed, 24 hr"	"SEG-1 cell line, vehicle pretreated, acid pulsed, 24 hr"
p_9984_1	"placenta, second trimester"	"placenta, First trimester"
p_9984_2	"placenta, C-section term"	"placenta, First trimester"
p_9987_1	"SEG1 cell, OSU-HDAC42 treated, 3h"	"SEG1 cell, vehicle treated, 3h"
p_9987_2	"SEG1 cell, OSU-HDAC42 treated, 6h"	"SEG1 cell, vehicle treated, 6h"
p_9987_3	"SEG1 cell, OSU-HDAC42 treated, 24h"	"SEG1 cell, vehicle treated, 24h"
p_9988_1	"monocyte, TREM1 antibody, 2hrs"	"monocyte, isotype control antibody, 2hrs"
p_9988_2	"monocyte, LPS low, 2hrs"	"monocyte, vehicle treated, 2hrs"
p_9988_3	"monocyte, TREM1 antibody+LPS, 2hrs"	"monocyte, control antibody+LPS, 2hrs"
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		
		